sitecode,subjectid,eventseq,eventid,eventname,eventdate,formid,subjectformseq,editdatetime,eventlabel,itemname,itemvalue,itemid
SiteCode,SubjectId,EventSeq,EventId,EventName,EventDate,FormId,SubjectFormSeq,EditDateTime,EventLabel,ItemName,ItemValue,ItemId
BEL08,BEL_08_885,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-23 23:49:00,Any visit,CM Number,1,CM_CMSPID
BEL08,BEL_08_885,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-23 23:50:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
BEL08,BEL_08_885,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-23 23:49:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
BEL08,BEL_08_885,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-23 23:49:00,Any visit,CM Indication,Hypertension,CM_CMINDC
BEL08,BEL_08_885,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-23 23:49:00,Any visit,CM Dose,100,CM_CMDOSE
BEL08,BEL_08_885,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-23 23:49:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL08,BEL_08_885,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-23 23:49:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
BEL08,BEL_08_885,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-23 23:49:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
BEL08,BEL_08_885,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-23 23:49:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
BEL08,BEL_08_885,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-23 23:49:00,Any visit,CM Start Date,2023-08-10,CM_CMSTDAT
BEL08,BEL_08_885,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-23 23:49:00,Any visit,CM Ongoing,No,CM_CMONGO
BEL08,BEL_08_885,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-23 23:49:00,Any visit,CM End Date,2023-08-10,CM_CMENDAT
BEL08,BEL_08_885,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-23 23:50:00,Any visit,CM Number,2,CM_CMSPID
BEL08,BEL_08_885,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-23 23:51:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
BEL08,BEL_08_885,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-23 23:50:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
BEL08,BEL_08_885,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-23 23:50:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
BEL08,BEL_08_885,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-23 23:50:00,Any visit,CM Dose,10,CM_CMDOSE
BEL08,BEL_08_885,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-23 23:50:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL08,BEL_08_885,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-23 23:50:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
BEL08,BEL_08_885,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-23 23:50:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
BEL08,BEL_08_885,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-23 23:50:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL08,BEL_08_885,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-23 23:50:00,Any visit,CM Start Date,2023-08-10,CM_CMSTDAT
BEL08,BEL_08_885,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-23 23:50:00,Any visit,CM Ongoing,No,CM_CMONGO
BEL08,BEL_08_885,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-23 23:50:00,Any visit,CM End Date,2023-08-10,CM_CMENDAT
BEL09,BEL_09_464,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 00:34:00,Any visit,CM Number,1,CM_CMSPID
BEL09,BEL_09_464,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 00:34:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
BEL09,BEL_09_464,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 00:34:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
BEL09,BEL_09_464,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 00:34:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
BEL09,BEL_09_464,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 00:34:00,Any visit,CM Dose,300,CM_CMDOSE
BEL09,BEL_09_464,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 00:34:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_464,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 00:34:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_464,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 00:34:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_464,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 00:34:00,Any visit,CM Start Date,2022-09-05,CM_CMSTDAT
BEL09,BEL_09_464,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 00:34:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_464,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 00:37:00,Any visit,CM Number,2,CM_CMSPID
BEL09,BEL_09_464,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 00:37:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
BEL09,BEL_09_464,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 00:37:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
BEL09,BEL_09_464,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 00:37:00,Any visit,CM Indication,Insomnia,CM_CMINDC
BEL09,BEL_09_464,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 00:37:00,Any visit,CM Dose,500,CM_CMDOSE
BEL09,BEL_09_464,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 00:37:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_464,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 00:37:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_464,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 00:37:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_464,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 00:37:00,Any visit,CM Start Date,2022-09-05,CM_CMSTDAT
BEL09,BEL_09_464,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 00:37:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_464,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 00:38:00,Any visit,CM Number,3,CM_CMSPID
BEL09,BEL_09_464,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 00:38:00,Any visit,CM Trade Name,Gliigestatrilat,CM_CMTRT
BEL09,BEL_09_464,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 00:38:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
BEL09,BEL_09_464,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 00:38:00,Any visit,CM Indication,Infection,CM_CMINDC
BEL09,BEL_09_464,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 00:38:00,Any visit,CM Dose,10,CM_CMDOSE
BEL09,BEL_09_464,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 00:38:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_464,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 00:38:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
BEL09,BEL_09_464,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 00:38:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_464,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 00:38:00,Any visit,CM Start Date,2022-09-05,CM_CMSTDAT
BEL09,BEL_09_464,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 00:38:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_464,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 00:39:00,Any visit,CM Number,4,CM_CMSPID
BEL09,BEL_09_464,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 00:39:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
BEL09,BEL_09_464,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 00:39:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
BEL09,BEL_09_464,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 00:39:00,Any visit,CM Indication,Insomnia,CM_CMINDC
BEL09,BEL_09_464,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 00:39:00,Any visit,CM Dose,10,CM_CMDOSE
BEL09,BEL_09_464,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 00:39:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_464,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 00:39:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_464,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 00:39:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_464,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 00:39:00,Any visit,CM Start Date,2013-01-01,CM_CMSTDAT
BEL09,BEL_09_464,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 00:39:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_464,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 00:42:00,Any visit,CM Number,5,CM_CMSPID
BEL09,BEL_09_464,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 00:42:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
BEL09,BEL_09_464,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 00:42:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
BEL09,BEL_09_464,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 00:42:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
BEL09,BEL_09_464,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 00:42:00,Any visit,CM Dose,100,CM_CMDOSE
BEL09,BEL_09_464,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 00:42:00,Any visit,CM Unit,Microgram (µg),CM_CMDOSU
BEL09,BEL_09_464,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 00:42:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_464,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 00:42:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_464,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 00:42:00,Any visit,CM Start Date,2007-01-01,CM_CMSTDAT
BEL09,BEL_09_464,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 00:42:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_464,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 00:43:00,Any visit,CM Number,6,CM_CMSPID
BEL09,BEL_09_464,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 00:43:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
BEL09,BEL_09_464,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 00:43:00,Any visit,CM Active Ingredient,Meloxicam,CM_CMINGRD
BEL09,BEL_09_464,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 00:43:00,Any visit,CM Indication,Infection,CM_CMINDC
BEL09,BEL_09_464,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 00:43:00,Any visit,CM Dose,5,CM_CMDOSE
BEL09,BEL_09_464,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 00:43:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_464,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 00:43:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
BEL09,BEL_09_464,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 00:43:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_464,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 00:43:00,Any visit,CM Start Date,2022-09-05,CM_CMSTDAT
BEL09,BEL_09_464,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 00:43:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_464,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 00:44:00,Any visit,CM Number,7,CM_CMSPID
BEL09,BEL_09_464,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 00:44:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
BEL09,BEL_09_464,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 00:44:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
BEL09,BEL_09_464,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 00:44:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
BEL09,BEL_09_464,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 00:44:00,Any visit,CM Dose,1,CM_CMDOSE
BEL09,BEL_09_464,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 00:44:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
BEL09,BEL_09_464,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 00:44:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
BEL09,BEL_09_464,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 00:44:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_464,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 00:44:00,Any visit,CM Start Date,1990-01-01,CM_CMSTDAT
BEL09,BEL_09_464,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 00:44:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_464,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 00:45:00,Any visit,CM Number,8,CM_CMSPID
BEL09,BEL_09_464,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 00:45:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
BEL09,BEL_09_464,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 00:45:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
BEL09,BEL_09_464,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 00:45:00,Any visit,CM Indication,Pain,CM_CMINDC
BEL09,BEL_09_464,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 00:45:00,Any visit,CM Dose,1,CM_CMDOSE
BEL09,BEL_09_464,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 00:45:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_464,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 00:45:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
BEL09,BEL_09_464,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 00:45:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_464,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 00:45:00,Any visit,CM Start Date,2023-07-28,CM_CMSTDAT
BEL09,BEL_09_464,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 00:45:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_464,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 00:46:00,Any visit,CM Number,9,CM_CMSPID
BEL09,BEL_09_464,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 00:46:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
BEL09,BEL_09_464,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 00:46:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
BEL09,BEL_09_464,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 00:46:00,Any visit,CM Indication,Insomnia,CM_CMINDC
BEL09,BEL_09_464,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 00:46:00,Any visit,CM Dose,5,CM_CMDOSE
BEL09,BEL_09_464,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 00:46:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_464,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 00:46:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_464,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 00:46:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_464,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 00:46:00,Any visit,CM Start Date,2023-04-30,CM_CMSTDAT
BEL09,BEL_09_464,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 00:46:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_464,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 00:49:00,Any visit,CM Number,10,CM_CMSPID
BEL09,BEL_09_464,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 00:49:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
BEL09,BEL_09_464,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 00:51:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
BEL09,BEL_09_464,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 00:49:00,Any visit,CM Indication,Adverse event,CM_CMINDC
BEL09,BEL_09_464,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 00:49:00,Any visit,CM Dose,1,CM_CMDOSE
BEL09,BEL_09_464,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 00:49:00,Any visit,CM Unit,Other,CM_CMDOSU
BEL09,BEL_09_464,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 00:49:00,Any visit,CM Unit Other,sachet,CM_CMDOSU_OTH
BEL09,BEL_09_464,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 00:49:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
BEL09,BEL_09_464,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 00:49:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_464,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 00:49:00,Any visit,CM Start Date,1990-01-01,CM_CMSTDAT
BEL09,BEL_09_464,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 00:49:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_464,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 00:52:00,Any visit,CM Number,11,CM_CMSPID
BEL09,BEL_09_464,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 00:52:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
BEL09,BEL_09_464,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 00:52:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
BEL09,BEL_09_464,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 00:52:00,Any visit,CM Indication,Adverse event,CM_CMINDC
BEL09,BEL_09_464,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 00:52:00,Any visit,CM Dose,1,CM_CMDOSE
BEL09,BEL_09_464,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 00:52:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
BEL09,BEL_09_464,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 00:53:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
BEL09,BEL_09_464,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 00:52:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_464,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 00:52:00,Any visit,CM Start Date,1990-01-01,CM_CMSTDAT
BEL09,BEL_09_464,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 00:52:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_464,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 00:54:00,Any visit,CM Number,12,CM_CMSPID
BEL09,BEL_09_464,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 00:54:00,Any visit,CM Trade Name,Bolidilanil,CM_CMTRT
BEL09,BEL_09_464,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 00:54:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
BEL09,BEL_09_464,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 00:54:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
BEL09,BEL_09_464,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 00:54:00,Any visit,CM Dose,250,CM_CMDOSE
BEL09,BEL_09_464,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 00:54:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_464,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 00:54:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
BEL09,BEL_09_464,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 00:54:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_464,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 00:54:00,Any visit,CM Start Date,2017-01-01,CM_CMSTDAT
BEL09,BEL_09_464,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 00:54:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_464,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 00:55:00,Any visit,CM Number,13,CM_CMSPID
BEL09,BEL_09_464,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 00:55:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
BEL09,BEL_09_464,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 00:55:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
BEL09,BEL_09_464,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 00:55:00,Any visit,CM Indication,Infection,CM_CMINDC
BEL09,BEL_09_464,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 00:55:00,Any visit,CM Dose,8,CM_CMDOSE
BEL09,BEL_09_464,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 00:55:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_464,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 00:55:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
BEL09,BEL_09_464,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 00:55:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_464,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 00:55:00,Any visit,CM Start Date,2022-09-05,CM_CMSTDAT
BEL09,BEL_09_464,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 00:55:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_464,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 00:39:00,Any visit,CM Related Medical History,Atrial fibrillation,CM_MHREL
BEL09,BEL_09_464,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 00:42:00,Any visit,CM Related Medical History,Arhtritis,CM_MHREL
BEL09,BEL_09_464,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 00:46:00,Any visit,CM Related Medical History,Familial Mediterranean fever,CM_MHREL
BEL09,BEL_09_464,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 00:49:00,Any visit,CM Related Medical History,Familial Mediterranean fever,CM_MHREL
BEL09,BEL_09_464,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 00:52:00,Any visit,CM Related Medical History,Atrial fibrillation,CM_MHREL
BEL09,BEL_09_464,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 00:54:00,Any visit,CM Related Medical History,Hypothyroidism,CM_MHREL
BEL09,BEL_09_361,1,COMMON_CM,Any visit,2023-06-09,CM,1,2023-06-09 08:55:00,Any visit,CM Number,1,CM_CMSPID
BEL09,BEL_09_361,1,COMMON_CM,Any visit,2023-06-09,CM,1,2023-06-09 08:55:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
BEL09,BEL_09_361,1,COMMON_CM,Any visit,2023-06-09,CM,1,2023-06-09 08:55:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
BEL09,BEL_09_361,1,COMMON_CM,Any visit,2023-06-09,CM,1,2023-06-09 08:55:00,Any visit,CM Indication,Nausea,CM_CMINDC
BEL09,BEL_09_361,1,COMMON_CM,Any visit,2023-06-09,CM,1,2023-06-09 08:55:00,Any visit,CM Dose,1000,CM_CMDOSE
BEL09,BEL_09_361,1,COMMON_CM,Any visit,2023-06-09,CM,1,2023-06-09 08:55:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_361,1,COMMON_CM,Any visit,2023-06-09,CM,1,2023-06-09 08:55:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_361,1,COMMON_CM,Any visit,2023-06-09,CM,1,2023-06-09 08:55:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_361,1,COMMON_CM,Any visit,2023-06-09,CM,1,2023-06-09 08:55:00,Any visit,CM Start Date,2021-01-NK,CM_CMSTDAT
BEL09,BEL_09_361,1,COMMON_CM,Any visit,2023-06-09,CM,1,2023-06-09 08:55:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_361,2,COMMON_CM,Any visit,2023-06-09,CM,2,2023-06-09 08:56:00,Any visit,CM Number,2,CM_CMSPID
BEL09,BEL_09_361,2,COMMON_CM,Any visit,2023-06-09,CM,2,2023-06-09 08:56:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
BEL09,BEL_09_361,2,COMMON_CM,Any visit,2023-06-09,CM,2,2023-06-09 08:56:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
BEL09,BEL_09_361,2,COMMON_CM,Any visit,2023-06-09,CM,2,2023-06-09 08:56:00,Any visit,CM Indication,Pain,CM_CMINDC
BEL09,BEL_09_361,2,COMMON_CM,Any visit,2023-06-09,CM,2,2023-06-09 08:56:00,Any visit,CM Dose,450,CM_CMDOSE
BEL09,BEL_09_361,2,COMMON_CM,Any visit,2023-06-09,CM,2,2023-06-09 08:56:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_361,2,COMMON_CM,Any visit,2023-06-09,CM,2,2023-06-09 08:56:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_361,2,COMMON_CM,Any visit,2023-06-09,CM,2,2023-06-09 08:56:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_361,2,COMMON_CM,Any visit,2023-06-09,CM,2,2023-06-09 08:56:00,Any visit,CM Start Date,2023-06-NK,CM_CMSTDAT
BEL09,BEL_09_361,2,COMMON_CM,Any visit,2023-06-09,CM,2,2023-06-09 08:56:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_361,3,COMMON_CM,Any visit,2023-06-09,CM,3,2023-06-09 09:02:00,Any visit,CM Number,3,CM_CMSPID
BEL09,BEL_09_361,3,COMMON_CM,Any visit,2023-06-09,CM,3,2023-06-09 09:02:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
BEL09,BEL_09_361,3,COMMON_CM,Any visit,2023-06-09,CM,3,2023-06-09 09:02:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
BEL09,BEL_09_361,3,COMMON_CM,Any visit,2023-06-09,CM,3,2023-06-09 09:02:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
BEL09,BEL_09_361,3,COMMON_CM,Any visit,2023-06-09,CM,3,2023-06-09 09:02:00,Any visit,CM Dose,100,CM_CMDOSE
BEL09,BEL_09_361,3,COMMON_CM,Any visit,2023-06-09,CM,3,2023-06-09 09:02:00,Any visit,CM Unit,Other,CM_CMDOSU
BEL09,BEL_09_361,3,COMMON_CM,Any visit,2023-06-09,CM,3,2023-06-09 09:02:00,Any visit,CM Unit Other,µg/ml,CM_CMDOSU_OTH
BEL09,BEL_09_361,3,COMMON_CM,Any visit,2023-06-09,CM,3,2023-06-09 09:02:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_361,3,COMMON_CM,Any visit,2023-06-09,CM,3,2023-06-09 09:02:00,Any visit,CM Route,Other,CM_CMROUTE
BEL09,BEL_09_361,3,COMMON_CM,Any visit,2023-06-09,CM,3,2023-06-09 09:02:00,Any visit,CM Route Other,intraocular,CM_CMROUTE_OTH
BEL09,BEL_09_361,3,COMMON_CM,Any visit,2023-06-09,CM,3,2023-06-09 09:02:00,Any visit,CM Start Date,2003-NK-NK,CM_CMSTDAT
BEL09,BEL_09_361,3,COMMON_CM,Any visit,2023-06-09,CM,3,2023-06-09 09:02:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_361,4,COMMON_CM,Any visit,2023-06-09,CM,4,2023-06-09 09:07:00,Any visit,CM Number,4,CM_CMSPID
BEL09,BEL_09_361,4,COMMON_CM,Any visit,2023-06-09,CM,4,2023-06-09 09:07:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
BEL09,BEL_09_361,4,COMMON_CM,Any visit,2023-06-09,CM,4,2023-06-09 09:07:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
BEL09,BEL_09_361,4,COMMON_CM,Any visit,2023-06-09,CM,4,2023-06-09 09:07:00,Any visit,CM Indication,Adverse event,CM_CMINDC
BEL09,BEL_09_361,4,COMMON_CM,Any visit,2023-06-09,CM,4,2023-06-09 09:07:00,Any visit,CM Dose,2,CM_CMDOSE
BEL09,BEL_09_361,4,COMMON_CM,Any visit,2023-06-09,CM,4,2023-06-09 09:07:00,Any visit,CM Unit,Other,CM_CMDOSU
BEL09,BEL_09_361,4,COMMON_CM,Any visit,2023-06-09,CM,4,2023-06-09 09:07:00,Any visit,CM Unit Other,bumper,CM_CMDOSU_OTH
BEL09,BEL_09_361,4,COMMON_CM,Any visit,2023-06-09,CM,4,2023-06-09 09:07:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_361,4,COMMON_CM,Any visit,2023-06-09,CM,4,2023-06-09 09:07:00,Any visit,CM Route,Inhalation (p.i.),CM_CMROUTE
BEL09,BEL_09_361,4,COMMON_CM,Any visit,2023-06-09,CM,4,2023-06-09 09:07:00,Any visit,CM Start Date,2020-NK-NK,CM_CMSTDAT
BEL09,BEL_09_361,4,COMMON_CM,Any visit,2023-06-09,CM,4,2023-06-13 07:28:00,Any visit,CM Ongoing,No,CM_CMONGO
BEL09,BEL_09_361,4,COMMON_CM,Any visit,2023-06-09,CM,4,2023-06-13 07:28:00,Any visit,CM End Date,2023-06-09,CM_CMENDAT
BEL09,BEL_09_361,5,COMMON_CM,Any visit,2023-06-09,CM,5,2023-06-09 10:10:00,Any visit,CM Number,5,CM_CMSPID
BEL09,BEL_09_361,5,COMMON_CM,Any visit,2023-06-09,CM,5,2023-06-09 10:10:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
BEL09,BEL_09_361,5,COMMON_CM,Any visit,2023-06-09,CM,5,2023-06-09 10:10:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
BEL09,BEL_09_361,5,COMMON_CM,Any visit,2023-06-09,CM,5,2023-06-09 10:10:00,Any visit,CM Indication,Hypertension,CM_CMINDC
BEL09,BEL_09_361,5,COMMON_CM,Any visit,2023-06-09,CM,5,2023-06-09 10:10:00,Any visit,CM Dose,20,CM_CMDOSE
BEL09,BEL_09_361,5,COMMON_CM,Any visit,2023-06-09,CM,5,2023-06-09 10:10:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_361,5,COMMON_CM,Any visit,2023-06-09,CM,5,2023-06-09 10:10:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_361,5,COMMON_CM,Any visit,2023-06-09,CM,5,2023-06-09 10:10:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_361,5,COMMON_CM,Any visit,2023-06-09,CM,5,2023-06-09 10:10:00,Any visit,CM Start Date,2023-06-NK,CM_CMSTDAT
BEL09,BEL_09_361,5,COMMON_CM,Any visit,2023-06-09,CM,5,2023-06-09 10:10:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_361,6,COMMON_CM,Any visit,2023-06-09,CM,6,2023-06-09 10:12:00,Any visit,CM Number,6,CM_CMSPID
BEL09,BEL_09_361,6,COMMON_CM,Any visit,2023-06-09,CM,6,2023-06-09 10:12:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
BEL09,BEL_09_361,6,COMMON_CM,Any visit,2023-06-09,CM,6,2023-06-09 10:12:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
BEL09,BEL_09_361,6,COMMON_CM,Any visit,2023-06-09,CM,6,2023-06-09 10:12:00,Any visit,CM Indication,Infection,CM_CMINDC
BEL09,BEL_09_361,6,COMMON_CM,Any visit,2023-06-09,CM,6,2023-06-09 10:12:00,Any visit,CM Dose,10,CM_CMDOSE
BEL09,BEL_09_361,6,COMMON_CM,Any visit,2023-06-09,CM,6,2023-06-09 10:12:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_361,6,COMMON_CM,Any visit,2023-06-09,CM,6,2023-06-09 10:12:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_361,6,COMMON_CM,Any visit,2023-06-09,CM,6,2023-06-09 10:12:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_361,6,COMMON_CM,Any visit,2023-06-09,CM,6,2023-06-09 10:12:00,Any visit,CM Start Date,2023-06-03,CM_CMSTDAT
BEL09,BEL_09_361,6,COMMON_CM,Any visit,2023-06-09,CM,6,2023-08-07 09:06:00,Any visit,CM Ongoing,No,CM_CMONGO
BEL09,BEL_09_361,6,COMMON_CM,Any visit,2023-06-09,CM,6,2023-08-07 09:06:00,Any visit,CM End Date,2023-07-20,CM_CMENDAT
BEL09,BEL_09_361,7,COMMON_CM,Any visit,2023-06-09,CM,7,2023-06-09 10:14:00,Any visit,CM Number,7,CM_CMSPID
BEL09,BEL_09_361,7,COMMON_CM,Any visit,2023-06-09,CM,7,2023-06-09 10:14:00,Any visit,CM Trade Name,Gliigestatrilat,CM_CMTRT
BEL09,BEL_09_361,7,COMMON_CM,Any visit,2023-06-09,CM,7,2023-06-09 10:14:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
BEL09,BEL_09_361,7,COMMON_CM,Any visit,2023-06-09,CM,7,2023-06-09 10:14:00,Any visit,CM Indication,Nausea,CM_CMINDC
BEL09,BEL_09_361,7,COMMON_CM,Any visit,2023-06-09,CM,7,2023-06-09 10:14:00,Any visit,CM Dose,5,CM_CMDOSE
BEL09,BEL_09_361,7,COMMON_CM,Any visit,2023-06-09,CM,7,2023-06-09 10:14:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_361,7,COMMON_CM,Any visit,2023-06-09,CM,7,2023-06-09 10:14:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_361,7,COMMON_CM,Any visit,2023-06-09,CM,7,2023-06-09 10:14:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_361,7,COMMON_CM,Any visit,2023-06-09,CM,7,2023-06-09 10:14:00,Any visit,CM Start Date,2023-06-08,CM_CMSTDAT
BEL09,BEL_09_361,7,COMMON_CM,Any visit,2023-06-09,CM,7,2023-06-09 10:14:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_361,8,COMMON_CM,Any visit,2023-06-09,CM,8,2023-06-09 11:42:00,Any visit,CM Number,8,CM_CMSPID
BEL09,BEL_09_361,8,COMMON_CM,Any visit,2023-06-09,CM,8,2023-06-09 11:42:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
BEL09,BEL_09_361,8,COMMON_CM,Any visit,2023-06-09,CM,8,2023-06-09 11:42:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
BEL09,BEL_09_361,8,COMMON_CM,Any visit,2023-06-09,CM,8,2023-06-09 11:42:00,Any visit,CM Indication,Insomnia,CM_CMINDC
BEL09,BEL_09_361,8,COMMON_CM,Any visit,2023-06-09,CM,8,2023-06-09 11:42:00,Any visit,CM Dose,5,CM_CMDOSE
BEL09,BEL_09_361,8,COMMON_CM,Any visit,2023-06-09,CM,8,2023-06-09 11:42:00,Any visit,CM Unit,Milligram/Milliliter (mg/mL),CM_CMDOSU
BEL09,BEL_09_361,8,COMMON_CM,Any visit,2023-06-09,CM,8,2023-06-09 11:42:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
BEL09,BEL_09_361,8,COMMON_CM,Any visit,2023-06-09,CM,8,2023-06-09 11:42:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
BEL09,BEL_09_361,8,COMMON_CM,Any visit,2023-06-09,CM,8,2023-06-09 11:42:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
BEL09,BEL_09_361,8,COMMON_CM,Any visit,2023-06-09,CM,8,2023-06-09 11:42:00,Any visit,CM Start Date,2023-06-05,CM_CMSTDAT
BEL09,BEL_09_361,8,COMMON_CM,Any visit,2023-06-09,CM,8,2023-06-09 11:42:00,Any visit,CM Ongoing,No,CM_CMONGO
BEL09,BEL_09_361,8,COMMON_CM,Any visit,2023-06-09,CM,8,2023-06-09 11:42:00,Any visit,CM End Date,2023-06-05,CM_CMENDAT
BEL09,BEL_09_361,9,COMMON_CM,Any visit,2023-06-09,CM,9,2023-06-09 12:10:00,Any visit,CM Number,9,CM_CMSPID
BEL09,BEL_09_361,9,COMMON_CM,Any visit,2023-06-09,CM,9,2023-06-09 12:10:00,Any visit,CM Trade Name,Gliigestatrilat,CM_CMTRT
BEL09,BEL_09_361,9,COMMON_CM,Any visit,2023-06-09,CM,9,2023-06-09 12:10:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
BEL09,BEL_09_361,9,COMMON_CM,Any visit,2023-06-09,CM,9,2023-06-09 12:10:00,Any visit,CM Indication,Pain,CM_CMINDC
BEL09,BEL_09_361,9,COMMON_CM,Any visit,2023-06-09,CM,9,2023-06-09 12:10:00,Any visit,CM Dose,4,CM_CMDOSE
BEL09,BEL_09_361,9,COMMON_CM,Any visit,2023-06-09,CM,9,2023-06-09 12:10:00,Any visit,CM Unit,Milligram/Milliliter (mg/mL),CM_CMDOSU
BEL09,BEL_09_361,9,COMMON_CM,Any visit,2023-06-09,CM,9,2023-06-09 12:10:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
BEL09,BEL_09_361,9,COMMON_CM,Any visit,2023-06-09,CM,9,2023-06-09 12:10:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
BEL09,BEL_09_361,9,COMMON_CM,Any visit,2023-06-09,CM,9,2023-06-09 12:10:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
BEL09,BEL_09_361,9,COMMON_CM,Any visit,2023-06-09,CM,9,2023-06-09 12:10:00,Any visit,CM Start Date,2023-06-08,CM_CMSTDAT
BEL09,BEL_09_361,9,COMMON_CM,Any visit,2023-06-09,CM,9,2023-06-09 12:10:00,Any visit,CM Ongoing,No,CM_CMONGO
BEL09,BEL_09_361,9,COMMON_CM,Any visit,2023-06-09,CM,9,2023-06-09 12:10:00,Any visit,CM End Date,2023-06-08,CM_CMENDAT
BEL09,BEL_09_361,10,COMMON_CM,Any visit,2023-06-09,CM,10,2023-06-09 12:12:00,Any visit,CM Number,10,CM_CMSPID
BEL09,BEL_09_361,10,COMMON_CM,Any visit,2023-06-09,CM,10,2023-06-09 12:12:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
BEL09,BEL_09_361,10,COMMON_CM,Any visit,2023-06-09,CM,10,2023-06-09 12:12:00,Any visit,CM Active Ingredient,Meloxicam,CM_CMINGRD
BEL09,BEL_09_361,10,COMMON_CM,Any visit,2023-06-09,CM,10,2023-06-09 12:12:00,Any visit,CM Indication,Pain,CM_CMINDC
BEL09,BEL_09_361,10,COMMON_CM,Any visit,2023-06-09,CM,10,2023-06-09 12:12:00,Any visit,CM Dose,100,CM_CMDOSE
BEL09,BEL_09_361,10,COMMON_CM,Any visit,2023-06-09,CM,10,2023-06-09 12:12:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_361,10,COMMON_CM,Any visit,2023-06-09,CM,10,2023-06-09 12:12:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
BEL09,BEL_09_361,10,COMMON_CM,Any visit,2023-06-09,CM,10,2023-06-09 12:12:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
BEL09,BEL_09_361,10,COMMON_CM,Any visit,2023-06-09,CM,10,2023-06-09 12:12:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
BEL09,BEL_09_361,10,COMMON_CM,Any visit,2023-06-09,CM,10,2023-06-09 12:12:00,Any visit,CM Start Date,2023-06-08,CM_CMSTDAT
BEL09,BEL_09_361,10,COMMON_CM,Any visit,2023-06-09,CM,10,2023-06-09 12:12:00,Any visit,CM Ongoing,No,CM_CMONGO
BEL09,BEL_09_361,10,COMMON_CM,Any visit,2023-06-09,CM,10,2023-06-09 12:12:00,Any visit,CM End Date,2023-06-08,CM_CMENDAT
BEL09,BEL_09_361,11,COMMON_CM,Any visit,2023-06-09,CM,11,2023-06-09 12:15:00,Any visit,CM Number,11,CM_CMSPID
BEL09,BEL_09_361,11,COMMON_CM,Any visit,2023-06-09,CM,11,2023-06-09 12:15:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
BEL09,BEL_09_361,11,COMMON_CM,Any visit,2023-06-09,CM,11,2023-06-09 12:15:00,Any visit,CM Active Ingredient,Meloxicam,CM_CMINGRD
BEL09,BEL_09_361,11,COMMON_CM,Any visit,2023-06-09,CM,11,2023-06-09 12:15:00,Any visit,CM Indication,Pain,CM_CMINDC
BEL09,BEL_09_361,11,COMMON_CM,Any visit,2023-06-09,CM,11,2023-06-09 12:15:00,Any visit,CM Dose,2,CM_CMDOSE
BEL09,BEL_09_361,11,COMMON_CM,Any visit,2023-06-09,CM,11,2023-06-09 12:15:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
BEL09,BEL_09_361,11,COMMON_CM,Any visit,2023-06-09,CM,11,2023-06-09 12:15:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
BEL09,BEL_09_361,11,COMMON_CM,Any visit,2023-06-09,CM,11,2023-06-09 12:15:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
BEL09,BEL_09_361,11,COMMON_CM,Any visit,2023-06-09,CM,11,2023-06-09 12:15:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
BEL09,BEL_09_361,11,COMMON_CM,Any visit,2023-06-09,CM,11,2023-06-09 12:15:00,Any visit,CM Start Date,2023-06-08,CM_CMSTDAT
BEL09,BEL_09_361,11,COMMON_CM,Any visit,2023-06-09,CM,11,2023-06-09 12:15:00,Any visit,CM Ongoing,No,CM_CMONGO
BEL09,BEL_09_361,11,COMMON_CM,Any visit,2023-06-09,CM,11,2023-06-09 12:15:00,Any visit,CM End Date,2023-06-08,CM_CMENDAT
BEL09,BEL_09_361,12,COMMON_CM,Any visit,2023-06-13,CM,12,2023-06-13 07:31:00,Any visit,CM Number,12,CM_CMSPID
BEL09,BEL_09_361,12,COMMON_CM,Any visit,2023-06-13,CM,12,2023-06-13 07:31:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
BEL09,BEL_09_361,12,COMMON_CM,Any visit,2023-06-13,CM,12,2023-06-13 07:31:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
BEL09,BEL_09_361,12,COMMON_CM,Any visit,2023-06-13,CM,12,2023-06-13 07:31:00,Any visit,CM Indication,Infection,CM_CMINDC
BEL09,BEL_09_361,12,COMMON_CM,Any visit,2023-06-13,CM,12,2023-06-13 07:31:00,Any visit,CM Dose,100,CM_CMDOSE
BEL09,BEL_09_361,12,COMMON_CM,Any visit,2023-06-13,CM,12,2023-06-13 07:31:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_361,12,COMMON_CM,Any visit,2023-06-13,CM,12,2023-06-13 07:31:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_361,12,COMMON_CM,Any visit,2023-06-13,CM,12,2023-06-13 07:31:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_361,12,COMMON_CM,Any visit,2023-06-13,CM,12,2023-06-13 07:31:00,Any visit,CM Start Date,2021-NK-NK,CM_CMSTDAT
BEL09,BEL_09_361,12,COMMON_CM,Any visit,2023-06-13,CM,12,2023-06-13 07:31:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_361,13,COMMON_CM,Any visit,2023-06-13,CM,13,2023-06-13 07:36:00,Any visit,CM Number,13,CM_CMSPID
BEL09,BEL_09_361,13,COMMON_CM,Any visit,2023-06-13,CM,13,2023-06-13 07:36:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
BEL09,BEL_09_361,13,COMMON_CM,Any visit,2023-06-13,CM,13,2023-06-13 07:36:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
BEL09,BEL_09_361,13,COMMON_CM,Any visit,2023-06-13,CM,13,2023-06-13 07:37:00,Any visit,CM Indication,Infection,CM_CMINDC
BEL09,BEL_09_361,13,COMMON_CM,Any visit,2023-06-13,CM,13,2023-06-13 07:36:00,Any visit,CM Dose,1,CM_CMDOSE
BEL09,BEL_09_361,13,COMMON_CM,Any visit,2023-06-13,CM,13,2023-06-13 07:36:00,Any visit,CM Unit,Other,CM_CMDOSU
BEL09,BEL_09_361,13,COMMON_CM,Any visit,2023-06-13,CM,13,2023-06-13 07:36:00,Any visit,CM Unit Other,bumper,CM_CMDOSU_OTH
BEL09,BEL_09_361,13,COMMON_CM,Any visit,2023-06-13,CM,13,2023-06-13 07:36:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_361,13,COMMON_CM,Any visit,2023-06-13,CM,13,2023-06-13 07:36:00,Any visit,CM Route,Nasal,CM_CMROUTE
BEL09,BEL_09_361,13,COMMON_CM,Any visit,2023-06-13,CM,13,2023-06-13 07:36:00,Any visit,CM Start Date,2023-06-09,CM_CMSTDAT
BEL09,BEL_09_361,13,COMMON_CM,Any visit,2023-06-13,CM,13,2023-06-13 07:36:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_361,14,COMMON_CM,Any visit,2023-06-13,CM,14,2023-06-13 07:43:00,Any visit,CM Number,14,CM_CMSPID
BEL09,BEL_09_361,14,COMMON_CM,Any visit,2023-06-13,CM,14,2023-06-13 07:43:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
BEL09,BEL_09_361,14,COMMON_CM,Any visit,2023-06-13,CM,14,2023-06-13 07:43:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
BEL09,BEL_09_361,14,COMMON_CM,Any visit,2023-06-13,CM,14,2023-06-13 07:43:00,Any visit,CM Indication,Pain,CM_CMINDC
BEL09,BEL_09_361,14,COMMON_CM,Any visit,2023-06-13,CM,14,2023-06-13 07:43:00,Any visit,CM Dose,10,CM_CMDOSE
BEL09,BEL_09_361,14,COMMON_CM,Any visit,2023-06-13,CM,14,2023-06-13 07:43:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_361,14,COMMON_CM,Any visit,2023-06-13,CM,14,2023-06-13 07:43:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_361,14,COMMON_CM,Any visit,2023-06-13,CM,14,2023-06-13 07:43:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_361,14,COMMON_CM,Any visit,2023-06-13,CM,14,2023-06-13 07:43:00,Any visit,CM Start Date,2023-06-10,CM_CMSTDAT
BEL09,BEL_09_361,14,COMMON_CM,Any visit,2023-06-13,CM,14,2023-06-13 07:43:00,Any visit,CM Ongoing,No,CM_CMONGO
BEL09,BEL_09_361,14,COMMON_CM,Any visit,2023-06-13,CM,14,2023-06-13 07:43:00,Any visit,CM End Date,2023-06-11,CM_CMENDAT
BEL09,BEL_09_361,15,COMMON_CM,Any visit,2023-06-13,CM,15,2023-06-13 11:03:00,Any visit,CM Number,15,CM_CMSPID
BEL09,BEL_09_361,15,COMMON_CM,Any visit,2023-06-13,CM,15,2023-06-13 11:03:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
BEL09,BEL_09_361,15,COMMON_CM,Any visit,2023-06-13,CM,15,2023-06-16 07:35:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
BEL09,BEL_09_361,15,COMMON_CM,Any visit,2023-06-13,CM,15,2023-06-13 11:03:00,Any visit,CM Indication,Infection,CM_CMINDC
BEL09,BEL_09_361,15,COMMON_CM,Any visit,2023-06-13,CM,15,2023-06-16 07:35:00,Any visit,CM Dose,2500,CM_CMDOSE
BEL09,BEL_09_361,15,COMMON_CM,Any visit,2023-06-13,CM,15,2023-06-16 07:35:00,Any visit,CM Unit,Microgram (µg),CM_CMDOSU
BEL09,BEL_09_361,15,COMMON_CM,Any visit,2023-06-13,CM,15,2023-06-16 07:35:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
BEL09,BEL_09_361,15,COMMON_CM,Any visit,2023-06-13,CM,15,2023-06-16 07:35:00,Any visit,CM Route,Inhalation (p.i.),CM_CMROUTE
BEL09,BEL_09_361,15,COMMON_CM,Any visit,2023-06-13,CM,15,2023-06-13 11:03:00,Any visit,CM Start Date,2023-06-13,CM_CMSTDAT
BEL09,BEL_09_361,15,COMMON_CM,Any visit,2023-06-13,CM,15,2023-06-13 11:03:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_361,16,COMMON_CM,Any visit,2023-06-16,CM,16,2023-06-16 06:13:00,Any visit,CM Number,16,CM_CMSPID
BEL09,BEL_09_361,16,COMMON_CM,Any visit,2023-06-16,CM,16,2023-06-16 06:13:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
BEL09,BEL_09_361,16,COMMON_CM,Any visit,2023-06-16,CM,16,2023-06-16 07:33:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
BEL09,BEL_09_361,16,COMMON_CM,Any visit,2023-06-16,CM,16,2023-06-16 06:13:00,Any visit,CM Indication,Insomnia,CM_CMINDC
BEL09,BEL_09_361,16,COMMON_CM,Any visit,2023-06-16,CM,16,2023-06-16 06:13:00,Any visit,CM Dose,1,CM_CMDOSE
BEL09,BEL_09_361,16,COMMON_CM,Any visit,2023-06-16,CM,16,2023-06-16 06:13:00,Any visit,CM Unit,Milligram/Milliliter (mg/mL),CM_CMDOSU
BEL09,BEL_09_361,16,COMMON_CM,Any visit,2023-06-16,CM,16,2023-06-16 06:13:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
BEL09,BEL_09_361,16,COMMON_CM,Any visit,2023-06-16,CM,16,2023-06-16 06:13:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_361,16,COMMON_CM,Any visit,2023-06-16,CM,16,2023-06-16 06:13:00,Any visit,CM Start Date,2023-06-15,CM_CMSTDAT
BEL09,BEL_09_361,16,COMMON_CM,Any visit,2023-06-16,CM,16,2023-06-16 06:13:00,Any visit,CM Ongoing,No,CM_CMONGO
BEL09,BEL_09_361,16,COMMON_CM,Any visit,2023-06-16,CM,16,2023-06-16 06:13:00,Any visit,CM End Date,2023-06-15,CM_CMENDAT
BEL09,BEL_09_361,17,COMMON_CM,Any visit,2023-06-16,CM,17,2023-06-16 07:14:00,Any visit,CM Number,17,CM_CMSPID
BEL09,BEL_09_361,17,COMMON_CM,Any visit,2023-06-16,CM,17,2023-06-16 07:14:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
BEL09,BEL_09_361,17,COMMON_CM,Any visit,2023-06-16,CM,17,2023-06-16 07:14:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
BEL09,BEL_09_361,17,COMMON_CM,Any visit,2023-06-16,CM,17,2023-06-16 07:17:00,Any visit,CM Indication,Adverse event,CM_CMINDC
BEL09,BEL_09_361,17,COMMON_CM,Any visit,2023-06-16,CM,17,2023-06-16 07:14:00,Any visit,CM Dose,100,CM_CMDOSE
BEL09,BEL_09_361,17,COMMON_CM,Any visit,2023-06-16,CM,17,2023-06-16 07:14:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_361,17,COMMON_CM,Any visit,2023-06-16,CM,17,2023-06-16 07:14:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
BEL09,BEL_09_361,17,COMMON_CM,Any visit,2023-06-16,CM,17,2023-06-16 07:14:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
BEL09,BEL_09_361,17,COMMON_CM,Any visit,2023-06-16,CM,17,2023-06-16 07:14:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
BEL09,BEL_09_361,17,COMMON_CM,Any visit,2023-06-16,CM,17,2023-06-16 07:14:00,Any visit,CM Start Date,2023-06-14,CM_CMSTDAT
BEL09,BEL_09_361,17,COMMON_CM,Any visit,2023-06-16,CM,17,2023-06-16 07:14:00,Any visit,CM Ongoing,No,CM_CMONGO
BEL09,BEL_09_361,17,COMMON_CM,Any visit,2023-06-16,CM,17,2023-06-16 07:14:00,Any visit,CM End Date,2023-06-14,CM_CMENDAT
BEL09,BEL_09_361,18,COMMON_CM,Any visit,2023-06-16,CM,18,2023-06-16 07:27:00,Any visit,CM Number,18,CM_CMSPID
BEL09,BEL_09_361,18,COMMON_CM,Any visit,2023-06-16,CM,18,2023-06-16 07:27:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
BEL09,BEL_09_361,18,COMMON_CM,Any visit,2023-06-16,CM,18,2023-06-16 07:27:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
BEL09,BEL_09_361,18,COMMON_CM,Any visit,2023-06-16,CM,18,2023-06-16 07:27:00,Any visit,CM Indication,Nausea,CM_CMINDC
BEL09,BEL_09_361,18,COMMON_CM,Any visit,2023-06-16,CM,18,2023-06-16 07:32:00,Any visit,CM Dose,3750,CM_CMDOSE
BEL09,BEL_09_361,18,COMMON_CM,Any visit,2023-06-16,CM,18,2023-06-16 07:32:00,Any visit,CM Unit,Microgram (µg),CM_CMDOSU
BEL09,BEL_09_361,18,COMMON_CM,Any visit,2023-06-16,CM,18,2023-06-16 07:27:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
BEL09,BEL_09_361,18,COMMON_CM,Any visit,2023-06-16,CM,18,2023-06-16 07:27:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_361,18,COMMON_CM,Any visit,2023-06-16,CM,18,2023-06-16 07:27:00,Any visit,CM Start Date,2023-06-15,CM_CMSTDAT
BEL09,BEL_09_361,18,COMMON_CM,Any visit,2023-06-16,CM,18,2023-06-16 07:27:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_361,20,COMMON_CM,Any visit,2023-06-16,CM,20,2023-06-16 07:31:00,Any visit,CM Number,20,CM_CMSPID
BEL09,BEL_09_361,20,COMMON_CM,Any visit,2023-06-16,CM,20,2023-06-16 07:31:00,Any visit,CM Trade Name,Bolidilanil,CM_CMTRT
BEL09,BEL_09_361,20,COMMON_CM,Any visit,2023-06-16,CM,20,2023-06-16 07:31:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
BEL09,BEL_09_361,20,COMMON_CM,Any visit,2023-06-16,CM,20,2023-06-16 07:31:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
BEL09,BEL_09_361,20,COMMON_CM,Any visit,2023-06-16,CM,20,2023-06-16 07:31:00,Any visit,CM Dose,500,CM_CMDOSE
BEL09,BEL_09_361,20,COMMON_CM,Any visit,2023-06-16,CM,20,2023-06-16 07:31:00,Any visit,CM Unit,Microgram (µg),CM_CMDOSU
BEL09,BEL_09_361,20,COMMON_CM,Any visit,2023-06-16,CM,20,2023-06-16 07:31:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
BEL09,BEL_09_361,20,COMMON_CM,Any visit,2023-06-16,CM,20,2023-06-16 07:31:00,Any visit,CM Route,Inhalation (p.i.),CM_CMROUTE
BEL09,BEL_09_361,20,COMMON_CM,Any visit,2023-06-16,CM,20,2023-06-16 07:31:00,Any visit,CM Start Date,2023-06-14,CM_CMSTDAT
BEL09,BEL_09_361,20,COMMON_CM,Any visit,2023-06-16,CM,20,2023-06-16 07:31:00,Any visit,CM Ongoing,No,CM_CMONGO
BEL09,BEL_09_361,20,COMMON_CM,Any visit,2023-06-16,CM,20,2023-06-16 07:31:00,Any visit,CM End Date,2023-06-15,CM_CMENDAT
BEL09,BEL_09_361,21,COMMON_CM,Any visit,2023-06-16,CM,21,2023-06-16 07:39:00,Any visit,CM Number,21,CM_CMSPID
BEL09,BEL_09_361,21,COMMON_CM,Any visit,2023-06-16,CM,21,2023-06-16 07:39:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
BEL09,BEL_09_361,21,COMMON_CM,Any visit,2023-06-16,CM,21,2023-06-16 07:39:00,Any visit,CM Active Ingredient,Meloxicam,CM_CMINGRD
BEL09,BEL_09_361,21,COMMON_CM,Any visit,2023-06-16,CM,21,2023-06-16 07:39:00,Any visit,CM Indication,Infection,CM_CMINDC
BEL09,BEL_09_361,21,COMMON_CM,Any visit,2023-06-16,CM,21,2023-06-16 07:39:00,Any visit,CM Dose,4500,CM_CMDOSE
BEL09,BEL_09_361,21,COMMON_CM,Any visit,2023-06-16,CM,21,2023-06-16 07:39:00,Any visit,CM Unit,Other,CM_CMDOSU
BEL09,BEL_09_361,21,COMMON_CM,Any visit,2023-06-16,CM,21,2023-06-16 07:39:00,Any visit,CM Unit Other,I.E.,CM_CMDOSU_OTH
BEL09,BEL_09_361,21,COMMON_CM,Any visit,2023-06-16,CM,21,2023-06-16 07:39:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_361,21,COMMON_CM,Any visit,2023-06-16,CM,21,2023-06-16 07:39:00,Any visit,CM Route,Subcutaneous (s.c.),CM_CMROUTE
BEL09,BEL_09_361,21,COMMON_CM,Any visit,2023-06-16,CM,21,2023-06-16 07:39:00,Any visit,CM Start Date,2023-06-14,CM_CMSTDAT
BEL09,BEL_09_361,21,COMMON_CM,Any visit,2023-06-16,CM,21,2023-06-16 07:39:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_361,22,COMMON_CM,Any visit,2023-07-27,CM,22,2023-07-27 11:22:00,Any visit,CM Number,22,CM_CMSPID
BEL09,BEL_09_361,22,COMMON_CM,Any visit,2023-07-27,CM,22,2023-07-27 11:22:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
BEL09,BEL_09_361,22,COMMON_CM,Any visit,2023-07-27,CM,22,2023-07-27 11:22:00,Any visit,CM Active Ingredient,Meloxicam,CM_CMINGRD
BEL09,BEL_09_361,22,COMMON_CM,Any visit,2023-07-27,CM,22,2023-07-27 11:22:00,Any visit,CM Indication,Insomnia,CM_CMINDC
BEL09,BEL_09_361,22,COMMON_CM,Any visit,2023-07-27,CM,22,2023-07-27 11:22:00,Any visit,CM Dose,5,CM_CMDOSE
BEL09,BEL_09_361,22,COMMON_CM,Any visit,2023-07-27,CM,22,2023-07-27 11:22:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_361,22,COMMON_CM,Any visit,2023-07-27,CM,22,2023-07-27 11:22:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_361,22,COMMON_CM,Any visit,2023-07-27,CM,22,2023-07-27 11:22:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_361,22,COMMON_CM,Any visit,2023-07-27,CM,22,2023-07-27 11:22:00,Any visit,CM Start Date,2023-07-06,CM_CMSTDAT
BEL09,BEL_09_361,22,COMMON_CM,Any visit,2023-07-27,CM,22,2023-07-27 11:22:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_361,23,COMMON_CM,Any visit,2023-07-27,CM,23,2023-07-27 11:26:00,Any visit,CM Number,23,CM_CMSPID
BEL09,BEL_09_361,23,COMMON_CM,Any visit,2023-07-27,CM,23,2023-07-27 11:26:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
BEL09,BEL_09_361,23,COMMON_CM,Any visit,2023-07-27,CM,23,2023-07-27 11:26:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
BEL09,BEL_09_361,23,COMMON_CM,Any visit,2023-07-27,CM,23,2023-07-27 11:26:00,Any visit,CM Indication,Pain,CM_CMINDC
BEL09,BEL_09_361,23,COMMON_CM,Any visit,2023-07-27,CM,23,2023-07-27 11:26:00,Any visit,CM Dose,2,CM_CMDOSE
BEL09,BEL_09_361,23,COMMON_CM,Any visit,2023-07-27,CM,23,2023-07-27 11:26:00,Any visit,CM Unit,Other,CM_CMDOSU
BEL09,BEL_09_361,23,COMMON_CM,Any visit,2023-07-27,CM,23,2023-07-27 11:26:00,Any visit,CM Unit Other,puffs,CM_CMDOSU_OTH
BEL09,BEL_09_361,23,COMMON_CM,Any visit,2023-07-27,CM,23,2023-07-27 11:26:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_361,23,COMMON_CM,Any visit,2023-07-27,CM,23,2023-07-27 11:26:00,Any visit,CM Route,Inhalation (p.i.),CM_CMROUTE
BEL09,BEL_09_361,23,COMMON_CM,Any visit,2023-07-27,CM,23,2023-07-27 11:31:00,Any visit,CM Start Date,2023-06-22,CM_CMSTDAT
BEL09,BEL_09_361,23,COMMON_CM,Any visit,2023-07-27,CM,23,2023-07-27 11:26:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_361,24,COMMON_CM,Any visit,2023-07-27,CM,24,2023-07-27 12:28:00,Any visit,CM Number,24,CM_CMSPID
BEL09,BEL_09_361,24,COMMON_CM,Any visit,2023-07-27,CM,24,2023-07-27 12:28:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
BEL09,BEL_09_361,24,COMMON_CM,Any visit,2023-07-27,CM,24,2023-07-27 12:28:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
BEL09,BEL_09_361,24,COMMON_CM,Any visit,2023-07-27,CM,24,2023-07-27 12:28:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
BEL09,BEL_09_361,24,COMMON_CM,Any visit,2023-07-27,CM,24,2023-07-27 12:28:00,Any visit,CM Dose,500,CM_CMDOSE
BEL09,BEL_09_361,24,COMMON_CM,Any visit,2023-07-27,CM,24,2023-07-27 12:28:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_361,24,COMMON_CM,Any visit,2023-07-27,CM,24,2023-07-27 12:28:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
BEL09,BEL_09_361,24,COMMON_CM,Any visit,2023-07-27,CM,24,2023-07-27 12:28:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_361,24,COMMON_CM,Any visit,2023-07-27,CM,24,2023-07-27 12:28:00,Any visit,CM Start Date,2023-07-20,CM_CMSTDAT
BEL09,BEL_09_361,24,COMMON_CM,Any visit,2023-07-27,CM,24,2023-07-27 12:28:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_361,25,COMMON_CM,Any visit,2023-07-27,CM,25,2023-07-27 12:30:00,Any visit,CM Number,25,CM_CMSPID
BEL09,BEL_09_361,25,COMMON_CM,Any visit,2023-07-27,CM,25,2023-07-27 12:30:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
BEL09,BEL_09_361,25,COMMON_CM,Any visit,2023-07-27,CM,25,2023-07-27 12:30:00,Any visit,CM Active Ingredient,Meloxicam,CM_CMINGRD
BEL09,BEL_09_361,25,COMMON_CM,Any visit,2023-07-27,CM,25,2023-07-27 12:30:00,Any visit,CM Indication,Hypertension,CM_CMINDC
BEL09,BEL_09_361,25,COMMON_CM,Any visit,2023-07-27,CM,25,2023-07-27 12:30:00,Any visit,CM Dose,10,CM_CMDOSE
BEL09,BEL_09_361,25,COMMON_CM,Any visit,2023-07-27,CM,25,2023-07-27 12:30:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_361,25,COMMON_CM,Any visit,2023-07-27,CM,25,2023-07-27 12:30:00,Any visit,CM Frequency,4 times per day (QID),CM_CMDOSFRQ
BEL09,BEL_09_361,25,COMMON_CM,Any visit,2023-07-27,CM,25,2023-07-27 12:30:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_361,25,COMMON_CM,Any visit,2023-07-27,CM,25,2023-07-27 12:30:00,Any visit,CM Start Date,2023-07-20,CM_CMSTDAT
BEL09,BEL_09_361,25,COMMON_CM,Any visit,2023-07-27,CM,25,2023-07-27 12:30:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_361,26,COMMON_CM,Any visit,2023-07-27,CM,26,2023-07-27 12:34:00,Any visit,CM Number,26,CM_CMSPID
BEL09,BEL_09_361,26,COMMON_CM,Any visit,2023-07-27,CM,26,2023-07-27 12:34:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
BEL09,BEL_09_361,26,COMMON_CM,Any visit,2023-07-27,CM,26,2023-07-27 12:34:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
BEL09,BEL_09_361,26,COMMON_CM,Any visit,2023-07-27,CM,26,2023-07-27 12:34:00,Any visit,CM Dose,500,CM_CMDOSE
BEL09,BEL_09_361,26,COMMON_CM,Any visit,2023-07-27,CM,26,2023-07-27 12:34:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_361,26,COMMON_CM,Any visit,2023-07-27,CM,26,2023-07-27 12:34:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
BEL09,BEL_09_361,26,COMMON_CM,Any visit,2023-07-27,CM,26,2023-07-27 12:34:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_361,27,COMMON_CM,Any visit,2023-07-27,CM,27,2023-07-27 12:36:00,Any visit,CM Number,27,CM_CMSPID
BEL09,BEL_09_361,27,COMMON_CM,Any visit,2023-07-27,CM,27,2023-07-27 12:36:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
BEL09,BEL_09_361,27,COMMON_CM,Any visit,2023-07-27,CM,27,2023-07-27 12:36:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
BEL09,BEL_09_361,27,COMMON_CM,Any visit,2023-07-27,CM,27,2023-08-07 12:15:00,Any visit,CM Indication,Infection,CM_CMINDC
BEL09,BEL_09_361,27,COMMON_CM,Any visit,2023-07-27,CM,27,2023-07-27 12:36:00,Any visit,CM Dose,500,CM_CMDOSE
BEL09,BEL_09_361,27,COMMON_CM,Any visit,2023-07-27,CM,27,2023-07-27 12:36:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_361,27,COMMON_CM,Any visit,2023-07-27,CM,27,2023-07-27 12:36:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
BEL09,BEL_09_361,27,COMMON_CM,Any visit,2023-07-27,CM,27,2023-07-27 12:36:00,Any visit,CM Frequency Other,500-0-1000mg,CM_CMDOSFRQ_OTH
BEL09,BEL_09_361,27,COMMON_CM,Any visit,2023-07-27,CM,27,2023-07-27 12:36:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL09,BEL_09_361,27,COMMON_CM,Any visit,2023-07-27,CM,27,2023-07-27 12:36:00,Any visit,CM Start Date,2023-07-12,CM_CMSTDAT
BEL09,BEL_09_361,27,COMMON_CM,Any visit,2023-07-27,CM,27,2023-08-07 09:08:00,Any visit,CM Ongoing,No,CM_CMONGO
BEL09,BEL_09_361,27,COMMON_CM,Any visit,2023-07-27,CM,27,2023-08-07 09:08:00,Any visit,CM End Date,2023-08-03,CM_CMENDAT
BEL09,BEL_09_361,15,COMMON_CM,Any visit,2023-06-13,CM,15,2023-06-16 07:35:00,Any visit,CM Related AE,Tachycardia,CM_AEREL
BEL09,BEL_09_361,20,COMMON_CM,Any visit,2023-06-16,CM,20,2023-06-16 07:31:00,Any visit,CM Related AE,Urinary incontinence,CM_AEREL
BEL09,BEL_09_361,23,COMMON_CM,Any visit,2023-07-27,CM,23,2023-07-27 11:26:00,Any visit,CM Related AE,Tachycardia,CM_AEREL
BEL09,BEL_09_361,24,COMMON_CM,Any visit,2023-07-27,CM,24,2023-07-27 12:28:00,Any visit,CM Related AE,Sepsis,CM_AEREL
BEL09,BEL_09_361,25,COMMON_CM,Any visit,2023-07-27,CM,25,2023-07-27 12:30:00,Any visit,CM Related AE,Lower back pain,CM_AEREL
BEL09,BEL_09_361,1,COMMON_CM,Any visit,2023-06-09,CM,1,2023-06-09 08:55:00,Any visit,CM Related Medical History,COPD,CM_MHREL
BEL09,BEL_09_361,2,COMMON_CM,Any visit,2023-06-09,CM,2,2023-06-09 08:56:00,Any visit,CM Related Medical History,Diabetes mellitus,CM_MHREL
BEL09,BEL_09_361,3,COMMON_CM,Any visit,2023-06-09,CM,3,2023-06-09 09:02:00,Any visit,CM Related Medical History,COPD,CM_MHREL
BEL09,BEL_09_361,4,COMMON_CM,Any visit,2023-06-09,CM,4,2023-06-09 09:07:00,Any visit,CM Related Medical History,Hypertension,CM_MHREL
BEL09,BEL_09_361,13,COMMON_CM,Any visit,2023-06-13,CM,13,2023-06-13 07:36:00,Any visit,CM Related Medical History,COPD,CM_MHREL
BEL09,BEL_09_361,14,COMMON_CM,Any visit,2023-06-13,CM,14,2023-06-13 07:43:00,Any visit,CM Related Medical History,COPD,CM_MHREL
BEL09,BEL_09_361,18,COMMON_CM,Any visit,2023-06-16,CM,18,2023-06-16 07:27:00,Any visit,CM Related Medical History,COPD,CM_MHREL
NLD06,NLD_06_755,1,COMMON_CM,Any visit,2023-07-07,CM,1,2023-07-07 13:27:00,Any visit,CM Number,1,CM_CMSPID
NLD06,NLD_06_755,1,COMMON_CM,Any visit,2023-07-07,CM,1,2023-07-07 13:27:00,Any visit,CM Trade Name,Gliigestatrilat,CM_CMTRT
NLD06,NLD_06_755,1,COMMON_CM,Any visit,2023-07-07,CM,1,2023-07-07 13:27:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
NLD06,NLD_06_755,1,COMMON_CM,Any visit,2023-07-07,CM,1,2023-07-07 13:27:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD06,NLD_06_755,1,COMMON_CM,Any visit,2023-07-07,CM,1,2023-07-07 13:27:00,Any visit,CM Dose,40,CM_CMDOSE
NLD06,NLD_06_755,1,COMMON_CM,Any visit,2023-07-07,CM,1,2023-07-07 13:27:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,1,COMMON_CM,Any visit,2023-07-07,CM,1,2023-07-07 13:27:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
NLD06,NLD_06_755,1,COMMON_CM,Any visit,2023-07-07,CM,1,2023-07-07 13:27:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,1,COMMON_CM,Any visit,2023-07-07,CM,1,2023-07-07 13:27:00,Any visit,CM Start Date,2023-04-03,CM_CMSTDAT
NLD06,NLD_06_755,1,COMMON_CM,Any visit,2023-07-07,CM,1,2023-07-07 13:27:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD06,NLD_06_755,2,COMMON_CM,Any visit,2023-07-07,CM,2,2023-07-07 13:38:00,Any visit,CM Number,2,CM_CMSPID
NLD06,NLD_06_755,2,COMMON_CM,Any visit,2023-07-07,CM,2,2023-07-07 13:38:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
NLD06,NLD_06_755,2,COMMON_CM,Any visit,2023-07-07,CM,2,2023-07-07 13:38:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
NLD06,NLD_06_755,2,COMMON_CM,Any visit,2023-07-07,CM,2,2023-07-07 13:38:00,Any visit,CM Indication,Adverse event,CM_CMINDC
NLD06,NLD_06_755,2,COMMON_CM,Any visit,2023-07-07,CM,2,2023-07-07 13:38:00,Any visit,CM Dose,2,CM_CMDOSE
NLD06,NLD_06_755,2,COMMON_CM,Any visit,2023-07-07,CM,2,2023-07-07 13:38:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,2,COMMON_CM,Any visit,2023-07-07,CM,2,2023-07-07 13:38:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
NLD06,NLD_06_755,2,COMMON_CM,Any visit,2023-07-07,CM,2,2023-07-07 13:38:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,2,COMMON_CM,Any visit,2023-07-07,CM,2,2023-07-07 13:38:00,Any visit,CM Start Date,2015-NK-NK,CM_CMSTDAT
NLD06,NLD_06_755,2,COMMON_CM,Any visit,2023-07-07,CM,2,2023-08-30 12:05:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,2,COMMON_CM,Any visit,2023-07-07,CM,2,2023-08-30 12:05:00,Any visit,CM End Date,2023-08-21,CM_CMENDAT
NLD06,NLD_06_755,3,COMMON_CM,Any visit,2023-07-07,CM,3,2023-07-07 13:41:00,Any visit,CM Number,3,CM_CMSPID
NLD06,NLD_06_755,3,COMMON_CM,Any visit,2023-07-07,CM,3,2023-07-07 13:41:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
NLD06,NLD_06_755,3,COMMON_CM,Any visit,2023-07-07,CM,3,2023-07-07 13:41:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
NLD06,NLD_06_755,3,COMMON_CM,Any visit,2023-07-07,CM,3,2023-07-07 13:41:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD06,NLD_06_755,3,COMMON_CM,Any visit,2023-07-07,CM,3,2023-07-07 13:41:00,Any visit,CM Dose,100,CM_CMDOSE
NLD06,NLD_06_755,3,COMMON_CM,Any visit,2023-07-07,CM,3,2023-07-07 13:41:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,3,COMMON_CM,Any visit,2023-07-07,CM,3,2023-07-07 13:41:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
NLD06,NLD_06_755,3,COMMON_CM,Any visit,2023-07-07,CM,3,2023-07-07 13:41:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,3,COMMON_CM,Any visit,2023-07-07,CM,3,2023-07-07 13:41:00,Any visit,CM Start Date,2023-07-05,CM_CMSTDAT
NLD06,NLD_06_755,3,COMMON_CM,Any visit,2023-07-07,CM,3,2023-07-07 13:41:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD06,NLD_06_755,4,COMMON_CM,Any visit,2023-07-07,CM,4,2023-07-07 13:44:00,Any visit,CM Number,4,CM_CMSPID
NLD06,NLD_06_755,4,COMMON_CM,Any visit,2023-07-07,CM,4,2023-07-07 13:44:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
NLD06,NLD_06_755,4,COMMON_CM,Any visit,2023-07-07,CM,4,2023-07-07 13:44:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
NLD06,NLD_06_755,4,COMMON_CM,Any visit,2023-07-07,CM,4,2023-07-07 13:44:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
NLD06,NLD_06_755,4,COMMON_CM,Any visit,2023-07-07,CM,4,2023-07-07 13:44:00,Any visit,CM Dose,500,CM_CMDOSE
NLD06,NLD_06_755,4,COMMON_CM,Any visit,2023-07-07,CM,4,2023-07-07 13:44:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,4,COMMON_CM,Any visit,2023-07-07,CM,4,2023-07-07 13:44:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD06,NLD_06_755,4,COMMON_CM,Any visit,2023-07-07,CM,4,2023-07-07 13:44:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,4,COMMON_CM,Any visit,2023-07-07,CM,4,2023-07-07 13:44:00,Any visit,CM Start Date,2023-07-05,CM_CMSTDAT
NLD06,NLD_06_755,4,COMMON_CM,Any visit,2023-07-07,CM,4,2023-07-07 13:44:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD06,NLD_06_755,5,COMMON_CM,Any visit,2023-07-07,CM,5,2023-07-07 14:02:00,Any visit,CM Number,5,CM_CMSPID
NLD06,NLD_06_755,5,COMMON_CM,Any visit,2023-07-07,CM,5,2023-07-07 14:03:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
NLD06,NLD_06_755,5,COMMON_CM,Any visit,2023-07-07,CM,5,2023-07-07 14:02:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
NLD06,NLD_06_755,5,COMMON_CM,Any visit,2023-07-07,CM,5,2023-07-07 14:03:00,Any visit,CM Indication,Nausea,CM_CMINDC
NLD06,NLD_06_755,5,COMMON_CM,Any visit,2023-07-07,CM,5,2023-07-07 14:02:00,Any visit,CM Dose,400,CM_CMDOSE
NLD06,NLD_06_755,5,COMMON_CM,Any visit,2023-07-07,CM,5,2023-07-07 14:02:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,5,COMMON_CM,Any visit,2023-07-07,CM,5,2023-07-07 14:02:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
NLD06,NLD_06_755,5,COMMON_CM,Any visit,2023-07-07,CM,5,2023-07-07 14:02:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,5,COMMON_CM,Any visit,2023-07-07,CM,5,2023-07-07 14:02:00,Any visit,CM Start Date,2022-11-22,CM_CMSTDAT
NLD06,NLD_06_755,5,COMMON_CM,Any visit,2023-07-07,CM,5,2023-08-30 12:05:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,5,COMMON_CM,Any visit,2023-07-07,CM,5,2023-08-30 12:05:00,Any visit,CM End Date,2023-08-22,CM_CMENDAT
NLD06,NLD_06_755,6,COMMON_CM,Any visit,2023-07-10,CM,6,2023-07-10 12:33:00,Any visit,CM Number,6,CM_CMSPID
NLD06,NLD_06_755,6,COMMON_CM,Any visit,2023-07-10,CM,6,2023-07-10 12:33:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
NLD06,NLD_06_755,6,COMMON_CM,Any visit,2023-07-10,CM,6,2023-07-10 12:33:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
NLD06,NLD_06_755,6,COMMON_CM,Any visit,2023-07-10,CM,6,2023-07-10 12:33:00,Any visit,CM Indication,Adverse event,CM_CMINDC
NLD06,NLD_06_755,6,COMMON_CM,Any visit,2023-07-10,CM,6,2023-07-10 12:33:00,Any visit,CM Dose,1,CM_CMDOSE
NLD06,NLD_06_755,6,COMMON_CM,Any visit,2023-07-10,CM,6,2023-07-10 12:33:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
NLD06,NLD_06_755,6,COMMON_CM,Any visit,2023-07-10,CM,6,2023-07-10 12:33:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD06,NLD_06_755,6,COMMON_CM,Any visit,2023-07-10,CM,6,2023-07-10 12:33:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,6,COMMON_CM,Any visit,2023-07-10,CM,6,2023-07-10 12:33:00,Any visit,CM Start Date,2023-07-08,CM_CMSTDAT
NLD06,NLD_06_755,6,COMMON_CM,Any visit,2023-07-10,CM,6,2023-07-10 12:33:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,6,COMMON_CM,Any visit,2023-07-10,CM,6,2023-07-10 12:33:00,Any visit,CM End Date,2023-07-08,CM_CMENDAT
NLD06,NLD_06_755,7,COMMON_CM,Any visit,2023-07-10,CM,7,2023-07-10 12:38:00,Any visit,CM Number,7,CM_CMSPID
NLD06,NLD_06_755,7,COMMON_CM,Any visit,2023-07-10,CM,7,2023-07-10 12:38:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
NLD06,NLD_06_755,7,COMMON_CM,Any visit,2023-07-10,CM,7,2023-07-10 12:38:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
NLD06,NLD_06_755,7,COMMON_CM,Any visit,2023-07-10,CM,7,2023-07-10 12:38:00,Any visit,CM Indication,Nausea,CM_CMINDC
NLD06,NLD_06_755,7,COMMON_CM,Any visit,2023-07-10,CM,7,2023-07-10 12:38:00,Any visit,CM Dose,4,CM_CMDOSE
NLD06,NLD_06_755,7,COMMON_CM,Any visit,2023-07-10,CM,7,2023-07-10 12:38:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
NLD06,NLD_06_755,7,COMMON_CM,Any visit,2023-07-10,CM,7,2023-07-10 12:38:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
NLD06,NLD_06_755,7,COMMON_CM,Any visit,2023-07-10,CM,7,2023-07-10 12:38:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD06,NLD_06_755,7,COMMON_CM,Any visit,2023-07-10,CM,7,2023-07-10 12:38:00,Any visit,CM Start Date,2023-07-08,CM_CMSTDAT
NLD06,NLD_06_755,7,COMMON_CM,Any visit,2023-07-10,CM,7,2023-07-10 12:38:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD06,NLD_06_755,8,COMMON_CM,Any visit,2023-07-10,CM,8,2023-07-10 12:43:00,Any visit,CM Number,8,CM_CMSPID
NLD06,NLD_06_755,8,COMMON_CM,Any visit,2023-07-10,CM,8,2023-07-10 12:43:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
NLD06,NLD_06_755,8,COMMON_CM,Any visit,2023-07-10,CM,8,2023-07-10 12:43:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
NLD06,NLD_06_755,8,COMMON_CM,Any visit,2023-07-10,CM,8,2023-07-10 12:43:00,Any visit,CM Indication,Nausea,CM_CMINDC
NLD06,NLD_06_755,8,COMMON_CM,Any visit,2023-07-10,CM,8,2023-07-10 12:43:00,Any visit,CM Dose,250,CM_CMDOSE
NLD06,NLD_06_755,8,COMMON_CM,Any visit,2023-07-10,CM,8,2023-07-10 12:43:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,8,COMMON_CM,Any visit,2023-07-10,CM,8,2023-07-10 12:43:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
NLD06,NLD_06_755,8,COMMON_CM,Any visit,2023-07-10,CM,8,2023-07-10 12:43:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
NLD06,NLD_06_755,8,COMMON_CM,Any visit,2023-07-10,CM,8,2023-07-10 12:43:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD06,NLD_06_755,8,COMMON_CM,Any visit,2023-07-10,CM,8,2023-07-10 12:43:00,Any visit,CM Start Date,2023-07-08,CM_CMSTDAT
NLD06,NLD_06_755,8,COMMON_CM,Any visit,2023-07-10,CM,8,2023-07-10 12:43:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,8,COMMON_CM,Any visit,2023-07-10,CM,8,2023-07-10 12:43:00,Any visit,CM End Date,2023-07-08,CM_CMENDAT
NLD06,NLD_06_755,9,COMMON_CM,Any visit,2023-08-03,CM,9,2023-08-03 13:36:00,Any visit,CM Number,9,CM_CMSPID
NLD06,NLD_06_755,9,COMMON_CM,Any visit,2023-08-03,CM,9,2023-08-03 13:36:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
NLD06,NLD_06_755,9,COMMON_CM,Any visit,2023-08-03,CM,9,2023-08-03 13:36:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
NLD06,NLD_06_755,9,COMMON_CM,Any visit,2023-08-03,CM,9,2023-08-03 13:36:00,Any visit,CM Indication,Adverse event,CM_CMINDC
NLD06,NLD_06_755,9,COMMON_CM,Any visit,2023-08-03,CM,9,2023-08-03 13:36:00,Any visit,CM Dose,2,CM_CMDOSE
NLD06,NLD_06_755,9,COMMON_CM,Any visit,2023-08-03,CM,9,2023-08-03 13:36:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
NLD06,NLD_06_755,9,COMMON_CM,Any visit,2023-08-03,CM,9,2023-08-03 13:36:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
NLD06,NLD_06_755,9,COMMON_CM,Any visit,2023-08-03,CM,9,2023-08-03 13:36:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD06,NLD_06_755,9,COMMON_CM,Any visit,2023-08-03,CM,9,2023-08-03 13:36:00,Any visit,CM Start Date,2023-08-01,CM_CMSTDAT
NLD06,NLD_06_755,9,COMMON_CM,Any visit,2023-08-03,CM,9,2023-08-03 13:36:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD06,NLD_06_755,10,COMMON_CM,Any visit,2023-08-09,CM,10,2023-08-09 11:22:00,Any visit,CM Number,10,CM_CMSPID
NLD06,NLD_06_755,10,COMMON_CM,Any visit,2023-08-09,CM,10,2023-08-09 11:22:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
NLD06,NLD_06_755,10,COMMON_CM,Any visit,2023-08-09,CM,10,2023-08-09 11:22:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
NLD06,NLD_06_755,10,COMMON_CM,Any visit,2023-08-09,CM,10,2023-08-09 11:23:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD06,NLD_06_755,10,COMMON_CM,Any visit,2023-08-09,CM,10,2023-08-09 11:22:00,Any visit,CM Dose,600,CM_CMDOSE
NLD06,NLD_06_755,10,COMMON_CM,Any visit,2023-08-09,CM,10,2023-08-09 11:22:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,10,COMMON_CM,Any visit,2023-08-09,CM,10,2023-08-09 11:22:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
NLD06,NLD_06_755,10,COMMON_CM,Any visit,2023-08-09,CM,10,2023-08-09 11:23:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,10,COMMON_CM,Any visit,2023-08-09,CM,10,2023-08-09 11:22:00,Any visit,CM Start Date,2023-07-11,CM_CMSTDAT
NLD06,NLD_06_755,10,COMMON_CM,Any visit,2023-08-09,CM,10,2023-08-09 11:22:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,10,COMMON_CM,Any visit,2023-08-09,CM,10,2023-08-09 11:22:00,Any visit,CM End Date,2023-07-20,CM_CMENDAT
NLD06,NLD_06_755,11,COMMON_CM,Any visit,2023-08-09,CM,11,2023-08-09 11:26:00,Any visit,CM Number,11,CM_CMSPID
NLD06,NLD_06_755,11,COMMON_CM,Any visit,2023-08-09,CM,11,2023-08-09 11:26:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
NLD06,NLD_06_755,11,COMMON_CM,Any visit,2023-08-09,CM,11,2023-08-09 11:26:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
NLD06,NLD_06_755,11,COMMON_CM,Any visit,2023-08-09,CM,11,2023-08-09 11:26:00,Any visit,CM Indication,Infection,CM_CMINDC
NLD06,NLD_06_755,11,COMMON_CM,Any visit,2023-08-09,CM,11,2023-08-09 11:26:00,Any visit,CM Dose,1200,CM_CMDOSE
NLD06,NLD_06_755,11,COMMON_CM,Any visit,2023-08-09,CM,11,2023-08-09 11:26:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,11,COMMON_CM,Any visit,2023-08-09,CM,11,2023-08-09 11:26:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
NLD06,NLD_06_755,11,COMMON_CM,Any visit,2023-08-09,CM,11,2023-08-09 11:26:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,11,COMMON_CM,Any visit,2023-08-09,CM,11,2023-08-09 11:26:00,Any visit,CM Start Date,2023-07-21,CM_CMSTDAT
NLD06,NLD_06_755,11,COMMON_CM,Any visit,2023-08-09,CM,11,2023-08-09 11:26:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,11,COMMON_CM,Any visit,2023-08-09,CM,11,2023-08-09 11:26:00,Any visit,CM End Date,2023-08-03,CM_CMENDAT
NLD06,NLD_06_755,12,COMMON_CM,Any visit,2023-08-09,CM,12,2023-08-09 11:31:00,Any visit,CM Number,12,CM_CMSPID
NLD06,NLD_06_755,12,COMMON_CM,Any visit,2023-08-09,CM,12,2023-08-09 11:31:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
NLD06,NLD_06_755,12,COMMON_CM,Any visit,2023-08-09,CM,12,2023-08-09 11:31:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
NLD06,NLD_06_755,12,COMMON_CM,Any visit,2023-08-09,CM,12,2023-08-09 11:31:00,Any visit,CM Indication,Nausea,CM_CMINDC
NLD06,NLD_06_755,12,COMMON_CM,Any visit,2023-08-09,CM,12,2023-08-09 11:31:00,Any visit,CM Dose,1,CM_CMDOSE
NLD06,NLD_06_755,12,COMMON_CM,Any visit,2023-08-09,CM,12,2023-08-09 11:31:00,Any visit,CM Unit,Other,CM_CMDOSU
NLD06,NLD_06_755,12,COMMON_CM,Any visit,2023-08-09,CM,12,2023-08-09 11:31:00,Any visit,CM Unit Other,Tablett,CM_CMDOSU_OTH
NLD06,NLD_06_755,12,COMMON_CM,Any visit,2023-08-09,CM,12,2023-08-09 11:31:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
NLD06,NLD_06_755,12,COMMON_CM,Any visit,2023-08-09,CM,12,2023-08-09 11:31:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,12,COMMON_CM,Any visit,2023-08-09,CM,12,2023-08-09 11:31:00,Any visit,CM Start Date,2023-07-14,CM_CMSTDAT
NLD06,NLD_06_755,12,COMMON_CM,Any visit,2023-08-09,CM,12,2023-08-09 11:31:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,12,COMMON_CM,Any visit,2023-08-09,CM,12,2023-08-09 11:31:00,Any visit,CM End Date,2023-07-21,CM_CMENDAT
NLD06,NLD_06_755,13,COMMON_CM,Any visit,2023-08-09,CM,13,2023-08-09 11:46:00,Any visit,CM Number,13,CM_CMSPID
NLD06,NLD_06_755,13,COMMON_CM,Any visit,2023-08-09,CM,13,2023-08-09 11:46:00,Any visit,CM Trade Name,Bolidilanil,CM_CMTRT
NLD06,NLD_06_755,13,COMMON_CM,Any visit,2023-08-09,CM,13,2023-08-09 11:46:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
NLD06,NLD_06_755,13,COMMON_CM,Any visit,2023-08-09,CM,13,2023-08-09 11:46:00,Any visit,CM Indication,Nausea,CM_CMINDC
NLD06,NLD_06_755,13,COMMON_CM,Any visit,2023-08-09,CM,13,2023-08-09 11:46:00,Any visit,CM Dose,4,CM_CMDOSE
NLD06,NLD_06_755,13,COMMON_CM,Any visit,2023-08-09,CM,13,2023-08-09 11:46:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,13,COMMON_CM,Any visit,2023-08-09,CM,13,2023-08-10 07:49:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
NLD06,NLD_06_755,13,COMMON_CM,Any visit,2023-08-09,CM,13,2023-08-09 11:48:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD06,NLD_06_755,13,COMMON_CM,Any visit,2023-08-09,CM,13,2023-08-09 11:46:00,Any visit,CM Start Date,2023-07-13,CM_CMSTDAT
NLD06,NLD_06_755,13,COMMON_CM,Any visit,2023-08-09,CM,13,2023-08-10 07:49:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD06,NLD_06_755,14,COMMON_CM,Any visit,2023-08-09,CM,14,2023-08-09 12:06:00,Any visit,CM Number,14,CM_CMSPID
NLD06,NLD_06_755,14,COMMON_CM,Any visit,2023-08-09,CM,14,2023-08-09 12:06:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
NLD06,NLD_06_755,14,COMMON_CM,Any visit,2023-08-09,CM,14,2023-08-09 12:06:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
NLD06,NLD_06_755,14,COMMON_CM,Any visit,2023-08-09,CM,14,2023-08-09 12:06:00,Any visit,CM Indication,Nausea,CM_CMINDC
NLD06,NLD_06_755,14,COMMON_CM,Any visit,2023-08-09,CM,14,2023-08-09 12:06:00,Any visit,CM Dose,20,CM_CMDOSE
NLD06,NLD_06_755,14,COMMON_CM,Any visit,2023-08-09,CM,14,2023-08-09 12:06:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,14,COMMON_CM,Any visit,2023-08-09,CM,14,2023-08-09 12:06:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
NLD06,NLD_06_755,14,COMMON_CM,Any visit,2023-08-09,CM,14,2023-08-09 12:06:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
NLD06,NLD_06_755,14,COMMON_CM,Any visit,2023-08-09,CM,14,2023-08-09 12:06:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD06,NLD_06_755,14,COMMON_CM,Any visit,2023-08-09,CM,14,2023-08-09 12:06:00,Any visit,CM Start Date,2023-07-15,CM_CMSTDAT
NLD06,NLD_06_755,14,COMMON_CM,Any visit,2023-08-09,CM,14,2023-08-09 12:06:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,14,COMMON_CM,Any visit,2023-08-09,CM,14,2023-08-09 12:06:00,Any visit,CM End Date,2023-07-15,CM_CMENDAT
NLD06,NLD_06_755,15,COMMON_CM,Any visit,2023-08-09,CM,15,2023-08-09 12:36:00,Any visit,CM Number,15,CM_CMSPID
NLD06,NLD_06_755,15,COMMON_CM,Any visit,2023-08-09,CM,15,2023-08-09 12:36:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
NLD06,NLD_06_755,15,COMMON_CM,Any visit,2023-08-09,CM,15,2023-08-09 12:36:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
NLD06,NLD_06_755,15,COMMON_CM,Any visit,2023-08-09,CM,15,2023-08-09 12:36:00,Any visit,CM Indication,Infection,CM_CMINDC
NLD06,NLD_06_755,15,COMMON_CM,Any visit,2023-08-09,CM,15,2023-08-09 12:36:00,Any visit,CM Dose,1000,CM_CMDOSE
NLD06,NLD_06_755,15,COMMON_CM,Any visit,2023-08-09,CM,15,2023-08-09 12:36:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,15,COMMON_CM,Any visit,2023-08-09,CM,15,2023-08-09 12:36:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
NLD06,NLD_06_755,15,COMMON_CM,Any visit,2023-08-09,CM,15,2023-08-09 12:36:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
NLD06,NLD_06_755,15,COMMON_CM,Any visit,2023-08-09,CM,15,2023-08-09 12:36:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,15,COMMON_CM,Any visit,2023-08-09,CM,15,2023-08-09 12:36:00,Any visit,CM Start Date,2023-07-17,CM_CMSTDAT
NLD06,NLD_06_755,15,COMMON_CM,Any visit,2023-08-09,CM,15,2023-08-09 12:36:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,15,COMMON_CM,Any visit,2023-08-09,CM,15,2023-08-09 12:36:00,Any visit,CM End Date,2023-07-17,CM_CMENDAT
NLD06,NLD_06_755,16,COMMON_CM,Any visit,2023-08-09,CM,16,2023-08-09 12:45:00,Any visit,CM Number,16,CM_CMSPID
NLD06,NLD_06_755,16,COMMON_CM,Any visit,2023-08-09,CM,16,2023-08-09 12:45:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
NLD06,NLD_06_755,16,COMMON_CM,Any visit,2023-08-09,CM,16,2023-08-30 09:23:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
NLD06,NLD_06_755,16,COMMON_CM,Any visit,2023-08-09,CM,16,2023-08-09 12:45:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD06,NLD_06_755,16,COMMON_CM,Any visit,2023-08-09,CM,16,2023-08-09 12:45:00,Any visit,CM Dose,5,CM_CMDOSE
NLD06,NLD_06_755,16,COMMON_CM,Any visit,2023-08-09,CM,16,2023-08-09 12:45:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,16,COMMON_CM,Any visit,2023-08-09,CM,16,2023-08-09 12:45:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD06,NLD_06_755,16,COMMON_CM,Any visit,2023-08-09,CM,16,2023-08-09 12:45:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,16,COMMON_CM,Any visit,2023-08-09,CM,16,2023-08-09 12:45:00,Any visit,CM Start Date,2023-07-18,CM_CMSTDAT
NLD06,NLD_06_755,16,COMMON_CM,Any visit,2023-08-09,CM,16,2023-08-09 12:45:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD06,NLD_06_755,17,COMMON_CM,Any visit,2023-08-09,CM,17,2023-08-09 13:04:00,Any visit,CM Number,17,CM_CMSPID
NLD06,NLD_06_755,17,COMMON_CM,Any visit,2023-08-09,CM,17,2023-08-09 13:04:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
NLD06,NLD_06_755,17,COMMON_CM,Any visit,2023-08-09,CM,17,2023-08-09 13:04:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
NLD06,NLD_06_755,17,COMMON_CM,Any visit,2023-08-09,CM,17,2023-08-09 13:04:00,Any visit,CM Indication,Nausea,CM_CMINDC
NLD06,NLD_06_755,17,COMMON_CM,Any visit,2023-08-09,CM,17,2023-08-09 13:04:00,Any visit,CM Dose,500,CM_CMDOSE
NLD06,NLD_06_755,17,COMMON_CM,Any visit,2023-08-09,CM,17,2023-08-09 13:04:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,17,COMMON_CM,Any visit,2023-08-09,CM,17,2023-08-09 13:04:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
NLD06,NLD_06_755,17,COMMON_CM,Any visit,2023-08-09,CM,17,2023-08-09 13:04:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,17,COMMON_CM,Any visit,2023-08-09,CM,17,2023-08-09 13:04:00,Any visit,CM Start Date,2023-07-18,CM_CMSTDAT
NLD06,NLD_06_755,17,COMMON_CM,Any visit,2023-08-09,CM,17,2023-08-09 13:04:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,17,COMMON_CM,Any visit,2023-08-09,CM,17,2023-08-09 13:04:00,Any visit,CM End Date,2023-07-19,CM_CMENDAT
NLD06,NLD_06_755,18,COMMON_CM,Any visit,2023-08-09,CM,18,2023-08-09 13:06:00,Any visit,CM Number,18,CM_CMSPID
NLD06,NLD_06_755,18,COMMON_CM,Any visit,2023-08-09,CM,18,2023-08-09 13:06:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
NLD06,NLD_06_755,18,COMMON_CM,Any visit,2023-08-09,CM,18,2023-08-09 13:06:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
NLD06,NLD_06_755,18,COMMON_CM,Any visit,2023-08-09,CM,18,2023-08-09 13:06:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD06,NLD_06_755,18,COMMON_CM,Any visit,2023-08-09,CM,18,2023-08-09 13:06:00,Any visit,CM Dose,1000,CM_CMDOSE
NLD06,NLD_06_755,18,COMMON_CM,Any visit,2023-08-09,CM,18,2023-08-09 13:06:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,18,COMMON_CM,Any visit,2023-08-09,CM,18,2023-08-09 13:06:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
NLD06,NLD_06_755,18,COMMON_CM,Any visit,2023-08-09,CM,18,2023-08-09 13:06:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,18,COMMON_CM,Any visit,2023-08-09,CM,18,2023-08-09 13:06:00,Any visit,CM Start Date,2023-07-19,CM_CMSTDAT
NLD06,NLD_06_755,18,COMMON_CM,Any visit,2023-08-09,CM,18,2023-08-09 13:06:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD06,NLD_06_755,19,COMMON_CM,Any visit,2023-08-09,CM,19,2023-08-09 13:13:00,Any visit,CM Number,19,CM_CMSPID
NLD06,NLD_06_755,19,COMMON_CM,Any visit,2023-08-09,CM,19,2023-08-09 13:13:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
NLD06,NLD_06_755,19,COMMON_CM,Any visit,2023-08-09,CM,19,2023-08-09 13:13:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
NLD06,NLD_06_755,19,COMMON_CM,Any visit,2023-08-09,CM,19,2023-08-09 13:13:00,Any visit,CM Indication,Hypertension,CM_CMINDC
NLD06,NLD_06_755,19,COMMON_CM,Any visit,2023-08-09,CM,19,2023-08-09 13:13:00,Any visit,CM Dose,20,CM_CMDOSE
NLD06,NLD_06_755,19,COMMON_CM,Any visit,2023-08-09,CM,19,2023-08-09 13:13:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,19,COMMON_CM,Any visit,2023-08-09,CM,19,2023-08-09 13:13:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD06,NLD_06_755,19,COMMON_CM,Any visit,2023-08-09,CM,19,2023-08-09 13:13:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD06,NLD_06_755,19,COMMON_CM,Any visit,2023-08-09,CM,19,2023-08-09 13:13:00,Any visit,CM Start Date,2023-07-20,CM_CMSTDAT
NLD06,NLD_06_755,19,COMMON_CM,Any visit,2023-08-09,CM,19,2023-08-09 13:13:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,19,COMMON_CM,Any visit,2023-08-09,CM,19,2023-08-09 13:13:00,Any visit,CM End Date,2023-07-24,CM_CMENDAT
NLD06,NLD_06_755,20,COMMON_CM,Any visit,2023-08-09,CM,20,2023-08-09 13:25:00,Any visit,CM Number,20,CM_CMSPID
NLD06,NLD_06_755,20,COMMON_CM,Any visit,2023-08-09,CM,20,2023-08-09 13:25:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
NLD06,NLD_06_755,20,COMMON_CM,Any visit,2023-08-09,CM,20,2023-08-09 13:25:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
NLD06,NLD_06_755,20,COMMON_CM,Any visit,2023-08-09,CM,20,2023-08-09 13:25:00,Any visit,CM Indication,Adverse event,CM_CMINDC
NLD06,NLD_06_755,20,COMMON_CM,Any visit,2023-08-09,CM,20,2023-08-09 13:25:00,Any visit,CM Dose,5,CM_CMDOSE
NLD06,NLD_06_755,20,COMMON_CM,Any visit,2023-08-09,CM,20,2023-08-09 13:25:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,20,COMMON_CM,Any visit,2023-08-09,CM,20,2023-08-09 13:25:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD06,NLD_06_755,20,COMMON_CM,Any visit,2023-08-09,CM,20,2023-08-09 13:25:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,20,COMMON_CM,Any visit,2023-08-09,CM,20,2023-08-09 13:25:00,Any visit,CM Start Date,2023-07-25,CM_CMSTDAT
NLD06,NLD_06_755,20,COMMON_CM,Any visit,2023-08-09,CM,20,2023-08-09 13:25:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,20,COMMON_CM,Any visit,2023-08-09,CM,20,2023-08-09 13:25:00,Any visit,CM End Date,2023-07-31,CM_CMENDAT
NLD06,NLD_06_755,21,COMMON_CM,Any visit,2023-08-09,CM,21,2023-08-09 14:06:00,Any visit,CM Number,21,CM_CMSPID
NLD06,NLD_06_755,21,COMMON_CM,Any visit,2023-08-09,CM,21,2023-08-09 14:06:00,Any visit,CM Trade Name,Sulfatoxipladib,CM_CMTRT
NLD06,NLD_06_755,21,COMMON_CM,Any visit,2023-08-09,CM,21,2023-08-09 14:06:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
NLD06,NLD_06_755,21,COMMON_CM,Any visit,2023-08-09,CM,21,2023-08-09 14:06:00,Any visit,CM Indication,Hypertension,CM_CMINDC
NLD06,NLD_06_755,21,COMMON_CM,Any visit,2023-08-09,CM,21,2023-08-09 14:06:00,Any visit,CM Dose,1250,CM_CMDOSE
NLD06,NLD_06_755,21,COMMON_CM,Any visit,2023-08-09,CM,21,2023-08-09 14:06:00,Any visit,CM Unit,International Unit (IU),CM_CMDOSU
NLD06,NLD_06_755,21,COMMON_CM,Any visit,2023-08-09,CM,21,2023-08-09 14:06:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
NLD06,NLD_06_755,21,COMMON_CM,Any visit,2023-08-09,CM,21,2023-08-09 14:06:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
NLD06,NLD_06_755,21,COMMON_CM,Any visit,2023-08-09,CM,21,2023-08-09 14:06:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD06,NLD_06_755,21,COMMON_CM,Any visit,2023-08-09,CM,21,2023-08-09 14:06:00,Any visit,CM Start Date,2023-08-02,CM_CMSTDAT
NLD06,NLD_06_755,21,COMMON_CM,Any visit,2023-08-09,CM,21,2023-08-09 14:06:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,21,COMMON_CM,Any visit,2023-08-09,CM,21,2023-08-09 14:06:00,Any visit,CM End Date,2023-08-02,CM_CMENDAT
NLD06,NLD_06_755,22,COMMON_CM,Any visit,2023-08-09,CM,22,2023-08-09 14:14:00,Any visit,CM Number,22,CM_CMSPID
NLD06,NLD_06_755,22,COMMON_CM,Any visit,2023-08-09,CM,22,2023-08-09 14:14:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
NLD06,NLD_06_755,22,COMMON_CM,Any visit,2023-08-09,CM,22,2023-08-09 14:14:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
NLD06,NLD_06_755,22,COMMON_CM,Any visit,2023-08-09,CM,22,2023-08-09 14:14:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD06,NLD_06_755,22,COMMON_CM,Any visit,2023-08-09,CM,22,2023-08-09 14:14:00,Any visit,CM Dose,10,CM_CMDOSE
NLD06,NLD_06_755,22,COMMON_CM,Any visit,2023-08-09,CM,22,2023-08-09 14:14:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,22,COMMON_CM,Any visit,2023-08-09,CM,22,2023-08-09 14:14:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD06,NLD_06_755,22,COMMON_CM,Any visit,2023-08-09,CM,22,2023-08-09 14:14:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD06,NLD_06_755,22,COMMON_CM,Any visit,2023-08-09,CM,22,2023-08-09 14:14:00,Any visit,CM Start Date,2023-08-04,CM_CMSTDAT
NLD06,NLD_06_755,22,COMMON_CM,Any visit,2023-08-09,CM,22,2023-08-09 14:14:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,22,COMMON_CM,Any visit,2023-08-09,CM,22,2023-08-09 14:14:00,Any visit,CM End Date,2023-08-06,CM_CMENDAT
NLD06,NLD_06_755,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 07:12:00,Any visit,CM Number,23,CM_CMSPID
NLD06,NLD_06_755,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 07:12:00,Any visit,CM Trade Name,Gliigestatrilat,CM_CMTRT
NLD06,NLD_06_755,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 07:12:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
NLD06,NLD_06_755,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 07:12:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
NLD06,NLD_06_755,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 07:12:00,Any visit,CM Dose,1000,CM_CMDOSE
NLD06,NLD_06_755,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 07:12:00,Any visit,CM Unit,Microgram (µg),CM_CMDOSU
NLD06,NLD_06_755,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 07:12:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
NLD06,NLD_06_755,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 07:12:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
NLD06,NLD_06_755,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 07:12:00,Any visit,CM Route,Subcutaneous (s.c.),CM_CMROUTE
NLD06,NLD_06_755,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 07:12:00,Any visit,CM Start Date,2023-08-07,CM_CMSTDAT
NLD06,NLD_06_755,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 07:12:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 07:12:00,Any visit,CM End Date,2023-08-07,CM_CMENDAT
NLD06,NLD_06_755,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 07:23:00,Any visit,CM Number,24,CM_CMSPID
NLD06,NLD_06_755,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 07:23:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
NLD06,NLD_06_755,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 07:23:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
NLD06,NLD_06_755,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 07:23:00,Any visit,CM Indication,Insomnia,CM_CMINDC
NLD06,NLD_06_755,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 07:23:00,Any visit,CM Dose,4,CM_CMDOSE
NLD06,NLD_06_755,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 07:23:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 07:23:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
NLD06,NLD_06_755,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 07:23:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
NLD06,NLD_06_755,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 07:23:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 07:23:00,Any visit,CM Start Date,2023-07-14,CM_CMSTDAT
NLD06,NLD_06_755,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 07:23:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 07:23:00,Any visit,CM End Date,2023-07-14,CM_CMENDAT
NLD06,NLD_06_755,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 07:26:00,Any visit,CM Number,25,CM_CMSPID
NLD06,NLD_06_755,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 07:26:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
NLD06,NLD_06_755,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 07:26:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
NLD06,NLD_06_755,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 07:26:00,Any visit,CM Indication,Insomnia,CM_CMINDC
NLD06,NLD_06_755,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 07:26:00,Any visit,CM Dose,1,CM_CMDOSE
NLD06,NLD_06_755,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 07:26:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
NLD06,NLD_06_755,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 07:48:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
NLD06,NLD_06_755,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 07:26:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 07:26:00,Any visit,CM Start Date,2023-07-14,CM_CMSTDAT
NLD06,NLD_06_755,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 07:48:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD06,NLD_06_755,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 07:42:00,Any visit,CM Number,26,CM_CMSPID
NLD06,NLD_06_755,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 07:42:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
NLD06,NLD_06_755,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 07:42:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
NLD06,NLD_06_755,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 07:44:00,Any visit,CM Indication,Nausea,CM_CMINDC
NLD06,NLD_06_755,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 07:42:00,Any visit,CM Dose,200,CM_CMDOSE
NLD06,NLD_06_755,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 07:42:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 07:47:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
NLD06,NLD_06_755,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 07:42:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD06,NLD_06_755,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 07:42:00,Any visit,CM Start Date,2023-07-14,CM_CMSTDAT
NLD06,NLD_06_755,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 07:47:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD06,NLD_06_755,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 08:17:00,Any visit,CM Number,27,CM_CMSPID
NLD06,NLD_06_755,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 08:17:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
NLD06,NLD_06_755,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 08:17:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
NLD06,NLD_06_755,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 08:17:00,Any visit,CM Indication,Adverse event,CM_CMINDC
NLD06,NLD_06_755,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 08:17:00,Any visit,CM Dose,20,CM_CMDOSE
NLD06,NLD_06_755,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 08:17:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 08:17:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
NLD06,NLD_06_755,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 08:17:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
NLD06,NLD_06_755,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 08:17:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 08:17:00,Any visit,CM Start Date,2023-08-08,CM_CMSTDAT
NLD06,NLD_06_755,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 08:17:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 08:17:00,Any visit,CM End Date,2023-08-08,CM_CMENDAT
NLD06,NLD_06_755,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 08:21:00,Any visit,CM Number,28,CM_CMSPID
NLD06,NLD_06_755,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 08:21:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
NLD06,NLD_06_755,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 08:21:00,Any visit,CM Active Ingredient,Meloxicam,CM_CMINGRD
NLD06,NLD_06_755,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 08:21:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
NLD06,NLD_06_755,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 08:21:00,Any visit,CM Dose,1000,CM_CMDOSE
NLD06,NLD_06_755,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 08:21:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 08:21:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD06,NLD_06_755,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 08:21:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD06,NLD_06_755,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 08:21:00,Any visit,CM Start Date,2023-08-08,CM_CMSTDAT
NLD06,NLD_06_755,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 08:21:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD06,NLD_06_755,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 08:34:00,Any visit,CM Number,29,CM_CMSPID
NLD06,NLD_06_755,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 08:34:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
NLD06,NLD_06_755,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 08:34:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
NLD06,NLD_06_755,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 08:34:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
NLD06,NLD_06_755,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 08:34:00,Any visit,CM Dose,1,CM_CMDOSE
NLD06,NLD_06_755,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 08:34:00,Any visit,CM Unit,Unknown,CM_CMDOSU
NLD06,NLD_06_755,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 08:34:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
NLD06,NLD_06_755,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 08:34:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 08:34:00,Any visit,CM Start Date,2023-07-26,CM_CMSTDAT
NLD06,NLD_06_755,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 08:34:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD06,NLD_06_755,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 08:41:00,Any visit,CM Number,30,CM_CMSPID
NLD06,NLD_06_755,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 08:41:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
NLD06,NLD_06_755,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 08:41:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
NLD06,NLD_06_755,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 08:41:00,Any visit,CM Indication,Insomnia,CM_CMINDC
NLD06,NLD_06_755,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 08:41:00,Any visit,CM Dose,20,CM_CMDOSE
NLD06,NLD_06_755,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 08:41:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 08:41:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
NLD06,NLD_06_755,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 08:41:00,Any visit,CM Route,Inhalation (p.i.),CM_CMROUTE
NLD06,NLD_06_755,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 08:41:00,Any visit,CM Start Date,2023-07-23,CM_CMSTDAT
NLD06,NLD_06_755,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 08:41:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD06,NLD_06_755,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 08:46:00,Any visit,CM Number,31,CM_CMSPID
NLD06,NLD_06_755,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 08:46:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
NLD06,NLD_06_755,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 08:46:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
NLD06,NLD_06_755,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 08:46:00,Any visit,CM Indication,Adverse event,CM_CMINDC
NLD06,NLD_06_755,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 08:46:00,Any visit,CM Dose,5,CM_CMDOSE
NLD06,NLD_06_755,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 08:46:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 08:49:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
NLD06,NLD_06_755,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 08:49:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
NLD06,NLD_06_755,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 08:46:00,Any visit,CM Route,Inhalation (p.i.),CM_CMROUTE
NLD06,NLD_06_755,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 08:46:00,Any visit,CM Start Date,2023-07-14,CM_CMSTDAT
NLD06,NLD_06_755,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 08:49:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 08:49:00,Any visit,CM End Date,2023-07-14,CM_CMENDAT
NLD06,NLD_06_755,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 08:51:00,Any visit,CM Number,32,CM_CMSPID
NLD06,NLD_06_755,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 08:51:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
NLD06,NLD_06_755,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 08:51:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
NLD06,NLD_06_755,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 08:51:00,Any visit,CM Indication,Insomnia,CM_CMINDC
NLD06,NLD_06_755,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 08:51:00,Any visit,CM Dose,250,CM_CMDOSE
NLD06,NLD_06_755,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 08:51:00,Any visit,CM Unit,Microgram (µg),CM_CMDOSU
NLD06,NLD_06_755,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 08:51:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
NLD06,NLD_06_755,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 08:51:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
NLD06,NLD_06_755,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 08:51:00,Any visit,CM Route,Inhalation (p.i.),CM_CMROUTE
NLD06,NLD_06_755,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 08:51:00,Any visit,CM Start Date,2023-07-14,CM_CMSTDAT
NLD06,NLD_06_755,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 08:51:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 08:51:00,Any visit,CM End Date,2023-07-14,CM_CMENDAT
NLD06,NLD_06_755,33,COMMON_CM,Any visit,2023-08-23,CM,33,2023-08-23 13:24:00,Any visit,CM Number,33,CM_CMSPID
NLD06,NLD_06_755,33,COMMON_CM,Any visit,2023-08-23,CM,33,2023-08-23 13:24:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
NLD06,NLD_06_755,33,COMMON_CM,Any visit,2023-08-23,CM,33,2023-08-23 13:24:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
NLD06,NLD_06_755,33,COMMON_CM,Any visit,2023-08-23,CM,33,2023-08-23 13:24:00,Any visit,CM Indication,Nausea,CM_CMINDC
NLD06,NLD_06_755,33,COMMON_CM,Any visit,2023-08-23,CM,33,2023-08-23 13:24:00,Any visit,CM Dose,10,CM_CMDOSE
NLD06,NLD_06_755,33,COMMON_CM,Any visit,2023-08-23,CM,33,2023-08-23 13:24:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,33,COMMON_CM,Any visit,2023-08-23,CM,33,2023-08-23 13:24:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
NLD06,NLD_06_755,33,COMMON_CM,Any visit,2023-08-23,CM,33,2023-08-23 13:24:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD06,NLD_06_755,33,COMMON_CM,Any visit,2023-08-23,CM,33,2023-08-23 13:24:00,Any visit,CM Start Date,2023-08-22,CM_CMSTDAT
NLD06,NLD_06_755,33,COMMON_CM,Any visit,2023-08-23,CM,33,2023-08-23 13:24:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD06,NLD_06_755,34,COMMON_CM,Any visit,2023-08-23,CM,34,2023-08-23 13:26:00,Any visit,CM Number,34,CM_CMSPID
NLD06,NLD_06_755,34,COMMON_CM,Any visit,2023-08-23,CM,34,2023-08-23 13:26:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
NLD06,NLD_06_755,34,COMMON_CM,Any visit,2023-08-23,CM,34,2023-08-23 13:26:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
NLD06,NLD_06_755,34,COMMON_CM,Any visit,2023-08-23,CM,34,2023-08-23 13:26:00,Any visit,CM Indication,Hypertension,CM_CMINDC
NLD06,NLD_06_755,34,COMMON_CM,Any visit,2023-08-23,CM,34,2023-08-23 13:26:00,Any visit,CM Dose,20,CM_CMDOSE
NLD06,NLD_06_755,34,COMMON_CM,Any visit,2023-08-23,CM,34,2023-08-23 13:26:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,34,COMMON_CM,Any visit,2023-08-23,CM,34,2023-08-23 13:26:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
NLD06,NLD_06_755,34,COMMON_CM,Any visit,2023-08-23,CM,34,2023-08-23 13:26:00,Any visit,CM Frequency Other,continous,CM_CMDOSFRQ_OTH
NLD06,NLD_06_755,34,COMMON_CM,Any visit,2023-08-23,CM,34,2023-08-23 13:26:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD06,NLD_06_755,34,COMMON_CM,Any visit,2023-08-23,CM,34,2023-08-23 13:26:00,Any visit,CM Start Date,2023-08-22,CM_CMSTDAT
NLD06,NLD_06_755,34,COMMON_CM,Any visit,2023-08-23,CM,34,2023-08-23 13:26:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD06,NLD_06_755,35,COMMON_CM,Any visit,2023-08-30,CM,35,2023-08-30 09:21:00,Any visit,CM Number,35,CM_CMSPID
NLD06,NLD_06_755,35,COMMON_CM,Any visit,2023-08-30,CM,35,2023-08-30 09:21:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
NLD06,NLD_06_755,35,COMMON_CM,Any visit,2023-08-30,CM,35,2023-08-30 09:21:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
NLD06,NLD_06_755,35,COMMON_CM,Any visit,2023-08-30,CM,35,2023-08-30 11:03:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD06,NLD_06_755,35,COMMON_CM,Any visit,2023-08-30,CM,35,2023-08-30 09:21:00,Any visit,CM Dose,200,CM_CMDOSE
NLD06,NLD_06_755,35,COMMON_CM,Any visit,2023-08-30,CM,35,2023-08-30 09:21:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,35,COMMON_CM,Any visit,2023-08-30,CM,35,2023-08-30 09:21:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
NLD06,NLD_06_755,35,COMMON_CM,Any visit,2023-08-30,CM,35,2023-08-30 09:21:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
NLD06,NLD_06_755,35,COMMON_CM,Any visit,2023-08-30,CM,35,2023-08-30 09:21:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD06,NLD_06_755,35,COMMON_CM,Any visit,2023-08-30,CM,35,2023-08-30 09:21:00,Any visit,CM Start Date,2023-08-11,CM_CMSTDAT
NLD06,NLD_06_755,35,COMMON_CM,Any visit,2023-08-30,CM,35,2023-08-30 09:21:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,35,COMMON_CM,Any visit,2023-08-30,CM,35,2023-08-30 09:21:00,Any visit,CM End Date,2023-08-11,CM_CMENDAT
NLD06,NLD_06_755,36,COMMON_CM,Any visit,2023-08-30,CM,36,2023-08-30 10:57:00,Any visit,CM Number,36,CM_CMSPID
NLD06,NLD_06_755,36,COMMON_CM,Any visit,2023-08-30,CM,36,2023-08-30 10:57:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
NLD06,NLD_06_755,36,COMMON_CM,Any visit,2023-08-30,CM,36,2023-08-30 10:57:00,Any visit,CM Active Ingredient,Meloxicam,CM_CMINGRD
NLD06,NLD_06_755,36,COMMON_CM,Any visit,2023-08-30,CM,36,2023-08-30 10:57:00,Any visit,CM Indication,Infection,CM_CMINDC
NLD06,NLD_06_755,36,COMMON_CM,Any visit,2023-08-30,CM,36,2023-08-30 10:57:00,Any visit,CM Dose,7,CM_CMDOSE
NLD06,NLD_06_755,36,COMMON_CM,Any visit,2023-08-30,CM,36,2023-08-30 10:57:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,36,COMMON_CM,Any visit,2023-08-30,CM,36,2023-08-30 10:57:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
NLD06,NLD_06_755,36,COMMON_CM,Any visit,2023-08-30,CM,36,2023-08-30 10:57:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
NLD06,NLD_06_755,36,COMMON_CM,Any visit,2023-08-30,CM,36,2023-08-30 10:59:00,Any visit,CM Route,Subcutaneous (s.c.),CM_CMROUTE
NLD06,NLD_06_755,36,COMMON_CM,Any visit,2023-08-30,CM,36,2023-08-30 10:57:00,Any visit,CM Start Date,2023-08-11,CM_CMSTDAT
NLD06,NLD_06_755,36,COMMON_CM,Any visit,2023-08-30,CM,36,2023-08-30 10:57:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,36,COMMON_CM,Any visit,2023-08-30,CM,36,2023-08-30 10:57:00,Any visit,CM End Date,2023-08-11,CM_CMENDAT
NLD06,NLD_06_755,37,COMMON_CM,Any visit,2023-08-30,CM,37,2023-08-30 11:06:00,Any visit,CM Number,37,CM_CMSPID
NLD06,NLD_06_755,37,COMMON_CM,Any visit,2023-08-30,CM,37,2023-08-30 11:06:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
NLD06,NLD_06_755,37,COMMON_CM,Any visit,2023-08-30,CM,37,2023-08-30 11:06:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
NLD06,NLD_06_755,37,COMMON_CM,Any visit,2023-08-30,CM,37,2023-08-30 11:06:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD06,NLD_06_755,37,COMMON_CM,Any visit,2023-08-30,CM,37,2023-08-30 11:06:00,Any visit,CM Dose,20,CM_CMDOSE
NLD06,NLD_06_755,37,COMMON_CM,Any visit,2023-08-30,CM,37,2023-08-30 11:06:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,37,COMMON_CM,Any visit,2023-08-30,CM,37,2023-08-30 11:06:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
NLD06,NLD_06_755,37,COMMON_CM,Any visit,2023-08-30,CM,37,2023-08-30 11:06:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD06,NLD_06_755,37,COMMON_CM,Any visit,2023-08-30,CM,37,2023-08-30 11:06:00,Any visit,CM Start Date,2023-08-14,CM_CMSTDAT
NLD06,NLD_06_755,37,COMMON_CM,Any visit,2023-08-30,CM,37,2023-08-30 11:06:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,37,COMMON_CM,Any visit,2023-08-30,CM,37,2023-08-30 11:06:00,Any visit,CM End Date,2023-08-16,CM_CMENDAT
NLD06,NLD_06_755,38,COMMON_CM,Any visit,2023-08-30,CM,38,2023-08-30 11:40:00,Any visit,CM Number,38,CM_CMSPID
NLD06,NLD_06_755,38,COMMON_CM,Any visit,2023-08-30,CM,38,2023-08-30 11:40:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
NLD06,NLD_06_755,38,COMMON_CM,Any visit,2023-08-30,CM,38,2023-08-30 11:40:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
NLD06,NLD_06_755,38,COMMON_CM,Any visit,2023-08-30,CM,38,2023-08-30 11:40:00,Any visit,CM Indication,Insomnia,CM_CMINDC
NLD06,NLD_06_755,38,COMMON_CM,Any visit,2023-08-30,CM,38,2023-08-30 11:40:00,Any visit,CM Dose,1250,CM_CMDOSE
NLD06,NLD_06_755,38,COMMON_CM,Any visit,2023-08-30,CM,38,2023-08-30 11:40:00,Any visit,CM Unit,International Unit (IU),CM_CMDOSU
NLD06,NLD_06_755,38,COMMON_CM,Any visit,2023-08-30,CM,38,2023-08-30 11:40:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
NLD06,NLD_06_755,38,COMMON_CM,Any visit,2023-08-30,CM,38,2023-08-30 11:40:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
NLD06,NLD_06_755,38,COMMON_CM,Any visit,2023-08-30,CM,38,2023-08-30 11:40:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD06,NLD_06_755,38,COMMON_CM,Any visit,2023-08-30,CM,38,2023-08-30 11:40:00,Any visit,CM Start Date,2023-08-09,CM_CMSTDAT
NLD06,NLD_06_755,38,COMMON_CM,Any visit,2023-08-30,CM,38,2023-08-30 11:40:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,38,COMMON_CM,Any visit,2023-08-30,CM,38,2023-08-30 11:40:00,Any visit,CM End Date,2023-08-09,CM_CMENDAT
NLD06,NLD_06_755,39,COMMON_CM,Any visit,2023-08-30,CM,39,2023-08-30 11:58:00,Any visit,CM Number,39,CM_CMSPID
NLD06,NLD_06_755,39,COMMON_CM,Any visit,2023-08-30,CM,39,2023-08-30 11:58:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
NLD06,NLD_06_755,39,COMMON_CM,Any visit,2023-08-30,CM,39,2023-08-30 11:58:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
NLD06,NLD_06_755,39,COMMON_CM,Any visit,2023-08-30,CM,39,2023-08-30 11:58:00,Any visit,CM Indication,Insomnia,CM_CMINDC
NLD06,NLD_06_755,39,COMMON_CM,Any visit,2023-08-30,CM,39,2023-08-30 11:58:00,Any visit,CM Dose,50,CM_CMDOSE
NLD06,NLD_06_755,39,COMMON_CM,Any visit,2023-08-30,CM,39,2023-08-30 11:58:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,39,COMMON_CM,Any visit,2023-08-30,CM,39,2023-08-30 11:58:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
NLD06,NLD_06_755,39,COMMON_CM,Any visit,2023-08-30,CM,39,2023-08-30 11:58:00,Any visit,CM Frequency Other,once,CM_CMDOSFRQ_OTH
NLD06,NLD_06_755,39,COMMON_CM,Any visit,2023-08-30,CM,39,2023-08-30 11:58:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,39,COMMON_CM,Any visit,2023-08-30,CM,39,2023-08-30 11:58:00,Any visit,CM Start Date,2023-08-18,CM_CMSTDAT
NLD06,NLD_06_755,39,COMMON_CM,Any visit,2023-08-30,CM,39,2023-08-30 11:58:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,39,COMMON_CM,Any visit,2023-08-30,CM,39,2023-08-30 11:58:00,Any visit,CM End Date,2023-08-18,CM_CMENDAT
NLD06,NLD_06_755,40,COMMON_CM,Any visit,2023-08-30,CM,40,2023-08-30 12:01:00,Any visit,CM Number,40,CM_CMSPID
NLD06,NLD_06_755,40,COMMON_CM,Any visit,2023-08-30,CM,40,2023-08-30 12:01:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
NLD06,NLD_06_755,40,COMMON_CM,Any visit,2023-08-30,CM,40,2023-08-30 12:01:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
NLD06,NLD_06_755,40,COMMON_CM,Any visit,2023-08-30,CM,40,2023-08-30 12:01:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD06,NLD_06_755,40,COMMON_CM,Any visit,2023-08-30,CM,40,2023-08-30 12:01:00,Any visit,CM Dose,15,CM_CMDOSE
NLD06,NLD_06_755,40,COMMON_CM,Any visit,2023-08-30,CM,40,2023-08-30 12:01:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,40,COMMON_CM,Any visit,2023-08-30,CM,40,2023-08-30 12:01:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
NLD06,NLD_06_755,40,COMMON_CM,Any visit,2023-08-30,CM,40,2023-08-30 12:01:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,40,COMMON_CM,Any visit,2023-08-30,CM,40,2023-08-30 12:01:00,Any visit,CM Start Date,2023-08-19,CM_CMSTDAT
NLD06,NLD_06_755,40,COMMON_CM,Any visit,2023-08-30,CM,40,2023-08-30 12:01:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,40,COMMON_CM,Any visit,2023-08-30,CM,40,2023-08-30 12:01:00,Any visit,CM End Date,2023-08-22,CM_CMENDAT
NLD06,NLD_06_755,41,COMMON_CM,Any visit,2023-08-30,CM,41,2023-08-30 12:03:00,Any visit,CM Number,41,CM_CMSPID
NLD06,NLD_06_755,41,COMMON_CM,Any visit,2023-08-30,CM,41,2023-08-30 12:03:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
NLD06,NLD_06_755,41,COMMON_CM,Any visit,2023-08-30,CM,41,2023-08-30 12:03:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
NLD06,NLD_06_755,41,COMMON_CM,Any visit,2023-08-30,CM,41,2023-08-30 12:03:00,Any visit,CM Indication,Infection,CM_CMINDC
NLD06,NLD_06_755,41,COMMON_CM,Any visit,2023-08-30,CM,41,2023-08-30 12:03:00,Any visit,CM Dose,30,CM_CMDOSE
NLD06,NLD_06_755,41,COMMON_CM,Any visit,2023-08-30,CM,41,2023-08-30 12:03:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,41,COMMON_CM,Any visit,2023-08-30,CM,41,2023-08-30 12:03:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
NLD06,NLD_06_755,41,COMMON_CM,Any visit,2023-08-30,CM,41,2023-08-30 12:03:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,41,COMMON_CM,Any visit,2023-08-30,CM,41,2023-08-30 12:03:00,Any visit,CM Start Date,2023-08-20,CM_CMSTDAT
NLD06,NLD_06_755,41,COMMON_CM,Any visit,2023-08-30,CM,41,2023-08-30 12:03:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,41,COMMON_CM,Any visit,2023-08-30,CM,41,2023-08-30 12:03:00,Any visit,CM End Date,2023-08-22,CM_CMENDAT
NLD06,NLD_06_755,42,COMMON_CM,Any visit,2023-08-30,CM,42,2023-08-30 12:13:00,Any visit,CM Number,42,CM_CMSPID
NLD06,NLD_06_755,42,COMMON_CM,Any visit,2023-08-30,CM,42,2023-08-30 12:13:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
NLD06,NLD_06_755,42,COMMON_CM,Any visit,2023-08-30,CM,42,2023-08-30 12:13:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
NLD06,NLD_06_755,42,COMMON_CM,Any visit,2023-08-30,CM,42,2023-08-30 12:13:00,Any visit,CM Indication,Insomnia,CM_CMINDC
NLD06,NLD_06_755,42,COMMON_CM,Any visit,2023-08-30,CM,42,2023-08-30 12:13:00,Any visit,CM Dose,600,CM_CMDOSE
NLD06,NLD_06_755,42,COMMON_CM,Any visit,2023-08-30,CM,42,2023-08-30 12:13:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_755,42,COMMON_CM,Any visit,2023-08-30,CM,42,2023-08-30 12:13:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
NLD06,NLD_06_755,42,COMMON_CM,Any visit,2023-08-30,CM,42,2023-08-30 12:13:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_755,42,COMMON_CM,Any visit,2023-08-30,CM,42,2023-08-30 12:13:00,Any visit,CM Start Date,2023-08-06,CM_CMSTDAT
NLD06,NLD_06_755,42,COMMON_CM,Any visit,2023-08-30,CM,42,2023-08-30 12:13:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_755,42,COMMON_CM,Any visit,2023-08-30,CM,42,2023-08-30 12:13:00,Any visit,CM End Date,2023-08-21,CM_CMENDAT
NLD06,NLD_06_755,6,COMMON_CM,Any visit,2023-07-10,CM,6,2023-07-10 12:33:00,Any visit,CM Related AE,Anemia,CM_AEREL
NLD06,NLD_06_755,7,COMMON_CM,Any visit,2023-07-10,CM,7,2023-07-10 12:38:00,Any visit,CM Related AE,Urinary tract infection,CM_AEREL
NLD06,NLD_06_755,8,COMMON_CM,Any visit,2023-07-10,CM,8,2023-07-10 12:43:00,Any visit,CM Related AE,Urinary tract infection,CM_AEREL
NLD06,NLD_06_755,9,COMMON_CM,Any visit,2023-08-03,CM,9,2023-08-09 13:35:00,Any visit,CM Related AE,Allergic reaction,CM_AEREL
NLD06,NLD_06_755,10,COMMON_CM,Any visit,2023-08-09,CM,10,2023-08-09 11:22:00,Any visit,CM Related AE,Pneumothorax,CM_AEREL
NLD06,NLD_06_755,11,COMMON_CM,Any visit,2023-08-09,CM,11,2023-08-09 11:26:00,Any visit,CM Related AE,Diarrhea,CM_AEREL
NLD06,NLD_06_755,12,COMMON_CM,Any visit,2023-08-09,CM,12,2023-08-09 11:31:00,Any visit,CM Related AE,Urinary tract infection,CM_AEREL
NLD06,NLD_06_755,13,COMMON_CM,Any visit,2023-08-09,CM,13,2023-08-09 11:46:00,Any visit,CM Related AE,Tachycardia,CM_AEREL
NLD06,NLD_06_755,14,COMMON_CM,Any visit,2023-08-09,CM,14,2023-08-09 12:06:00,Any visit,CM Related AE,Tachycardia,CM_AEREL
NLD06,NLD_06_755,15,COMMON_CM,Any visit,2023-08-09,CM,15,2023-08-09 12:36:00,Any visit,CM Related AE,Tachycardia,CM_AEREL
NLD06,NLD_06_755,16,COMMON_CM,Any visit,2023-08-09,CM,16,2023-08-09 12:45:00,Any visit,CM Related AE,Nausea,CM_AEREL
NLD06,NLD_06_755,17,COMMON_CM,Any visit,2023-08-09,CM,17,2023-08-09 13:04:00,Any visit,CM Related AE,Pneumothorax,CM_AEREL
NLD06,NLD_06_755,18,COMMON_CM,Any visit,2023-08-09,CM,18,2023-08-09 13:06:00,Any visit,CM Related AE,Diarrhea,CM_AEREL
NLD06,NLD_06_755,19,COMMON_CM,Any visit,2023-08-09,CM,19,2023-08-09 13:13:00,Any visit,CM Related AE,Diarrhea,CM_AEREL
NLD06,NLD_06_755,21,COMMON_CM,Any visit,2023-08-09,CM,21,2023-08-09 14:06:00,Any visit,CM Related AE,Nausea,CM_AEREL
NLD06,NLD_06_755,22,COMMON_CM,Any visit,2023-08-09,CM,22,2023-08-09 14:14:00,Any visit,CM Related AE,Lower back pain,CM_AEREL
NLD06,NLD_06_755,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 07:12:00,Any visit,CM Related AE,Nausea,CM_AEREL
NLD06,NLD_06_755,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 07:23:00,Any visit,CM Related AE,Nausea,CM_AEREL
NLD06,NLD_06_755,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 07:26:00,Any visit,CM Related AE,Tachycardia,CM_AEREL
NLD06,NLD_06_755,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 07:44:00,Any visit,CM Related AE,Nausea,CM_AEREL
NLD06,NLD_06_755,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 08:34:00,Any visit,CM Related AE,Nausea,CM_AEREL
NLD06,NLD_06_755,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 08:41:00,Any visit,CM Related AE,Nausea,CM_AEREL
NLD06,NLD_06_755,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 08:46:00,Any visit,CM Related AE,Stroke,CM_AEREL
NLD06,NLD_06_755,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 08:51:00,Any visit,CM Related AE,Nausea,CM_AEREL
NLD06,NLD_06_755,33,COMMON_CM,Any visit,2023-08-23,CM,33,2023-08-23 13:24:00,Any visit,CM Related AE,Nausea,CM_AEREL
NLD06,NLD_06_755,34,COMMON_CM,Any visit,2023-08-23,CM,34,2023-08-23 13:26:00,Any visit,CM Related AE,Allergic reaction,CM_AEREL
NLD06,NLD_06_755,35,COMMON_CM,Any visit,2023-08-30,CM,35,2023-08-30 11:03:00,Any visit,CM Related AE,Hypotension,CM_AEREL
NLD06,NLD_06_755,37,COMMON_CM,Any visit,2023-08-30,CM,37,2023-08-30 11:06:00,Any visit,CM Related AE,Atrial fibrillation,CM_AEREL
NLD06,NLD_06_755,38,COMMON_CM,Any visit,2023-08-30,CM,38,2023-08-30 11:40:00,Any visit,CM Related AE,Nausea,CM_AEREL
NLD06,NLD_06_755,39,COMMON_CM,Any visit,2023-08-30,CM,39,2023-08-30 11:58:00,Any visit,CM Related AE,Urinary tract infection,CM_AEREL
NLD06,NLD_06_755,40,COMMON_CM,Any visit,2023-08-30,CM,40,2023-08-30 12:01:00,Any visit,CM Related AE,Nausea,CM_AEREL
NLD06,NLD_06_755,41,COMMON_CM,Any visit,2023-08-30,CM,41,2023-08-30 12:03:00,Any visit,CM Related AE,Allergic reaction,CM_AEREL
NLD06,NLD_06_755,42,COMMON_CM,Any visit,2023-08-30,CM,42,2023-08-30 12:13:00,Any visit,CM Related AE,Anemia,CM_AEREL
NLD06,NLD_06_755,2,COMMON_CM,Any visit,2023-07-07,CM,2,2023-07-07 13:38:00,Any visit,CM Related Medical History,Chronic hepatitis,CM_MHREL
BEL09,BEL_09_556,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 08:51:00,Any visit,CM Number,1,CM_CMSPID
BEL09,BEL_09_556,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 08:51:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
BEL09,BEL_09_556,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 08:51:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
BEL09,BEL_09_556,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 08:51:00,Any visit,CM Indication,Infection,CM_CMINDC
BEL09,BEL_09_556,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 08:51:00,Any visit,CM Dose,70,CM_CMDOSE
BEL09,BEL_09_556,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 08:51:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_556,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 08:51:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL09,BEL_09_556,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 08:51:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
BEL09,BEL_09_556,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 08:51:00,Any visit,CM Start Date,2023-08-15,CM_CMSTDAT
BEL09,BEL_09_556,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 08:51:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL09,BEL_09_556,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-17 09:08:00,Any visit,CM Number,2,CM_CMSPID
BEL09,BEL_09_556,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-17 09:08:00,Any visit,CM Trade Name,Sulfatoxipladib,CM_CMTRT
BEL09,BEL_09_556,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-17 09:08:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
BEL09,BEL_09_556,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-17 09:08:00,Any visit,CM Indication,Insomnia,CM_CMINDC
BEL09,BEL_09_556,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-29 11:02:00,Any visit,CM Dose,4500,CM_CMDOSE
BEL09,BEL_09_556,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-29 11:02:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL09,BEL_09_556,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-17 09:09:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
BEL09,BEL_09_556,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-17 09:09:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
BEL09,BEL_09_556,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-17 09:08:00,Any visit,CM Start Date,2023-08-15,CM_CMSTDAT
BEL09,BEL_09_556,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-17 09:08:00,Any visit,CM Ongoing,Yes,CM_CMONGO
DEU02,DEU_02_866,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 07:23:00,Any visit,CM Number,1,CM_CMSPID
DEU02,DEU_02_866,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 07:23:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
DEU02,DEU_02_866,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 07:23:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
DEU02,DEU_02_866,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 07:23:00,Any visit,CM Indication,Nausea,CM_CMINDC
DEU02,DEU_02_866,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 07:23:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_866,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 07:23:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_866,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 07:23:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_866,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 07:23:00,Any visit,CM Start Date,2021-10-12,CM_CMSTDAT
DEU02,DEU_02_866,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 07:23:00,Any visit,CM Ongoing,Yes,CM_CMONGO
DEU02,DEU_02_866,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 07:24:00,Any visit,CM Number,2,CM_CMSPID
DEU02,DEU_02_866,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 07:24:00,Any visit,CM Trade Name,Sulfatoxipladib,CM_CMTRT
DEU02,DEU_02_866,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 07:24:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
DEU02,DEU_02_866,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 07:26:00,Any visit,CM Indication,Adverse event,CM_CMINDC
DEU02,DEU_02_866,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 07:24:00,Any visit,CM Dose,2000,CM_CMDOSE
DEU02,DEU_02_866,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 07:24:00,Any visit,CM Unit,International Unit (IU),CM_CMDOSU
DEU02,DEU_02_866,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 07:24:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_866,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 07:24:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_866,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 07:24:00,Any visit,CM Start Date,2021-04-NK,CM_CMSTDAT
DEU02,DEU_02_866,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 07:24:00,Any visit,CM Ongoing,Yes,CM_CMONGO
DEU02,DEU_02_866,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 07:26:00,Any visit,CM Number,3,CM_CMSPID
DEU02,DEU_02_866,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 07:26:00,Any visit,CM Trade Name,Bolidilanil,CM_CMTRT
DEU02,DEU_02_866,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 07:26:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
DEU02,DEU_02_866,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 07:26:00,Any visit,CM Indication,Hypertension,CM_CMINDC
DEU02,DEU_02_866,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 07:26:00,Any visit,CM Dose,880,CM_CMDOSE
DEU02,DEU_02_866,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 07:26:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_866,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 07:26:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_866,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 07:26:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_866,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 07:26:00,Any visit,CM Start Date,2021-04-NK,CM_CMSTDAT
DEU02,DEU_02_866,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 07:26:00,Any visit,CM Ongoing,Yes,CM_CMONGO
DEU02,DEU_02_866,4,COMMON_CM,Any visit,2023-08-30,CM,4,2023-08-30 07:29:00,Any visit,CM Number,4,CM_CMSPID
DEU02,DEU_02_866,4,COMMON_CM,Any visit,2023-08-30,CM,4,2023-08-30 07:29:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
DEU02,DEU_02_866,4,COMMON_CM,Any visit,2023-08-30,CM,4,2023-08-30 07:29:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
DEU02,DEU_02_866,4,COMMON_CM,Any visit,2023-08-30,CM,4,2023-08-30 07:29:00,Any visit,CM Indication,Adverse event,CM_CMINDC
DEU02,DEU_02_866,4,COMMON_CM,Any visit,2023-08-30,CM,4,2023-08-30 07:29:00,Any visit,CM Dose,90,CM_CMDOSE
DEU02,DEU_02_866,4,COMMON_CM,Any visit,2023-08-30,CM,4,2023-08-30 07:29:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_866,4,COMMON_CM,Any visit,2023-08-30,CM,4,2023-08-30 07:29:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
DEU02,DEU_02_866,4,COMMON_CM,Any visit,2023-08-30,CM,4,2023-08-30 07:29:00,Any visit,CM Frequency Other,every 6 month,CM_CMDOSFRQ_OTH
DEU02,DEU_02_866,4,COMMON_CM,Any visit,2023-08-30,CM,4,2023-08-30 07:29:00,Any visit,CM Route,Subcutaneous (s.c.),CM_CMROUTE
DEU02,DEU_02_866,4,COMMON_CM,Any visit,2023-08-30,CM,4,2023-08-30 07:29:00,Any visit,CM Start Date,2021-04-NK,CM_CMSTDAT
DEU02,DEU_02_866,4,COMMON_CM,Any visit,2023-08-30,CM,4,2023-08-30 07:29:00,Any visit,CM Ongoing,Yes,CM_CMONGO
DEU02,DEU_02_866,5,COMMON_CM,Any visit,2023-08-30,CM,5,2023-08-30 07:30:00,Any visit,CM Number,5,CM_CMSPID
DEU02,DEU_02_866,5,COMMON_CM,Any visit,2023-08-30,CM,5,2023-08-30 07:30:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
DEU02,DEU_02_866,5,COMMON_CM,Any visit,2023-08-30,CM,5,2023-08-30 07:30:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
DEU02,DEU_02_866,5,COMMON_CM,Any visit,2023-08-30,CM,5,2023-08-30 07:30:00,Any visit,CM Indication,Insomnia,CM_CMINDC
DEU02,DEU_02_866,5,COMMON_CM,Any visit,2023-08-30,CM,5,2023-08-30 07:30:00,Any visit,CM Dose,500,CM_CMDOSE
DEU02,DEU_02_866,5,COMMON_CM,Any visit,2023-08-30,CM,5,2023-08-30 07:30:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_866,5,COMMON_CM,Any visit,2023-08-30,CM,5,2023-08-30 07:30:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_866,5,COMMON_CM,Any visit,2023-08-30,CM,5,2023-08-30 07:30:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_866,5,COMMON_CM,Any visit,2023-08-30,CM,5,2023-08-30 07:30:00,Any visit,CM Start Date,2023-08-12,CM_CMSTDAT
DEU02,DEU_02_866,5,COMMON_CM,Any visit,2023-08-30,CM,5,2023-08-31 08:41:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_866,5,COMMON_CM,Any visit,2023-08-30,CM,5,2023-08-31 08:41:00,Any visit,CM End Date,2023-08-29,CM_CMENDAT
DEU02,DEU_02_866,6,COMMON_CM,Any visit,2023-08-30,CM,6,2023-08-30 07:34:00,Any visit,CM Number,6,CM_CMSPID
DEU02,DEU_02_866,6,COMMON_CM,Any visit,2023-08-30,CM,6,2023-08-30 07:34:00,Any visit,CM Trade Name,Gliigestatrilat,CM_CMTRT
DEU02,DEU_02_866,6,COMMON_CM,Any visit,2023-08-30,CM,6,2023-08-30 07:34:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
DEU02,DEU_02_866,6,COMMON_CM,Any visit,2023-08-30,CM,6,2023-08-30 07:34:00,Any visit,CM Indication,Insomnia,CM_CMINDC
DEU02,DEU_02_866,6,COMMON_CM,Any visit,2023-08-30,CM,6,2023-08-30 07:34:00,Any visit,CM Dose,150,CM_CMDOSE
DEU02,DEU_02_866,6,COMMON_CM,Any visit,2023-08-30,CM,6,2023-08-30 07:34:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_866,6,COMMON_CM,Any visit,2023-08-30,CM,6,2023-08-30 07:34:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_866,6,COMMON_CM,Any visit,2023-08-30,CM,6,2023-08-30 07:34:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_866,6,COMMON_CM,Any visit,2023-08-30,CM,6,2023-08-30 07:34:00,Any visit,CM Start Date,2021-09-21,CM_CMSTDAT
DEU02,DEU_02_866,6,COMMON_CM,Any visit,2023-08-30,CM,6,2023-08-30 07:34:00,Any visit,CM Ongoing,Yes,CM_CMONGO
DEU02,DEU_02_866,7,COMMON_CM,Any visit,2023-08-30,CM,7,2023-08-30 07:36:00,Any visit,CM Number,7,CM_CMSPID
DEU02,DEU_02_866,7,COMMON_CM,Any visit,2023-08-30,CM,7,2023-08-30 07:37:00,Any visit,CM Trade Name,Bolidilanil,CM_CMTRT
DEU02,DEU_02_866,7,COMMON_CM,Any visit,2023-08-30,CM,7,2023-08-30 07:36:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
DEU02,DEU_02_866,7,COMMON_CM,Any visit,2023-08-30,CM,7,2023-08-30 07:36:00,Any visit,CM Indication,Hypertension,CM_CMINDC
DEU02,DEU_02_866,7,COMMON_CM,Any visit,2023-08-30,CM,7,2023-08-30 07:36:00,Any visit,CM Dose,5,CM_CMDOSE
DEU02,DEU_02_866,7,COMMON_CM,Any visit,2023-08-30,CM,7,2023-08-30 07:36:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_866,7,COMMON_CM,Any visit,2023-08-30,CM,7,2023-08-30 07:36:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_866,7,COMMON_CM,Any visit,2023-08-30,CM,7,2023-08-30 07:36:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_866,7,COMMON_CM,Any visit,2023-08-30,CM,7,2023-08-30 07:36:00,Any visit,CM Start Date,2021-10-12,CM_CMSTDAT
DEU02,DEU_02_866,7,COMMON_CM,Any visit,2023-08-30,CM,7,2023-08-30 07:36:00,Any visit,CM Ongoing,Yes,CM_CMONGO
DEU02,DEU_02_866,8,COMMON_CM,Any visit,2023-08-30,CM,8,2023-08-30 07:42:00,Any visit,CM Number,8,CM_CMSPID
DEU02,DEU_02_866,8,COMMON_CM,Any visit,2023-08-30,CM,8,2023-08-30 07:42:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
DEU02,DEU_02_866,8,COMMON_CM,Any visit,2023-08-30,CM,8,2023-08-30 07:42:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
DEU02,DEU_02_866,8,COMMON_CM,Any visit,2023-08-30,CM,8,2023-08-30 07:42:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
DEU02,DEU_02_866,8,COMMON_CM,Any visit,2023-08-30,CM,8,2023-08-30 07:42:00,Any visit,CM Dose,1,CM_CMDOSE
DEU02,DEU_02_866,8,COMMON_CM,Any visit,2023-08-30,CM,8,2023-08-30 07:42:00,Any visit,CM Unit,Other,CM_CMDOSU
DEU02,DEU_02_866,8,COMMON_CM,Any visit,2023-08-30,CM,8,2023-08-30 07:42:00,Any visit,CM Unit Other,drop,CM_CMDOSU_OTH
DEU02,DEU_02_866,8,COMMON_CM,Any visit,2023-08-30,CM,8,2023-08-30 07:42:00,Any visit,CM Route,Topical,CM_CMROUTE
DEU02,DEU_02_866,8,COMMON_CM,Any visit,2023-08-30,CM,8,2023-08-30 07:42:00,Any visit,CM Start Date,2021-NK-NK,CM_CMSTDAT
DEU02,DEU_02_866,8,COMMON_CM,Any visit,2023-08-30,CM,8,2023-08-30 07:42:00,Any visit,CM Ongoing,Yes,CM_CMONGO
DEU02,DEU_02_866,9,COMMON_CM,Any visit,2023-08-30,CM,9,2023-08-30 07:44:00,Any visit,CM Number,9,CM_CMSPID
DEU02,DEU_02_866,9,COMMON_CM,Any visit,2023-08-30,CM,9,2023-08-30 07:44:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
DEU02,DEU_02_866,9,COMMON_CM,Any visit,2023-08-30,CM,9,2023-08-30 07:44:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
DEU02,DEU_02_866,9,COMMON_CM,Any visit,2023-08-30,CM,9,2023-08-30 07:44:00,Any visit,CM Indication,Nausea,CM_CMINDC
DEU02,DEU_02_866,9,COMMON_CM,Any visit,2023-08-30,CM,9,2023-08-30 07:44:00,Any visit,CM Dose,1,CM_CMDOSE
DEU02,DEU_02_866,9,COMMON_CM,Any visit,2023-08-30,CM,9,2023-08-30 07:44:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_866,9,COMMON_CM,Any visit,2023-08-30,CM,9,2023-08-30 07:44:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_866,9,COMMON_CM,Any visit,2023-08-30,CM,9,2023-08-30 07:44:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_866,9,COMMON_CM,Any visit,2023-08-30,CM,9,2023-08-30 07:44:00,Any visit,CM Start Date,2022-06-20,CM_CMSTDAT
DEU02,DEU_02_866,9,COMMON_CM,Any visit,2023-08-30,CM,9,2023-08-30 07:44:00,Any visit,CM Ongoing,Yes,CM_CMONGO
DEU02,DEU_02_866,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 08:51:00,Any visit,CM Number,10,CM_CMSPID
DEU02,DEU_02_866,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 08:51:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
DEU02,DEU_02_866,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 08:51:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
DEU02,DEU_02_866,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 08:51:00,Any visit,CM Indication,Adverse event,CM_CMINDC
DEU02,DEU_02_866,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 08:51:00,Any visit,CM Dose,500,CM_CMDOSE
DEU02,DEU_02_866,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 08:51:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_866,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 08:51:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_866,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 08:51:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_866,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 08:51:00,Any visit,CM Start Date,2023-08-30,CM_CMSTDAT
DEU02,DEU_02_866,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 08:51:00,Any visit,CM Ongoing,Yes,CM_CMONGO
DEU02,DEU_02_866,5,COMMON_CM,Any visit,2023-08-30,CM,5,2023-08-30 07:30:00,Any visit,CM Related AE,Urinary incontinence,CM_AEREL
DEU02,DEU_02_866,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 08:51:00,Any visit,CM Related AE,Urinary incontinence,CM_AEREL
DEU02,DEU_02_866,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 07:23:00,Any visit,CM Related Medical History,COPD,CM_MHREL
DEU02,DEU_02_866,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 07:24:00,Any visit,CM Related Medical History,COPD,CM_MHREL
DEU02,DEU_02_866,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 07:26:00,Any visit,CM Related Medical History,Diabetes mellitus,CM_MHREL
DEU02,DEU_02_866,4,COMMON_CM,Any visit,2023-08-30,CM,4,2023-08-30 07:29:00,Any visit,CM Related Medical History,Arhtritis,CM_MHREL
DEU02,DEU_02_866,6,COMMON_CM,Any visit,2023-08-30,CM,6,2023-08-30 07:34:00,Any visit,CM Related Medical History,Atrial fibrillation,CM_MHREL
DEU02,DEU_02_866,7,COMMON_CM,Any visit,2023-08-30,CM,7,2023-08-30 07:36:00,Any visit,CM Related Medical History,Arhtritis,CM_MHREL
DEU02,DEU_02_866,8,COMMON_CM,Any visit,2023-08-30,CM,8,2023-08-30 07:42:00,Any visit,CM Related Medical History,COPD,CM_MHREL
DEU02,DEU_02_866,9,COMMON_CM,Any visit,2023-08-30,CM,9,2023-08-30 07:44:00,Any visit,CM Related Medical History,Malaria,CM_MHREL
BEL07,BEL_07_193,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 08:57:00,Any visit,CM Number,1,CM_CMSPID
BEL07,BEL_07_193,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 08:57:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
BEL07,BEL_07_193,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 08:57:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
BEL07,BEL_07_193,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 08:57:00,Any visit,CM Indication,Nausea,CM_CMINDC
BEL07,BEL_07_193,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 08:57:00,Any visit,CM Dose,150,CM_CMDOSE
BEL07,BEL_07_193,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 08:57:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL07,BEL_07_193,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 08:57:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL07,BEL_07_193,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 08:57:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL07,BEL_07_193,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 08:57:00,Any visit,CM Start Date,2019-NK-NK,CM_CMSTDAT
BEL07,BEL_07_193,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 08:57:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL07,BEL_07_193,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 08:59:00,Any visit,CM Number,2,CM_CMSPID
BEL07,BEL_07_193,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 08:59:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
BEL07,BEL_07_193,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 08:59:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
BEL07,BEL_07_193,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 08:59:00,Any visit,CM Indication,Adverse event,CM_CMINDC
BEL07,BEL_07_193,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 08:59:00,Any visit,CM Dose,20,CM_CMDOSE
BEL07,BEL_07_193,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 08:59:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL07,BEL_07_193,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 08:59:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL07,BEL_07_193,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 08:59:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL07,BEL_07_193,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 08:59:00,Any visit,CM Start Date,2019-NK-NK,CM_CMSTDAT
BEL07,BEL_07_193,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 08:59:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL07,BEL_07_193,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 09:01:00,Any visit,CM Number,3,CM_CMSPID
BEL07,BEL_07_193,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 09:01:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
BEL07,BEL_07_193,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 09:01:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
BEL07,BEL_07_193,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 09:01:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
BEL07,BEL_07_193,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 09:01:00,Any visit,CM Dose,2,CM_CMDOSE
BEL07,BEL_07_193,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 09:01:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL07,BEL_07_193,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 09:01:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL07,BEL_07_193,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 09:01:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL07,BEL_07_193,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 09:01:00,Any visit,CM Start Date,2015-NK-NK,CM_CMSTDAT
BEL07,BEL_07_193,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 09:01:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL07,BEL_07_193,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 09:02:00,Any visit,CM Number,4,CM_CMSPID
BEL07,BEL_07_193,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 09:02:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
BEL07,BEL_07_193,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 09:02:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
BEL07,BEL_07_193,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 09:02:00,Any visit,CM Indication,Pain,CM_CMINDC
BEL07,BEL_07_193,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 09:02:00,Any visit,CM Dose,40,CM_CMDOSE
BEL07,BEL_07_193,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 09:02:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL07,BEL_07_193,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 09:02:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL07,BEL_07_193,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 09:02:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL07,BEL_07_193,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 09:02:00,Any visit,CM Start Date,2022-NK-NK,CM_CMSTDAT
BEL07,BEL_07_193,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 09:02:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL07,BEL_07_193,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 09:04:00,Any visit,CM Number,5,CM_CMSPID
BEL07,BEL_07_193,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 09:04:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
BEL07,BEL_07_193,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 09:04:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
BEL07,BEL_07_193,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 09:04:00,Any visit,CM Indication,Pain,CM_CMINDC
BEL07,BEL_07_193,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 09:04:00,Any visit,CM Dose,5,CM_CMDOSE
BEL07,BEL_07_193,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 09:04:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL07,BEL_07_193,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 09:04:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL07,BEL_07_193,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 09:04:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL07,BEL_07_193,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 09:04:00,Any visit,CM Start Date,2022-NK-NK,CM_CMSTDAT
BEL07,BEL_07_193,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 09:04:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL07,BEL_07_193,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 09:06:00,Any visit,CM Number,6,CM_CMSPID
BEL07,BEL_07_193,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 09:06:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
BEL07,BEL_07_193,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 09:06:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
BEL07,BEL_07_193,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 09:06:00,Any visit,CM Indication,Hypertension,CM_CMINDC
BEL07,BEL_07_193,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 09:06:00,Any visit,CM Dose,500,CM_CMDOSE
BEL07,BEL_07_193,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 09:06:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL07,BEL_07_193,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 09:06:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL07,BEL_07_193,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 09:06:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL07,BEL_07_193,6,COMMON_CM,Any visit,2023-08-31,CM,6,2023-08-31 09:06:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL07,BEL_07_193,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 09:09:00,Any visit,CM Number,7,CM_CMSPID
BEL07,BEL_07_193,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 09:09:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
BEL07,BEL_07_193,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 09:09:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
BEL07,BEL_07_193,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 09:09:00,Any visit,CM Indication,Adverse event,CM_CMINDC
BEL07,BEL_07_193,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 09:09:00,Any visit,CM Dose,13,CM_CMDOSE
BEL07,BEL_07_193,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 09:09:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
BEL07,BEL_07_193,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 09:09:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
BEL07,BEL_07_193,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 09:09:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL07,BEL_07_193,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 09:09:00,Any visit,CM Start Date,2022-09-30,CM_CMSTDAT
BEL07,BEL_07_193,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 09:09:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL07,BEL_07_193,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 09:21:00,Any visit,CM Number,8,CM_CMSPID
BEL07,BEL_07_193,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 09:21:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
BEL07,BEL_07_193,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 09:21:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
BEL07,BEL_07_193,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 09:21:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
BEL07,BEL_07_193,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 09:21:00,Any visit,CM Dose,100,CM_CMDOSE
BEL07,BEL_07_193,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 09:21:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL07,BEL_07_193,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 09:21:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
BEL07,BEL_07_193,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 09:21:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL07,BEL_07_193,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 09:21:00,Any visit,CM Start Date,2023-01-04,CM_CMSTDAT
BEL07,BEL_07_193,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 09:24:00,Any visit,CM Ongoing,No,CM_CMONGO
BEL07,BEL_07_193,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 09:24:00,Any visit,CM End Date,2023-08-29,CM_CMENDAT
BEL07,BEL_07_193,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 09:26:00,Any visit,CM Number,9,CM_CMSPID
BEL07,BEL_07_193,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 09:26:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
BEL07,BEL_07_193,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 09:26:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
BEL07,BEL_07_193,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 09:26:00,Any visit,CM Indication,Adverse event,CM_CMINDC
BEL07,BEL_07_193,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 09:26:00,Any visit,CM Dose,100,CM_CMDOSE
BEL07,BEL_07_193,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 09:26:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL07,BEL_07_193,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 09:26:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
BEL07,BEL_07_193,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 09:26:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL07,BEL_07_193,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 09:26:00,Any visit,CM Start Date,2023-08-30,CM_CMSTDAT
BEL07,BEL_07_193,9,COMMON_CM,Any visit,2023-08-31,CM,9,2023-08-31 09:26:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL07,BEL_07_193,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 09:27:00,Any visit,CM Number,10,CM_CMSPID
BEL07,BEL_07_193,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 09:27:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
BEL07,BEL_07_193,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 09:27:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
BEL07,BEL_07_193,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 09:27:00,Any visit,CM Indication,Adverse event,CM_CMINDC
BEL07,BEL_07_193,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 09:27:00,Any visit,CM Dose,875125,CM_CMDOSE
BEL07,BEL_07_193,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 09:27:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL07,BEL_07_193,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 09:27:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
BEL07,BEL_07_193,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 09:29:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL07,BEL_07_193,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 09:27:00,Any visit,CM Start Date,2023-08-30,CM_CMSTDAT
BEL07,BEL_07_193,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 09:27:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL07,BEL_07_193,1,COMMON_CM,Any visit,2023-08-31,CM,1,2023-08-31 08:57:00,Any visit,CM Related Medical History,Migraine,CM_MHREL
BEL07,BEL_07_193,2,COMMON_CM,Any visit,2023-08-31,CM,2,2023-08-31 08:59:00,Any visit,CM Related Medical History,Congestive heart failure,CM_MHREL
BEL07,BEL_07_193,3,COMMON_CM,Any visit,2023-08-31,CM,3,2023-08-31 09:01:00,Any visit,CM Related Medical History,Diabetes mellitus,CM_MHREL
BEL07,BEL_07_193,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 09:04:00,Any visit,CM Related Medical History,Hypertension,CM_MHREL
BEL07,BEL_07_193,7,COMMON_CM,Any visit,2023-08-31,CM,7,2023-08-31 09:09:00,Any visit,CM Related Medical History,Diabetes mellitus,CM_MHREL
BEL07,BEL_07_193,8,COMMON_CM,Any visit,2023-08-31,CM,8,2023-08-31 09:21:00,Any visit,CM Related Medical History,Hypothyroidism,CM_MHREL
BEL07,BEL_07_193,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 09:29:00,Any visit,CM Related Medical History,Congestive heart failure,CM_MHREL
DEU01,DEU_01_541,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 09:35:00,Any visit,CM Number,1,CM_CMSPID
DEU01,DEU_01_541,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 09:35:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
DEU01,DEU_01_541,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 09:39:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
DEU01,DEU_01_541,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 09:35:00,Any visit,CM Indication,Insomnia,CM_CMINDC
DEU01,DEU_01_541,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 09:35:00,Any visit,CM Dose,300,CM_CMDOSE
DEU01,DEU_01_541,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 09:35:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU01,DEU_01_541,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 09:35:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU01,DEU_01_541,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 09:35:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU01,DEU_01_541,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 09:35:00,Any visit,CM Start Date,2023-NK-NK,CM_CMSTDAT
DEU01,DEU_01_541,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 09:35:00,Any visit,CM Ongoing,Yes,CM_CMONGO
DEU01,DEU_01_541,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-17 10:15:00,Any visit,CM Number,2,CM_CMSPID
DEU01,DEU_01_541,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-17 10:15:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
DEU01,DEU_01_541,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-17 10:15:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
DEU01,DEU_01_541,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-17 10:15:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU01,DEU_01_541,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-17 10:15:00,Any visit,CM Dose,500,CM_CMDOSE
DEU01,DEU_01_541,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-17 10:15:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU01,DEU_01_541,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-17 10:15:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU01,DEU_01_541,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-17 10:15:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU01,DEU_01_541,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-17 10:15:00,Any visit,CM Start Date,2023-NK-NK,CM_CMSTDAT
DEU01,DEU_01_541,2,COMMON_CM,Any visit,2023-08-17,CM,2,2023-08-17 10:15:00,Any visit,CM Ongoing,Yes,CM_CMONGO
DEU01,DEU_01_541,3,COMMON_CM,Any visit,2023-09-01,CM,3,2023-09-01 14:11:00,Any visit,CM Number,3,CM_CMSPID
DEU01,DEU_01_541,3,COMMON_CM,Any visit,2023-09-01,CM,3,2023-09-01 14:11:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
DEU01,DEU_01_541,3,COMMON_CM,Any visit,2023-09-01,CM,3,2023-09-01 14:21:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
DEU01,DEU_01_541,3,COMMON_CM,Any visit,2023-09-01,CM,3,2023-09-01 14:11:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
DEU01,DEU_01_541,3,COMMON_CM,Any visit,2023-09-01,CM,3,2023-09-01 14:11:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU01,DEU_01_541,3,COMMON_CM,Any visit,2023-09-01,CM,3,2023-09-01 14:11:00,Any visit,CM Start Date,2023-08-30,CM_CMSTDAT
DEU01,DEU_01_541,3,COMMON_CM,Any visit,2023-09-01,CM,3,2023-09-01 14:11:00,Any visit,CM Ongoing,Yes,CM_CMONGO
DEU01,DEU_01_541,3,COMMON_CM,Any visit,2023-09-01,CM,3,2023-09-01 14:11:00,Any visit,CM Related AE,Diarrhea,CM_AEREL
NLD05,NLD_05_561,1,COMMON_CM,Any visit,2023-08-28,CM,1,2023-08-28 12:49:00,Any visit,CM Number,1,CM_CMSPID
NLD05,NLD_05_561,1,COMMON_CM,Any visit,2023-08-28,CM,1,2023-08-28 12:49:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
NLD05,NLD_05_561,1,COMMON_CM,Any visit,2023-08-28,CM,1,2023-08-28 12:49:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
NLD05,NLD_05_561,1,COMMON_CM,Any visit,2023-08-28,CM,1,2023-08-28 12:50:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD05,NLD_05_561,1,COMMON_CM,Any visit,2023-08-28,CM,1,2023-08-28 12:49:00,Any visit,CM Dose,5,CM_CMDOSE
NLD05,NLD_05_561,1,COMMON_CM,Any visit,2023-08-28,CM,1,2023-08-28 12:49:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD05,NLD_05_561,1,COMMON_CM,Any visit,2023-08-28,CM,1,2023-08-28 12:49:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD05,NLD_05_561,1,COMMON_CM,Any visit,2023-08-28,CM,1,2023-08-28 12:49:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD05,NLD_05_561,1,COMMON_CM,Any visit,2023-08-28,CM,1,2023-08-28 12:49:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD05,NLD_05_561,2,COMMON_CM,Any visit,2023-08-28,CM,2,2023-08-28 13:02:00,Any visit,CM Number,2,CM_CMSPID
NLD05,NLD_05_561,2,COMMON_CM,Any visit,2023-08-28,CM,2,2023-08-28 13:02:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
NLD05,NLD_05_561,2,COMMON_CM,Any visit,2023-08-28,CM,2,2023-08-28 13:02:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
NLD05,NLD_05_561,2,COMMON_CM,Any visit,2023-08-28,CM,2,2023-08-28 13:02:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD05,NLD_05_561,2,COMMON_CM,Any visit,2023-08-28,CM,2,2023-08-28 13:02:00,Any visit,CM Dose,5,CM_CMDOSE
NLD05,NLD_05_561,2,COMMON_CM,Any visit,2023-08-28,CM,2,2023-08-28 13:02:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD05,NLD_05_561,2,COMMON_CM,Any visit,2023-08-28,CM,2,2023-08-28 13:02:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD05,NLD_05_561,2,COMMON_CM,Any visit,2023-08-28,CM,2,2023-08-28 13:02:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD05,NLD_05_561,2,COMMON_CM,Any visit,2023-08-28,CM,2,2023-08-28 13:02:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD05,NLD_05_561,3,COMMON_CM,Any visit,2023-08-28,CM,3,2023-08-28 13:27:00,Any visit,CM Number,3,CM_CMSPID
NLD05,NLD_05_561,3,COMMON_CM,Any visit,2023-08-28,CM,3,2023-08-28 13:27:00,Any visit,CM Trade Name,Bolidilanil,CM_CMTRT
NLD05,NLD_05_561,3,COMMON_CM,Any visit,2023-08-28,CM,3,2023-08-28 13:27:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
NLD05,NLD_05_561,3,COMMON_CM,Any visit,2023-08-28,CM,3,2023-08-28 13:27:00,Any visit,CM Indication,Nausea,CM_CMINDC
NLD05,NLD_05_561,3,COMMON_CM,Any visit,2023-08-28,CM,3,2023-08-28 13:27:00,Any visit,CM Dose,40,CM_CMDOSE
NLD05,NLD_05_561,3,COMMON_CM,Any visit,2023-08-28,CM,3,2023-08-28 13:27:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD05,NLD_05_561,3,COMMON_CM,Any visit,2023-08-28,CM,3,2023-08-28 13:29:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD05,NLD_05_561,3,COMMON_CM,Any visit,2023-08-28,CM,3,2023-08-28 13:27:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD05,NLD_05_561,3,COMMON_CM,Any visit,2023-08-28,CM,3,2023-08-28 13:27:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD05,NLD_05_561,4,COMMON_CM,Any visit,2023-08-28,CM,4,2023-08-28 13:47:00,Any visit,CM Number,4,CM_CMSPID
NLD05,NLD_05_561,4,COMMON_CM,Any visit,2023-08-28,CM,4,2023-08-28 13:47:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
NLD05,NLD_05_561,4,COMMON_CM,Any visit,2023-08-28,CM,4,2023-08-28 13:47:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
NLD05,NLD_05_561,4,COMMON_CM,Any visit,2023-08-28,CM,4,2023-08-28 13:47:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
NLD05,NLD_05_561,4,COMMON_CM,Any visit,2023-08-28,CM,4,2023-08-28 13:47:00,Any visit,CM Dose,300,CM_CMDOSE
NLD05,NLD_05_561,4,COMMON_CM,Any visit,2023-08-28,CM,4,2023-08-28 13:47:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD05,NLD_05_561,4,COMMON_CM,Any visit,2023-08-28,CM,4,2023-08-28 13:47:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD05,NLD_05_561,4,COMMON_CM,Any visit,2023-08-28,CM,4,2023-08-28 13:47:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD05,NLD_05_561,4,COMMON_CM,Any visit,2023-08-28,CM,4,2023-08-28 13:47:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD05,NLD_05_561,5,COMMON_CM,Any visit,2023-08-28,CM,5,2023-08-28 14:02:00,Any visit,CM Number,5,CM_CMSPID
NLD05,NLD_05_561,5,COMMON_CM,Any visit,2023-08-28,CM,5,2023-08-28 14:02:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
NLD05,NLD_05_561,5,COMMON_CM,Any visit,2023-08-28,CM,5,2023-08-28 14:02:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
NLD05,NLD_05_561,5,COMMON_CM,Any visit,2023-08-28,CM,5,2023-08-28 14:02:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
NLD05,NLD_05_561,5,COMMON_CM,Any visit,2023-08-28,CM,5,2023-08-28 14:02:00,Any visit,CM Dose,500,CM_CMDOSE
NLD05,NLD_05_561,5,COMMON_CM,Any visit,2023-08-28,CM,5,2023-08-28 14:02:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD05,NLD_05_561,5,COMMON_CM,Any visit,2023-08-28,CM,5,2023-08-28 14:02:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD05,NLD_05_561,5,COMMON_CM,Any visit,2023-08-28,CM,5,2023-08-28 14:02:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD05,NLD_05_561,5,COMMON_CM,Any visit,2023-08-28,CM,5,2023-08-28 14:02:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD05,NLD_05_561,6,COMMON_CM,Any visit,2023-08-28,CM,6,2023-08-28 14:25:00,Any visit,CM Number,6,CM_CMSPID
NLD05,NLD_05_561,6,COMMON_CM,Any visit,2023-08-28,CM,6,2023-08-28 14:25:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
NLD05,NLD_05_561,6,COMMON_CM,Any visit,2023-08-28,CM,6,2023-08-28 14:25:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
NLD05,NLD_05_561,6,COMMON_CM,Any visit,2023-08-28,CM,6,2023-08-28 14:25:00,Any visit,CM Indication,Nausea,CM_CMINDC
NLD05,NLD_05_561,6,COMMON_CM,Any visit,2023-08-28,CM,6,2023-08-28 14:25:00,Any visit,CM Dose,1000,CM_CMDOSE
NLD05,NLD_05_561,6,COMMON_CM,Any visit,2023-08-28,CM,6,2023-08-28 14:25:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD05,NLD_05_561,6,COMMON_CM,Any visit,2023-08-28,CM,6,2023-08-28 14:25:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD05,NLD_05_561,6,COMMON_CM,Any visit,2023-08-28,CM,6,2023-08-28 14:25:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD05,NLD_05_561,6,COMMON_CM,Any visit,2023-08-28,CM,6,2023-08-28 14:25:00,Any visit,CM Ongoing,Yes,CM_CMONGO
NLD05,NLD_05_561,1,COMMON_CM,Any visit,2023-08-28,CM,1,2023-08-28 12:49:00,Any visit,CM Related Medical History,Congestive heart failure,CM_MHREL
NLD05,NLD_05_561,2,COMMON_CM,Any visit,2023-08-28,CM,2,2023-08-28 13:02:00,Any visit,CM Related Medical History,Chronic hepatitis,CM_MHREL
NLD05,NLD_05_561,3,COMMON_CM,Any visit,2023-08-28,CM,3,2023-08-28 13:27:00,Any visit,CM Related Medical History,Familial Mediterranean fever,CM_MHREL
NLD05,NLD_05_561,6,COMMON_CM,Any visit,2023-08-28,CM,6,2023-08-28 14:25:00,Any visit,CM Related Medical History,Diabetes mellitus,CM_MHREL
DEU01,DEU_01_977,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 14:07:00,Any visit,CM Number,1,CM_CMSPID
DEU01,DEU_01_977,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 14:07:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
DEU01,DEU_01_977,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 14:07:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
DEU01,DEU_01_977,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-18 11:08:00,Any visit,CM Indication,Pain,CM_CMINDC
DEU01,DEU_01_977,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-09-05 15:28:00,Any visit,CM Dose,1,CM_CMDOSE
DEU01,DEU_01_977,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-09-05 15:28:00,Any visit,CM Unit,Other,CM_CMDOSU
DEU01,DEU_01_977,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-09-05 15:28:00,Any visit,CM Unit Other,TABLET,CM_CMDOSU_OTH
DEU01,DEU_01_977,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-09-05 15:28:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU01,DEU_01_977,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 14:07:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU01,DEU_01_977,1,COMMON_CM,Any visit,2023-08-17,CM,1,2023-08-17 14:07:00,Any visit,CM Ongoing,Yes,CM_CMONGO
DEU01,DEU_01_977,2,COMMON_CM,Any visit,2023-09-05,CM,2,2023-09-05 15:25:00,Any visit,CM Number,2,CM_CMSPID
DEU01,DEU_01_977,2,COMMON_CM,Any visit,2023-09-05,CM,2,2023-09-05 15:25:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
DEU01,DEU_01_977,2,COMMON_CM,Any visit,2023-09-05,CM,2,2023-09-05 15:27:00,Any visit,CM Active Ingredient,Meloxicam,CM_CMINGRD
DEU01,DEU_01_977,2,COMMON_CM,Any visit,2023-09-05,CM,2,2023-09-05 15:25:00,Any visit,CM Indication,Nausea,CM_CMINDC
DEU01,DEU_01_977,2,COMMON_CM,Any visit,2023-09-05,CM,2,2023-09-05 15:25:00,Any visit,CM Dose,1,CM_CMDOSE
DEU01,DEU_01_977,2,COMMON_CM,Any visit,2023-09-05,CM,2,2023-09-05 15:25:00,Any visit,CM Unit,Other,CM_CMDOSU
DEU01,DEU_01_977,2,COMMON_CM,Any visit,2023-09-05,CM,2,2023-09-05 15:25:00,Any visit,CM Unit Other,TABLET,CM_CMDOSU_OTH
DEU01,DEU_01_977,2,COMMON_CM,Any visit,2023-09-05,CM,2,2023-09-05 15:25:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU01,DEU_01_977,2,COMMON_CM,Any visit,2023-09-05,CM,2,2023-09-05 15:25:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU01,DEU_01_977,2,COMMON_CM,Any visit,2023-09-05,CM,2,2023-09-05 15:25:00,Any visit,CM Ongoing,Yes,CM_CMONGO
DEU01,DEU_01_977,2,COMMON_CM,Any visit,2023-09-05,CM,2,2023-09-05 15:25:00,Any visit,CM Related Medical History,Malaria,CM_MHREL
NLD06,NLD_06_893,1,COMMON_CM,Any visit,2023-08-23,CM,1,2023-08-23 14:30:00,Any visit,CM Number,1,CM_CMSPID
NLD06,NLD_06_893,1,COMMON_CM,Any visit,2023-08-23,CM,1,2023-08-23 14:30:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
NLD06,NLD_06_893,1,COMMON_CM,Any visit,2023-08-23,CM,1,2023-08-23 14:30:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
NLD06,NLD_06_893,1,COMMON_CM,Any visit,2023-08-23,CM,1,2023-08-23 14:30:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
NLD06,NLD_06_893,1,COMMON_CM,Any visit,2023-08-23,CM,1,2023-08-23 14:30:00,Any visit,CM Dose,1,CM_CMDOSE
NLD06,NLD_06_893,1,COMMON_CM,Any visit,2023-08-23,CM,1,2023-08-23 14:30:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
NLD06,NLD_06_893,1,COMMON_CM,Any visit,2023-08-23,CM,1,2023-08-23 14:30:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD06,NLD_06_893,1,COMMON_CM,Any visit,2023-08-23,CM,1,2023-08-23 14:30:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_893,1,COMMON_CM,Any visit,2023-08-23,CM,1,2023-08-23 14:30:00,Any visit,CM Start Date,2021-03-24,CM_CMSTDAT
NLD06,NLD_06_893,1,COMMON_CM,Any visit,2023-08-23,CM,1,2023-08-23 14:30:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL04,BEL_04_133,1,COMMON_CM,Any visit,2023-06-23,CM,1,2023-06-23 09:17:00,Any visit,CM Number,1,CM_CMSPID
BEL04,BEL_04_133,1,COMMON_CM,Any visit,2023-06-23,CM,1,2023-06-23 09:17:00,Any visit,CM Trade Name,Gliigestatrilat,CM_CMTRT
BEL04,BEL_04_133,1,COMMON_CM,Any visit,2023-06-23,CM,1,2023-06-23 09:17:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
BEL04,BEL_04_133,1,COMMON_CM,Any visit,2023-06-23,CM,1,2023-06-23 09:17:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
BEL04,BEL_04_133,1,COMMON_CM,Any visit,2023-06-23,CM,1,2023-06-23 09:17:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL04,BEL_04_133,1,COMMON_CM,Any visit,2023-06-23,CM,1,2023-06-23 09:17:00,Any visit,CM Related Medical History,Epilepsy,CM_MHREL
NLD06,NLD_06_72,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 11:40:00,Any visit,CM Number,1,CM_CMSPID
NLD06,NLD_06_72,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 11:40:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
NLD06,NLD_06_72,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 11:40:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
NLD06,NLD_06_72,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 11:40:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
NLD06,NLD_06_72,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 11:40:00,Any visit,CM Dose,1,CM_CMDOSE
NLD06,NLD_06_72,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 11:40:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
NLD06,NLD_06_72,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 11:40:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
NLD06,NLD_06_72,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 11:40:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_72,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 11:40:00,Any visit,CM Start Date,2023-08-18,CM_CMSTDAT
NLD06,NLD_06_72,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 11:40:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_72,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 11:40:00,Any visit,CM End Date,2023-08-24,CM_CMENDAT
NLD06,NLD_06_72,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 11:41:00,Any visit,CM Number,2,CM_CMSPID
NLD06,NLD_06_72,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 11:41:00,Any visit,CM Trade Name,Sulfatoxipladib,CM_CMTRT
NLD06,NLD_06_72,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 11:41:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
NLD06,NLD_06_72,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 11:41:00,Any visit,CM Indication,Adverse event,CM_CMINDC
NLD06,NLD_06_72,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 11:41:00,Any visit,CM Dose,500,CM_CMDOSE
NLD06,NLD_06_72,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 11:41:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD06,NLD_06_72,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 11:41:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
NLD06,NLD_06_72,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 11:41:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD06,NLD_06_72,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 11:41:00,Any visit,CM Start Date,2023-08-18,CM_CMSTDAT
NLD06,NLD_06_72,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 11:41:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD06,NLD_06_72,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 11:41:00,Any visit,CM End Date,2023-08-24,CM_CMENDAT
NLD06,NLD_06_72,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 11:41:00,Any visit,CM Related AE,Lower back pain,CM_AEREL
NLD06,NLD_06_72,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 11:41:00,Any visit,CM Related AE,Lower back pain,CM_AEREL
DEU02,DEU_02_482,4,COMMON_CM,Any visit,2023-08-08,CM,4,2023-08-08 15:46:00,Any visit,CM Number,4,CM_CMSPID
DEU02,DEU_02_482,4,COMMON_CM,Any visit,2023-08-08,CM,4,2023-08-08 15:46:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
DEU02,DEU_02_482,4,COMMON_CM,Any visit,2023-08-08,CM,4,2023-08-08 15:46:00,Any visit,CM Indication,Pain,CM_CMINDC
DEU02,DEU_02_482,4,COMMON_CM,Any visit,2023-08-08,CM,4,2023-08-08 15:46:00,Any visit,CM Unit,Unknown,CM_CMDOSU
DEU02,DEU_02_482,4,COMMON_CM,Any visit,2023-08-08,CM,4,2023-08-08 15:46:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_482,4,COMMON_CM,Any visit,2023-08-08,CM,4,2023-08-08 15:46:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_482,4,COMMON_CM,Any visit,2023-08-08,CM,4,2023-08-08 15:46:00,Any visit,CM Ongoing,Yes,CM_CMONGO
DEU02,DEU_02_482,5,COMMON_CM,Any visit,2023-08-08,CM,5,2023-08-08 15:50:00,Any visit,CM Number,5,CM_CMSPID
DEU02,DEU_02_482,5,COMMON_CM,Any visit,2023-08-08,CM,5,2023-08-08 15:50:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
DEU02,DEU_02_482,5,COMMON_CM,Any visit,2023-08-08,CM,5,2023-08-08 15:50:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
DEU02,DEU_02_482,5,COMMON_CM,Any visit,2023-08-08,CM,5,2023-08-08 15:50:00,Any visit,CM Indication,Adverse event,CM_CMINDC
DEU02,DEU_02_482,5,COMMON_CM,Any visit,2023-08-08,CM,5,2023-08-08 15:50:00,Any visit,CM Dose,1,CM_CMDOSE
DEU02,DEU_02_482,5,COMMON_CM,Any visit,2023-08-08,CM,5,2023-08-08 15:50:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_482,5,COMMON_CM,Any visit,2023-08-08,CM,5,2023-08-08 15:50:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,5,COMMON_CM,Any visit,2023-08-08,CM,5,2023-08-08 15:50:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_482,5,COMMON_CM,Any visit,2023-08-08,CM,5,2023-08-08 15:50:00,Any visit,CM Start Date,2023-07-04,CM_CMSTDAT
DEU02,DEU_02_482,5,COMMON_CM,Any visit,2023-08-08,CM,5,2023-08-08 15:50:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,5,COMMON_CM,Any visit,2023-08-08,CM,5,2023-08-08 15:50:00,Any visit,CM End Date,2023-07-04,CM_CMENDAT
DEU02,DEU_02_482,6,COMMON_CM,Any visit,2023-08-08,CM,6,2023-08-08 15:52:00,Any visit,CM Number,6,CM_CMSPID
DEU02,DEU_02_482,6,COMMON_CM,Any visit,2023-08-08,CM,6,2023-08-08 15:52:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
DEU02,DEU_02_482,6,COMMON_CM,Any visit,2023-08-08,CM,6,2023-08-08 15:52:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
DEU02,DEU_02_482,6,COMMON_CM,Any visit,2023-08-08,CM,6,2023-08-08 15:52:00,Any visit,CM Indication,Pain,CM_CMINDC
DEU02,DEU_02_482,6,COMMON_CM,Any visit,2023-08-08,CM,6,2023-08-08 15:52:00,Any visit,CM Dose,500,CM_CMDOSE
DEU02,DEU_02_482,6,COMMON_CM,Any visit,2023-08-08,CM,6,2023-08-08 15:52:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,6,COMMON_CM,Any visit,2023-08-08,CM,6,2023-08-08 15:52:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
DEU02,DEU_02_482,6,COMMON_CM,Any visit,2023-08-08,CM,6,2023-08-08 15:52:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_482,6,COMMON_CM,Any visit,2023-08-08,CM,6,2023-08-08 15:52:00,Any visit,CM Start Date,2023-07-12,CM_CMSTDAT
DEU02,DEU_02_482,6,COMMON_CM,Any visit,2023-08-08,CM,6,2023-08-24 14:09:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,6,COMMON_CM,Any visit,2023-08-08,CM,6,2023-08-24 14:09:00,Any visit,CM End Date,2023-08-17,CM_CMENDAT
DEU02,DEU_02_482,7,COMMON_CM,Any visit,2023-08-08,CM,7,2023-08-08 15:58:00,Any visit,CM Number,7,CM_CMSPID
DEU02,DEU_02_482,7,COMMON_CM,Any visit,2023-08-08,CM,7,2023-08-08 15:58:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
DEU02,DEU_02_482,7,COMMON_CM,Any visit,2023-08-08,CM,7,2023-08-08 15:58:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_482,7,COMMON_CM,Any visit,2023-08-08,CM,7,2023-08-08 15:58:00,Any visit,CM Dose,1,CM_CMDOSE
DEU02,DEU_02_482,7,COMMON_CM,Any visit,2023-08-08,CM,7,2023-08-08 15:58:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_482,7,COMMON_CM,Any visit,2023-08-08,CM,7,2023-08-08 15:58:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
DEU02,DEU_02_482,7,COMMON_CM,Any visit,2023-08-08,CM,7,2023-08-08 15:58:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_482,7,COMMON_CM,Any visit,2023-08-08,CM,7,2023-08-08 15:58:00,Any visit,CM Start Date,2023-07-12,CM_CMSTDAT
DEU02,DEU_02_482,7,COMMON_CM,Any visit,2023-08-08,CM,7,2023-08-08 15:58:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,7,COMMON_CM,Any visit,2023-08-08,CM,7,2023-08-08 15:58:00,Any visit,CM End Date,2023-07-13,CM_CMENDAT
DEU02,DEU_02_482,8,COMMON_CM,Any visit,2023-08-08,CM,8,2023-08-08 16:00:00,Any visit,CM Number,8,CM_CMSPID
DEU02,DEU_02_482,8,COMMON_CM,Any visit,2023-08-08,CM,8,2023-08-09 07:53:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
DEU02,DEU_02_482,8,COMMON_CM,Any visit,2023-08-08,CM,8,2023-08-08 16:00:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
DEU02,DEU_02_482,8,COMMON_CM,Any visit,2023-08-08,CM,8,2023-08-08 16:00:00,Any visit,CM Indication,Pain,CM_CMINDC
DEU02,DEU_02_482,8,COMMON_CM,Any visit,2023-08-08,CM,8,2023-08-08 16:00:00,Any visit,CM Dose,1,CM_CMDOSE
DEU02,DEU_02_482,8,COMMON_CM,Any visit,2023-08-08,CM,8,2023-08-08 16:00:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_482,8,COMMON_CM,Any visit,2023-08-08,CM,8,2023-08-08 16:00:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,8,COMMON_CM,Any visit,2023-08-08,CM,8,2023-08-08 16:00:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_482,8,COMMON_CM,Any visit,2023-08-08,CM,8,2023-08-08 16:00:00,Any visit,CM Start Date,2023-07-13,CM_CMSTDAT
DEU02,DEU_02_482,8,COMMON_CM,Any visit,2023-08-08,CM,8,2023-08-08 16:00:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,8,COMMON_CM,Any visit,2023-08-08,CM,8,2023-08-08 16:00:00,Any visit,CM End Date,2023-07-13,CM_CMENDAT
DEU02,DEU_02_482,9,COMMON_CM,Any visit,2023-08-08,CM,9,2023-08-08 16:03:00,Any visit,CM Number,9,CM_CMSPID
DEU02,DEU_02_482,9,COMMON_CM,Any visit,2023-08-08,CM,9,2023-08-08 16:03:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
DEU02,DEU_02_482,9,COMMON_CM,Any visit,2023-08-08,CM,9,2023-08-08 16:03:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
DEU02,DEU_02_482,9,COMMON_CM,Any visit,2023-08-08,CM,9,2023-08-08 16:15:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_482,9,COMMON_CM,Any visit,2023-08-08,CM,9,2023-08-08 16:03:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_482,9,COMMON_CM,Any visit,2023-08-08,CM,9,2023-08-08 16:03:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
DEU02,DEU_02_482,9,COMMON_CM,Any visit,2023-08-08,CM,9,2023-08-08 16:03:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_482,9,COMMON_CM,Any visit,2023-08-08,CM,9,2023-08-08 16:03:00,Any visit,CM Start Date,2023-07-13,CM_CMSTDAT
DEU02,DEU_02_482,9,COMMON_CM,Any visit,2023-08-08,CM,9,2023-08-08 16:03:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,9,COMMON_CM,Any visit,2023-08-08,CM,9,2023-08-08 16:03:00,Any visit,CM End Date,2023-07-18,CM_CMENDAT
DEU02,DEU_02_482,10,COMMON_CM,Any visit,2023-08-08,CM,10,2023-08-08 16:04:00,Any visit,CM Number,10,CM_CMSPID
DEU02,DEU_02_482,10,COMMON_CM,Any visit,2023-08-08,CM,10,2023-08-09 07:56:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
DEU02,DEU_02_482,10,COMMON_CM,Any visit,2023-08-08,CM,10,2023-08-08 16:04:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
DEU02,DEU_02_482,10,COMMON_CM,Any visit,2023-08-08,CM,10,2023-08-08 16:04:00,Any visit,CM Indication,Nausea,CM_CMINDC
DEU02,DEU_02_482,10,COMMON_CM,Any visit,2023-08-08,CM,10,2023-08-08 16:04:00,Any visit,CM Dose,1,CM_CMDOSE
DEU02,DEU_02_482,10,COMMON_CM,Any visit,2023-08-08,CM,10,2023-08-08 16:04:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_482,10,COMMON_CM,Any visit,2023-08-08,CM,10,2023-08-08 16:04:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_482,10,COMMON_CM,Any visit,2023-08-08,CM,10,2023-08-08 16:04:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_482,10,COMMON_CM,Any visit,2023-08-08,CM,10,2023-08-08 16:04:00,Any visit,CM Start Date,2023-07-12,CM_CMSTDAT
DEU02,DEU_02_482,10,COMMON_CM,Any visit,2023-08-08,CM,10,2023-08-08 16:04:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,10,COMMON_CM,Any visit,2023-08-08,CM,10,2023-08-08 16:04:00,Any visit,CM End Date,2023-07-15,CM_CMENDAT
DEU02,DEU_02_482,11,COMMON_CM,Any visit,2023-08-08,CM,11,2023-08-08 16:14:00,Any visit,CM Number,11,CM_CMSPID
DEU02,DEU_02_482,11,COMMON_CM,Any visit,2023-08-08,CM,11,2023-08-08 16:14:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
DEU02,DEU_02_482,11,COMMON_CM,Any visit,2023-08-08,CM,11,2023-08-08 16:14:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
DEU02,DEU_02_482,11,COMMON_CM,Any visit,2023-08-08,CM,11,2023-08-08 16:14:00,Any visit,CM Indication,Hypertension,CM_CMINDC
DEU02,DEU_02_482,11,COMMON_CM,Any visit,2023-08-08,CM,11,2023-08-08 16:14:00,Any visit,CM Dose,200,CM_CMDOSE
DEU02,DEU_02_482,11,COMMON_CM,Any visit,2023-08-08,CM,11,2023-08-08 16:14:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,11,COMMON_CM,Any visit,2023-08-08,CM,11,2023-08-08 16:14:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
DEU02,DEU_02_482,11,COMMON_CM,Any visit,2023-08-08,CM,11,2023-08-08 16:14:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_482,11,COMMON_CM,Any visit,2023-08-08,CM,11,2023-08-08 16:14:00,Any visit,CM Start Date,2023-07-13,CM_CMSTDAT
DEU02,DEU_02_482,11,COMMON_CM,Any visit,2023-08-08,CM,11,2023-08-08 16:14:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,11,COMMON_CM,Any visit,2023-08-08,CM,11,2023-08-08 16:14:00,Any visit,CM End Date,2023-07-14,CM_CMENDAT
DEU02,DEU_02_482,12,COMMON_CM,Any visit,2023-08-08,CM,12,2023-08-08 16:16:00,Any visit,CM Number,12,CM_CMSPID
DEU02,DEU_02_482,12,COMMON_CM,Any visit,2023-08-08,CM,12,2023-08-08 16:16:00,Any visit,CM Trade Name,Gliigestatrilat,CM_CMTRT
DEU02,DEU_02_482,12,COMMON_CM,Any visit,2023-08-08,CM,12,2023-08-08 16:16:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
DEU02,DEU_02_482,12,COMMON_CM,Any visit,2023-08-08,CM,12,2023-08-08 16:16:00,Any visit,CM Indication,Adverse event,CM_CMINDC
DEU02,DEU_02_482,12,COMMON_CM,Any visit,2023-08-08,CM,12,2023-08-08 16:16:00,Any visit,CM Dose,100,CM_CMDOSE
DEU02,DEU_02_482,12,COMMON_CM,Any visit,2023-08-08,CM,12,2023-08-08 16:16:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,12,COMMON_CM,Any visit,2023-08-08,CM,12,2023-08-08 16:16:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,12,COMMON_CM,Any visit,2023-08-08,CM,12,2023-08-08 16:16:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_482,12,COMMON_CM,Any visit,2023-08-08,CM,12,2023-08-08 16:16:00,Any visit,CM Start Date,2023-07-15,CM_CMSTDAT
DEU02,DEU_02_482,12,COMMON_CM,Any visit,2023-08-08,CM,12,2023-08-08 16:16:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,12,COMMON_CM,Any visit,2023-08-08,CM,12,2023-08-08 16:16:00,Any visit,CM End Date,2023-07-17,CM_CMENDAT
DEU02,DEU_02_482,13,COMMON_CM,Any visit,2023-08-08,CM,13,2023-08-08 16:16:00,Any visit,CM Number,13,CM_CMSPID
DEU02,DEU_02_482,13,COMMON_CM,Any visit,2023-08-08,CM,13,2023-08-08 16:16:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
DEU02,DEU_02_482,13,COMMON_CM,Any visit,2023-08-08,CM,13,2023-08-08 16:16:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
DEU02,DEU_02_482,13,COMMON_CM,Any visit,2023-08-08,CM,13,2023-08-08 16:16:00,Any visit,CM Indication,Adverse event,CM_CMINDC
DEU02,DEU_02_482,13,COMMON_CM,Any visit,2023-08-08,CM,13,2023-08-08 16:16:00,Any visit,CM Dose,200,CM_CMDOSE
DEU02,DEU_02_482,13,COMMON_CM,Any visit,2023-08-08,CM,13,2023-08-08 16:16:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,13,COMMON_CM,Any visit,2023-08-08,CM,13,2023-08-08 16:16:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,13,COMMON_CM,Any visit,2023-08-08,CM,13,2023-08-08 16:16:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_482,13,COMMON_CM,Any visit,2023-08-08,CM,13,2023-08-08 16:16:00,Any visit,CM Start Date,2023-07-18,CM_CMSTDAT
DEU02,DEU_02_482,13,COMMON_CM,Any visit,2023-08-08,CM,13,2023-08-24 14:10:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,13,COMMON_CM,Any visit,2023-08-08,CM,13,2023-08-24 14:10:00,Any visit,CM End Date,2023-08-17,CM_CMENDAT
DEU02,DEU_02_482,14,COMMON_CM,Any visit,2023-08-08,CM,14,2023-08-08 16:18:00,Any visit,CM Number,14,CM_CMSPID
DEU02,DEU_02_482,14,COMMON_CM,Any visit,2023-08-08,CM,14,2023-08-08 16:18:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
DEU02,DEU_02_482,14,COMMON_CM,Any visit,2023-08-08,CM,14,2023-08-08 16:18:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
DEU02,DEU_02_482,14,COMMON_CM,Any visit,2023-08-08,CM,14,2023-08-08 16:18:00,Any visit,CM Indication,Adverse event,CM_CMINDC
DEU02,DEU_02_482,14,COMMON_CM,Any visit,2023-08-08,CM,14,2023-08-08 16:18:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,14,COMMON_CM,Any visit,2023-08-08,CM,14,2023-08-08 16:18:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,14,COMMON_CM,Any visit,2023-08-08,CM,14,2023-08-08 16:18:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_482,14,COMMON_CM,Any visit,2023-08-08,CM,14,2023-08-08 16:18:00,Any visit,CM Start Date,2023-07-27,CM_CMSTDAT
DEU02,DEU_02_482,14,COMMON_CM,Any visit,2023-08-08,CM,14,2023-08-08 16:18:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,14,COMMON_CM,Any visit,2023-08-08,CM,14,2023-08-08 16:18:00,Any visit,CM End Date,2023-07-27,CM_CMENDAT
DEU02,DEU_02_482,15,COMMON_CM,Any visit,2023-08-08,CM,15,2023-08-08 16:22:00,Any visit,CM Number,15,CM_CMSPID
DEU02,DEU_02_482,15,COMMON_CM,Any visit,2023-08-08,CM,15,2023-08-08 16:22:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
DEU02,DEU_02_482,15,COMMON_CM,Any visit,2023-08-08,CM,15,2023-08-08 16:22:00,Any visit,CM Active Ingredient,Meloxicam,CM_CMINGRD
DEU02,DEU_02_482,15,COMMON_CM,Any visit,2023-08-08,CM,15,2023-08-08 16:22:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_482,15,COMMON_CM,Any visit,2023-08-08,CM,15,2023-08-08 16:22:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,15,COMMON_CM,Any visit,2023-08-08,CM,15,2023-08-08 16:22:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,15,COMMON_CM,Any visit,2023-08-08,CM,15,2023-08-08 16:22:00,Any visit,CM Route,Inhalation (p.i.),CM_CMROUTE
DEU02,DEU_02_482,15,COMMON_CM,Any visit,2023-08-08,CM,15,2023-08-08 16:22:00,Any visit,CM Start Date,2023-07-31,CM_CMSTDAT
DEU02,DEU_02_482,15,COMMON_CM,Any visit,2023-08-08,CM,15,2023-08-08 16:22:00,Any visit,CM Ongoing,Yes,CM_CMONGO
DEU02,DEU_02_482,16,COMMON_CM,Any visit,2023-08-08,CM,16,2023-08-08 16:24:00,Any visit,CM Number,16,CM_CMSPID
DEU02,DEU_02_482,16,COMMON_CM,Any visit,2023-08-08,CM,16,2023-08-09 07:59:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
DEU02,DEU_02_482,16,COMMON_CM,Any visit,2023-08-08,CM,16,2023-08-08 16:24:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
DEU02,DEU_02_482,16,COMMON_CM,Any visit,2023-08-08,CM,16,2023-08-08 16:24:00,Any visit,CM Indication,Insomnia,CM_CMINDC
DEU02,DEU_02_482,16,COMMON_CM,Any visit,2023-08-08,CM,16,2023-08-09 08:07:00,Any visit,CM Dose,5,CM_CMDOSE
DEU02,DEU_02_482,16,COMMON_CM,Any visit,2023-08-08,CM,16,2023-08-09 08:07:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,16,COMMON_CM,Any visit,2023-08-08,CM,16,2023-08-08 16:24:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,16,COMMON_CM,Any visit,2023-08-08,CM,16,2023-08-09 08:07:00,Any visit,CM Route,Inhalation (p.i.),CM_CMROUTE
DEU02,DEU_02_482,16,COMMON_CM,Any visit,2023-08-08,CM,16,2023-08-08 16:24:00,Any visit,CM Start Date,2023-07-31,CM_CMSTDAT
DEU02,DEU_02_482,16,COMMON_CM,Any visit,2023-08-08,CM,16,2023-08-08 16:24:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,16,COMMON_CM,Any visit,2023-08-08,CM,16,2023-08-08 16:24:00,Any visit,CM End Date,2023-07-31,CM_CMENDAT
DEU02,DEU_02_482,17,COMMON_CM,Any visit,2023-08-08,CM,17,2023-08-08 16:25:00,Any visit,CM Number,17,CM_CMSPID
DEU02,DEU_02_482,17,COMMON_CM,Any visit,2023-08-08,CM,17,2023-08-08 16:25:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
DEU02,DEU_02_482,17,COMMON_CM,Any visit,2023-08-08,CM,17,2023-08-08 16:25:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
DEU02,DEU_02_482,17,COMMON_CM,Any visit,2023-08-08,CM,17,2023-08-08 16:25:00,Any visit,CM Indication,Pain,CM_CMINDC
DEU02,DEU_02_482,17,COMMON_CM,Any visit,2023-08-08,CM,17,2023-08-09 08:09:00,Any visit,CM Dose,200,CM_CMDOSE
DEU02,DEU_02_482,17,COMMON_CM,Any visit,2023-08-08,CM,17,2023-08-09 08:09:00,Any visit,CM Unit,Microgram (µg),CM_CMDOSU
DEU02,DEU_02_482,17,COMMON_CM,Any visit,2023-08-08,CM,17,2023-08-08 16:25:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,17,COMMON_CM,Any visit,2023-08-08,CM,17,2023-08-08 16:25:00,Any visit,CM Route,Inhalation (p.i.),CM_CMROUTE
DEU02,DEU_02_482,17,COMMON_CM,Any visit,2023-08-08,CM,17,2023-08-08 16:25:00,Any visit,CM Start Date,2023-08-01,CM_CMSTDAT
DEU02,DEU_02_482,17,COMMON_CM,Any visit,2023-08-08,CM,17,2023-08-24 14:15:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,17,COMMON_CM,Any visit,2023-08-08,CM,17,2023-08-24 14:15:00,Any visit,CM End Date,2023-08-09,CM_CMENDAT
DEU02,DEU_02_482,18,COMMON_CM,Any visit,2023-08-08,CM,18,2023-08-08 16:26:00,Any visit,CM Number,18,CM_CMSPID
DEU02,DEU_02_482,18,COMMON_CM,Any visit,2023-08-08,CM,18,2023-08-09 08:00:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
DEU02,DEU_02_482,18,COMMON_CM,Any visit,2023-08-08,CM,18,2023-08-08 16:26:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
DEU02,DEU_02_482,18,COMMON_CM,Any visit,2023-08-08,CM,18,2023-08-08 16:26:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_482,18,COMMON_CM,Any visit,2023-08-08,CM,18,2023-08-08 16:26:00,Any visit,CM Dose,1,CM_CMDOSE
DEU02,DEU_02_482,18,COMMON_CM,Any visit,2023-08-08,CM,18,2023-08-08 16:26:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_482,18,COMMON_CM,Any visit,2023-08-08,CM,18,2023-08-08 16:26:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_482,18,COMMON_CM,Any visit,2023-08-08,CM,18,2023-08-08 16:26:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_482,18,COMMON_CM,Any visit,2023-08-08,CM,18,2023-08-08 16:26:00,Any visit,CM Start Date,2023-07-29,CM_CMSTDAT
DEU02,DEU_02_482,18,COMMON_CM,Any visit,2023-08-08,CM,18,2023-08-08 16:26:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,18,COMMON_CM,Any visit,2023-08-08,CM,18,2023-08-08 16:26:00,Any visit,CM End Date,2023-07-31,CM_CMENDAT
DEU02,DEU_02_482,19,COMMON_CM,Any visit,2023-08-08,CM,19,2023-08-08 16:29:00,Any visit,CM Number,19,CM_CMSPID
DEU02,DEU_02_482,19,COMMON_CM,Any visit,2023-08-08,CM,19,2023-08-08 16:29:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
DEU02,DEU_02_482,19,COMMON_CM,Any visit,2023-08-08,CM,19,2023-08-08 16:29:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
DEU02,DEU_02_482,19,COMMON_CM,Any visit,2023-08-08,CM,19,2023-08-08 16:29:00,Any visit,CM Indication,Pain,CM_CMINDC
DEU02,DEU_02_482,19,COMMON_CM,Any visit,2023-08-08,CM,19,2023-08-08 16:29:00,Any visit,CM Dose,1,CM_CMDOSE
DEU02,DEU_02_482,19,COMMON_CM,Any visit,2023-08-08,CM,19,2023-08-08 16:29:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_482,19,COMMON_CM,Any visit,2023-08-08,CM,19,2023-08-08 16:29:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,19,COMMON_CM,Any visit,2023-08-08,CM,19,2023-08-08 16:29:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_482,19,COMMON_CM,Any visit,2023-08-08,CM,19,2023-08-08 16:29:00,Any visit,CM Start Date,2023-07-27,CM_CMSTDAT
DEU02,DEU_02_482,19,COMMON_CM,Any visit,2023-08-08,CM,19,2023-08-08 16:29:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,19,COMMON_CM,Any visit,2023-08-08,CM,19,2023-08-08 16:29:00,Any visit,CM End Date,2023-07-27,CM_CMENDAT
DEU02,DEU_02_482,20,COMMON_CM,Any visit,2023-08-08,CM,20,2023-08-08 16:31:00,Any visit,CM Number,20,CM_CMSPID
DEU02,DEU_02_482,20,COMMON_CM,Any visit,2023-08-08,CM,20,2023-08-08 16:31:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
DEU02,DEU_02_482,20,COMMON_CM,Any visit,2023-08-08,CM,20,2023-08-08 16:31:00,Any visit,CM Indication,Insomnia,CM_CMINDC
DEU02,DEU_02_482,20,COMMON_CM,Any visit,2023-08-08,CM,20,2023-08-08 16:31:00,Any visit,CM Dose,60,CM_CMDOSE
DEU02,DEU_02_482,20,COMMON_CM,Any visit,2023-08-08,CM,20,2023-08-08 16:31:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,20,COMMON_CM,Any visit,2023-08-08,CM,20,2023-08-08 16:31:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,20,COMMON_CM,Any visit,2023-08-08,CM,20,2023-08-08 16:31:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_482,20,COMMON_CM,Any visit,2023-08-08,CM,20,2023-08-08 16:31:00,Any visit,CM Start Date,2023-07-27,CM_CMSTDAT
DEU02,DEU_02_482,20,COMMON_CM,Any visit,2023-08-08,CM,20,2023-08-08 16:31:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,20,COMMON_CM,Any visit,2023-08-08,CM,20,2023-08-08 16:31:00,Any visit,CM End Date,2023-07-27,CM_CMENDAT
DEU02,DEU_02_482,21,COMMON_CM,Any visit,2023-08-08,CM,21,2023-08-08 16:33:00,Any visit,CM Number,21,CM_CMSPID
DEU02,DEU_02_482,21,COMMON_CM,Any visit,2023-08-08,CM,21,2023-08-08 16:33:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
DEU02,DEU_02_482,21,COMMON_CM,Any visit,2023-08-08,CM,21,2023-08-08 16:33:00,Any visit,CM Indication,Pain,CM_CMINDC
DEU02,DEU_02_482,21,COMMON_CM,Any visit,2023-08-08,CM,21,2023-08-08 16:33:00,Any visit,CM Unit,Unknown,CM_CMDOSU
DEU02,DEU_02_482,21,COMMON_CM,Any visit,2023-08-08,CM,21,2023-08-08 16:33:00,Any visit,CM Frequency,Unknown,CM_CMDOSFRQ
DEU02,DEU_02_482,21,COMMON_CM,Any visit,2023-08-08,CM,21,2023-08-09 08:11:00,Any visit,CM Route,Nasal,CM_CMROUTE
DEU02,DEU_02_482,21,COMMON_CM,Any visit,2023-08-08,CM,21,2023-08-08 16:33:00,Any visit,CM Start Date,2023-07-27,CM_CMSTDAT
DEU02,DEU_02_482,21,COMMON_CM,Any visit,2023-08-08,CM,21,2023-08-08 16:33:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,21,COMMON_CM,Any visit,2023-08-08,CM,21,2023-08-08 16:33:00,Any visit,CM End Date,2023-07-27,CM_CMENDAT
DEU02,DEU_02_482,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 11:15:00,Any visit,CM Number,22,CM_CMSPID
DEU02,DEU_02_482,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 11:15:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
DEU02,DEU_02_482,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 11:15:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
DEU02,DEU_02_482,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 11:15:00,Any visit,CM Indication,Nausea,CM_CMINDC
DEU02,DEU_02_482,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 11:15:00,Any visit,CM Dose,60,CM_CMDOSE
DEU02,DEU_02_482,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 11:15:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 11:15:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 11:15:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_482,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 11:15:00,Any visit,CM Start Date,2023-07-04,CM_CMSTDAT
DEU02,DEU_02_482,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 11:15:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 11:15:00,Any visit,CM End Date,2023-07-04,CM_CMENDAT
DEU02,DEU_02_482,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 11:16:00,Any visit,CM Number,23,CM_CMSPID
DEU02,DEU_02_482,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 11:16:00,Any visit,CM Trade Name,Gliigestatrilat,CM_CMTRT
DEU02,DEU_02_482,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 11:16:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
DEU02,DEU_02_482,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 11:16:00,Any visit,CM Indication,Nausea,CM_CMINDC
DEU02,DEU_02_482,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 11:16:00,Any visit,CM Dose,5,CM_CMDOSE
DEU02,DEU_02_482,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 11:16:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 11:16:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 11:16:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_482,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 11:16:00,Any visit,CM Start Date,2023-07-04,CM_CMSTDAT
DEU02,DEU_02_482,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 11:16:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 11:16:00,Any visit,CM End Date,2023-07-04,CM_CMENDAT
DEU02,DEU_02_482,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 11:18:00,Any visit,CM Number,24,CM_CMSPID
DEU02,DEU_02_482,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 11:18:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
DEU02,DEU_02_482,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 11:18:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
DEU02,DEU_02_482,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 11:18:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_482,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 11:18:00,Any visit,CM Dose,60,CM_CMDOSE
DEU02,DEU_02_482,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 11:18:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 11:18:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 11:18:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_482,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 11:18:00,Any visit,CM Start Date,2023-08-01,CM_CMSTDAT
DEU02,DEU_02_482,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 11:18:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 11:18:00,Any visit,CM End Date,2023-08-01,CM_CMENDAT
DEU02,DEU_02_482,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 11:19:00,Any visit,CM Number,25,CM_CMSPID
DEU02,DEU_02_482,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 11:19:00,Any visit,CM Trade Name,Gliigestatrilat,CM_CMTRT
DEU02,DEU_02_482,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 11:19:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
DEU02,DEU_02_482,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 11:19:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
DEU02,DEU_02_482,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 11:19:00,Any visit,CM Dose,5,CM_CMDOSE
DEU02,DEU_02_482,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 11:19:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 11:19:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 11:19:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_482,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 11:19:00,Any visit,CM Start Date,2023-08-01,CM_CMSTDAT
DEU02,DEU_02_482,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 11:19:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 11:19:00,Any visit,CM End Date,2023-08-01,CM_CMENDAT
DEU02,DEU_02_482,26,COMMON_CM,Any visit,2023-08-24,CM,26,2023-08-24 14:11:00,Any visit,CM Number,26,CM_CMSPID
DEU02,DEU_02_482,26,COMMON_CM,Any visit,2023-08-24,CM,26,2023-08-24 14:11:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
DEU02,DEU_02_482,26,COMMON_CM,Any visit,2023-08-24,CM,26,2023-08-24 14:11:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
DEU02,DEU_02_482,26,COMMON_CM,Any visit,2023-08-24,CM,26,2023-08-24 14:11:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_482,26,COMMON_CM,Any visit,2023-08-24,CM,26,2023-08-24 14:11:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,26,COMMON_CM,Any visit,2023-08-24,CM,26,2023-08-24 14:11:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,26,COMMON_CM,Any visit,2023-08-24,CM,26,2023-08-24 14:11:00,Any visit,CM Route,Inhalation (p.i.),CM_CMROUTE
DEU02,DEU_02_482,26,COMMON_CM,Any visit,2023-08-24,CM,26,2023-08-24 14:11:00,Any visit,CM Start Date,2023-08-04,CM_CMSTDAT
DEU02,DEU_02_482,26,COMMON_CM,Any visit,2023-08-24,CM,26,2023-08-24 14:11:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,26,COMMON_CM,Any visit,2023-08-24,CM,26,2023-08-24 14:11:00,Any visit,CM End Date,2023-08-04,CM_CMENDAT
DEU02,DEU_02_482,27,COMMON_CM,Any visit,2023-08-24,CM,27,2023-08-24 14:12:00,Any visit,CM Number,27,CM_CMSPID
DEU02,DEU_02_482,27,COMMON_CM,Any visit,2023-08-24,CM,27,2023-08-24 14:12:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
DEU02,DEU_02_482,27,COMMON_CM,Any visit,2023-08-24,CM,27,2023-08-24 14:12:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
DEU02,DEU_02_482,27,COMMON_CM,Any visit,2023-08-24,CM,27,2023-08-24 14:12:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
DEU02,DEU_02_482,27,COMMON_CM,Any visit,2023-08-24,CM,27,2023-08-24 14:12:00,Any visit,CM Dose,3,CM_CMDOSE
DEU02,DEU_02_482,27,COMMON_CM,Any visit,2023-08-24,CM,27,2023-08-24 14:12:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,27,COMMON_CM,Any visit,2023-08-24,CM,27,2023-08-24 14:12:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,27,COMMON_CM,Any visit,2023-08-24,CM,27,2023-08-24 14:12:00,Any visit,CM Route,Inhalation (p.i.),CM_CMROUTE
DEU02,DEU_02_482,27,COMMON_CM,Any visit,2023-08-24,CM,27,2023-08-24 14:12:00,Any visit,CM Start Date,2023-08-05,CM_CMSTDAT
DEU02,DEU_02_482,27,COMMON_CM,Any visit,2023-08-24,CM,27,2023-08-24 14:12:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,27,COMMON_CM,Any visit,2023-08-24,CM,27,2023-08-24 14:12:00,Any visit,CM End Date,2023-08-05,CM_CMENDAT
DEU02,DEU_02_482,28,COMMON_CM,Any visit,2023-08-24,CM,28,2023-08-24 14:13:00,Any visit,CM Number,28,CM_CMSPID
DEU02,DEU_02_482,28,COMMON_CM,Any visit,2023-08-24,CM,28,2023-08-24 14:13:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
DEU02,DEU_02_482,28,COMMON_CM,Any visit,2023-08-24,CM,28,2023-08-24 14:13:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
DEU02,DEU_02_482,28,COMMON_CM,Any visit,2023-08-24,CM,28,2023-08-24 14:13:00,Any visit,CM Indication,Nausea,CM_CMINDC
DEU02,DEU_02_482,28,COMMON_CM,Any visit,2023-08-24,CM,28,2023-08-24 14:13:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,28,COMMON_CM,Any visit,2023-08-24,CM,28,2023-08-24 14:13:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,28,COMMON_CM,Any visit,2023-08-24,CM,28,2023-08-24 14:13:00,Any visit,CM Route,Inhalation (p.i.),CM_CMROUTE
DEU02,DEU_02_482,28,COMMON_CM,Any visit,2023-08-24,CM,28,2023-08-24 14:13:00,Any visit,CM Start Date,2023-08-06,CM_CMSTDAT
DEU02,DEU_02_482,28,COMMON_CM,Any visit,2023-08-24,CM,28,2023-08-24 14:13:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,28,COMMON_CM,Any visit,2023-08-24,CM,28,2023-08-24 14:13:00,Any visit,CM End Date,2023-08-06,CM_CMENDAT
DEU02,DEU_02_482,29,COMMON_CM,Any visit,2023-08-24,CM,29,2023-08-24 14:13:00,Any visit,CM Number,29,CM_CMSPID
DEU02,DEU_02_482,29,COMMON_CM,Any visit,2023-08-24,CM,29,2023-08-24 14:13:00,Any visit,CM Trade Name,Sulfatoxipladib,CM_CMTRT
DEU02,DEU_02_482,29,COMMON_CM,Any visit,2023-08-24,CM,29,2023-08-24 14:13:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
DEU02,DEU_02_482,29,COMMON_CM,Any visit,2023-08-24,CM,29,2023-08-24 14:13:00,Any visit,CM Indication,Pain,CM_CMINDC
DEU02,DEU_02_482,29,COMMON_CM,Any visit,2023-08-24,CM,29,2023-08-24 14:13:00,Any visit,CM Dose,4,CM_CMDOSE
DEU02,DEU_02_482,29,COMMON_CM,Any visit,2023-08-24,CM,29,2023-08-24 14:13:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,29,COMMON_CM,Any visit,2023-08-24,CM,29,2023-08-24 14:13:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,29,COMMON_CM,Any visit,2023-08-24,CM,29,2023-08-24 14:13:00,Any visit,CM Route,Inhalation (p.i.),CM_CMROUTE
DEU02,DEU_02_482,29,COMMON_CM,Any visit,2023-08-24,CM,29,2023-08-24 14:13:00,Any visit,CM Start Date,2023-08-07,CM_CMSTDAT
DEU02,DEU_02_482,29,COMMON_CM,Any visit,2023-08-24,CM,29,2023-08-24 14:13:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,29,COMMON_CM,Any visit,2023-08-24,CM,29,2023-08-24 14:13:00,Any visit,CM End Date,2023-08-07,CM_CMENDAT
DEU02,DEU_02_482,30,COMMON_CM,Any visit,2023-08-24,CM,30,2023-08-24 14:14:00,Any visit,CM Number,30,CM_CMSPID
DEU02,DEU_02_482,30,COMMON_CM,Any visit,2023-08-24,CM,30,2023-08-24 14:14:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
DEU02,DEU_02_482,30,COMMON_CM,Any visit,2023-08-24,CM,30,2023-08-24 14:14:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
DEU02,DEU_02_482,30,COMMON_CM,Any visit,2023-08-24,CM,30,2023-08-24 14:14:00,Any visit,CM Indication,Hypertension,CM_CMINDC
DEU02,DEU_02_482,30,COMMON_CM,Any visit,2023-08-24,CM,30,2023-08-24 14:14:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,30,COMMON_CM,Any visit,2023-08-24,CM,30,2023-08-24 14:14:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,30,COMMON_CM,Any visit,2023-08-24,CM,30,2023-08-24 14:14:00,Any visit,CM Route,Inhalation (p.i.),CM_CMROUTE
DEU02,DEU_02_482,30,COMMON_CM,Any visit,2023-08-24,CM,30,2023-08-24 14:14:00,Any visit,CM Start Date,2023-08-09,CM_CMSTDAT
DEU02,DEU_02_482,30,COMMON_CM,Any visit,2023-08-24,CM,30,2023-08-24 14:14:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,30,COMMON_CM,Any visit,2023-08-24,CM,30,2023-08-24 14:14:00,Any visit,CM End Date,2023-08-09,CM_CMENDAT
DEU02,DEU_02_482,31,COMMON_CM,Any visit,2023-08-24,CM,31,2023-08-24 14:16:00,Any visit,CM Number,31,CM_CMSPID
DEU02,DEU_02_482,31,COMMON_CM,Any visit,2023-08-24,CM,31,2023-08-24 14:16:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
DEU02,DEU_02_482,31,COMMON_CM,Any visit,2023-08-24,CM,31,2023-08-24 14:16:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
DEU02,DEU_02_482,31,COMMON_CM,Any visit,2023-08-24,CM,31,2023-08-24 14:16:00,Any visit,CM Indication,Pain,CM_CMINDC
DEU02,DEU_02_482,31,COMMON_CM,Any visit,2023-08-24,CM,31,2023-08-24 14:16:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_482,31,COMMON_CM,Any visit,2023-08-24,CM,31,2023-08-24 14:16:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
DEU02,DEU_02_482,31,COMMON_CM,Any visit,2023-08-24,CM,31,2023-08-24 14:16:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_482,31,COMMON_CM,Any visit,2023-08-24,CM,31,2023-08-24 14:16:00,Any visit,CM Start Date,2023-08-12,CM_CMSTDAT
DEU02,DEU_02_482,31,COMMON_CM,Any visit,2023-08-24,CM,31,2023-08-24 14:16:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,31,COMMON_CM,Any visit,2023-08-24,CM,31,2023-08-24 14:16:00,Any visit,CM End Date,2023-08-18,CM_CMENDAT
DEU02,DEU_02_482,32,COMMON_CM,Any visit,2023-08-24,CM,32,2023-08-24 14:17:00,Any visit,CM Number,32,CM_CMSPID
DEU02,DEU_02_482,32,COMMON_CM,Any visit,2023-08-24,CM,32,2023-08-24 14:17:00,Any visit,CM Trade Name,Bolidilanil,CM_CMTRT
DEU02,DEU_02_482,32,COMMON_CM,Any visit,2023-08-24,CM,32,2023-08-24 14:17:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
DEU02,DEU_02_482,32,COMMON_CM,Any visit,2023-08-24,CM,32,2023-08-25 08:01:00,Any visit,CM Indication,Adverse event,CM_CMINDC
DEU02,DEU_02_482,32,COMMON_CM,Any visit,2023-08-24,CM,32,2023-08-24 14:17:00,Any visit,CM Dose,1,CM_CMDOSE
DEU02,DEU_02_482,32,COMMON_CM,Any visit,2023-08-24,CM,32,2023-08-24 14:17:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_482,32,COMMON_CM,Any visit,2023-08-24,CM,32,2023-08-24 14:17:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_482,32,COMMON_CM,Any visit,2023-08-24,CM,32,2023-08-24 14:17:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_482,32,COMMON_CM,Any visit,2023-08-24,CM,32,2023-08-24 14:17:00,Any visit,CM Start Date,2023-08-09,CM_CMSTDAT
DEU02,DEU_02_482,32,COMMON_CM,Any visit,2023-08-24,CM,32,2023-08-24 14:17:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,32,COMMON_CM,Any visit,2023-08-24,CM,32,2023-08-24 14:17:00,Any visit,CM End Date,2023-08-19,CM_CMENDAT
DEU02,DEU_02_482,33,COMMON_CM,Any visit,2023-08-24,CM,33,2023-08-24 14:18:00,Any visit,CM Number,33,CM_CMSPID
DEU02,DEU_02_482,33,COMMON_CM,Any visit,2023-08-24,CM,33,2023-08-24 14:18:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
DEU02,DEU_02_482,33,COMMON_CM,Any visit,2023-08-24,CM,33,2023-08-24 14:18:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
DEU02,DEU_02_482,33,COMMON_CM,Any visit,2023-08-24,CM,33,2023-08-24 14:18:00,Any visit,CM Indication,Adverse event,CM_CMINDC
DEU02,DEU_02_482,33,COMMON_CM,Any visit,2023-08-24,CM,33,2023-08-24 14:18:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,33,COMMON_CM,Any visit,2023-08-24,CM,33,2023-08-24 14:18:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_482,33,COMMON_CM,Any visit,2023-08-24,CM,33,2023-08-24 14:18:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_482,33,COMMON_CM,Any visit,2023-08-24,CM,33,2023-08-24 14:18:00,Any visit,CM Start Date,2023-08-17,CM_CMSTDAT
DEU02,DEU_02_482,33,COMMON_CM,Any visit,2023-08-24,CM,33,2023-08-24 14:18:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,33,COMMON_CM,Any visit,2023-08-24,CM,33,2023-08-24 14:18:00,Any visit,CM End Date,2023-08-19,CM_CMENDAT
DEU02,DEU_02_482,34,COMMON_CM,Any visit,2023-08-24,CM,34,2023-08-24 14:19:00,Any visit,CM Number,34,CM_CMSPID
DEU02,DEU_02_482,34,COMMON_CM,Any visit,2023-08-24,CM,34,2023-08-24 14:19:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
DEU02,DEU_02_482,34,COMMON_CM,Any visit,2023-08-24,CM,34,2023-08-24 14:19:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
DEU02,DEU_02_482,34,COMMON_CM,Any visit,2023-08-24,CM,34,2023-08-24 14:19:00,Any visit,CM Indication,Insomnia,CM_CMINDC
DEU02,DEU_02_482,34,COMMON_CM,Any visit,2023-08-24,CM,34,2023-08-24 14:19:00,Any visit,CM Unit,Other,CM_CMDOSU
DEU02,DEU_02_482,34,COMMON_CM,Any visit,2023-08-24,CM,34,2023-08-24 14:19:00,Any visit,CM Unit Other,L,CM_CMDOSU_OTH
DEU02,DEU_02_482,34,COMMON_CM,Any visit,2023-08-24,CM,34,2023-08-24 14:19:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_482,34,COMMON_CM,Any visit,2023-08-24,CM,34,2023-08-24 14:19:00,Any visit,CM Route,Nasal,CM_CMROUTE
DEU02,DEU_02_482,34,COMMON_CM,Any visit,2023-08-24,CM,34,2023-08-24 14:19:00,Any visit,CM Start Date,2023-08-11,CM_CMSTDAT
DEU02,DEU_02_482,34,COMMON_CM,Any visit,2023-08-24,CM,34,2023-08-24 14:19:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,34,COMMON_CM,Any visit,2023-08-24,CM,34,2023-08-24 14:19:00,Any visit,CM End Date,2023-08-19,CM_CMENDAT
DEU02,DEU_02_482,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 07:54:00,Any visit,CM Number,35,CM_CMSPID
DEU02,DEU_02_482,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 07:54:00,Any visit,CM Trade Name,Bolidilanil,CM_CMTRT
DEU02,DEU_02_482,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 07:54:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
DEU02,DEU_02_482,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 07:54:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_482,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 07:54:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 07:54:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_482,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 07:54:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_482,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 07:54:00,Any visit,CM Start Date,2023-08-11,CM_CMSTDAT
DEU02,DEU_02_482,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 07:54:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 07:54:00,Any visit,CM End Date,2023-08-15,CM_CMENDAT
DEU02,DEU_02_482,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 07:56:00,Any visit,CM Number,36,CM_CMSPID
DEU02,DEU_02_482,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 07:56:00,Any visit,CM Trade Name,Gliigestatrilat,CM_CMTRT
DEU02,DEU_02_482,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 07:56:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
DEU02,DEU_02_482,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 07:56:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_482,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 07:56:00,Any visit,CM Dose,4,CM_CMDOSE
DEU02,DEU_02_482,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 07:56:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 07:56:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 07:56:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_482,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 07:56:00,Any visit,CM Start Date,2023-08-13,CM_CMSTDAT
DEU02,DEU_02_482,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 07:56:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 07:56:00,Any visit,CM End Date,2023-08-13,CM_CMENDAT
DEU02,DEU_02_482,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 07:57:00,Any visit,CM Number,37,CM_CMSPID
DEU02,DEU_02_482,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 07:57:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
DEU02,DEU_02_482,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 07:57:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
DEU02,DEU_02_482,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 07:57:00,Any visit,CM Indication,Hypertension,CM_CMINDC
DEU02,DEU_02_482,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 07:57:00,Any visit,CM Dose,10,CM_CMDOSE
DEU02,DEU_02_482,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 07:57:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 07:57:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
DEU02,DEU_02_482,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 07:57:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_482,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 07:57:00,Any visit,CM Start Date,2023-08-13,CM_CMSTDAT
DEU02,DEU_02_482,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 07:57:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 07:57:00,Any visit,CM End Date,2023-08-17,CM_CMENDAT
DEU02,DEU_02_482,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 07:59:00,Any visit,CM Number,38,CM_CMSPID
DEU02,DEU_02_482,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 07:59:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
DEU02,DEU_02_482,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 07:59:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
DEU02,DEU_02_482,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 07:59:00,Any visit,CM Indication,Hypertension,CM_CMINDC
DEU02,DEU_02_482,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 07:59:00,Any visit,CM Dose,5,CM_CMDOSE
DEU02,DEU_02_482,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 07:59:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 07:59:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_482,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 07:59:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_482,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 07:59:00,Any visit,CM Start Date,2023-08-13,CM_CMSTDAT
DEU02,DEU_02_482,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 07:59:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 07:59:00,Any visit,CM End Date,2023-08-17,CM_CMENDAT
DEU02,DEU_02_482,39,COMMON_CM,Any visit,2023-08-25,CM,39,2023-08-25 08:00:00,Any visit,CM Number,39,CM_CMSPID
DEU02,DEU_02_482,39,COMMON_CM,Any visit,2023-08-25,CM,39,2023-08-25 08:00:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
DEU02,DEU_02_482,39,COMMON_CM,Any visit,2023-08-25,CM,39,2023-08-25 08:00:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
DEU02,DEU_02_482,39,COMMON_CM,Any visit,2023-08-25,CM,39,2023-08-25 08:00:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_482,39,COMMON_CM,Any visit,2023-08-25,CM,39,2023-08-25 08:00:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,39,COMMON_CM,Any visit,2023-08-25,CM,39,2023-08-25 08:00:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_482,39,COMMON_CM,Any visit,2023-08-25,CM,39,2023-08-25 08:00:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_482,39,COMMON_CM,Any visit,2023-08-25,CM,39,2023-08-25 08:00:00,Any visit,CM Start Date,2023-08-13,CM_CMSTDAT
DEU02,DEU_02_482,39,COMMON_CM,Any visit,2023-08-25,CM,39,2023-08-25 08:00:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,39,COMMON_CM,Any visit,2023-08-25,CM,39,2023-08-25 08:00:00,Any visit,CM End Date,2023-08-19,CM_CMENDAT
DEU02,DEU_02_482,40,COMMON_CM,Any visit,2023-08-25,CM,40,2023-08-25 08:04:00,Any visit,CM Number,40,CM_CMSPID
DEU02,DEU_02_482,40,COMMON_CM,Any visit,2023-08-25,CM,40,2023-08-25 08:04:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
DEU02,DEU_02_482,40,COMMON_CM,Any visit,2023-08-25,CM,40,2023-08-25 08:04:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
DEU02,DEU_02_482,40,COMMON_CM,Any visit,2023-08-25,CM,40,2023-08-25 08:04:00,Any visit,CM Indication,Pain,CM_CMINDC
DEU02,DEU_02_482,40,COMMON_CM,Any visit,2023-08-25,CM,40,2023-08-25 08:04:00,Any visit,CM Dose,100,CM_CMDOSE
DEU02,DEU_02_482,40,COMMON_CM,Any visit,2023-08-25,CM,40,2023-08-25 08:04:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,40,COMMON_CM,Any visit,2023-08-25,CM,40,2023-08-25 08:04:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,40,COMMON_CM,Any visit,2023-08-25,CM,40,2023-08-25 08:04:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_482,40,COMMON_CM,Any visit,2023-08-25,CM,40,2023-08-25 08:04:00,Any visit,CM Start Date,2023-08-16,CM_CMSTDAT
DEU02,DEU_02_482,40,COMMON_CM,Any visit,2023-08-25,CM,40,2023-08-25 08:04:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,40,COMMON_CM,Any visit,2023-08-25,CM,40,2023-08-25 08:04:00,Any visit,CM End Date,2023-08-16,CM_CMENDAT
DEU02,DEU_02_482,41,COMMON_CM,Any visit,2023-08-25,CM,41,2023-08-25 08:05:00,Any visit,CM Number,41,CM_CMSPID
DEU02,DEU_02_482,41,COMMON_CM,Any visit,2023-08-25,CM,41,2023-08-25 08:05:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
DEU02,DEU_02_482,41,COMMON_CM,Any visit,2023-08-25,CM,41,2023-08-25 08:05:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
DEU02,DEU_02_482,41,COMMON_CM,Any visit,2023-08-25,CM,41,2023-08-25 08:05:00,Any visit,CM Indication,Pain,CM_CMINDC
DEU02,DEU_02_482,41,COMMON_CM,Any visit,2023-08-25,CM,41,2023-08-25 08:05:00,Any visit,CM Dose,200,CM_CMDOSE
DEU02,DEU_02_482,41,COMMON_CM,Any visit,2023-08-25,CM,41,2023-08-25 08:05:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,41,COMMON_CM,Any visit,2023-08-25,CM,41,2023-08-25 08:05:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_482,41,COMMON_CM,Any visit,2023-08-25,CM,41,2023-08-25 08:05:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_482,41,COMMON_CM,Any visit,2023-08-25,CM,41,2023-08-25 08:05:00,Any visit,CM Start Date,2023-08-17,CM_CMSTDAT
DEU02,DEU_02_482,41,COMMON_CM,Any visit,2023-08-25,CM,41,2023-08-25 08:05:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,41,COMMON_CM,Any visit,2023-08-25,CM,41,2023-08-25 08:05:00,Any visit,CM End Date,2023-08-17,CM_CMENDAT
DEU02,DEU_02_482,42,COMMON_CM,Any visit,2023-08-25,CM,42,2023-08-25 08:08:00,Any visit,CM Number,42,CM_CMSPID
DEU02,DEU_02_482,42,COMMON_CM,Any visit,2023-08-25,CM,42,2023-08-25 08:08:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
DEU02,DEU_02_482,42,COMMON_CM,Any visit,2023-08-25,CM,42,2023-08-25 08:08:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
DEU02,DEU_02_482,42,COMMON_CM,Any visit,2023-08-25,CM,42,2023-08-25 08:08:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_482,42,COMMON_CM,Any visit,2023-08-25,CM,42,2023-08-25 08:08:00,Any visit,CM Dose,10,CM_CMDOSE
DEU02,DEU_02_482,42,COMMON_CM,Any visit,2023-08-25,CM,42,2023-08-25 08:08:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,42,COMMON_CM,Any visit,2023-08-25,CM,42,2023-08-25 08:08:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_482,42,COMMON_CM,Any visit,2023-08-25,CM,42,2023-08-25 08:08:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_482,42,COMMON_CM,Any visit,2023-08-25,CM,42,2023-08-25 08:08:00,Any visit,CM Start Date,2023-08-15,CM_CMSTDAT
DEU02,DEU_02_482,42,COMMON_CM,Any visit,2023-08-25,CM,42,2023-08-25 08:08:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,42,COMMON_CM,Any visit,2023-08-25,CM,42,2023-08-25 08:08:00,Any visit,CM End Date,2023-08-17,CM_CMENDAT
DEU02,DEU_02_482,43,COMMON_CM,Any visit,2023-08-25,CM,43,2023-08-25 08:09:00,Any visit,CM Number,43,CM_CMSPID
DEU02,DEU_02_482,43,COMMON_CM,Any visit,2023-08-25,CM,43,2023-08-25 08:09:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
DEU02,DEU_02_482,43,COMMON_CM,Any visit,2023-08-25,CM,43,2023-08-25 08:09:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
DEU02,DEU_02_482,43,COMMON_CM,Any visit,2023-08-25,CM,43,2023-08-25 08:09:00,Any visit,CM Indication,Adverse event,CM_CMINDC
DEU02,DEU_02_482,43,COMMON_CM,Any visit,2023-08-25,CM,43,2023-08-25 08:09:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_482,43,COMMON_CM,Any visit,2023-08-25,CM,43,2023-08-25 08:09:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_482,43,COMMON_CM,Any visit,2023-08-25,CM,43,2023-08-25 08:09:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_482,43,COMMON_CM,Any visit,2023-08-25,CM,43,2023-08-25 08:09:00,Any visit,CM Start Date,2023-08-17,CM_CMSTDAT
DEU02,DEU_02_482,43,COMMON_CM,Any visit,2023-08-25,CM,43,2023-08-25 08:09:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_482,43,COMMON_CM,Any visit,2023-08-25,CM,43,2023-08-25 08:09:00,Any visit,CM End Date,2023-08-19,CM_CMENDAT
DEU02,DEU_02_482,7,COMMON_CM,Any visit,2023-08-08,CM,7,2023-08-10 16:38:00,Any visit,CM Related AE,Pneumothorax,CM_AEREL
DEU02,DEU_02_482,8,COMMON_CM,Any visit,2023-08-08,CM,8,2023-08-10 16:39:00,Any visit,CM Related AE,Diarrhea,CM_AEREL
DEU02,DEU_02_482,9,COMMON_CM,Any visit,2023-08-08,CM,9,2023-08-10 16:39:00,Any visit,CM Related AE,Diarrhea,CM_AEREL
DEU02,DEU_02_482,10,COMMON_CM,Any visit,2023-08-08,CM,10,2023-08-10 16:39:00,Any visit,CM Related AE,Hypotension,CM_AEREL
DEU02,DEU_02_482,11,COMMON_CM,Any visit,2023-08-08,CM,11,2023-08-08 16:14:00,Any visit,CM Related AE,Atrial fibrillation,CM_AEREL
DEU02,DEU_02_482,12,COMMON_CM,Any visit,2023-08-08,CM,12,2023-08-08 16:16:00,Any visit,CM Related AE,Diarrhea,CM_AEREL
DEU02,DEU_02_482,13,COMMON_CM,Any visit,2023-08-08,CM,13,2023-08-08 16:16:00,Any visit,CM Related AE,Urinary tract infection,CM_AEREL
DEU02,DEU_02_482,14,COMMON_CM,Any visit,2023-08-08,CM,14,2023-08-08 16:18:00,Any visit,CM Related AE,Atrial fibrillation,CM_AEREL
DEU02,DEU_02_482,15,COMMON_CM,Any visit,2023-08-08,CM,15,2023-08-08 16:22:00,Any visit,CM Related AE,Atrial fibrillation,CM_AEREL
DEU02,DEU_02_482,16,COMMON_CM,Any visit,2023-08-08,CM,16,2023-08-08 16:24:00,Any visit,CM Related AE,Diarrhea,CM_AEREL
DEU02,DEU_02_482,17,COMMON_CM,Any visit,2023-08-08,CM,17,2023-08-08 16:25:00,Any visit,CM Related AE,Hypotension,CM_AEREL
DEU02,DEU_02_482,18,COMMON_CM,Any visit,2023-08-08,CM,18,2023-08-08 16:26:00,Any visit,CM Related AE,Diarrhea,CM_AEREL
DEU02,DEU_02_482,19,COMMON_CM,Any visit,2023-08-08,CM,19,2023-08-08 16:29:00,Any visit,CM Related AE,Hypotension,CM_AEREL
DEU02,DEU_02_482,20,COMMON_CM,Any visit,2023-08-08,CM,20,2023-08-08 16:31:00,Any visit,CM Related AE,Pneumothorax,CM_AEREL
DEU02,DEU_02_482,21,COMMON_CM,Any visit,2023-08-08,CM,21,2023-08-08 16:33:00,Any visit,CM Related AE,Hypotension,CM_AEREL
DEU02,DEU_02_482,26,COMMON_CM,Any visit,2023-08-24,CM,26,2023-08-24 14:11:00,Any visit,CM Related AE,Diarrhea,CM_AEREL
DEU02,DEU_02_482,27,COMMON_CM,Any visit,2023-08-24,CM,27,2023-08-24 14:12:00,Any visit,CM Related AE,Urinary tract infection,CM_AEREL
DEU02,DEU_02_482,28,COMMON_CM,Any visit,2023-08-24,CM,28,2023-08-24 14:13:00,Any visit,CM Related AE,Pneumothorax,CM_AEREL
DEU02,DEU_02_482,29,COMMON_CM,Any visit,2023-08-24,CM,29,2023-08-24 14:13:00,Any visit,CM Related AE,Allergic reaction,CM_AEREL
DEU02,DEU_02_482,30,COMMON_CM,Any visit,2023-08-24,CM,30,2023-08-24 14:14:00,Any visit,CM Related AE,Pneumothorax,CM_AEREL
DEU02,DEU_02_482,31,COMMON_CM,Any visit,2023-08-24,CM,31,2023-08-24 14:16:00,Any visit,CM Related AE,Hypotension,CM_AEREL
DEU02,DEU_02_482,32,COMMON_CM,Any visit,2023-08-24,CM,32,2023-08-25 08:01:00,Any visit,CM Related AE,Hypotension,CM_AEREL
DEU02,DEU_02_482,33,COMMON_CM,Any visit,2023-08-24,CM,33,2023-08-24 14:18:00,Any visit,CM Related AE,Allergic reaction,CM_AEREL
DEU02,DEU_02_482,34,COMMON_CM,Any visit,2023-08-24,CM,34,2023-08-24 14:19:00,Any visit,CM Related AE,Urinary incontinence,CM_AEREL
DEU02,DEU_02_482,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 07:54:00,Any visit,CM Related AE,Hypotension,CM_AEREL
DEU02,DEU_02_482,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 07:56:00,Any visit,CM Related AE,Hypotension,CM_AEREL
DEU02,DEU_02_482,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 07:57:00,Any visit,CM Related AE,Urinary incontinence,CM_AEREL
DEU02,DEU_02_482,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 07:59:00,Any visit,CM Related AE,Pneumothorax,CM_AEREL
DEU02,DEU_02_482,39,COMMON_CM,Any visit,2023-08-25,CM,39,2023-08-25 08:00:00,Any visit,CM Related AE,Diarrhea,CM_AEREL
DEU02,DEU_02_482,40,COMMON_CM,Any visit,2023-08-25,CM,40,2023-08-25 08:04:00,Any visit,CM Related AE,Pneumothorax,CM_AEREL
DEU02,DEU_02_482,41,COMMON_CM,Any visit,2023-08-25,CM,41,2023-08-25 08:05:00,Any visit,CM Related AE,Urinary tract infection,CM_AEREL
DEU02,DEU_02_482,42,COMMON_CM,Any visit,2023-08-25,CM,42,2023-08-25 08:08:00,Any visit,CM Related AE,Diarrhea,CM_AEREL
DEU02,DEU_02_482,43,COMMON_CM,Any visit,2023-08-25,CM,43,2023-08-25 08:09:00,Any visit,CM Related AE,Hypotension,CM_AEREL
DEU02,DEU_02_482,4,COMMON_CM,Any visit,2023-08-08,CM,4,2023-08-08 15:46:00,Any visit,CM Related Medical History,Migraine,CM_MHREL
DEU02,DEU_02_482,5,COMMON_CM,Any visit,2023-08-08,CM,5,2023-08-08 15:50:00,Any visit,CM Related Medical History,COPD,CM_MHREL
DEU02,DEU_02_482,6,COMMON_CM,Any visit,2023-08-08,CM,6,2023-08-08 15:52:00,Any visit,CM Related Medical History,Atrial fibrillation,CM_MHREL
DEU02,DEU_02_387,1,COMMON_CM,Any visit,2023-08-10,CM,1,2023-08-10 14:13:00,Any visit,CM Number,1,CM_CMSPID
DEU02,DEU_02_387,1,COMMON_CM,Any visit,2023-08-10,CM,1,2023-08-10 14:13:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
DEU02,DEU_02_387,1,COMMON_CM,Any visit,2023-08-10,CM,1,2023-08-10 14:13:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
DEU02,DEU_02_387,1,COMMON_CM,Any visit,2023-08-10,CM,1,2023-08-10 14:13:00,Any visit,CM Indication,Insomnia,CM_CMINDC
DEU02,DEU_02_387,1,COMMON_CM,Any visit,2023-08-10,CM,1,2023-08-10 14:13:00,Any visit,CM Dose,500,CM_CMDOSE
DEU02,DEU_02_387,1,COMMON_CM,Any visit,2023-08-10,CM,1,2023-08-10 14:13:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,1,COMMON_CM,Any visit,2023-08-10,CM,1,2023-08-10 14:13:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
DEU02,DEU_02_387,1,COMMON_CM,Any visit,2023-08-10,CM,1,2023-08-10 14:13:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,1,COMMON_CM,Any visit,2023-08-10,CM,1,2023-08-10 14:13:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,1,COMMON_CM,Any visit,2023-08-10,CM,1,2023-08-10 14:13:00,Any visit,CM End Date,2023-07-13,CM_CMENDAT
DEU02,DEU_02_387,2,COMMON_CM,Any visit,2023-08-10,CM,2,2023-08-10 14:14:00,Any visit,CM Number,2,CM_CMSPID
DEU02,DEU_02_387,2,COMMON_CM,Any visit,2023-08-10,CM,2,2023-08-10 14:14:00,Any visit,CM Trade Name,Gliigestatrilat,CM_CMTRT
DEU02,DEU_02_387,2,COMMON_CM,Any visit,2023-08-10,CM,2,2023-08-10 14:14:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
DEU02,DEU_02_387,2,COMMON_CM,Any visit,2023-08-10,CM,2,2023-08-10 14:14:00,Any visit,CM Indication,Insomnia,CM_CMINDC
DEU02,DEU_02_387,2,COMMON_CM,Any visit,2023-08-10,CM,2,2023-08-10 14:14:00,Any visit,CM Dose,1,CM_CMDOSE
DEU02,DEU_02_387,2,COMMON_CM,Any visit,2023-08-10,CM,2,2023-08-10 14:14:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_387,2,COMMON_CM,Any visit,2023-08-10,CM,2,2023-08-10 14:14:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
DEU02,DEU_02_387,2,COMMON_CM,Any visit,2023-08-10,CM,2,2023-08-10 14:14:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,2,COMMON_CM,Any visit,2023-08-10,CM,2,2023-08-10 14:14:00,Any visit,CM Start Date,2023-07-13,CM_CMSTDAT
DEU02,DEU_02_387,2,COMMON_CM,Any visit,2023-08-10,CM,2,2023-08-10 14:14:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,2,COMMON_CM,Any visit,2023-08-10,CM,2,2023-08-10 14:14:00,Any visit,CM End Date,2023-07-30,CM_CMENDAT
DEU02,DEU_02_387,3,COMMON_CM,Any visit,2023-08-10,CM,3,2023-08-10 14:16:00,Any visit,CM Number,3,CM_CMSPID
DEU02,DEU_02_387,3,COMMON_CM,Any visit,2023-08-10,CM,3,2023-08-10 14:16:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
DEU02,DEU_02_387,3,COMMON_CM,Any visit,2023-08-10,CM,3,2023-08-10 14:16:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
DEU02,DEU_02_387,3,COMMON_CM,Any visit,2023-08-10,CM,3,2023-08-10 14:16:00,Any visit,CM Indication,Adverse event,CM_CMINDC
DEU02,DEU_02_387,3,COMMON_CM,Any visit,2023-08-10,CM,3,2023-08-10 14:16:00,Any visit,CM Unit,International Unit (IU),CM_CMDOSU
DEU02,DEU_02_387,3,COMMON_CM,Any visit,2023-08-10,CM,3,2023-08-10 14:16:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_387,3,COMMON_CM,Any visit,2023-08-10,CM,3,2023-08-10 14:16:00,Any visit,CM Route,Subcutaneous (s.c.),CM_CMROUTE
DEU02,DEU_02_387,3,COMMON_CM,Any visit,2023-08-10,CM,3,2023-08-10 14:16:00,Any visit,CM Start Date,2023-07-31,CM_CMSTDAT
DEU02,DEU_02_387,3,COMMON_CM,Any visit,2023-08-10,CM,3,2023-08-10 14:16:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,3,COMMON_CM,Any visit,2023-08-10,CM,3,2023-08-10 14:16:00,Any visit,CM End Date,2023-08-04,CM_CMENDAT
DEU02,DEU_02_387,4,COMMON_CM,Any visit,2023-08-10,CM,4,2023-08-10 14:19:00,Any visit,CM Number,4,CM_CMSPID
DEU02,DEU_02_387,4,COMMON_CM,Any visit,2023-08-10,CM,4,2023-08-10 14:19:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
DEU02,DEU_02_387,4,COMMON_CM,Any visit,2023-08-10,CM,4,2023-08-10 14:19:00,Any visit,CM Active Ingredient,Meloxicam,CM_CMINGRD
DEU02,DEU_02_387,4,COMMON_CM,Any visit,2023-08-10,CM,4,2023-08-10 14:19:00,Any visit,CM Indication,Hypertension,CM_CMINDC
DEU02,DEU_02_387,4,COMMON_CM,Any visit,2023-08-10,CM,4,2023-08-10 14:19:00,Any visit,CM Dose,500,CM_CMDOSE
DEU02,DEU_02_387,4,COMMON_CM,Any visit,2023-08-10,CM,4,2023-08-10 14:19:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,4,COMMON_CM,Any visit,2023-08-10,CM,4,2023-08-10 14:19:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
DEU02,DEU_02_387,4,COMMON_CM,Any visit,2023-08-10,CM,4,2023-08-10 14:19:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,4,COMMON_CM,Any visit,2023-08-10,CM,4,2023-08-10 14:19:00,Any visit,CM Start Date,2023-07-03,CM_CMSTDAT
DEU02,DEU_02_387,4,COMMON_CM,Any visit,2023-08-10,CM,4,2023-08-10 14:19:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,4,COMMON_CM,Any visit,2023-08-10,CM,4,2023-08-10 14:19:00,Any visit,CM End Date,2023-07-08,CM_CMENDAT
DEU02,DEU_02_387,5,COMMON_CM,Any visit,2023-08-10,CM,5,2023-08-10 14:21:00,Any visit,CM Number,5,CM_CMSPID
DEU02,DEU_02_387,5,COMMON_CM,Any visit,2023-08-10,CM,5,2023-08-10 14:21:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
DEU02,DEU_02_387,5,COMMON_CM,Any visit,2023-08-10,CM,5,2023-08-10 14:21:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
DEU02,DEU_02_387,5,COMMON_CM,Any visit,2023-08-10,CM,5,2023-08-10 14:21:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
DEU02,DEU_02_387,5,COMMON_CM,Any visit,2023-08-10,CM,5,2023-08-10 14:21:00,Any visit,CM Dose,1,CM_CMDOSE
DEU02,DEU_02_387,5,COMMON_CM,Any visit,2023-08-10,CM,5,2023-08-10 14:21:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_387,5,COMMON_CM,Any visit,2023-08-10,CM,5,2023-08-10 14:21:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
DEU02,DEU_02_387,5,COMMON_CM,Any visit,2023-08-10,CM,5,2023-08-10 14:21:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,5,COMMON_CM,Any visit,2023-08-10,CM,5,2023-08-10 14:21:00,Any visit,CM Start Date,2023-07-08,CM_CMSTDAT
DEU02,DEU_02_387,5,COMMON_CM,Any visit,2023-08-10,CM,5,2023-08-10 14:21:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,5,COMMON_CM,Any visit,2023-08-10,CM,5,2023-08-10 14:21:00,Any visit,CM End Date,2023-07-10,CM_CMENDAT
DEU02,DEU_02_387,6,COMMON_CM,Any visit,2023-08-10,CM,6,2023-08-10 14:22:00,Any visit,CM Number,6,CM_CMSPID
DEU02,DEU_02_387,6,COMMON_CM,Any visit,2023-08-10,CM,6,2023-08-10 14:22:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
DEU02,DEU_02_387,6,COMMON_CM,Any visit,2023-08-10,CM,6,2023-08-10 14:22:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
DEU02,DEU_02_387,6,COMMON_CM,Any visit,2023-08-10,CM,6,2023-08-10 14:22:00,Any visit,CM Indication,Nausea,CM_CMINDC
DEU02,DEU_02_387,6,COMMON_CM,Any visit,2023-08-10,CM,6,2023-08-10 14:22:00,Any visit,CM Dose,300,CM_CMDOSE
DEU02,DEU_02_387,6,COMMON_CM,Any visit,2023-08-10,CM,6,2023-08-10 14:22:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,6,COMMON_CM,Any visit,2023-08-10,CM,6,2023-08-10 14:22:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
DEU02,DEU_02_387,6,COMMON_CM,Any visit,2023-08-10,CM,6,2023-08-10 14:22:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,6,COMMON_CM,Any visit,2023-08-10,CM,6,2023-08-10 14:22:00,Any visit,CM Start Date,2023-07-11,CM_CMSTDAT
DEU02,DEU_02_387,6,COMMON_CM,Any visit,2023-08-10,CM,6,2023-08-10 14:22:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,6,COMMON_CM,Any visit,2023-08-10,CM,6,2023-08-10 14:22:00,Any visit,CM End Date,2023-07-17,CM_CMENDAT
DEU02,DEU_02_387,7,COMMON_CM,Any visit,2023-08-10,CM,7,2023-08-10 14:23:00,Any visit,CM Number,7,CM_CMSPID
DEU02,DEU_02_387,7,COMMON_CM,Any visit,2023-08-10,CM,7,2023-08-10 14:23:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
DEU02,DEU_02_387,7,COMMON_CM,Any visit,2023-08-10,CM,7,2023-08-10 14:23:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
DEU02,DEU_02_387,7,COMMON_CM,Any visit,2023-08-10,CM,7,2023-08-10 14:23:00,Any visit,CM Indication,Pain,CM_CMINDC
DEU02,DEU_02_387,7,COMMON_CM,Any visit,2023-08-10,CM,7,2023-08-10 14:23:00,Any visit,CM Dose,1,CM_CMDOSE
DEU02,DEU_02_387,7,COMMON_CM,Any visit,2023-08-10,CM,7,2023-08-10 14:23:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_387,7,COMMON_CM,Any visit,2023-08-10,CM,7,2023-08-10 14:23:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
DEU02,DEU_02_387,7,COMMON_CM,Any visit,2023-08-10,CM,7,2023-08-10 14:23:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,7,COMMON_CM,Any visit,2023-08-10,CM,7,2023-08-10 14:23:00,Any visit,CM Start Date,2023-07-17,CM_CMSTDAT
DEU02,DEU_02_387,7,COMMON_CM,Any visit,2023-08-10,CM,7,2023-08-10 14:23:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,7,COMMON_CM,Any visit,2023-08-10,CM,7,2023-08-10 14:23:00,Any visit,CM End Date,2023-07-21,CM_CMENDAT
DEU02,DEU_02_387,8,COMMON_CM,Any visit,2023-08-10,CM,8,2023-08-10 14:24:00,Any visit,CM Number,8,CM_CMSPID
DEU02,DEU_02_387,8,COMMON_CM,Any visit,2023-08-10,CM,8,2023-08-10 14:24:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
DEU02,DEU_02_387,8,COMMON_CM,Any visit,2023-08-10,CM,8,2023-08-10 14:24:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
DEU02,DEU_02_387,8,COMMON_CM,Any visit,2023-08-10,CM,8,2023-08-10 14:24:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_387,8,COMMON_CM,Any visit,2023-08-10,CM,8,2023-08-10 14:24:00,Any visit,CM Dose,500,CM_CMDOSE
DEU02,DEU_02_387,8,COMMON_CM,Any visit,2023-08-10,CM,8,2023-08-10 14:24:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,8,COMMON_CM,Any visit,2023-08-10,CM,8,2023-08-10 14:24:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
DEU02,DEU_02_387,8,COMMON_CM,Any visit,2023-08-10,CM,8,2023-08-10 14:24:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,8,COMMON_CM,Any visit,2023-08-10,CM,8,2023-08-10 14:24:00,Any visit,CM Start Date,2023-07-22,CM_CMSTDAT
DEU02,DEU_02_387,8,COMMON_CM,Any visit,2023-08-10,CM,8,2023-08-10 14:24:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,8,COMMON_CM,Any visit,2023-08-10,CM,8,2023-08-10 14:24:00,Any visit,CM End Date,2023-08-05,CM_CMENDAT
DEU02,DEU_02_387,9,COMMON_CM,Any visit,2023-08-10,CM,9,2023-08-10 14:26:00,Any visit,CM Number,9,CM_CMSPID
DEU02,DEU_02_387,9,COMMON_CM,Any visit,2023-08-10,CM,9,2023-08-10 14:26:00,Any visit,CM Trade Name,Gliigestatrilat,CM_CMTRT
DEU02,DEU_02_387,9,COMMON_CM,Any visit,2023-08-10,CM,9,2023-08-10 14:26:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
DEU02,DEU_02_387,9,COMMON_CM,Any visit,2023-08-10,CM,9,2023-08-10 14:26:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
DEU02,DEU_02_387,9,COMMON_CM,Any visit,2023-08-10,CM,9,2023-08-10 14:26:00,Any visit,CM Unit,Other,CM_CMDOSU
DEU02,DEU_02_387,9,COMMON_CM,Any visit,2023-08-10,CM,9,2023-08-10 14:26:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
DEU02,DEU_02_387,9,COMMON_CM,Any visit,2023-08-10,CM,9,2023-08-10 14:26:00,Any visit,CM Route,Other,CM_CMROUTE
DEU02,DEU_02_387,9,COMMON_CM,Any visit,2023-08-10,CM,9,2023-08-10 14:26:00,Any visit,CM Route Other,MOUTH WASH,CM_CMROUTE_OTH
DEU02,DEU_02_387,9,COMMON_CM,Any visit,2023-08-10,CM,9,2023-08-10 14:26:00,Any visit,CM Start Date,2023-07-11,CM_CMSTDAT
DEU02,DEU_02_387,9,COMMON_CM,Any visit,2023-08-10,CM,9,2023-08-10 14:26:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,9,COMMON_CM,Any visit,2023-08-10,CM,9,2023-08-10 14:26:00,Any visit,CM End Date,2023-07-23,CM_CMENDAT
DEU02,DEU_02_387,10,COMMON_CM,Any visit,2023-08-10,CM,10,2023-08-10 14:27:00,Any visit,CM Number,10,CM_CMSPID
DEU02,DEU_02_387,10,COMMON_CM,Any visit,2023-08-10,CM,10,2023-08-10 14:30:00,Any visit,CM Trade Name,Bolidilanil,CM_CMTRT
DEU02,DEU_02_387,10,COMMON_CM,Any visit,2023-08-10,CM,10,2023-08-10 14:30:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
DEU02,DEU_02_387,10,COMMON_CM,Any visit,2023-08-10,CM,10,2023-08-10 14:27:00,Any visit,CM Indication,Pain,CM_CMINDC
DEU02,DEU_02_387,10,COMMON_CM,Any visit,2023-08-10,CM,10,2023-08-10 14:27:00,Any visit,CM Unit,Unknown,CM_CMDOSU
DEU02,DEU_02_387,10,COMMON_CM,Any visit,2023-08-10,CM,10,2023-08-10 14:27:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
DEU02,DEU_02_387,10,COMMON_CM,Any visit,2023-08-10,CM,10,2023-08-10 14:27:00,Any visit,CM Route,Other,CM_CMROUTE
DEU02,DEU_02_387,10,COMMON_CM,Any visit,2023-08-10,CM,10,2023-08-10 14:27:00,Any visit,CM Route Other,MOUTH WASH,CM_CMROUTE_OTH
DEU02,DEU_02_387,10,COMMON_CM,Any visit,2023-08-10,CM,10,2023-08-10 14:27:00,Any visit,CM Start Date,2023-07-11,CM_CMSTDAT
DEU02,DEU_02_387,10,COMMON_CM,Any visit,2023-08-10,CM,10,2023-08-10 14:27:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,10,COMMON_CM,Any visit,2023-08-10,CM,10,2023-08-10 14:27:00,Any visit,CM End Date,2023-07-17,CM_CMENDAT
DEU02,DEU_02_387,11,COMMON_CM,Any visit,2023-08-10,CM,11,2023-08-10 14:30:00,Any visit,CM Number,11,CM_CMSPID
DEU02,DEU_02_387,11,COMMON_CM,Any visit,2023-08-10,CM,11,2023-08-10 14:30:00,Any visit,CM Trade Name,Gliigestatrilat,CM_CMTRT
DEU02,DEU_02_387,11,COMMON_CM,Any visit,2023-08-10,CM,11,2023-08-10 14:30:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
DEU02,DEU_02_387,11,COMMON_CM,Any visit,2023-08-10,CM,11,2023-08-10 14:30:00,Any visit,CM Indication,Hypertension,CM_CMINDC
DEU02,DEU_02_387,11,COMMON_CM,Any visit,2023-08-10,CM,11,2023-08-10 14:30:00,Any visit,CM Unit,Unknown,CM_CMDOSU
DEU02,DEU_02_387,11,COMMON_CM,Any visit,2023-08-10,CM,11,2023-08-10 14:30:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
DEU02,DEU_02_387,11,COMMON_CM,Any visit,2023-08-10,CM,11,2023-08-10 14:30:00,Any visit,CM Route,Other,CM_CMROUTE
DEU02,DEU_02_387,11,COMMON_CM,Any visit,2023-08-10,CM,11,2023-08-10 14:30:00,Any visit,CM Route Other,MOUTH WASH,CM_CMROUTE_OTH
DEU02,DEU_02_387,11,COMMON_CM,Any visit,2023-08-10,CM,11,2023-08-10 14:30:00,Any visit,CM Start Date,2023-07-11,CM_CMSTDAT
DEU02,DEU_02_387,11,COMMON_CM,Any visit,2023-08-10,CM,11,2023-08-10 14:30:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,11,COMMON_CM,Any visit,2023-08-10,CM,11,2023-08-10 14:30:00,Any visit,CM End Date,2023-07-17,CM_CMENDAT
DEU02,DEU_02_387,12,COMMON_CM,Any visit,2023-08-10,CM,12,2023-08-10 14:36:00,Any visit,CM Number,12,CM_CMSPID
DEU02,DEU_02_387,12,COMMON_CM,Any visit,2023-08-10,CM,12,2023-08-10 14:36:00,Any visit,CM Trade Name,Sulfatoxipladib,CM_CMTRT
DEU02,DEU_02_387,12,COMMON_CM,Any visit,2023-08-10,CM,12,2023-08-10 14:36:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
DEU02,DEU_02_387,12,COMMON_CM,Any visit,2023-08-10,CM,12,2023-08-10 14:36:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
DEU02,DEU_02_387,12,COMMON_CM,Any visit,2023-08-10,CM,12,2023-08-10 14:36:00,Any visit,CM Dose,20,CM_CMDOSE
DEU02,DEU_02_387,12,COMMON_CM,Any visit,2023-08-10,CM,12,2023-08-10 14:36:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,12,COMMON_CM,Any visit,2023-08-10,CM,12,2023-08-10 14:36:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_387,12,COMMON_CM,Any visit,2023-08-10,CM,12,2023-08-10 14:36:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,12,COMMON_CM,Any visit,2023-08-10,CM,12,2023-08-10 14:36:00,Any visit,CM Start Date,2023-07-07,CM_CMSTDAT
DEU02,DEU_02_387,12,COMMON_CM,Any visit,2023-08-10,CM,12,2023-08-10 14:36:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,12,COMMON_CM,Any visit,2023-08-10,CM,12,2023-08-10 14:36:00,Any visit,CM End Date,2023-07-07,CM_CMENDAT
DEU02,DEU_02_387,13,COMMON_CM,Any visit,2023-08-10,CM,13,2023-08-10 14:41:00,Any visit,CM Number,13,CM_CMSPID
DEU02,DEU_02_387,13,COMMON_CM,Any visit,2023-08-10,CM,13,2023-08-10 14:41:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
DEU02,DEU_02_387,13,COMMON_CM,Any visit,2023-08-10,CM,13,2023-08-10 14:41:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
DEU02,DEU_02_387,13,COMMON_CM,Any visit,2023-08-10,CM,13,2023-08-10 14:41:00,Any visit,CM Indication,Nausea,CM_CMINDC
DEU02,DEU_02_387,13,COMMON_CM,Any visit,2023-08-10,CM,13,2023-08-10 14:41:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_387,13,COMMON_CM,Any visit,2023-08-10,CM,13,2023-08-10 14:41:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
DEU02,DEU_02_387,13,COMMON_CM,Any visit,2023-08-10,CM,13,2023-08-10 14:41:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,13,COMMON_CM,Any visit,2023-08-10,CM,13,2023-08-10 14:41:00,Any visit,CM Start Date,2023-07-11,CM_CMSTDAT
DEU02,DEU_02_387,13,COMMON_CM,Any visit,2023-08-10,CM,13,2023-08-10 14:41:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,13,COMMON_CM,Any visit,2023-08-10,CM,13,2023-08-10 14:41:00,Any visit,CM End Date,2023-07-17,CM_CMENDAT
DEU02,DEU_02_387,14,COMMON_CM,Any visit,2023-08-10,CM,14,2023-08-10 14:43:00,Any visit,CM Number,14,CM_CMSPID
DEU02,DEU_02_387,14,COMMON_CM,Any visit,2023-08-10,CM,14,2023-08-10 14:43:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
DEU02,DEU_02_387,14,COMMON_CM,Any visit,2023-08-10,CM,14,2023-08-10 14:43:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
DEU02,DEU_02_387,14,COMMON_CM,Any visit,2023-08-10,CM,14,2023-08-10 14:43:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_387,14,COMMON_CM,Any visit,2023-08-10,CM,14,2023-08-10 14:43:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_387,14,COMMON_CM,Any visit,2023-08-10,CM,14,2023-08-10 14:43:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
DEU02,DEU_02_387,14,COMMON_CM,Any visit,2023-08-10,CM,14,2023-08-10 14:43:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,14,COMMON_CM,Any visit,2023-08-10,CM,14,2023-08-10 14:43:00,Any visit,CM Start Date,2023-07-18,CM_CMSTDAT
DEU02,DEU_02_387,14,COMMON_CM,Any visit,2023-08-10,CM,14,2023-08-10 14:43:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,14,COMMON_CM,Any visit,2023-08-10,CM,14,2023-08-10 14:43:00,Any visit,CM End Date,2023-07-20,CM_CMENDAT
DEU02,DEU_02_387,15,COMMON_CM,Any visit,2023-08-10,CM,15,2023-08-10 14:44:00,Any visit,CM Number,15,CM_CMSPID
DEU02,DEU_02_387,15,COMMON_CM,Any visit,2023-08-10,CM,15,2023-08-10 14:44:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
DEU02,DEU_02_387,15,COMMON_CM,Any visit,2023-08-10,CM,15,2023-08-10 14:44:00,Any visit,CM Active Ingredient,Meloxicam,CM_CMINGRD
DEU02,DEU_02_387,15,COMMON_CM,Any visit,2023-08-10,CM,15,2023-08-10 14:44:00,Any visit,CM Indication,Adverse event,CM_CMINDC
DEU02,DEU_02_387,15,COMMON_CM,Any visit,2023-08-10,CM,15,2023-08-10 14:44:00,Any visit,CM Dose,500,CM_CMDOSE
DEU02,DEU_02_387,15,COMMON_CM,Any visit,2023-08-10,CM,15,2023-08-10 14:44:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,15,COMMON_CM,Any visit,2023-08-10,CM,15,2023-08-10 14:44:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
DEU02,DEU_02_387,15,COMMON_CM,Any visit,2023-08-10,CM,15,2023-08-10 14:44:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,15,COMMON_CM,Any visit,2023-08-10,CM,15,2023-08-10 14:44:00,Any visit,CM Start Date,2023-07-18,CM_CMSTDAT
DEU02,DEU_02_387,15,COMMON_CM,Any visit,2023-08-10,CM,15,2023-08-10 14:44:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,15,COMMON_CM,Any visit,2023-08-10,CM,15,2023-08-10 14:44:00,Any visit,CM End Date,2023-07-20,CM_CMENDAT
DEU02,DEU_02_387,16,COMMON_CM,Any visit,2023-08-10,CM,16,2023-08-10 14:46:00,Any visit,CM Number,16,CM_CMSPID
DEU02,DEU_02_387,16,COMMON_CM,Any visit,2023-08-10,CM,16,2023-08-10 14:46:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
DEU02,DEU_02_387,16,COMMON_CM,Any visit,2023-08-10,CM,16,2023-08-10 14:46:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
DEU02,DEU_02_387,16,COMMON_CM,Any visit,2023-08-10,CM,16,2023-08-11 09:12:00,Any visit,CM Indication,Insomnia,CM_CMINDC
DEU02,DEU_02_387,16,COMMON_CM,Any visit,2023-08-10,CM,16,2023-08-10 14:46:00,Any visit,CM Dose,1,CM_CMDOSE
DEU02,DEU_02_387,16,COMMON_CM,Any visit,2023-08-10,CM,16,2023-08-10 14:46:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_387,16,COMMON_CM,Any visit,2023-08-10,CM,16,2023-08-10 14:46:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_387,16,COMMON_CM,Any visit,2023-08-10,CM,16,2023-08-10 14:46:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,16,COMMON_CM,Any visit,2023-08-10,CM,16,2023-08-10 14:46:00,Any visit,CM Start Date,2023-07-11,CM_CMSTDAT
DEU02,DEU_02_387,16,COMMON_CM,Any visit,2023-08-10,CM,16,2023-08-10 14:46:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,16,COMMON_CM,Any visit,2023-08-10,CM,16,2023-08-10 14:46:00,Any visit,CM End Date,2023-07-15,CM_CMENDAT
DEU02,DEU_02_387,17,COMMON_CM,Any visit,2023-08-10,CM,17,2023-08-10 14:52:00,Any visit,CM Number,17,CM_CMSPID
DEU02,DEU_02_387,17,COMMON_CM,Any visit,2023-08-10,CM,17,2023-08-10 14:52:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
DEU02,DEU_02_387,17,COMMON_CM,Any visit,2023-08-10,CM,17,2023-08-10 14:52:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
DEU02,DEU_02_387,17,COMMON_CM,Any visit,2023-08-10,CM,17,2023-08-11 09:13:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_387,17,COMMON_CM,Any visit,2023-08-10,CM,17,2023-08-10 14:52:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,17,COMMON_CM,Any visit,2023-08-10,CM,17,2023-08-10 14:52:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_387,17,COMMON_CM,Any visit,2023-08-10,CM,17,2023-08-10 14:52:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,17,COMMON_CM,Any visit,2023-08-10,CM,17,2023-08-10 14:52:00,Any visit,CM Start Date,2023-07-17,CM_CMSTDAT
DEU02,DEU_02_387,17,COMMON_CM,Any visit,2023-08-10,CM,17,2023-08-10 14:52:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,17,COMMON_CM,Any visit,2023-08-10,CM,17,2023-08-10 14:52:00,Any visit,CM End Date,2023-07-23,CM_CMENDAT
DEU02,DEU_02_387,18,COMMON_CM,Any visit,2023-08-10,CM,18,2023-08-10 14:56:00,Any visit,CM Number,18,CM_CMSPID
DEU02,DEU_02_387,18,COMMON_CM,Any visit,2023-08-10,CM,18,2023-08-10 14:56:00,Any visit,CM Trade Name,Bolidilanil,CM_CMTRT
DEU02,DEU_02_387,18,COMMON_CM,Any visit,2023-08-10,CM,18,2023-08-10 14:56:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
DEU02,DEU_02_387,18,COMMON_CM,Any visit,2023-08-10,CM,18,2023-08-10 14:56:00,Any visit,CM Indication,Hypertension,CM_CMINDC
DEU02,DEU_02_387,18,COMMON_CM,Any visit,2023-08-10,CM,18,2023-08-10 14:56:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_387,18,COMMON_CM,Any visit,2023-08-10,CM,18,2023-08-10 14:56:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
DEU02,DEU_02_387,18,COMMON_CM,Any visit,2023-08-10,CM,18,2023-08-10 14:56:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,18,COMMON_CM,Any visit,2023-08-10,CM,18,2023-08-10 14:56:00,Any visit,CM Start Date,2023-07-24,CM_CMSTDAT
DEU02,DEU_02_387,18,COMMON_CM,Any visit,2023-08-10,CM,18,2023-08-10 14:56:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,18,COMMON_CM,Any visit,2023-08-10,CM,18,2023-08-10 14:56:00,Any visit,CM End Date,2023-07-25,CM_CMENDAT
DEU02,DEU_02_387,19,COMMON_CM,Any visit,2023-08-10,CM,19,2023-08-10 14:57:00,Any visit,CM Number,19,CM_CMSPID
DEU02,DEU_02_387,19,COMMON_CM,Any visit,2023-08-10,CM,19,2023-08-10 14:57:00,Any visit,CM Trade Name,Sulfatoxipladib,CM_CMTRT
DEU02,DEU_02_387,19,COMMON_CM,Any visit,2023-08-10,CM,19,2023-08-10 14:57:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
DEU02,DEU_02_387,19,COMMON_CM,Any visit,2023-08-10,CM,19,2023-08-10 14:57:00,Any visit,CM Indication,Adverse event,CM_CMINDC
DEU02,DEU_02_387,19,COMMON_CM,Any visit,2023-08-10,CM,19,2023-08-10 14:57:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_387,19,COMMON_CM,Any visit,2023-08-10,CM,19,2023-08-10 14:57:00,Any visit,CM Frequency,4 times per day (QID),CM_CMDOSFRQ
DEU02,DEU_02_387,19,COMMON_CM,Any visit,2023-08-10,CM,19,2023-08-10 14:57:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,19,COMMON_CM,Any visit,2023-08-10,CM,19,2023-08-10 14:57:00,Any visit,CM Start Date,2023-07-25,CM_CMSTDAT
DEU02,DEU_02_387,19,COMMON_CM,Any visit,2023-08-10,CM,19,2023-08-10 14:57:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,19,COMMON_CM,Any visit,2023-08-10,CM,19,2023-08-10 14:57:00,Any visit,CM End Date,2023-07-30,CM_CMENDAT
DEU02,DEU_02_387,20,COMMON_CM,Any visit,2023-08-10,CM,20,2023-08-10 14:59:00,Any visit,CM Number,20,CM_CMSPID
DEU02,DEU_02_387,20,COMMON_CM,Any visit,2023-08-10,CM,20,2023-08-10 14:59:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
DEU02,DEU_02_387,20,COMMON_CM,Any visit,2023-08-10,CM,20,2023-08-10 14:59:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
DEU02,DEU_02_387,20,COMMON_CM,Any visit,2023-08-10,CM,20,2023-08-10 14:59:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_387,20,COMMON_CM,Any visit,2023-08-10,CM,20,2023-08-10 14:59:00,Any visit,CM Dose,500,CM_CMDOSE
DEU02,DEU_02_387,20,COMMON_CM,Any visit,2023-08-10,CM,20,2023-08-10 14:59:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,20,COMMON_CM,Any visit,2023-08-10,CM,20,2023-08-10 14:59:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
DEU02,DEU_02_387,20,COMMON_CM,Any visit,2023-08-10,CM,20,2023-08-10 14:59:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,20,COMMON_CM,Any visit,2023-08-10,CM,20,2023-08-10 14:59:00,Any visit,CM Start Date,2023-07-24,CM_CMSTDAT
DEU02,DEU_02_387,20,COMMON_CM,Any visit,2023-08-10,CM,20,2023-08-10 14:59:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,20,COMMON_CM,Any visit,2023-08-10,CM,20,2023-08-10 14:59:00,Any visit,CM End Date,2023-08-06,CM_CMENDAT
DEU02,DEU_02_387,21,COMMON_CM,Any visit,2023-08-10,CM,21,2023-08-10 15:00:00,Any visit,CM Number,21,CM_CMSPID
DEU02,DEU_02_387,21,COMMON_CM,Any visit,2023-08-10,CM,21,2023-08-10 15:00:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
DEU02,DEU_02_387,21,COMMON_CM,Any visit,2023-08-10,CM,21,2023-08-10 15:00:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
DEU02,DEU_02_387,21,COMMON_CM,Any visit,2023-08-10,CM,21,2023-08-10 15:00:00,Any visit,CM Indication,Insomnia,CM_CMINDC
DEU02,DEU_02_387,21,COMMON_CM,Any visit,2023-08-10,CM,21,2023-08-10 15:00:00,Any visit,CM Dose,200,CM_CMDOSE
DEU02,DEU_02_387,21,COMMON_CM,Any visit,2023-08-10,CM,21,2023-08-10 15:00:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,21,COMMON_CM,Any visit,2023-08-10,CM,21,2023-08-10 15:00:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_387,21,COMMON_CM,Any visit,2023-08-10,CM,21,2023-08-10 15:00:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,21,COMMON_CM,Any visit,2023-08-10,CM,21,2023-08-10 15:00:00,Any visit,CM Start Date,2023-07-26,CM_CMSTDAT
DEU02,DEU_02_387,21,COMMON_CM,Any visit,2023-08-10,CM,21,2023-08-10 15:00:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,21,COMMON_CM,Any visit,2023-08-10,CM,21,2023-08-10 15:00:00,Any visit,CM End Date,2023-07-26,CM_CMENDAT
DEU02,DEU_02_387,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 15:02:00,Any visit,CM Number,22,CM_CMSPID
DEU02,DEU_02_387,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 15:02:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
DEU02,DEU_02_387,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 15:02:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
DEU02,DEU_02_387,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 15:02:00,Any visit,CM Indication,Nausea,CM_CMINDC
DEU02,DEU_02_387,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 15:02:00,Any visit,CM Dose,200,CM_CMDOSE
DEU02,DEU_02_387,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 15:02:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 15:02:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_387,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 15:02:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 15:02:00,Any visit,CM Start Date,2023-07-28,CM_CMSTDAT
DEU02,DEU_02_387,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 15:02:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-10 15:02:00,Any visit,CM End Date,2023-07-28,CM_CMENDAT
DEU02,DEU_02_387,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 15:03:00,Any visit,CM Number,23,CM_CMSPID
DEU02,DEU_02_387,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 15:03:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
DEU02,DEU_02_387,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 15:03:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
DEU02,DEU_02_387,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 15:03:00,Any visit,CM Indication,Pain,CM_CMINDC
DEU02,DEU_02_387,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 15:03:00,Any visit,CM Dose,200,CM_CMDOSE
DEU02,DEU_02_387,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 15:03:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 15:03:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_387,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 15:03:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 15:03:00,Any visit,CM Start Date,2023-07-30,CM_CMSTDAT
DEU02,DEU_02_387,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 15:03:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-10 15:03:00,Any visit,CM End Date,2023-08-06,CM_CMENDAT
DEU02,DEU_02_387,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 15:04:00,Any visit,CM Number,24,CM_CMSPID
DEU02,DEU_02_387,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 15:04:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
DEU02,DEU_02_387,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 15:04:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
DEU02,DEU_02_387,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 15:04:00,Any visit,CM Indication,Pain,CM_CMINDC
DEU02,DEU_02_387,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 15:04:00,Any visit,CM Dose,500,CM_CMDOSE
DEU02,DEU_02_387,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 15:04:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 15:04:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_387,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 15:04:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 15:04:00,Any visit,CM Start Date,2023-07-28,CM_CMSTDAT
DEU02,DEU_02_387,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 15:04:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-10 15:04:00,Any visit,CM End Date,2023-07-30,CM_CMENDAT
DEU02,DEU_02_387,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 15:04:00,Any visit,CM Number,25,CM_CMSPID
DEU02,DEU_02_387,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 15:04:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
DEU02,DEU_02_387,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 15:04:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
DEU02,DEU_02_387,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 15:04:00,Any visit,CM Indication,Pain,CM_CMINDC
DEU02,DEU_02_387,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 15:04:00,Any visit,CM Dose,350,CM_CMDOSE
DEU02,DEU_02_387,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 15:04:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 15:04:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_387,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 15:04:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 15:04:00,Any visit,CM Start Date,2023-08-04,CM_CMSTDAT
DEU02,DEU_02_387,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 15:04:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-10 15:04:00,Any visit,CM End Date,2023-08-04,CM_CMENDAT
DEU02,DEU_02_387,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 15:05:00,Any visit,CM Number,26,CM_CMSPID
DEU02,DEU_02_387,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 15:05:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
DEU02,DEU_02_387,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 15:05:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
DEU02,DEU_02_387,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 15:05:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
DEU02,DEU_02_387,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 15:05:00,Any visit,CM Dose,1,CM_CMDOSE
DEU02,DEU_02_387,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 15:05:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_387,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 15:05:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_387,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 15:05:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 15:05:00,Any visit,CM Start Date,2023-07-31,CM_CMSTDAT
DEU02,DEU_02_387,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 15:05:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-10 15:05:00,Any visit,CM End Date,2023-07-31,CM_CMENDAT
DEU02,DEU_02_387,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 15:06:00,Any visit,CM Number,27,CM_CMSPID
DEU02,DEU_02_387,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 15:06:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
DEU02,DEU_02_387,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 15:06:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
DEU02,DEU_02_387,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 15:06:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_387,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 15:06:00,Any visit,CM Dose,1,CM_CMDOSE
DEU02,DEU_02_387,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 15:06:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_387,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 15:06:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
DEU02,DEU_02_387,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 15:06:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 15:06:00,Any visit,CM Start Date,2023-07-31,CM_CMSTDAT
DEU02,DEU_02_387,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 15:06:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-10 15:06:00,Any visit,CM End Date,2023-08-03,CM_CMENDAT
DEU02,DEU_02_387,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 15:07:00,Any visit,CM Number,28,CM_CMSPID
DEU02,DEU_02_387,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 15:07:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
DEU02,DEU_02_387,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 15:07:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
DEU02,DEU_02_387,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 15:07:00,Any visit,CM Indication,Insomnia,CM_CMINDC
DEU02,DEU_02_387,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 15:07:00,Any visit,CM Dose,2,CM_CMDOSE
DEU02,DEU_02_387,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 15:07:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_387,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 15:07:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
DEU02,DEU_02_387,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 15:07:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 15:07:00,Any visit,CM Start Date,2023-08-03,CM_CMSTDAT
DEU02,DEU_02_387,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 15:07:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-10 15:07:00,Any visit,CM End Date,2023-08-05,CM_CMENDAT
DEU02,DEU_02_387,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 15:08:00,Any visit,CM Number,29,CM_CMSPID
DEU02,DEU_02_387,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 15:08:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
DEU02,DEU_02_387,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 15:08:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
DEU02,DEU_02_387,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 15:08:00,Any visit,CM Indication,Hypertension,CM_CMINDC
DEU02,DEU_02_387,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 15:08:00,Any visit,CM Dose,500,CM_CMDOSE
DEU02,DEU_02_387,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 15:08:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 15:08:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_387,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 15:08:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 15:08:00,Any visit,CM Start Date,2023-07-31,CM_CMSTDAT
DEU02,DEU_02_387,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 15:08:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-10 15:08:00,Any visit,CM End Date,2023-08-02,CM_CMENDAT
DEU02,DEU_02_387,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 15:09:00,Any visit,CM Number,30,CM_CMSPID
DEU02,DEU_02_387,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 15:09:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
DEU02,DEU_02_387,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 15:09:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
DEU02,DEU_02_387,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 15:09:00,Any visit,CM Indication,Hypertension,CM_CMINDC
DEU02,DEU_02_387,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 15:09:00,Any visit,CM Dose,750,CM_CMDOSE
DEU02,DEU_02_387,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 15:09:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 15:09:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
DEU02,DEU_02_387,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 15:09:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 15:09:00,Any visit,CM Start Date,2023-08-03,CM_CMSTDAT
DEU02,DEU_02_387,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 15:09:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-10 15:09:00,Any visit,CM End Date,2023-08-04,CM_CMENDAT
DEU02,DEU_02_387,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 15:10:00,Any visit,CM Number,31,CM_CMSPID
DEU02,DEU_02_387,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 15:10:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
DEU02,DEU_02_387,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 15:10:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
DEU02,DEU_02_387,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 15:10:00,Any visit,CM Indication,Adverse event,CM_CMINDC
DEU02,DEU_02_387,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 15:10:00,Any visit,CM Dose,1,CM_CMDOSE
DEU02,DEU_02_387,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 15:10:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_387,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 15:10:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_387,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 15:10:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 15:10:00,Any visit,CM Start Date,2023-08-05,CM_CMSTDAT
DEU02,DEU_02_387,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 15:10:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-10 15:10:00,Any visit,CM End Date,2023-08-06,CM_CMENDAT
DEU02,DEU_02_387,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 15:11:00,Any visit,CM Number,32,CM_CMSPID
DEU02,DEU_02_387,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 15:11:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
DEU02,DEU_02_387,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 15:11:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
DEU02,DEU_02_387,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 15:11:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_387,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 15:11:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 15:11:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
DEU02,DEU_02_387,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 15:11:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 15:11:00,Any visit,CM Start Date,2023-07-24,CM_CMSTDAT
DEU02,DEU_02_387,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 15:11:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-10 15:11:00,Any visit,CM End Date,2023-07-24,CM_CMENDAT
DEU02,DEU_02_387,33,COMMON_CM,Any visit,2023-08-10,CM,33,2023-08-10 15:12:00,Any visit,CM Number,33,CM_CMSPID
DEU02,DEU_02_387,33,COMMON_CM,Any visit,2023-08-10,CM,33,2023-08-10 15:12:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
DEU02,DEU_02_387,33,COMMON_CM,Any visit,2023-08-10,CM,33,2023-08-10 15:12:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
DEU02,DEU_02_387,33,COMMON_CM,Any visit,2023-08-10,CM,33,2023-08-10 15:12:00,Any visit,CM Indication,Insomnia,CM_CMINDC
DEU02,DEU_02_387,33,COMMON_CM,Any visit,2023-08-10,CM,33,2023-08-10 15:12:00,Any visit,CM Dose,1,CM_CMDOSE
DEU02,DEU_02_387,33,COMMON_CM,Any visit,2023-08-10,CM,33,2023-08-10 15:12:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_387,33,COMMON_CM,Any visit,2023-08-10,CM,33,2023-08-10 15:12:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_387,33,COMMON_CM,Any visit,2023-08-10,CM,33,2023-08-10 15:12:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,33,COMMON_CM,Any visit,2023-08-10,CM,33,2023-08-10 15:12:00,Any visit,CM Start Date,2023-07-24,CM_CMSTDAT
DEU02,DEU_02_387,33,COMMON_CM,Any visit,2023-08-10,CM,33,2023-08-10 15:12:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,33,COMMON_CM,Any visit,2023-08-10,CM,33,2023-08-10 15:12:00,Any visit,CM End Date,2023-08-08,CM_CMENDAT
DEU02,DEU_02_387,34,COMMON_CM,Any visit,2023-08-10,CM,34,2023-08-10 15:13:00,Any visit,CM Number,34,CM_CMSPID
DEU02,DEU_02_387,34,COMMON_CM,Any visit,2023-08-10,CM,34,2023-08-10 15:13:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
DEU02,DEU_02_387,34,COMMON_CM,Any visit,2023-08-10,CM,34,2023-08-10 15:13:00,Any visit,CM Active Ingredient,Meloxicam,CM_CMINGRD
DEU02,DEU_02_387,34,COMMON_CM,Any visit,2023-08-10,CM,34,2023-08-10 15:13:00,Any visit,CM Indication,Hypertension,CM_CMINDC
DEU02,DEU_02_387,34,COMMON_CM,Any visit,2023-08-10,CM,34,2023-08-10 15:13:00,Any visit,CM Dose,20,CM_CMDOSE
DEU02,DEU_02_387,34,COMMON_CM,Any visit,2023-08-10,CM,34,2023-08-10 15:13:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,34,COMMON_CM,Any visit,2023-08-10,CM,34,2023-08-10 15:13:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_387,34,COMMON_CM,Any visit,2023-08-10,CM,34,2023-08-10 15:13:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,34,COMMON_CM,Any visit,2023-08-10,CM,34,2023-08-10 15:13:00,Any visit,CM Start Date,2023-07-24,CM_CMSTDAT
DEU02,DEU_02_387,34,COMMON_CM,Any visit,2023-08-10,CM,34,2023-08-10 15:13:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,34,COMMON_CM,Any visit,2023-08-10,CM,34,2023-08-10 15:13:00,Any visit,CM End Date,2023-07-25,CM_CMENDAT
DEU02,DEU_02_387,35,COMMON_CM,Any visit,2023-08-10,CM,35,2023-08-10 15:15:00,Any visit,CM Number,35,CM_CMSPID
DEU02,DEU_02_387,35,COMMON_CM,Any visit,2023-08-10,CM,35,2023-08-10 15:15:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
DEU02,DEU_02_387,35,COMMON_CM,Any visit,2023-08-10,CM,35,2023-08-10 15:15:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
DEU02,DEU_02_387,35,COMMON_CM,Any visit,2023-08-10,CM,35,2023-08-10 15:15:00,Any visit,CM Indication,Insomnia,CM_CMINDC
DEU02,DEU_02_387,35,COMMON_CM,Any visit,2023-08-10,CM,35,2023-08-10 15:15:00,Any visit,CM Dose,50,CM_CMDOSE
DEU02,DEU_02_387,35,COMMON_CM,Any visit,2023-08-10,CM,35,2023-08-10 15:15:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,35,COMMON_CM,Any visit,2023-08-10,CM,35,2023-08-10 15:15:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_387,35,COMMON_CM,Any visit,2023-08-10,CM,35,2023-08-10 15:15:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,35,COMMON_CM,Any visit,2023-08-10,CM,35,2023-08-10 15:15:00,Any visit,CM Start Date,2023-07-28,CM_CMSTDAT
DEU02,DEU_02_387,35,COMMON_CM,Any visit,2023-08-10,CM,35,2023-08-10 15:15:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,35,COMMON_CM,Any visit,2023-08-10,CM,35,2023-08-10 15:15:00,Any visit,CM End Date,2023-07-31,CM_CMENDAT
DEU02,DEU_02_387,36,COMMON_CM,Any visit,2023-08-10,CM,36,2023-08-10 15:16:00,Any visit,CM Number,36,CM_CMSPID
DEU02,DEU_02_387,36,COMMON_CM,Any visit,2023-08-10,CM,36,2023-08-10 15:16:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
DEU02,DEU_02_387,36,COMMON_CM,Any visit,2023-08-10,CM,36,2023-08-10 15:16:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
DEU02,DEU_02_387,36,COMMON_CM,Any visit,2023-08-10,CM,36,2023-08-10 15:16:00,Any visit,CM Indication,Insomnia,CM_CMINDC
DEU02,DEU_02_387,36,COMMON_CM,Any visit,2023-08-10,CM,36,2023-08-10 15:16:00,Any visit,CM Dose,150,CM_CMDOSE
DEU02,DEU_02_387,36,COMMON_CM,Any visit,2023-08-10,CM,36,2023-08-10 15:16:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,36,COMMON_CM,Any visit,2023-08-10,CM,36,2023-08-10 15:16:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_387,36,COMMON_CM,Any visit,2023-08-10,CM,36,2023-08-10 15:16:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,36,COMMON_CM,Any visit,2023-08-10,CM,36,2023-08-10 15:16:00,Any visit,CM Start Date,2023-07-25,CM_CMSTDAT
DEU02,DEU_02_387,36,COMMON_CM,Any visit,2023-08-10,CM,36,2023-08-10 15:16:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,36,COMMON_CM,Any visit,2023-08-10,CM,36,2023-08-10 15:16:00,Any visit,CM End Date,2023-07-26,CM_CMENDAT
DEU02,DEU_02_387,37,COMMON_CM,Any visit,2023-08-10,CM,37,2023-08-10 15:17:00,Any visit,CM Number,37,CM_CMSPID
DEU02,DEU_02_387,37,COMMON_CM,Any visit,2023-08-10,CM,37,2023-08-10 15:17:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
DEU02,DEU_02_387,37,COMMON_CM,Any visit,2023-08-10,CM,37,2023-08-10 15:17:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
DEU02,DEU_02_387,37,COMMON_CM,Any visit,2023-08-10,CM,37,2023-08-10 15:17:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_387,37,COMMON_CM,Any visit,2023-08-10,CM,37,2023-08-10 15:17:00,Any visit,CM Dose,100,CM_CMDOSE
DEU02,DEU_02_387,37,COMMON_CM,Any visit,2023-08-10,CM,37,2023-08-10 15:17:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,37,COMMON_CM,Any visit,2023-08-10,CM,37,2023-08-10 15:17:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
DEU02,DEU_02_387,37,COMMON_CM,Any visit,2023-08-10,CM,37,2023-08-10 15:17:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,37,COMMON_CM,Any visit,2023-08-10,CM,37,2023-08-10 15:17:00,Any visit,CM Start Date,2023-07-26,CM_CMSTDAT
DEU02,DEU_02_387,37,COMMON_CM,Any visit,2023-08-10,CM,37,2023-08-10 15:17:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,37,COMMON_CM,Any visit,2023-08-10,CM,37,2023-08-10 15:17:00,Any visit,CM End Date,2023-07-29,CM_CMENDAT
DEU02,DEU_02_387,38,COMMON_CM,Any visit,2023-08-10,CM,38,2023-08-10 15:18:00,Any visit,CM Number,38,CM_CMSPID
DEU02,DEU_02_387,38,COMMON_CM,Any visit,2023-08-10,CM,38,2023-08-10 15:18:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
DEU02,DEU_02_387,38,COMMON_CM,Any visit,2023-08-10,CM,38,2023-08-10 15:18:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
DEU02,DEU_02_387,38,COMMON_CM,Any visit,2023-08-10,CM,38,2023-08-10 15:18:00,Any visit,CM Indication,Nausea,CM_CMINDC
DEU02,DEU_02_387,38,COMMON_CM,Any visit,2023-08-10,CM,38,2023-08-10 15:18:00,Any visit,CM Dose,50,CM_CMDOSE
DEU02,DEU_02_387,38,COMMON_CM,Any visit,2023-08-10,CM,38,2023-08-10 15:18:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,38,COMMON_CM,Any visit,2023-08-10,CM,38,2023-08-10 15:18:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
DEU02,DEU_02_387,38,COMMON_CM,Any visit,2023-08-10,CM,38,2023-08-10 15:18:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,38,COMMON_CM,Any visit,2023-08-10,CM,38,2023-08-10 15:18:00,Any visit,CM Start Date,2023-07-29,CM_CMSTDAT
DEU02,DEU_02_387,38,COMMON_CM,Any visit,2023-08-10,CM,38,2023-08-10 15:18:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,38,COMMON_CM,Any visit,2023-08-10,CM,38,2023-08-10 15:18:00,Any visit,CM End Date,2023-08-03,CM_CMENDAT
DEU02,DEU_02_387,39,COMMON_CM,Any visit,2023-08-10,CM,39,2023-08-10 15:20:00,Any visit,CM Number,39,CM_CMSPID
DEU02,DEU_02_387,39,COMMON_CM,Any visit,2023-08-10,CM,39,2023-08-10 15:20:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
DEU02,DEU_02_387,39,COMMON_CM,Any visit,2023-08-10,CM,39,2023-08-10 15:20:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
DEU02,DEU_02_387,39,COMMON_CM,Any visit,2023-08-10,CM,39,2023-08-10 15:20:00,Any visit,CM Indication,Nausea,CM_CMINDC
DEU02,DEU_02_387,39,COMMON_CM,Any visit,2023-08-10,CM,39,2023-08-10 15:20:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,39,COMMON_CM,Any visit,2023-08-10,CM,39,2023-08-10 15:20:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_387,39,COMMON_CM,Any visit,2023-08-10,CM,39,2023-08-10 15:20:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,39,COMMON_CM,Any visit,2023-08-10,CM,39,2023-08-10 15:20:00,Any visit,CM Start Date,2023-08-02,CM_CMSTDAT
DEU02,DEU_02_387,39,COMMON_CM,Any visit,2023-08-10,CM,39,2023-08-10 15:20:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,39,COMMON_CM,Any visit,2023-08-10,CM,39,2023-08-10 15:20:00,Any visit,CM End Date,2023-08-08,CM_CMENDAT
DEU02,DEU_02_387,40,COMMON_CM,Any visit,2023-08-10,CM,40,2023-08-10 15:21:00,Any visit,CM Number,40,CM_CMSPID
DEU02,DEU_02_387,40,COMMON_CM,Any visit,2023-08-10,CM,40,2023-08-10 15:21:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
DEU02,DEU_02_387,40,COMMON_CM,Any visit,2023-08-10,CM,40,2023-08-10 15:21:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
DEU02,DEU_02_387,40,COMMON_CM,Any visit,2023-08-10,CM,40,2023-08-10 15:21:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_387,40,COMMON_CM,Any visit,2023-08-10,CM,40,2023-08-10 15:21:00,Any visit,CM Unit,Other,CM_CMDOSU
DEU02,DEU_02_387,40,COMMON_CM,Any visit,2023-08-10,CM,40,2023-08-10 15:21:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_387,40,COMMON_CM,Any visit,2023-08-10,CM,40,2023-08-10 15:21:00,Any visit,CM Route,Nasal,CM_CMROUTE
DEU02,DEU_02_387,40,COMMON_CM,Any visit,2023-08-10,CM,40,2023-08-10 15:21:00,Any visit,CM Start Date,2023-07-25,CM_CMSTDAT
DEU02,DEU_02_387,40,COMMON_CM,Any visit,2023-08-10,CM,40,2023-08-10 15:21:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,40,COMMON_CM,Any visit,2023-08-10,CM,40,2023-08-10 15:21:00,Any visit,CM End Date,2023-08-08,CM_CMENDAT
DEU02,DEU_02_387,41,COMMON_CM,Any visit,2023-08-10,CM,41,2023-08-10 15:22:00,Any visit,CM Number,41,CM_CMSPID
DEU02,DEU_02_387,41,COMMON_CM,Any visit,2023-08-10,CM,41,2023-08-10 15:22:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
DEU02,DEU_02_387,41,COMMON_CM,Any visit,2023-08-10,CM,41,2023-08-10 15:22:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
DEU02,DEU_02_387,41,COMMON_CM,Any visit,2023-08-10,CM,41,2023-08-10 15:22:00,Any visit,CM Indication,Hypertension,CM_CMINDC
DEU02,DEU_02_387,41,COMMON_CM,Any visit,2023-08-10,CM,41,2023-08-10 15:22:00,Any visit,CM Dose,1,CM_CMDOSE
DEU02,DEU_02_387,41,COMMON_CM,Any visit,2023-08-10,CM,41,2023-08-10 15:22:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_387,41,COMMON_CM,Any visit,2023-08-10,CM,41,2023-08-10 15:22:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
DEU02,DEU_02_387,41,COMMON_CM,Any visit,2023-08-10,CM,41,2023-08-10 15:22:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,41,COMMON_CM,Any visit,2023-08-10,CM,41,2023-08-10 15:22:00,Any visit,CM Start Date,2023-08-03,CM_CMSTDAT
DEU02,DEU_02_387,41,COMMON_CM,Any visit,2023-08-10,CM,41,2023-08-10 15:22:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,41,COMMON_CM,Any visit,2023-08-10,CM,41,2023-08-10 15:22:00,Any visit,CM End Date,2023-08-08,CM_CMENDAT
DEU02,DEU_02_387,42,COMMON_CM,Any visit,2023-08-10,CM,42,2023-08-10 15:29:00,Any visit,CM Number,42,CM_CMSPID
DEU02,DEU_02_387,42,COMMON_CM,Any visit,2023-08-10,CM,42,2023-08-10 15:29:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
DEU02,DEU_02_387,42,COMMON_CM,Any visit,2023-08-10,CM,42,2023-08-10 15:29:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
DEU02,DEU_02_387,42,COMMON_CM,Any visit,2023-08-10,CM,42,2023-08-10 15:29:00,Any visit,CM Indication,Insomnia,CM_CMINDC
DEU02,DEU_02_387,42,COMMON_CM,Any visit,2023-08-10,CM,42,2023-08-10 15:29:00,Any visit,CM Unit,Other,CM_CMDOSU
DEU02,DEU_02_387,42,COMMON_CM,Any visit,2023-08-10,CM,42,2023-08-10 15:29:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_387,42,COMMON_CM,Any visit,2023-08-10,CM,42,2023-08-10 15:29:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,42,COMMON_CM,Any visit,2023-08-10,CM,42,2023-08-10 15:29:00,Any visit,CM Start Date,2023-07-24,CM_CMSTDAT
DEU02,DEU_02_387,42,COMMON_CM,Any visit,2023-08-10,CM,42,2023-08-10 15:29:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,42,COMMON_CM,Any visit,2023-08-10,CM,42,2023-08-10 15:29:00,Any visit,CM End Date,2023-07-24,CM_CMENDAT
DEU02,DEU_02_387,43,COMMON_CM,Any visit,2023-08-10,CM,43,2023-08-10 15:30:00,Any visit,CM Number,43,CM_CMSPID
DEU02,DEU_02_387,43,COMMON_CM,Any visit,2023-08-10,CM,43,2023-08-10 15:30:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
DEU02,DEU_02_387,43,COMMON_CM,Any visit,2023-08-10,CM,43,2023-08-10 15:30:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
DEU02,DEU_02_387,43,COMMON_CM,Any visit,2023-08-10,CM,43,2023-08-10 15:30:00,Any visit,CM Indication,Nausea,CM_CMINDC
DEU02,DEU_02_387,43,COMMON_CM,Any visit,2023-08-10,CM,43,2023-08-10 15:30:00,Any visit,CM Dose,100000,CM_CMDOSE
DEU02,DEU_02_387,43,COMMON_CM,Any visit,2023-08-10,CM,43,2023-08-10 15:30:00,Any visit,CM Unit,International Unit (IU),CM_CMDOSU
DEU02,DEU_02_387,43,COMMON_CM,Any visit,2023-08-10,CM,43,2023-08-10 15:30:00,Any visit,CM Frequency,4 times per day (QID),CM_CMDOSFRQ
DEU02,DEU_02_387,43,COMMON_CM,Any visit,2023-08-10,CM,43,2023-08-10 15:30:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,43,COMMON_CM,Any visit,2023-08-10,CM,43,2023-08-10 15:30:00,Any visit,CM Start Date,2023-07-24,CM_CMSTDAT
DEU02,DEU_02_387,43,COMMON_CM,Any visit,2023-08-10,CM,43,2023-08-10 15:30:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,43,COMMON_CM,Any visit,2023-08-10,CM,43,2023-08-10 15:30:00,Any visit,CM End Date,2023-08-06,CM_CMENDAT
DEU02,DEU_02_387,44,COMMON_CM,Any visit,2023-08-10,CM,44,2023-08-10 15:32:00,Any visit,CM Number,44,CM_CMSPID
DEU02,DEU_02_387,44,COMMON_CM,Any visit,2023-08-10,CM,44,2023-08-10 15:32:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
DEU02,DEU_02_387,44,COMMON_CM,Any visit,2023-08-10,CM,44,2023-08-10 15:32:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
DEU02,DEU_02_387,44,COMMON_CM,Any visit,2023-08-10,CM,44,2023-08-10 15:32:00,Any visit,CM Indication,Pain,CM_CMINDC
DEU02,DEU_02_387,44,COMMON_CM,Any visit,2023-08-10,CM,44,2023-08-10 15:32:00,Any visit,CM Dose,20,CM_CMDOSE
DEU02,DEU_02_387,44,COMMON_CM,Any visit,2023-08-10,CM,44,2023-08-10 15:32:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
DEU02,DEU_02_387,44,COMMON_CM,Any visit,2023-08-10,CM,44,2023-08-10 15:32:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_387,44,COMMON_CM,Any visit,2023-08-10,CM,44,2023-08-10 15:32:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,44,COMMON_CM,Any visit,2023-08-10,CM,44,2023-08-10 15:32:00,Any visit,CM Start Date,2023-07-27,CM_CMSTDAT
DEU02,DEU_02_387,44,COMMON_CM,Any visit,2023-08-10,CM,44,2023-08-10 15:32:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,44,COMMON_CM,Any visit,2023-08-10,CM,44,2023-08-10 15:32:00,Any visit,CM End Date,2023-08-04,CM_CMENDAT
DEU02,DEU_02_387,45,COMMON_CM,Any visit,2023-08-10,CM,45,2023-08-10 15:38:00,Any visit,CM Number,45,CM_CMSPID
DEU02,DEU_02_387,45,COMMON_CM,Any visit,2023-08-10,CM,45,2023-08-10 15:38:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
DEU02,DEU_02_387,45,COMMON_CM,Any visit,2023-08-10,CM,45,2023-08-10 15:38:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
DEU02,DEU_02_387,45,COMMON_CM,Any visit,2023-08-10,CM,45,2023-08-10 15:38:00,Any visit,CM Indication,Nausea,CM_CMINDC
DEU02,DEU_02_387,45,COMMON_CM,Any visit,2023-08-10,CM,45,2023-08-10 15:38:00,Any visit,CM Dose,5,CM_CMDOSE
DEU02,DEU_02_387,45,COMMON_CM,Any visit,2023-08-10,CM,45,2023-08-10 15:38:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,45,COMMON_CM,Any visit,2023-08-10,CM,45,2023-08-10 15:38:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_387,45,COMMON_CM,Any visit,2023-08-10,CM,45,2023-08-10 15:38:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
DEU02,DEU_02_387,45,COMMON_CM,Any visit,2023-08-10,CM,45,2023-08-10 15:38:00,Any visit,CM Start Date,2023-07-29,CM_CMSTDAT
DEU02,DEU_02_387,45,COMMON_CM,Any visit,2023-08-10,CM,45,2023-08-10 15:38:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,45,COMMON_CM,Any visit,2023-08-10,CM,45,2023-08-10 15:38:00,Any visit,CM End Date,2023-08-01,CM_CMENDAT
DEU02,DEU_02_387,46,COMMON_CM,Any visit,2023-08-10,CM,46,2023-08-10 15:40:00,Any visit,CM Number,46,CM_CMSPID
DEU02,DEU_02_387,46,COMMON_CM,Any visit,2023-08-10,CM,46,2023-08-10 15:40:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
DEU02,DEU_02_387,46,COMMON_CM,Any visit,2023-08-10,CM,46,2023-08-10 15:40:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
DEU02,DEU_02_387,46,COMMON_CM,Any visit,2023-08-10,CM,46,2023-08-10 15:40:00,Any visit,CM Indication,Nausea,CM_CMINDC
DEU02,DEU_02_387,46,COMMON_CM,Any visit,2023-08-10,CM,46,2023-08-10 15:40:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,46,COMMON_CM,Any visit,2023-08-10,CM,46,2023-08-10 15:40:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
DEU02,DEU_02_387,46,COMMON_CM,Any visit,2023-08-10,CM,46,2023-08-10 15:40:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,46,COMMON_CM,Any visit,2023-08-10,CM,46,2023-08-10 15:40:00,Any visit,CM Start Date,2023-08-04,CM_CMSTDAT
DEU02,DEU_02_387,46,COMMON_CM,Any visit,2023-08-10,CM,46,2023-08-10 15:40:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,46,COMMON_CM,Any visit,2023-08-10,CM,46,2023-08-10 15:40:00,Any visit,CM End Date,2023-08-08,CM_CMENDAT
DEU02,DEU_02_387,47,COMMON_CM,Any visit,2023-08-10,CM,47,2023-08-10 15:42:00,Any visit,CM Number,47,CM_CMSPID
DEU02,DEU_02_387,47,COMMON_CM,Any visit,2023-08-10,CM,47,2023-08-10 15:42:00,Any visit,CM Trade Name,Sulfatoxipladib,CM_CMTRT
DEU02,DEU_02_387,47,COMMON_CM,Any visit,2023-08-10,CM,47,2023-08-10 15:42:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
DEU02,DEU_02_387,47,COMMON_CM,Any visit,2023-08-10,CM,47,2023-08-10 15:42:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_387,47,COMMON_CM,Any visit,2023-08-10,CM,47,2023-08-10 15:42:00,Any visit,CM Dose,40,CM_CMDOSE
DEU02,DEU_02_387,47,COMMON_CM,Any visit,2023-08-10,CM,47,2023-08-10 15:42:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,47,COMMON_CM,Any visit,2023-08-10,CM,47,2023-08-10 15:42:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_387,47,COMMON_CM,Any visit,2023-08-10,CM,47,2023-08-10 15:42:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,47,COMMON_CM,Any visit,2023-08-10,CM,47,2023-08-10 15:42:00,Any visit,CM Start Date,2023-07-24,CM_CMSTDAT
DEU02,DEU_02_387,47,COMMON_CM,Any visit,2023-08-10,CM,47,2023-08-10 15:42:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,47,COMMON_CM,Any visit,2023-08-10,CM,47,2023-08-10 15:42:00,Any visit,CM End Date,2023-07-24,CM_CMENDAT
DEU02,DEU_02_387,48,COMMON_CM,Any visit,2023-08-10,CM,48,2023-08-10 15:43:00,Any visit,CM Number,48,CM_CMSPID
DEU02,DEU_02_387,48,COMMON_CM,Any visit,2023-08-10,CM,48,2023-08-10 15:43:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
DEU02,DEU_02_387,48,COMMON_CM,Any visit,2023-08-10,CM,48,2023-08-10 15:43:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
DEU02,DEU_02_387,48,COMMON_CM,Any visit,2023-08-10,CM,48,2023-08-10 15:43:00,Any visit,CM Indication,Infection,CM_CMINDC
DEU02,DEU_02_387,48,COMMON_CM,Any visit,2023-08-10,CM,48,2023-08-10 15:43:00,Any visit,CM Dose,20,CM_CMDOSE
DEU02,DEU_02_387,48,COMMON_CM,Any visit,2023-08-10,CM,48,2023-08-10 15:43:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,48,COMMON_CM,Any visit,2023-08-10,CM,48,2023-08-10 15:43:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_387,48,COMMON_CM,Any visit,2023-08-10,CM,48,2023-08-10 15:43:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,48,COMMON_CM,Any visit,2023-08-10,CM,48,2023-08-10 15:43:00,Any visit,CM Start Date,2023-07-25,CM_CMSTDAT
DEU02,DEU_02_387,48,COMMON_CM,Any visit,2023-08-10,CM,48,2023-08-10 15:43:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,48,COMMON_CM,Any visit,2023-08-10,CM,48,2023-08-10 15:43:00,Any visit,CM End Date,2023-07-25,CM_CMENDAT
DEU02,DEU_02_387,49,COMMON_CM,Any visit,2023-08-10,CM,49,2023-08-10 15:43:00,Any visit,CM Number,49,CM_CMSPID
DEU02,DEU_02_387,49,COMMON_CM,Any visit,2023-08-10,CM,49,2023-08-10 15:43:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
DEU02,DEU_02_387,49,COMMON_CM,Any visit,2023-08-10,CM,49,2023-08-10 15:43:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
DEU02,DEU_02_387,49,COMMON_CM,Any visit,2023-08-10,CM,49,2023-08-10 15:43:00,Any visit,CM Indication,Pain,CM_CMINDC
DEU02,DEU_02_387,49,COMMON_CM,Any visit,2023-08-10,CM,49,2023-08-10 15:43:00,Any visit,CM Dose,40,CM_CMDOSE
DEU02,DEU_02_387,49,COMMON_CM,Any visit,2023-08-10,CM,49,2023-08-10 15:43:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,49,COMMON_CM,Any visit,2023-08-10,CM,49,2023-08-10 15:43:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
DEU02,DEU_02_387,49,COMMON_CM,Any visit,2023-08-10,CM,49,2023-08-10 15:43:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,49,COMMON_CM,Any visit,2023-08-10,CM,49,2023-08-10 15:43:00,Any visit,CM Start Date,2023-07-28,CM_CMSTDAT
DEU02,DEU_02_387,49,COMMON_CM,Any visit,2023-08-10,CM,49,2023-08-10 15:43:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,49,COMMON_CM,Any visit,2023-08-10,CM,49,2023-08-10 15:43:00,Any visit,CM End Date,2023-07-28,CM_CMENDAT
DEU02,DEU_02_387,50,COMMON_CM,Any visit,2023-08-11,CM,50,2023-08-11 08:38:00,Any visit,CM Number,50,CM_CMSPID
DEU02,DEU_02_387,50,COMMON_CM,Any visit,2023-08-11,CM,50,2023-08-11 08:38:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
DEU02,DEU_02_387,50,COMMON_CM,Any visit,2023-08-11,CM,50,2023-08-11 08:38:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
DEU02,DEU_02_387,50,COMMON_CM,Any visit,2023-08-11,CM,50,2023-08-11 08:38:00,Any visit,CM Indication,Insomnia,CM_CMINDC
DEU02,DEU_02_387,50,COMMON_CM,Any visit,2023-08-11,CM,50,2023-08-11 08:38:00,Any visit,CM Dose,60,CM_CMDOSE
DEU02,DEU_02_387,50,COMMON_CM,Any visit,2023-08-11,CM,50,2023-08-11 08:38:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,50,COMMON_CM,Any visit,2023-08-11,CM,50,2023-08-11 08:38:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_387,50,COMMON_CM,Any visit,2023-08-11,CM,50,2023-08-11 08:38:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,50,COMMON_CM,Any visit,2023-08-11,CM,50,2023-08-11 08:38:00,Any visit,CM Start Date,2023-07-07,CM_CMSTDAT
DEU02,DEU_02_387,50,COMMON_CM,Any visit,2023-08-11,CM,50,2023-08-11 08:38:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,50,COMMON_CM,Any visit,2023-08-11,CM,50,2023-08-11 08:38:00,Any visit,CM End Date,2023-07-07,CM_CMENDAT
DEU02,DEU_02_387,51,COMMON_CM,Any visit,2023-08-11,CM,51,2023-08-11 08:39:00,Any visit,CM Number,51,CM_CMSPID
DEU02,DEU_02_387,51,COMMON_CM,Any visit,2023-08-11,CM,51,2023-08-11 08:39:00,Any visit,CM Trade Name,Bolidilanil,CM_CMTRT
DEU02,DEU_02_387,51,COMMON_CM,Any visit,2023-08-11,CM,51,2023-08-11 08:39:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
DEU02,DEU_02_387,51,COMMON_CM,Any visit,2023-08-11,CM,51,2023-08-11 08:39:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
DEU02,DEU_02_387,51,COMMON_CM,Any visit,2023-08-11,CM,51,2023-08-11 08:39:00,Any visit,CM Dose,5,CM_CMDOSE
DEU02,DEU_02_387,51,COMMON_CM,Any visit,2023-08-11,CM,51,2023-08-11 08:39:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
DEU02,DEU_02_387,51,COMMON_CM,Any visit,2023-08-11,CM,51,2023-08-11 08:39:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
DEU02,DEU_02_387,51,COMMON_CM,Any visit,2023-08-11,CM,51,2023-08-11 08:39:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
DEU02,DEU_02_387,51,COMMON_CM,Any visit,2023-08-11,CM,51,2023-08-11 08:39:00,Any visit,CM Start Date,2023-07-07,CM_CMSTDAT
DEU02,DEU_02_387,51,COMMON_CM,Any visit,2023-08-11,CM,51,2023-08-11 08:39:00,Any visit,CM Ongoing,No,CM_CMONGO
DEU02,DEU_02_387,51,COMMON_CM,Any visit,2023-08-11,CM,51,2023-08-11 08:39:00,Any visit,CM End Date,2023-07-07,CM_CMENDAT
DEU02,DEU_02_387,13,COMMON_CM,Any visit,2023-08-10,CM,13,2023-08-10 14:41:00,Any visit,CM Related AE,Nausea,CM_AEREL
DEU02,DEU_02_387,14,COMMON_CM,Any visit,2023-08-10,CM,14,2023-08-10 14:43:00,Any visit,CM Related AE,Allergic reaction,CM_AEREL
DEU02,DEU_02_387,15,COMMON_CM,Any visit,2023-08-10,CM,15,2023-08-10 14:44:00,Any visit,CM Related AE,Anemia,CM_AEREL
DEU02,DEU_02_387,16,COMMON_CM,Any visit,2023-08-10,CM,16,2023-08-11 09:12:00,Any visit,CM Related AE,Lower back pain,CM_AEREL
DEU02,DEU_02_387,17,COMMON_CM,Any visit,2023-08-10,CM,17,2023-08-11 09:13:00,Any visit,CM Related AE,Hypotension,CM_AEREL
DEU02,DEU_02_387,18,COMMON_CM,Any visit,2023-08-10,CM,18,2023-08-11 09:13:00,Any visit,CM Related AE,Hypotension,CM_AEREL
DEU02,DEU_02_387,19,COMMON_CM,Any visit,2023-08-10,CM,19,2023-08-11 09:14:00,Any visit,CM Related AE,Anemia,CM_AEREL
DEU02,DEU_02_387,20,COMMON_CM,Any visit,2023-08-10,CM,20,2023-08-11 09:14:00,Any visit,CM Related AE,Nausea,CM_AEREL
DEU02,DEU_02_387,21,COMMON_CM,Any visit,2023-08-10,CM,21,2023-08-11 09:14:00,Any visit,CM Related AE,Nausea,CM_AEREL
DEU02,DEU_02_387,22,COMMON_CM,Any visit,2023-08-10,CM,22,2023-08-11 09:14:00,Any visit,CM Related AE,Hypotension,CM_AEREL
DEU02,DEU_02_387,23,COMMON_CM,Any visit,2023-08-10,CM,23,2023-08-11 09:14:00,Any visit,CM Related AE,Allergic reaction,CM_AEREL
DEU02,DEU_02_387,24,COMMON_CM,Any visit,2023-08-10,CM,24,2023-08-11 09:14:00,Any visit,CM Related AE,Nausea,CM_AEREL
DEU02,DEU_02_387,25,COMMON_CM,Any visit,2023-08-10,CM,25,2023-08-11 09:14:00,Any visit,CM Related AE,Lower back pain,CM_AEREL
DEU02,DEU_02_387,26,COMMON_CM,Any visit,2023-08-10,CM,26,2023-08-11 09:15:00,Any visit,CM Related AE,Lower back pain,CM_AEREL
DEU02,DEU_02_387,27,COMMON_CM,Any visit,2023-08-10,CM,27,2023-08-11 09:15:00,Any visit,CM Related AE,Sepsis,CM_AEREL
DEU02,DEU_02_387,28,COMMON_CM,Any visit,2023-08-10,CM,28,2023-08-11 09:15:00,Any visit,CM Related AE,Nausea,CM_AEREL
DEU02,DEU_02_387,29,COMMON_CM,Any visit,2023-08-10,CM,29,2023-08-11 09:15:00,Any visit,CM Related AE,Sepsis,CM_AEREL
DEU02,DEU_02_387,30,COMMON_CM,Any visit,2023-08-10,CM,30,2023-08-11 09:15:00,Any visit,CM Related AE,Allergic reaction,CM_AEREL
DEU02,DEU_02_387,31,COMMON_CM,Any visit,2023-08-10,CM,31,2023-08-11 09:16:00,Any visit,CM Related AE,Sepsis,CM_AEREL
DEU02,DEU_02_387,32,COMMON_CM,Any visit,2023-08-10,CM,32,2023-08-11 09:16:00,Any visit,CM Related AE,Lower back pain,CM_AEREL
DEU02,DEU_02_387,33,COMMON_CM,Any visit,2023-08-10,CM,33,2023-08-11 09:16:00,Any visit,CM Related AE,Anemia,CM_AEREL
DEU02,DEU_02_387,34,COMMON_CM,Any visit,2023-08-10,CM,34,2023-08-11 09:16:00,Any visit,CM Related AE,Sepsis,CM_AEREL
DEU02,DEU_02_387,35,COMMON_CM,Any visit,2023-08-10,CM,35,2023-08-11 09:16:00,Any visit,CM Related AE,Anemia,CM_AEREL
DEU02,DEU_02_387,36,COMMON_CM,Any visit,2023-08-10,CM,36,2023-08-11 09:17:00,Any visit,CM Related AE,Anemia,CM_AEREL
DEU02,DEU_02_387,37,COMMON_CM,Any visit,2023-08-10,CM,37,2023-08-11 09:17:00,Any visit,CM Related AE,Anemia,CM_AEREL
DEU02,DEU_02_387,38,COMMON_CM,Any visit,2023-08-10,CM,38,2023-08-11 09:17:00,Any visit,CM Related AE,Urinary incontinence,CM_AEREL
DEU02,DEU_02_387,39,COMMON_CM,Any visit,2023-08-10,CM,39,2023-08-11 09:17:00,Any visit,CM Related AE,Urinary incontinence,CM_AEREL
DEU02,DEU_02_387,40,COMMON_CM,Any visit,2023-08-10,CM,40,2023-08-11 09:17:00,Any visit,CM Related AE,Nausea,CM_AEREL
DEU02,DEU_02_387,41,COMMON_CM,Any visit,2023-08-10,CM,41,2023-08-11 09:17:00,Any visit,CM Related AE,Anemia,CM_AEREL
DEU02,DEU_02_387,42,COMMON_CM,Any visit,2023-08-10,CM,42,2023-08-10 15:29:00,Any visit,CM Related AE,Nausea,CM_AEREL
DEU02,DEU_02_387,43,COMMON_CM,Any visit,2023-08-10,CM,43,2023-08-10 15:30:00,Any visit,CM Related AE,Sepsis,CM_AEREL
DEU02,DEU_02_387,44,COMMON_CM,Any visit,2023-08-10,CM,44,2023-08-10 15:32:00,Any visit,CM Related AE,Nausea,CM_AEREL
DEU02,DEU_02_387,45,COMMON_CM,Any visit,2023-08-10,CM,45,2023-08-10 15:38:00,Any visit,CM Related AE,Anemia,CM_AEREL
DEU02,DEU_02_387,46,COMMON_CM,Any visit,2023-08-10,CM,46,2023-08-10 15:40:00,Any visit,CM Related AE,Allergic reaction,CM_AEREL
DEU02,DEU_02_387,1,COMMON_CM,Any visit,2023-08-10,CM,1,2023-08-10 14:13:00,Any visit,CM Related Medical History,Congestive heart failure,CM_MHREL
DEU02,DEU_02_387,2,COMMON_CM,Any visit,2023-08-10,CM,2,2023-08-10 14:14:00,Any visit,CM Related Medical History,Congestive heart failure,CM_MHREL
DEU02,DEU_02_387,3,COMMON_CM,Any visit,2023-08-10,CM,3,2023-08-10 14:16:00,Any visit,CM Related Medical History,Familial Mediterranean fever,CM_MHREL
DEU02,DEU_02_387,4,COMMON_CM,Any visit,2023-08-10,CM,4,2023-08-10 14:19:00,Any visit,CM Related Medical History,Familial Mediterranean fever,CM_MHREL
DEU02,DEU_02_387,5,COMMON_CM,Any visit,2023-08-10,CM,5,2023-08-10 14:21:00,Any visit,CM Related Medical History,Familial Mediterranean fever,CM_MHREL
DEU02,DEU_02_387,6,COMMON_CM,Any visit,2023-08-10,CM,6,2023-08-10 14:22:00,Any visit,CM Related Medical History,Hypothyroidism,CM_MHREL
DEU02,DEU_02_387,7,COMMON_CM,Any visit,2023-08-10,CM,7,2023-08-10 14:23:00,Any visit,CM Related Medical History,Osteoporosis,CM_MHREL
DEU02,DEU_02_387,8,COMMON_CM,Any visit,2023-08-10,CM,8,2023-08-10 14:24:00,Any visit,CM Related Medical History,Migraine,CM_MHREL
DEU02,DEU_02_387,9,COMMON_CM,Any visit,2023-08-10,CM,9,2023-08-10 14:26:00,Any visit,CM Related Medical History,Congestive heart failure,CM_MHREL
DEU02,DEU_02_387,10,COMMON_CM,Any visit,2023-08-10,CM,10,2023-08-10 14:27:00,Any visit,CM Related Medical History,Chronic hepatitis,CM_MHREL
DEU02,DEU_02_387,11,COMMON_CM,Any visit,2023-08-10,CM,11,2023-08-10 14:30:00,Any visit,CM Related Medical History,Familial Mediterranean fever,CM_MHREL
NLD03,NLD_03_207,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 12:06:00,Any visit,CM Number,1,CM_CMSPID
NLD03,NLD_03_207,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 12:06:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
NLD03,NLD_03_207,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 12:06:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
NLD03,NLD_03_207,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 12:06:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD03,NLD_03_207,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 12:06:00,Any visit,CM Dose,10,CM_CMDOSE
NLD03,NLD_03_207,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 12:06:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 12:06:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 12:06:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD03,NLD_03_207,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 12:06:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 12:06:00,Any visit,CM End Date,2023-08-02,CM_CMENDAT
NLD03,NLD_03_207,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 12:07:00,Any visit,CM Number,2,CM_CMSPID
NLD03,NLD_03_207,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 12:07:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
NLD03,NLD_03_207,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 12:07:00,Any visit,CM Active Ingredient,Meloxicam,CM_CMINGRD
NLD03,NLD_03_207,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 12:07:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD03,NLD_03_207,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 12:07:00,Any visit,CM Dose,5,CM_CMDOSE
NLD03,NLD_03_207,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 12:07:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 12:07:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 12:07:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD03,NLD_03_207,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 12:07:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 12:07:00,Any visit,CM End Date,2023-08-02,CM_CMENDAT
NLD03,NLD_03_207,3,COMMON_CM,Any visit,2023-08-25,CM,3,2023-08-25 12:08:00,Any visit,CM Number,3,CM_CMSPID
NLD03,NLD_03_207,3,COMMON_CM,Any visit,2023-08-25,CM,3,2023-08-25 12:08:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
NLD03,NLD_03_207,3,COMMON_CM,Any visit,2023-08-25,CM,3,2023-08-25 12:08:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
NLD03,NLD_03_207,3,COMMON_CM,Any visit,2023-08-25,CM,3,2023-08-25 12:08:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD03,NLD_03_207,3,COMMON_CM,Any visit,2023-08-25,CM,3,2023-08-25 12:08:00,Any visit,CM Dose,80,CM_CMDOSE
NLD03,NLD_03_207,3,COMMON_CM,Any visit,2023-08-25,CM,3,2023-08-25 12:08:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,3,COMMON_CM,Any visit,2023-08-25,CM,3,2023-08-25 12:08:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,3,COMMON_CM,Any visit,2023-08-25,CM,3,2023-08-25 12:08:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD03,NLD_03_207,3,COMMON_CM,Any visit,2023-08-25,CM,3,2023-08-25 12:08:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,3,COMMON_CM,Any visit,2023-08-25,CM,3,2023-08-25 12:08:00,Any visit,CM End Date,2023-08-02,CM_CMENDAT
NLD03,NLD_03_207,4,COMMON_CM,Any visit,2023-08-25,CM,4,2023-08-25 12:09:00,Any visit,CM Number,4,CM_CMSPID
NLD03,NLD_03_207,4,COMMON_CM,Any visit,2023-08-25,CM,4,2023-08-25 12:09:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
NLD03,NLD_03_207,4,COMMON_CM,Any visit,2023-08-25,CM,4,2023-08-25 12:09:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
NLD03,NLD_03_207,4,COMMON_CM,Any visit,2023-08-25,CM,4,2023-08-25 12:09:00,Any visit,CM Indication,Insomnia,CM_CMINDC
NLD03,NLD_03_207,4,COMMON_CM,Any visit,2023-08-25,CM,4,2023-08-25 12:09:00,Any visit,CM Dose,50,CM_CMDOSE
NLD03,NLD_03_207,4,COMMON_CM,Any visit,2023-08-25,CM,4,2023-08-25 12:09:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,4,COMMON_CM,Any visit,2023-08-25,CM,4,2023-08-25 12:09:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,4,COMMON_CM,Any visit,2023-08-25,CM,4,2023-08-25 12:09:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD03,NLD_03_207,4,COMMON_CM,Any visit,2023-08-25,CM,4,2023-08-25 12:09:00,Any visit,CM Start Date,2022-12-13,CM_CMSTDAT
NLD03,NLD_03_207,4,COMMON_CM,Any visit,2023-08-25,CM,4,2023-08-25 12:09:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,4,COMMON_CM,Any visit,2023-08-25,CM,4,2023-08-25 12:09:00,Any visit,CM End Date,2023-08-02,CM_CMENDAT
NLD03,NLD_03_207,5,COMMON_CM,Any visit,2023-08-25,CM,5,2023-08-25 12:11:00,Any visit,CM Number,5,CM_CMSPID
NLD03,NLD_03_207,5,COMMON_CM,Any visit,2023-08-25,CM,5,2023-08-25 12:11:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
NLD03,NLD_03_207,5,COMMON_CM,Any visit,2023-08-25,CM,5,2023-08-25 12:11:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
NLD03,NLD_03_207,5,COMMON_CM,Any visit,2023-08-25,CM,5,2023-08-25 12:11:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD03,NLD_03_207,5,COMMON_CM,Any visit,2023-08-25,CM,5,2023-08-25 12:11:00,Any visit,CM Dose,160,CM_CMDOSE
NLD03,NLD_03_207,5,COMMON_CM,Any visit,2023-08-25,CM,5,2023-08-25 12:11:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,5,COMMON_CM,Any visit,2023-08-25,CM,5,2023-08-25 12:11:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,5,COMMON_CM,Any visit,2023-08-25,CM,5,2023-08-25 12:11:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD03,NLD_03_207,5,COMMON_CM,Any visit,2023-08-25,CM,5,2023-08-25 12:11:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,5,COMMON_CM,Any visit,2023-08-25,CM,5,2023-08-25 12:11:00,Any visit,CM End Date,2023-08-02,CM_CMENDAT
NLD03,NLD_03_207,6,COMMON_CM,Any visit,2023-08-25,CM,6,2023-08-25 12:12:00,Any visit,CM Number,6,CM_CMSPID
NLD03,NLD_03_207,6,COMMON_CM,Any visit,2023-08-25,CM,6,2023-08-25 12:12:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
NLD03,NLD_03_207,6,COMMON_CM,Any visit,2023-08-25,CM,6,2023-08-25 12:12:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
NLD03,NLD_03_207,6,COMMON_CM,Any visit,2023-08-25,CM,6,2023-08-25 12:12:00,Any visit,CM Indication,Nausea,CM_CMINDC
NLD03,NLD_03_207,6,COMMON_CM,Any visit,2023-08-25,CM,6,2023-08-25 12:12:00,Any visit,CM Dose,100,CM_CMDOSE
NLD03,NLD_03_207,6,COMMON_CM,Any visit,2023-08-25,CM,6,2023-08-25 12:12:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,6,COMMON_CM,Any visit,2023-08-25,CM,6,2023-08-25 12:12:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,6,COMMON_CM,Any visit,2023-08-25,CM,6,2023-08-25 12:12:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD03,NLD_03_207,6,COMMON_CM,Any visit,2023-08-25,CM,6,2023-08-25 12:12:00,Any visit,CM Start Date,2023-02-02,CM_CMSTDAT
NLD03,NLD_03_207,6,COMMON_CM,Any visit,2023-08-25,CM,6,2023-08-25 12:12:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,6,COMMON_CM,Any visit,2023-08-25,CM,6,2023-08-25 12:12:00,Any visit,CM End Date,2023-08-08,CM_CMENDAT
NLD03,NLD_03_207,7,COMMON_CM,Any visit,2023-08-25,CM,7,2023-08-25 12:13:00,Any visit,CM Number,7,CM_CMSPID
NLD03,NLD_03_207,7,COMMON_CM,Any visit,2023-08-25,CM,7,2023-08-25 12:13:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
NLD03,NLD_03_207,7,COMMON_CM,Any visit,2023-08-25,CM,7,2023-08-25 12:13:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
NLD03,NLD_03_207,7,COMMON_CM,Any visit,2023-08-25,CM,7,2023-08-25 12:13:00,Any visit,CM Indication,Hypertension,CM_CMINDC
NLD03,NLD_03_207,7,COMMON_CM,Any visit,2023-08-25,CM,7,2023-08-25 12:13:00,Any visit,CM Dose,200,CM_CMDOSE
NLD03,NLD_03_207,7,COMMON_CM,Any visit,2023-08-25,CM,7,2023-08-25 12:13:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,7,COMMON_CM,Any visit,2023-08-25,CM,7,2023-08-25 12:13:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,7,COMMON_CM,Any visit,2023-08-25,CM,7,2023-08-25 12:13:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD03,NLD_03_207,7,COMMON_CM,Any visit,2023-08-25,CM,7,2023-08-25 12:13:00,Any visit,CM Start Date,2023-01-17,CM_CMSTDAT
NLD03,NLD_03_207,7,COMMON_CM,Any visit,2023-08-25,CM,7,2023-08-25 12:13:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,7,COMMON_CM,Any visit,2023-08-25,CM,7,2023-08-25 12:13:00,Any visit,CM End Date,2023-08-11,CM_CMENDAT
NLD03,NLD_03_207,8,COMMON_CM,Any visit,2023-08-25,CM,8,2023-08-25 12:14:00,Any visit,CM Number,8,CM_CMSPID
NLD03,NLD_03_207,8,COMMON_CM,Any visit,2023-08-25,CM,8,2023-08-25 12:14:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
NLD03,NLD_03_207,8,COMMON_CM,Any visit,2023-08-25,CM,8,2023-08-25 12:14:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
NLD03,NLD_03_207,8,COMMON_CM,Any visit,2023-08-25,CM,8,2023-08-25 12:14:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
NLD03,NLD_03_207,8,COMMON_CM,Any visit,2023-08-25,CM,8,2023-08-25 12:14:00,Any visit,CM Dose,100,CM_CMDOSE
NLD03,NLD_03_207,8,COMMON_CM,Any visit,2023-08-25,CM,8,2023-08-25 12:14:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,8,COMMON_CM,Any visit,2023-08-25,CM,8,2023-08-25 12:14:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,8,COMMON_CM,Any visit,2023-08-25,CM,8,2023-08-25 12:14:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD03,NLD_03_207,8,COMMON_CM,Any visit,2023-08-25,CM,8,2023-08-25 12:14:00,Any visit,CM Start Date,2023-08-12,CM_CMSTDAT
NLD03,NLD_03_207,8,COMMON_CM,Any visit,2023-08-25,CM,8,2023-08-25 12:14:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,8,COMMON_CM,Any visit,2023-08-25,CM,8,2023-08-25 12:14:00,Any visit,CM End Date,2023-08-12,CM_CMENDAT
NLD03,NLD_03_207,9,COMMON_CM,Any visit,2023-08-25,CM,9,2023-08-25 12:15:00,Any visit,CM Number,9,CM_CMSPID
NLD03,NLD_03_207,9,COMMON_CM,Any visit,2023-08-25,CM,9,2023-08-25 12:15:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
NLD03,NLD_03_207,9,COMMON_CM,Any visit,2023-08-25,CM,9,2023-08-25 12:15:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
NLD03,NLD_03_207,9,COMMON_CM,Any visit,2023-08-25,CM,9,2023-08-25 12:15:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD03,NLD_03_207,9,COMMON_CM,Any visit,2023-08-25,CM,9,2023-08-25 12:15:00,Any visit,CM Dose,5,CM_CMDOSE
NLD03,NLD_03_207,9,COMMON_CM,Any visit,2023-08-25,CM,9,2023-08-25 12:15:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,9,COMMON_CM,Any visit,2023-08-25,CM,9,2023-08-25 12:15:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,9,COMMON_CM,Any visit,2023-08-25,CM,9,2023-08-25 12:15:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD03,NLD_03_207,9,COMMON_CM,Any visit,2023-08-25,CM,9,2023-08-25 12:15:00,Any visit,CM Start Date,2023-01-13,CM_CMSTDAT
NLD03,NLD_03_207,9,COMMON_CM,Any visit,2023-08-25,CM,9,2023-08-25 12:15:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,9,COMMON_CM,Any visit,2023-08-25,CM,9,2023-08-25 12:15:00,Any visit,CM End Date,2023-08-02,CM_CMENDAT
NLD03,NLD_03_207,10,COMMON_CM,Any visit,2023-08-25,CM,10,2023-08-25 12:16:00,Any visit,CM Number,10,CM_CMSPID
NLD03,NLD_03_207,10,COMMON_CM,Any visit,2023-08-25,CM,10,2023-08-25 12:16:00,Any visit,CM Trade Name,Gliigestatrilat,CM_CMTRT
NLD03,NLD_03_207,10,COMMON_CM,Any visit,2023-08-25,CM,10,2023-08-25 12:16:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
NLD03,NLD_03_207,10,COMMON_CM,Any visit,2023-08-25,CM,10,2023-08-25 12:16:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD03,NLD_03_207,10,COMMON_CM,Any visit,2023-08-25,CM,10,2023-08-25 12:16:00,Any visit,CM Dose,20,CM_CMDOSE
NLD03,NLD_03_207,10,COMMON_CM,Any visit,2023-08-25,CM,10,2023-08-25 12:16:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,10,COMMON_CM,Any visit,2023-08-25,CM,10,2023-08-25 12:16:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,10,COMMON_CM,Any visit,2023-08-25,CM,10,2023-08-25 12:16:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD03,NLD_03_207,10,COMMON_CM,Any visit,2023-08-25,CM,10,2023-08-25 12:16:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,10,COMMON_CM,Any visit,2023-08-25,CM,10,2023-08-25 12:16:00,Any visit,CM End Date,2023-08-02,CM_CMENDAT
NLD03,NLD_03_207,11,COMMON_CM,Any visit,2023-08-25,CM,11,2023-08-25 12:19:00,Any visit,CM Number,11,CM_CMSPID
NLD03,NLD_03_207,11,COMMON_CM,Any visit,2023-08-25,CM,11,2023-08-25 12:19:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
NLD03,NLD_03_207,11,COMMON_CM,Any visit,2023-08-25,CM,11,2023-08-25 12:19:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
NLD03,NLD_03_207,11,COMMON_CM,Any visit,2023-08-25,CM,11,2023-08-25 12:19:00,Any visit,CM Indication,Nausea,CM_CMINDC
NLD03,NLD_03_207,11,COMMON_CM,Any visit,2023-08-25,CM,11,2023-08-25 12:19:00,Any visit,CM Dose,1,CM_CMDOSE
NLD03,NLD_03_207,11,COMMON_CM,Any visit,2023-08-25,CM,11,2023-08-25 12:19:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
NLD03,NLD_03_207,11,COMMON_CM,Any visit,2023-08-25,CM,11,2023-08-25 12:19:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
NLD03,NLD_03_207,11,COMMON_CM,Any visit,2023-08-25,CM,11,2023-08-25 12:19:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD03,NLD_03_207,11,COMMON_CM,Any visit,2023-08-25,CM,11,2023-08-25 12:19:00,Any visit,CM Start Date,2023-07-28,CM_CMSTDAT
NLD03,NLD_03_207,11,COMMON_CM,Any visit,2023-08-25,CM,11,2023-08-25 12:19:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,11,COMMON_CM,Any visit,2023-08-25,CM,11,2023-08-25 12:19:00,Any visit,CM End Date,2023-08-02,CM_CMENDAT
NLD03,NLD_03_207,12,COMMON_CM,Any visit,2023-08-25,CM,12,2023-08-25 12:22:00,Any visit,CM Number,12,CM_CMSPID
NLD03,NLD_03_207,12,COMMON_CM,Any visit,2023-08-25,CM,12,2023-08-25 12:22:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
NLD03,NLD_03_207,12,COMMON_CM,Any visit,2023-08-25,CM,12,2023-08-25 12:22:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
NLD03,NLD_03_207,12,COMMON_CM,Any visit,2023-08-25,CM,12,2023-08-25 12:22:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD03,NLD_03_207,12,COMMON_CM,Any visit,2023-08-25,CM,12,2023-08-25 12:22:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,12,COMMON_CM,Any visit,2023-08-25,CM,12,2023-08-25 12:22:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,12,COMMON_CM,Any visit,2023-08-25,CM,12,2023-08-25 12:22:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD03,NLD_03_207,12,COMMON_CM,Any visit,2023-08-25,CM,12,2023-08-25 12:22:00,Any visit,CM Start Date,2023-07-29,CM_CMSTDAT
NLD03,NLD_03_207,12,COMMON_CM,Any visit,2023-08-25,CM,12,2023-08-25 12:22:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,12,COMMON_CM,Any visit,2023-08-25,CM,12,2023-08-25 12:22:00,Any visit,CM End Date,2023-07-29,CM_CMENDAT
NLD03,NLD_03_207,13,COMMON_CM,Any visit,2023-08-25,CM,13,2023-08-25 12:22:00,Any visit,CM Number,13,CM_CMSPID
NLD03,NLD_03_207,13,COMMON_CM,Any visit,2023-08-25,CM,13,2023-08-25 12:22:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
NLD03,NLD_03_207,13,COMMON_CM,Any visit,2023-08-25,CM,13,2023-08-25 12:22:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
NLD03,NLD_03_207,13,COMMON_CM,Any visit,2023-08-25,CM,13,2023-08-25 12:22:00,Any visit,CM Indication,Adverse event,CM_CMINDC
NLD03,NLD_03_207,13,COMMON_CM,Any visit,2023-08-25,CM,13,2023-08-25 12:22:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,13,COMMON_CM,Any visit,2023-08-25,CM,13,2023-08-25 12:22:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
NLD03,NLD_03_207,13,COMMON_CM,Any visit,2023-08-25,CM,13,2023-08-25 12:22:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,13,COMMON_CM,Any visit,2023-08-25,CM,13,2023-08-25 12:22:00,Any visit,CM Start Date,2023-08-04,CM_CMSTDAT
NLD03,NLD_03_207,13,COMMON_CM,Any visit,2023-08-25,CM,13,2023-08-25 12:22:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,13,COMMON_CM,Any visit,2023-08-25,CM,13,2023-08-25 12:22:00,Any visit,CM End Date,2023-08-14,CM_CMENDAT
NLD03,NLD_03_207,14,COMMON_CM,Any visit,2023-08-25,CM,14,2023-08-25 12:24:00,Any visit,CM Number,14,CM_CMSPID
NLD03,NLD_03_207,14,COMMON_CM,Any visit,2023-08-25,CM,14,2023-08-25 12:24:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
NLD03,NLD_03_207,14,COMMON_CM,Any visit,2023-08-25,CM,14,2023-08-25 12:24:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
NLD03,NLD_03_207,14,COMMON_CM,Any visit,2023-08-25,CM,14,2023-08-25 12:24:00,Any visit,CM Indication,Adverse event,CM_CMINDC
NLD03,NLD_03_207,14,COMMON_CM,Any visit,2023-08-25,CM,14,2023-08-25 12:24:00,Any visit,CM Dose,50,CM_CMDOSE
NLD03,NLD_03_207,14,COMMON_CM,Any visit,2023-08-25,CM,14,2023-08-25 12:24:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,14,COMMON_CM,Any visit,2023-08-25,CM,14,2023-08-25 12:24:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
NLD03,NLD_03_207,14,COMMON_CM,Any visit,2023-08-25,CM,14,2023-08-25 12:24:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,14,COMMON_CM,Any visit,2023-08-25,CM,14,2023-08-25 12:24:00,Any visit,CM Start Date,2023-08-04,CM_CMSTDAT
NLD03,NLD_03_207,14,COMMON_CM,Any visit,2023-08-25,CM,14,2023-08-25 12:24:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,14,COMMON_CM,Any visit,2023-08-25,CM,14,2023-08-25 12:24:00,Any visit,CM End Date,2023-08-04,CM_CMENDAT
NLD03,NLD_03_207,15,COMMON_CM,Any visit,2023-08-25,CM,15,2023-08-25 12:25:00,Any visit,CM Number,15,CM_CMSPID
NLD03,NLD_03_207,15,COMMON_CM,Any visit,2023-08-25,CM,15,2023-08-25 12:25:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
NLD03,NLD_03_207,15,COMMON_CM,Any visit,2023-08-25,CM,15,2023-08-25 12:25:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
NLD03,NLD_03_207,15,COMMON_CM,Any visit,2023-08-25,CM,15,2023-08-25 12:25:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD03,NLD_03_207,15,COMMON_CM,Any visit,2023-08-25,CM,15,2023-08-25 12:25:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,15,COMMON_CM,Any visit,2023-08-25,CM,15,2023-08-25 12:25:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
NLD03,NLD_03_207,15,COMMON_CM,Any visit,2023-08-25,CM,15,2023-08-25 12:25:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,15,COMMON_CM,Any visit,2023-08-25,CM,15,2023-08-25 12:25:00,Any visit,CM Start Date,2023-08-06,CM_CMSTDAT
NLD03,NLD_03_207,15,COMMON_CM,Any visit,2023-08-25,CM,15,2023-08-25 12:25:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,15,COMMON_CM,Any visit,2023-08-25,CM,15,2023-08-25 12:25:00,Any visit,CM End Date,2023-08-06,CM_CMENDAT
NLD03,NLD_03_207,16,COMMON_CM,Any visit,2023-08-25,CM,16,2023-08-25 12:26:00,Any visit,CM Number,16,CM_CMSPID
NLD03,NLD_03_207,16,COMMON_CM,Any visit,2023-08-25,CM,16,2023-08-25 12:26:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
NLD03,NLD_03_207,16,COMMON_CM,Any visit,2023-08-25,CM,16,2023-08-25 12:26:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
NLD03,NLD_03_207,16,COMMON_CM,Any visit,2023-08-25,CM,16,2023-08-25 12:26:00,Any visit,CM Indication,Hypertension,CM_CMINDC
NLD03,NLD_03_207,16,COMMON_CM,Any visit,2023-08-25,CM,16,2023-08-25 12:26:00,Any visit,CM Dose,1,CM_CMDOSE
NLD03,NLD_03_207,16,COMMON_CM,Any visit,2023-08-25,CM,16,2023-08-25 12:26:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
NLD03,NLD_03_207,16,COMMON_CM,Any visit,2023-08-25,CM,16,2023-08-25 12:26:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,16,COMMON_CM,Any visit,2023-08-25,CM,16,2023-08-25 12:26:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,16,COMMON_CM,Any visit,2023-08-25,CM,16,2023-08-25 12:26:00,Any visit,CM Start Date,2023-08-03,CM_CMSTDAT
NLD03,NLD_03_207,16,COMMON_CM,Any visit,2023-08-25,CM,16,2023-08-25 12:26:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,16,COMMON_CM,Any visit,2023-08-25,CM,16,2023-08-25 12:26:00,Any visit,CM End Date,2023-08-03,CM_CMENDAT
NLD03,NLD_03_207,17,COMMON_CM,Any visit,2023-08-25,CM,17,2023-08-25 12:27:00,Any visit,CM Number,17,CM_CMSPID
NLD03,NLD_03_207,17,COMMON_CM,Any visit,2023-08-25,CM,17,2023-08-25 12:27:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
NLD03,NLD_03_207,17,COMMON_CM,Any visit,2023-08-25,CM,17,2023-08-25 12:27:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
NLD03,NLD_03_207,17,COMMON_CM,Any visit,2023-08-25,CM,17,2023-08-25 12:27:00,Any visit,CM Indication,Infection,CM_CMINDC
NLD03,NLD_03_207,17,COMMON_CM,Any visit,2023-08-25,CM,17,2023-08-25 12:27:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
NLD03,NLD_03_207,17,COMMON_CM,Any visit,2023-08-25,CM,17,2023-08-25 12:27:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
NLD03,NLD_03_207,17,COMMON_CM,Any visit,2023-08-25,CM,17,2023-08-25 12:27:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,17,COMMON_CM,Any visit,2023-08-25,CM,17,2023-08-25 12:27:00,Any visit,CM Start Date,2023-08-04,CM_CMSTDAT
NLD03,NLD_03_207,17,COMMON_CM,Any visit,2023-08-25,CM,17,2023-08-25 12:27:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,17,COMMON_CM,Any visit,2023-08-25,CM,17,2023-08-25 12:27:00,Any visit,CM End Date,2023-08-13,CM_CMENDAT
NLD03,NLD_03_207,18,COMMON_CM,Any visit,2023-08-25,CM,18,2023-08-25 12:28:00,Any visit,CM Number,18,CM_CMSPID
NLD03,NLD_03_207,18,COMMON_CM,Any visit,2023-08-25,CM,18,2023-08-25 12:28:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
NLD03,NLD_03_207,18,COMMON_CM,Any visit,2023-08-25,CM,18,2023-08-25 12:28:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
NLD03,NLD_03_207,18,COMMON_CM,Any visit,2023-08-25,CM,18,2023-08-25 12:28:00,Any visit,CM Indication,Hypertension,CM_CMINDC
NLD03,NLD_03_207,18,COMMON_CM,Any visit,2023-08-25,CM,18,2023-08-25 12:28:00,Any visit,CM Dose,1,CM_CMDOSE
NLD03,NLD_03_207,18,COMMON_CM,Any visit,2023-08-25,CM,18,2023-08-25 12:28:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
NLD03,NLD_03_207,18,COMMON_CM,Any visit,2023-08-25,CM,18,2023-08-25 12:28:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,18,COMMON_CM,Any visit,2023-08-25,CM,18,2023-08-25 12:28:00,Any visit,CM Route,Unknown,CM_CMROUTE
NLD03,NLD_03_207,18,COMMON_CM,Any visit,2023-08-25,CM,18,2023-08-25 12:28:00,Any visit,CM Start Date,2023-08-02,CM_CMSTDAT
NLD03,NLD_03_207,18,COMMON_CM,Any visit,2023-08-25,CM,18,2023-08-25 12:28:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,18,COMMON_CM,Any visit,2023-08-25,CM,18,2023-08-25 12:28:00,Any visit,CM End Date,2023-08-02,CM_CMENDAT
NLD03,NLD_03_207,19,COMMON_CM,Any visit,2023-08-25,CM,19,2023-08-25 12:29:00,Any visit,CM Number,19,CM_CMSPID
NLD03,NLD_03_207,19,COMMON_CM,Any visit,2023-08-25,CM,19,2023-08-25 12:29:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
NLD03,NLD_03_207,19,COMMON_CM,Any visit,2023-08-25,CM,19,2023-08-25 12:29:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
NLD03,NLD_03_207,19,COMMON_CM,Any visit,2023-08-25,CM,19,2023-08-25 12:29:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
NLD03,NLD_03_207,19,COMMON_CM,Any visit,2023-08-25,CM,19,2023-08-25 12:29:00,Any visit,CM Dose,1,CM_CMDOSE
NLD03,NLD_03_207,19,COMMON_CM,Any visit,2023-08-25,CM,19,2023-08-25 12:29:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
NLD03,NLD_03_207,19,COMMON_CM,Any visit,2023-08-25,CM,19,2023-08-25 12:29:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
NLD03,NLD_03_207,19,COMMON_CM,Any visit,2023-08-25,CM,19,2023-08-25 12:29:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,19,COMMON_CM,Any visit,2023-08-25,CM,19,2023-08-25 12:29:00,Any visit,CM Start Date,2023-08-03,CM_CMSTDAT
NLD03,NLD_03_207,19,COMMON_CM,Any visit,2023-08-25,CM,19,2023-08-25 12:29:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,19,COMMON_CM,Any visit,2023-08-25,CM,19,2023-08-25 12:29:00,Any visit,CM End Date,2023-08-08,CM_CMENDAT
NLD03,NLD_03_207,20,COMMON_CM,Any visit,2023-08-25,CM,20,2023-08-25 12:31:00,Any visit,CM Number,20,CM_CMSPID
NLD03,NLD_03_207,20,COMMON_CM,Any visit,2023-08-25,CM,20,2023-08-25 12:31:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
NLD03,NLD_03_207,20,COMMON_CM,Any visit,2023-08-25,CM,20,2023-08-25 12:31:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
NLD03,NLD_03_207,20,COMMON_CM,Any visit,2023-08-25,CM,20,2023-08-25 12:31:00,Any visit,CM Indication,Infection,CM_CMINDC
NLD03,NLD_03_207,20,COMMON_CM,Any visit,2023-08-25,CM,20,2023-08-25 12:31:00,Any visit,CM Unit,Other,CM_CMDOSU
NLD03,NLD_03_207,20,COMMON_CM,Any visit,2023-08-25,CM,20,2023-08-25 12:31:00,Any visit,CM Unit Other,L,CM_CMDOSU_OTH
NLD03,NLD_03_207,20,COMMON_CM,Any visit,2023-08-25,CM,20,2023-08-25 12:31:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
NLD03,NLD_03_207,20,COMMON_CM,Any visit,2023-08-25,CM,20,2023-08-25 12:31:00,Any visit,CM Route,Nasal,CM_CMROUTE
NLD03,NLD_03_207,20,COMMON_CM,Any visit,2023-08-25,CM,20,2023-08-25 12:31:00,Any visit,CM Start Date,2023-08-03,CM_CMSTDAT
NLD03,NLD_03_207,20,COMMON_CM,Any visit,2023-08-25,CM,20,2023-08-25 12:31:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,20,COMMON_CM,Any visit,2023-08-25,CM,20,2023-08-25 12:31:00,Any visit,CM End Date,2023-08-14,CM_CMENDAT
NLD03,NLD_03_207,21,COMMON_CM,Any visit,2023-08-25,CM,21,2023-08-25 12:32:00,Any visit,CM Number,21,CM_CMSPID
NLD03,NLD_03_207,21,COMMON_CM,Any visit,2023-08-25,CM,21,2023-08-25 12:32:00,Any visit,CM Trade Name,Bolidilanil,CM_CMTRT
NLD03,NLD_03_207,21,COMMON_CM,Any visit,2023-08-25,CM,21,2023-08-25 12:32:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
NLD03,NLD_03_207,21,COMMON_CM,Any visit,2023-08-25,CM,21,2023-08-25 12:32:00,Any visit,CM Indication,Hypertension,CM_CMINDC
NLD03,NLD_03_207,21,COMMON_CM,Any visit,2023-08-25,CM,21,2023-08-25 12:32:00,Any visit,CM Dose,40,CM_CMDOSE
NLD03,NLD_03_207,21,COMMON_CM,Any visit,2023-08-25,CM,21,2023-08-25 12:32:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,21,COMMON_CM,Any visit,2023-08-25,CM,21,2023-08-25 12:32:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,21,COMMON_CM,Any visit,2023-08-25,CM,21,2023-08-25 12:32:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,21,COMMON_CM,Any visit,2023-08-25,CM,21,2023-08-25 12:32:00,Any visit,CM Start Date,2023-08-03,CM_CMSTDAT
NLD03,NLD_03_207,21,COMMON_CM,Any visit,2023-08-25,CM,21,2023-08-25 12:32:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,21,COMMON_CM,Any visit,2023-08-25,CM,21,2023-08-25 12:32:00,Any visit,CM End Date,2023-08-03,CM_CMENDAT
NLD03,NLD_03_207,22,COMMON_CM,Any visit,2023-08-25,CM,22,2023-08-25 12:33:00,Any visit,CM Number,22,CM_CMSPID
NLD03,NLD_03_207,22,COMMON_CM,Any visit,2023-08-25,CM,22,2023-08-25 12:33:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
NLD03,NLD_03_207,22,COMMON_CM,Any visit,2023-08-25,CM,22,2023-08-25 12:33:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
NLD03,NLD_03_207,22,COMMON_CM,Any visit,2023-08-25,CM,22,2023-08-25 12:33:00,Any visit,CM Indication,Adverse event,CM_CMINDC
NLD03,NLD_03_207,22,COMMON_CM,Any visit,2023-08-25,CM,22,2023-08-25 12:33:00,Any visit,CM Dose,8,CM_CMDOSE
NLD03,NLD_03_207,22,COMMON_CM,Any visit,2023-08-25,CM,22,2023-08-25 12:33:00,Any visit,CM Unit,Other,CM_CMDOSU
NLD03,NLD_03_207,22,COMMON_CM,Any visit,2023-08-25,CM,22,2023-08-25 12:33:00,Any visit,CM Unit Other,mg/h,CM_CMDOSU_OTH
NLD03,NLD_03_207,22,COMMON_CM,Any visit,2023-08-25,CM,22,2023-08-25 12:33:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
NLD03,NLD_03_207,22,COMMON_CM,Any visit,2023-08-25,CM,22,2023-08-25 12:33:00,Any visit,CM Frequency Other,-----,CM_CMDOSFRQ_OTH
NLD03,NLD_03_207,22,COMMON_CM,Any visit,2023-08-25,CM,22,2023-08-25 12:33:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,22,COMMON_CM,Any visit,2023-08-25,CM,22,2023-08-25 12:33:00,Any visit,CM Start Date,2023-08-04,CM_CMSTDAT
NLD03,NLD_03_207,22,COMMON_CM,Any visit,2023-08-25,CM,22,2023-08-25 12:33:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,22,COMMON_CM,Any visit,2023-08-25,CM,22,2023-08-25 12:33:00,Any visit,CM End Date,2023-08-05,CM_CMENDAT
NLD03,NLD_03_207,23,COMMON_CM,Any visit,2023-08-25,CM,23,2023-08-25 12:34:00,Any visit,CM Number,23,CM_CMSPID
NLD03,NLD_03_207,23,COMMON_CM,Any visit,2023-08-25,CM,23,2023-08-25 12:34:00,Any visit,CM Trade Name,Sulfatoxipladib,CM_CMTRT
NLD03,NLD_03_207,23,COMMON_CM,Any visit,2023-08-25,CM,23,2023-08-25 12:34:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
NLD03,NLD_03_207,23,COMMON_CM,Any visit,2023-08-25,CM,23,2023-08-25 12:34:00,Any visit,CM Indication,Hypertension,CM_CMINDC
NLD03,NLD_03_207,23,COMMON_CM,Any visit,2023-08-25,CM,23,2023-08-25 12:34:00,Any visit,CM Dose,1,CM_CMDOSE
NLD03,NLD_03_207,23,COMMON_CM,Any visit,2023-08-25,CM,23,2023-08-25 12:34:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
NLD03,NLD_03_207,23,COMMON_CM,Any visit,2023-08-25,CM,23,2023-08-25 12:34:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
NLD03,NLD_03_207,23,COMMON_CM,Any visit,2023-08-25,CM,23,2023-08-25 12:34:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,23,COMMON_CM,Any visit,2023-08-25,CM,23,2023-08-25 12:34:00,Any visit,CM Start Date,2023-08-04,CM_CMSTDAT
NLD03,NLD_03_207,23,COMMON_CM,Any visit,2023-08-25,CM,23,2023-08-25 12:34:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,23,COMMON_CM,Any visit,2023-08-25,CM,23,2023-08-25 12:34:00,Any visit,CM End Date,2023-08-14,CM_CMENDAT
NLD03,NLD_03_207,24,COMMON_CM,Any visit,2023-08-25,CM,24,2023-08-25 12:35:00,Any visit,CM Number,24,CM_CMSPID
NLD03,NLD_03_207,24,COMMON_CM,Any visit,2023-08-25,CM,24,2023-08-25 12:35:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
NLD03,NLD_03_207,24,COMMON_CM,Any visit,2023-08-25,CM,24,2023-08-25 12:35:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
NLD03,NLD_03_207,24,COMMON_CM,Any visit,2023-08-25,CM,24,2023-08-25 12:35:00,Any visit,CM Indication,Infection,CM_CMINDC
NLD03,NLD_03_207,24,COMMON_CM,Any visit,2023-08-25,CM,24,2023-08-25 12:35:00,Any visit,CM Dose,2,CM_CMDOSE
NLD03,NLD_03_207,24,COMMON_CM,Any visit,2023-08-25,CM,24,2023-08-25 12:35:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
NLD03,NLD_03_207,24,COMMON_CM,Any visit,2023-08-25,CM,24,2023-08-25 12:35:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,24,COMMON_CM,Any visit,2023-08-25,CM,24,2023-08-25 12:35:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,24,COMMON_CM,Any visit,2023-08-25,CM,24,2023-08-25 12:35:00,Any visit,CM Start Date,2023-08-06,CM_CMSTDAT
NLD03,NLD_03_207,24,COMMON_CM,Any visit,2023-08-25,CM,24,2023-08-25 12:35:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,24,COMMON_CM,Any visit,2023-08-25,CM,24,2023-08-25 12:35:00,Any visit,CM End Date,2023-08-06,CM_CMENDAT
NLD03,NLD_03_207,25,COMMON_CM,Any visit,2023-08-25,CM,25,2023-08-25 12:36:00,Any visit,CM Number,25,CM_CMSPID
NLD03,NLD_03_207,25,COMMON_CM,Any visit,2023-08-25,CM,25,2023-08-25 12:36:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
NLD03,NLD_03_207,25,COMMON_CM,Any visit,2023-08-25,CM,25,2023-08-25 12:36:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
NLD03,NLD_03_207,25,COMMON_CM,Any visit,2023-08-25,CM,25,2023-08-25 12:36:00,Any visit,CM Indication,Nausea,CM_CMINDC
NLD03,NLD_03_207,25,COMMON_CM,Any visit,2023-08-25,CM,25,2023-08-25 12:36:00,Any visit,CM Dose,1,CM_CMDOSE
NLD03,NLD_03_207,25,COMMON_CM,Any visit,2023-08-25,CM,25,2023-08-25 12:36:00,Any visit,CM Unit,Gram (g),CM_CMDOSU
NLD03,NLD_03_207,25,COMMON_CM,Any visit,2023-08-25,CM,25,2023-08-25 12:36:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,25,COMMON_CM,Any visit,2023-08-25,CM,25,2023-08-25 12:36:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,25,COMMON_CM,Any visit,2023-08-25,CM,25,2023-08-25 12:36:00,Any visit,CM Start Date,2023-08-06,CM_CMSTDAT
NLD03,NLD_03_207,25,COMMON_CM,Any visit,2023-08-25,CM,25,2023-08-25 12:36:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,25,COMMON_CM,Any visit,2023-08-25,CM,25,2023-08-25 12:36:00,Any visit,CM End Date,2023-08-06,CM_CMENDAT
NLD03,NLD_03_207,26,COMMON_CM,Any visit,2023-08-25,CM,26,2023-08-25 12:37:00,Any visit,CM Number,26,CM_CMSPID
NLD03,NLD_03_207,26,COMMON_CM,Any visit,2023-08-25,CM,26,2023-08-25 12:37:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
NLD03,NLD_03_207,26,COMMON_CM,Any visit,2023-08-25,CM,26,2023-08-25 12:37:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
NLD03,NLD_03_207,26,COMMON_CM,Any visit,2023-08-25,CM,26,2023-08-25 12:37:00,Any visit,CM Indication,Nausea,CM_CMINDC
NLD03,NLD_03_207,26,COMMON_CM,Any visit,2023-08-25,CM,26,2023-08-25 12:37:00,Any visit,CM Dose,25,CM_CMDOSE
NLD03,NLD_03_207,26,COMMON_CM,Any visit,2023-08-25,CM,26,2023-08-25 12:37:00,Any visit,CM Unit,Other,CM_CMDOSU
NLD03,NLD_03_207,26,COMMON_CM,Any visit,2023-08-25,CM,26,2023-08-25 12:37:00,Any visit,CM Unit Other,µg/h,CM_CMDOSU_OTH
NLD03,NLD_03_207,26,COMMON_CM,Any visit,2023-08-25,CM,26,2023-08-25 12:37:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
NLD03,NLD_03_207,26,COMMON_CM,Any visit,2023-08-25,CM,26,2023-08-25 12:37:00,Any visit,CM Frequency Other,---,CM_CMDOSFRQ_OTH
NLD03,NLD_03_207,26,COMMON_CM,Any visit,2023-08-25,CM,26,2023-08-25 12:37:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,26,COMMON_CM,Any visit,2023-08-25,CM,26,2023-08-25 12:37:00,Any visit,CM Start Date,2023-08-06,CM_CMSTDAT
NLD03,NLD_03_207,26,COMMON_CM,Any visit,2023-08-25,CM,26,2023-08-25 12:37:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,26,COMMON_CM,Any visit,2023-08-25,CM,26,2023-08-25 12:37:00,Any visit,CM End Date,2023-08-09,CM_CMENDAT
NLD03,NLD_03_207,27,COMMON_CM,Any visit,2023-08-25,CM,27,2023-08-25 12:38:00,Any visit,CM Number,27,CM_CMSPID
NLD03,NLD_03_207,27,COMMON_CM,Any visit,2023-08-25,CM,27,2023-08-25 12:38:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
NLD03,NLD_03_207,27,COMMON_CM,Any visit,2023-08-25,CM,27,2023-08-25 12:38:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
NLD03,NLD_03_207,27,COMMON_CM,Any visit,2023-08-25,CM,27,2023-08-25 12:38:00,Any visit,CM Indication,Nausea,CM_CMINDC
NLD03,NLD_03_207,27,COMMON_CM,Any visit,2023-08-25,CM,27,2023-08-25 12:38:00,Any visit,CM Dose,40,CM_CMDOSE
NLD03,NLD_03_207,27,COMMON_CM,Any visit,2023-08-25,CM,27,2023-08-25 12:38:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,27,COMMON_CM,Any visit,2023-08-25,CM,27,2023-08-25 12:38:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,27,COMMON_CM,Any visit,2023-08-25,CM,27,2023-08-25 12:38:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,27,COMMON_CM,Any visit,2023-08-25,CM,27,2023-08-25 12:38:00,Any visit,CM Start Date,2023-08-06,CM_CMSTDAT
NLD03,NLD_03_207,27,COMMON_CM,Any visit,2023-08-25,CM,27,2023-08-25 12:38:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,27,COMMON_CM,Any visit,2023-08-25,CM,27,2023-08-25 12:38:00,Any visit,CM End Date,2023-08-06,CM_CMENDAT
NLD03,NLD_03_207,28,COMMON_CM,Any visit,2023-08-25,CM,28,2023-08-25 12:41:00,Any visit,CM Number,28,CM_CMSPID
NLD03,NLD_03_207,28,COMMON_CM,Any visit,2023-08-25,CM,28,2023-08-25 12:41:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
NLD03,NLD_03_207,28,COMMON_CM,Any visit,2023-08-25,CM,28,2023-08-25 12:41:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
NLD03,NLD_03_207,28,COMMON_CM,Any visit,2023-08-25,CM,28,2023-08-25 12:41:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD03,NLD_03_207,28,COMMON_CM,Any visit,2023-08-25,CM,28,2023-08-25 12:41:00,Any visit,CM Dose,20,CM_CMDOSE
NLD03,NLD_03_207,28,COMMON_CM,Any visit,2023-08-25,CM,28,2023-08-25 12:41:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,28,COMMON_CM,Any visit,2023-08-25,CM,28,2023-08-25 12:41:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,28,COMMON_CM,Any visit,2023-08-25,CM,28,2023-08-25 12:41:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,28,COMMON_CM,Any visit,2023-08-25,CM,28,2023-08-25 12:41:00,Any visit,CM Start Date,2023-08-05,CM_CMSTDAT
NLD03,NLD_03_207,28,COMMON_CM,Any visit,2023-08-25,CM,28,2023-08-25 12:41:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,28,COMMON_CM,Any visit,2023-08-25,CM,28,2023-08-25 12:41:00,Any visit,CM End Date,2023-08-05,CM_CMENDAT
NLD03,NLD_03_207,29,COMMON_CM,Any visit,2023-08-25,CM,29,2023-08-25 12:46:00,Any visit,CM Number,29,CM_CMSPID
NLD03,NLD_03_207,29,COMMON_CM,Any visit,2023-08-25,CM,29,2023-08-25 12:46:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
NLD03,NLD_03_207,29,COMMON_CM,Any visit,2023-08-25,CM,29,2023-08-25 12:46:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
NLD03,NLD_03_207,29,COMMON_CM,Any visit,2023-08-25,CM,29,2023-08-25 12:46:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD03,NLD_03_207,29,COMMON_CM,Any visit,2023-08-25,CM,29,2023-08-25 12:46:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,29,COMMON_CM,Any visit,2023-08-25,CM,29,2023-08-25 12:46:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,29,COMMON_CM,Any visit,2023-08-25,CM,29,2023-08-25 12:46:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
NLD03,NLD_03_207,29,COMMON_CM,Any visit,2023-08-25,CM,29,2023-08-25 12:46:00,Any visit,CM Start Date,2023-08-12,CM_CMSTDAT
NLD03,NLD_03_207,29,COMMON_CM,Any visit,2023-08-25,CM,29,2023-08-25 12:46:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,29,COMMON_CM,Any visit,2023-08-25,CM,29,2023-08-25 12:46:00,Any visit,CM End Date,2023-08-12,CM_CMENDAT
NLD03,NLD_03_207,30,COMMON_CM,Any visit,2023-08-25,CM,30,2023-08-25 12:50:00,Any visit,CM Number,30,CM_CMSPID
NLD03,NLD_03_207,30,COMMON_CM,Any visit,2023-08-25,CM,30,2023-08-25 12:50:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
NLD03,NLD_03_207,30,COMMON_CM,Any visit,2023-08-25,CM,30,2023-08-25 12:50:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
NLD03,NLD_03_207,30,COMMON_CM,Any visit,2023-08-25,CM,30,2023-08-25 12:50:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
NLD03,NLD_03_207,30,COMMON_CM,Any visit,2023-08-25,CM,30,2023-08-25 12:50:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,30,COMMON_CM,Any visit,2023-08-25,CM,30,2023-08-25 12:50:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
NLD03,NLD_03_207,30,COMMON_CM,Any visit,2023-08-25,CM,30,2023-08-25 12:50:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,30,COMMON_CM,Any visit,2023-08-25,CM,30,2023-08-25 12:50:00,Any visit,CM Start Date,2023-08-10,CM_CMSTDAT
NLD03,NLD_03_207,30,COMMON_CM,Any visit,2023-08-25,CM,30,2023-08-25 12:50:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,30,COMMON_CM,Any visit,2023-08-25,CM,30,2023-08-25 12:50:00,Any visit,CM End Date,2023-08-14,CM_CMENDAT
NLD03,NLD_03_207,31,COMMON_CM,Any visit,2023-08-25,CM,31,2023-08-25 12:52:00,Any visit,CM Number,31,CM_CMSPID
NLD03,NLD_03_207,31,COMMON_CM,Any visit,2023-08-25,CM,31,2023-08-25 12:52:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
NLD03,NLD_03_207,31,COMMON_CM,Any visit,2023-08-25,CM,31,2023-08-25 12:52:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
NLD03,NLD_03_207,31,COMMON_CM,Any visit,2023-08-25,CM,31,2023-08-25 12:52:00,Any visit,CM Indication,Hypertension,CM_CMINDC
NLD03,NLD_03_207,31,COMMON_CM,Any visit,2023-08-25,CM,31,2023-08-25 12:52:00,Any visit,CM Dose,5,CM_CMDOSE
NLD03,NLD_03_207,31,COMMON_CM,Any visit,2023-08-25,CM,31,2023-08-25 12:52:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,31,COMMON_CM,Any visit,2023-08-25,CM,31,2023-08-25 12:52:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,31,COMMON_CM,Any visit,2023-08-25,CM,31,2023-08-25 12:52:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,31,COMMON_CM,Any visit,2023-08-25,CM,31,2023-08-25 12:52:00,Any visit,CM Start Date,2023-08-07,CM_CMSTDAT
NLD03,NLD_03_207,31,COMMON_CM,Any visit,2023-08-25,CM,31,2023-08-25 12:52:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,31,COMMON_CM,Any visit,2023-08-25,CM,31,2023-08-25 12:52:00,Any visit,CM End Date,2023-08-07,CM_CMENDAT
NLD03,NLD_03_207,32,COMMON_CM,Any visit,2023-08-25,CM,32,2023-08-25 12:53:00,Any visit,CM Number,32,CM_CMSPID
NLD03,NLD_03_207,32,COMMON_CM,Any visit,2023-08-25,CM,32,2023-08-25 12:53:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
NLD03,NLD_03_207,32,COMMON_CM,Any visit,2023-08-25,CM,32,2023-08-25 12:53:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
NLD03,NLD_03_207,32,COMMON_CM,Any visit,2023-08-25,CM,32,2023-08-25 12:53:00,Any visit,CM Indication,Hypertension,CM_CMINDC
NLD03,NLD_03_207,32,COMMON_CM,Any visit,2023-08-25,CM,32,2023-08-25 12:53:00,Any visit,CM Dose,5,CM_CMDOSE
NLD03,NLD_03_207,32,COMMON_CM,Any visit,2023-08-25,CM,32,2023-08-25 12:53:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,32,COMMON_CM,Any visit,2023-08-25,CM,32,2023-08-25 12:53:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,32,COMMON_CM,Any visit,2023-08-25,CM,32,2023-08-25 12:53:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,32,COMMON_CM,Any visit,2023-08-25,CM,32,2023-08-25 12:53:00,Any visit,CM Start Date,2023-08-12,CM_CMSTDAT
NLD03,NLD_03_207,32,COMMON_CM,Any visit,2023-08-25,CM,32,2023-08-25 12:53:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,32,COMMON_CM,Any visit,2023-08-25,CM,32,2023-08-25 12:53:00,Any visit,CM End Date,2023-08-12,CM_CMENDAT
NLD03,NLD_03_207,33,COMMON_CM,Any visit,2023-08-25,CM,33,2023-08-25 12:56:00,Any visit,CM Number,33,CM_CMSPID
NLD03,NLD_03_207,33,COMMON_CM,Any visit,2023-08-25,CM,33,2023-08-25 12:56:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
NLD03,NLD_03_207,33,COMMON_CM,Any visit,2023-08-25,CM,33,2023-08-25 12:56:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
NLD03,NLD_03_207,33,COMMON_CM,Any visit,2023-08-25,CM,33,2023-08-25 12:56:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
NLD03,NLD_03_207,33,COMMON_CM,Any visit,2023-08-25,CM,33,2023-08-25 12:56:00,Any visit,CM Unit,Other,CM_CMDOSU
NLD03,NLD_03_207,33,COMMON_CM,Any visit,2023-08-25,CM,33,2023-08-25 12:56:00,Any visit,CM Frequency,3 times per day (TID),CM_CMDOSFRQ
NLD03,NLD_03_207,33,COMMON_CM,Any visit,2023-08-25,CM,33,2023-08-25 12:56:00,Any visit,CM Route,Other,CM_CMROUTE
NLD03,NLD_03_207,33,COMMON_CM,Any visit,2023-08-25,CM,33,2023-08-25 12:56:00,Any visit,CM Route Other,MOUTH WASH,CM_CMROUTE_OTH
NLD03,NLD_03_207,33,COMMON_CM,Any visit,2023-08-25,CM,33,2023-08-25 12:56:00,Any visit,CM Start Date,2023-08-08,CM_CMSTDAT
NLD03,NLD_03_207,33,COMMON_CM,Any visit,2023-08-25,CM,33,2023-08-25 12:56:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,33,COMMON_CM,Any visit,2023-08-25,CM,33,2023-08-25 12:56:00,Any visit,CM End Date,2023-08-14,CM_CMENDAT
NLD03,NLD_03_207,34,COMMON_CM,Any visit,2023-08-25,CM,34,2023-08-25 12:57:00,Any visit,CM Number,34,CM_CMSPID
NLD03,NLD_03_207,34,COMMON_CM,Any visit,2023-08-25,CM,34,2023-08-25 12:57:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
NLD03,NLD_03_207,34,COMMON_CM,Any visit,2023-08-25,CM,34,2023-08-25 12:57:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
NLD03,NLD_03_207,34,COMMON_CM,Any visit,2023-08-25,CM,34,2023-08-25 12:57:00,Any visit,CM Indication,Nausea,CM_CMINDC
NLD03,NLD_03_207,34,COMMON_CM,Any visit,2023-08-25,CM,34,2023-08-25 12:57:00,Any visit,CM Dose,100000,CM_CMDOSE
NLD03,NLD_03_207,34,COMMON_CM,Any visit,2023-08-25,CM,34,2023-08-25 12:57:00,Any visit,CM Unit,International Unit (IU),CM_CMDOSU
NLD03,NLD_03_207,34,COMMON_CM,Any visit,2023-08-25,CM,34,2023-08-25 12:57:00,Any visit,CM Frequency,4 times per day (QID),CM_CMDOSFRQ
NLD03,NLD_03_207,34,COMMON_CM,Any visit,2023-08-25,CM,34,2023-08-25 12:57:00,Any visit,CM Route,Other,CM_CMROUTE
NLD03,NLD_03_207,34,COMMON_CM,Any visit,2023-08-25,CM,34,2023-08-25 12:57:00,Any visit,CM Route Other,MOUTH WASH,CM_CMROUTE_OTH
NLD03,NLD_03_207,34,COMMON_CM,Any visit,2023-08-25,CM,34,2023-08-25 12:57:00,Any visit,CM Start Date,2023-08-11,CM_CMSTDAT
NLD03,NLD_03_207,34,COMMON_CM,Any visit,2023-08-25,CM,34,2023-08-25 12:57:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,34,COMMON_CM,Any visit,2023-08-25,CM,34,2023-08-25 12:57:00,Any visit,CM End Date,2023-08-14,CM_CMENDAT
NLD03,NLD_03_207,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 13:11:00,Any visit,CM Number,35,CM_CMSPID
NLD03,NLD_03_207,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 13:11:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
NLD03,NLD_03_207,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 13:11:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
NLD03,NLD_03_207,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 13:11:00,Any visit,CM Indication,Adverse event,CM_CMINDC
NLD03,NLD_03_207,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 13:11:00,Any visit,CM Dose,1,CM_CMDOSE
NLD03,NLD_03_207,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 13:11:00,Any visit,CM Unit,Other,CM_CMDOSU
NLD03,NLD_03_207,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 13:11:00,Any visit,CM Unit Other,mg/72h,CM_CMDOSU_OTH
NLD03,NLD_03_207,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 13:11:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
NLD03,NLD_03_207,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 13:11:00,Any visit,CM Frequency Other,na,CM_CMDOSFRQ_OTH
NLD03,NLD_03_207,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 13:11:00,Any visit,CM Route,Transdermal,CM_CMROUTE
NLD03,NLD_03_207,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 13:11:00,Any visit,CM Start Date,2023-08-14,CM_CMSTDAT
NLD03,NLD_03_207,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 13:11:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,35,COMMON_CM,Any visit,2023-08-25,CM,35,2023-08-25 13:11:00,Any visit,CM End Date,2023-08-14,CM_CMENDAT
NLD03,NLD_03_207,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 13:13:00,Any visit,CM Number,36,CM_CMSPID
NLD03,NLD_03_207,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 13:13:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
NLD03,NLD_03_207,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 13:13:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
NLD03,NLD_03_207,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 13:13:00,Any visit,CM Indication,Infection,CM_CMINDC
NLD03,NLD_03_207,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 13:13:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 13:13:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
NLD03,NLD_03_207,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 13:13:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 13:13:00,Any visit,CM Start Date,2023-08-07,CM_CMSTDAT
NLD03,NLD_03_207,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 13:13:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,36,COMMON_CM,Any visit,2023-08-25,CM,36,2023-08-25 13:13:00,Any visit,CM End Date,2023-08-11,CM_CMENDAT
NLD03,NLD_03_207,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 13:19:00,Any visit,CM Number,37,CM_CMSPID
NLD03,NLD_03_207,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 13:19:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
NLD03,NLD_03_207,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 13:19:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
NLD03,NLD_03_207,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 13:19:00,Any visit,CM Indication,Nausea,CM_CMINDC
NLD03,NLD_03_207,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 13:19:00,Any visit,CM Dose,60,CM_CMDOSE
NLD03,NLD_03_207,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 13:19:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 13:19:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 13:19:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 13:19:00,Any visit,CM Start Date,2023-07-06,CM_CMSTDAT
NLD03,NLD_03_207,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 13:19:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,37,COMMON_CM,Any visit,2023-08-25,CM,37,2023-08-25 13:19:00,Any visit,CM End Date,2023-07-06,CM_CMENDAT
NLD03,NLD_03_207,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 13:20:00,Any visit,CM Number,38,CM_CMSPID
NLD03,NLD_03_207,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 13:20:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
NLD03,NLD_03_207,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 13:20:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
NLD03,NLD_03_207,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 13:20:00,Any visit,CM Indication,Pain,CM_CMINDC
NLD03,NLD_03_207,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 13:20:00,Any visit,CM Dose,5,CM_CMDOSE
NLD03,NLD_03_207,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 13:20:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
NLD03,NLD_03_207,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 13:20:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
NLD03,NLD_03_207,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 13:20:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
NLD03,NLD_03_207,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 13:20:00,Any visit,CM Start Date,2023-07-06,CM_CMSTDAT
NLD03,NLD_03_207,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 13:20:00,Any visit,CM Ongoing,No,CM_CMONGO
NLD03,NLD_03_207,38,COMMON_CM,Any visit,2023-08-25,CM,38,2023-08-25 13:20:00,Any visit,CM End Date,2023-07-06,CM_CMENDAT
NLD03,NLD_03_207,11,COMMON_CM,Any visit,2023-08-25,CM,11,2023-08-25 12:19:00,Any visit,CM Related AE,Fever,CM_AEREL
NLD03,NLD_03_207,12,COMMON_CM,Any visit,2023-08-25,CM,12,2023-08-25 12:22:00,Any visit,CM Related AE,Urinary tract infection,CM_AEREL
NLD03,NLD_03_207,13,COMMON_CM,Any visit,2023-08-25,CM,13,2023-08-25 12:22:00,Any visit,CM Related AE,Fever,CM_AEREL
NLD03,NLD_03_207,14,COMMON_CM,Any visit,2023-08-25,CM,14,2023-08-25 12:24:00,Any visit,CM Related AE,Nausea,CM_AEREL
NLD03,NLD_03_207,15,COMMON_CM,Any visit,2023-08-25,CM,15,2023-08-25 12:25:00,Any visit,CM Related AE,Nausea,CM_AEREL
NLD03,NLD_03_207,16,COMMON_CM,Any visit,2023-08-25,CM,16,2023-08-25 12:26:00,Any visit,CM Related AE,Hypotension,CM_AEREL
NLD03,NLD_03_207,17,COMMON_CM,Any visit,2023-08-25,CM,17,2023-08-25 12:27:00,Any visit,CM Related AE,Anemia,CM_AEREL
NLD03,NLD_03_207,18,COMMON_CM,Any visit,2023-08-25,CM,18,2023-08-25 12:28:00,Any visit,CM Related AE,Anemia,CM_AEREL
NLD03,NLD_03_207,19,COMMON_CM,Any visit,2023-08-25,CM,19,2023-08-25 12:29:00,Any visit,CM Related AE,Sepsis,CM_AEREL
NLD03,NLD_03_207,20,COMMON_CM,Any visit,2023-08-25,CM,20,2023-08-25 12:31:00,Any visit,CM Related AE,Nausea,CM_AEREL
NLD03,NLD_03_207,21,COMMON_CM,Any visit,2023-08-25,CM,21,2023-08-25 12:32:00,Any visit,CM Related AE,Sepsis,CM_AEREL
NLD03,NLD_03_207,22,COMMON_CM,Any visit,2023-08-25,CM,22,2023-08-25 12:33:00,Any visit,CM Related AE,Nausea,CM_AEREL
NLD03,NLD_03_207,23,COMMON_CM,Any visit,2023-08-25,CM,23,2023-08-25 12:34:00,Any visit,CM Related AE,Fever,CM_AEREL
NLD03,NLD_03_207,24,COMMON_CM,Any visit,2023-08-25,CM,24,2023-08-25 12:35:00,Any visit,CM Related AE,Urinary tract infection,CM_AEREL
NLD03,NLD_03_207,25,COMMON_CM,Any visit,2023-08-25,CM,25,2023-08-25 12:36:00,Any visit,CM Related AE,Hypotension,CM_AEREL
NLD03,NLD_03_207,26,COMMON_CM,Any visit,2023-08-25,CM,26,2023-08-25 12:37:00,Any visit,CM Related AE,Nausea,CM_AEREL
NLD03,NLD_03_207,27,COMMON_CM,Any visit,2023-08-25,CM,27,2023-08-25 12:38:00,Any visit,CM Related AE,Nausea,CM_AEREL
NLD03,NLD_03_207,29,COMMON_CM,Any visit,2023-08-25,CM,29,2023-08-25 12:46:00,Any visit,CM Related AE,Anemia,CM_AEREL
NLD03,NLD_03_207,30,COMMON_CM,Any visit,2023-08-25,CM,30,2023-08-25 12:50:00,Any visit,CM Related AE,Fever,CM_AEREL
NLD03,NLD_03_207,1,COMMON_CM,Any visit,2023-08-25,CM,1,2023-08-25 12:06:00,Any visit,CM Related Medical History,COPD,CM_MHREL
NLD03,NLD_03_207,2,COMMON_CM,Any visit,2023-08-25,CM,2,2023-08-25 12:07:00,Any visit,CM Related Medical History,Hypertension,CM_MHREL
NLD03,NLD_03_207,3,COMMON_CM,Any visit,2023-08-25,CM,3,2023-08-25 12:08:00,Any visit,CM Related Medical History,COPD,CM_MHREL
NLD03,NLD_03_207,4,COMMON_CM,Any visit,2023-08-25,CM,4,2023-08-25 12:09:00,Any visit,CM Related Medical History,Hypertension,CM_MHREL
NLD03,NLD_03_207,5,COMMON_CM,Any visit,2023-08-25,CM,5,2023-08-25 12:11:00,Any visit,CM Related Medical History,Sickle cell anemia,CM_MHREL
NLD03,NLD_03_207,6,COMMON_CM,Any visit,2023-08-25,CM,6,2023-08-25 12:12:00,Any visit,CM Related Medical History,Osteoporosis,CM_MHREL
NLD03,NLD_03_207,7,COMMON_CM,Any visit,2023-08-25,CM,7,2023-08-25 12:13:00,Any visit,CM Related Medical History,Hypertension,CM_MHREL
NLD03,NLD_03_207,8,COMMON_CM,Any visit,2023-08-25,CM,8,2023-08-25 12:14:00,Any visit,CM Related Medical History,Epilepsy,CM_MHREL
NLD03,NLD_03_207,9,COMMON_CM,Any visit,2023-08-25,CM,9,2023-08-25 12:15:00,Any visit,CM Related Medical History,Sickle cell anemia,CM_MHREL
NLD03,NLD_03_207,10,COMMON_CM,Any visit,2023-08-25,CM,10,2023-08-25 12:16:00,Any visit,CM Related Medical History,Epilepsy,CM_MHREL
NLD03,NLD_03_207,33,COMMON_CM,Any visit,2023-08-25,CM,33,2023-08-25 12:56:00,Any visit,CM Related Medical History,Hypertension,CM_MHREL
NLD03,NLD_03_207,34,COMMON_CM,Any visit,2023-08-25,CM,34,2023-08-25 12:57:00,Any visit,CM Related Medical History,Diabetes mellitus,CM_MHREL
BEL08,BEL_08_45,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-24 11:45:00,Any visit,CM Number,1,CM_CMSPID
BEL08,BEL_08_45,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-24 11:45:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
BEL08,BEL_08_45,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-24 11:45:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
BEL08,BEL_08_45,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-24 11:46:00,Any visit,CM Indication,Insomnia,CM_CMINDC
BEL08,BEL_08_45,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-24 11:45:00,Any visit,CM Dose,600,CM_CMDOSE
BEL08,BEL_08_45,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-24 11:45:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL08,BEL_08_45,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-24 11:45:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
BEL08,BEL_08_45,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-24 11:45:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL08,BEL_08_45,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-24 11:45:00,Any visit,CM Start Date,2023-06-NK,CM_CMSTDAT
BEL08,BEL_08_45,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-24 11:45:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL08,BEL_08_45,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-24 11:48:00,Any visit,CM Number,2,CM_CMSPID
BEL08,BEL_08_45,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-24 11:48:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
BEL08,BEL_08_45,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-24 11:48:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
BEL08,BEL_08_45,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-24 11:48:00,Any visit,CM Indication,Infection,CM_CMINDC
BEL08,BEL_08_45,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-24 11:48:00,Any visit,CM Dose,10,CM_CMDOSE
BEL08,BEL_08_45,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-24 11:48:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL08,BEL_08_45,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-24 11:48:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL08,BEL_08_45,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-24 11:48:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL08,BEL_08_45,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-24 11:48:00,Any visit,CM Start Date,2023-06-NK,CM_CMSTDAT
BEL08,BEL_08_45,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-24 11:48:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL08,BEL_08_45,3,COMMON_CM,Any visit,2023-08-24,CM,3,2023-08-24 11:50:00,Any visit,CM Number,3,CM_CMSPID
BEL08,BEL_08_45,3,COMMON_CM,Any visit,2023-08-24,CM,3,2023-08-24 11:50:00,Any visit,CM Trade Name,Sulfatoxipladib,CM_CMTRT
BEL08,BEL_08_45,3,COMMON_CM,Any visit,2023-08-24,CM,3,2023-08-24 11:50:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
BEL08,BEL_08_45,3,COMMON_CM,Any visit,2023-08-24,CM,3,2023-08-24 11:50:00,Any visit,CM Dose,125,CM_CMDOSE
BEL08,BEL_08_45,3,COMMON_CM,Any visit,2023-08-24,CM,3,2023-08-24 11:50:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL08,BEL_08_45,3,COMMON_CM,Any visit,2023-08-24,CM,3,2023-08-24 11:50:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL08,BEL_08_45,3,COMMON_CM,Any visit,2023-08-24,CM,3,2023-09-01 13:09:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL08,BEL_08_45,3,COMMON_CM,Any visit,2023-08-24,CM,3,2023-08-24 11:50:00,Any visit,CM Start Date,2023-06-NK,CM_CMSTDAT
BEL08,BEL_08_45,3,COMMON_CM,Any visit,2023-08-24,CM,3,2023-08-24 11:50:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL08,BEL_08_45,4,COMMON_CM,Any visit,2023-08-24,CM,4,2023-08-24 11:52:00,Any visit,CM Number,4,CM_CMSPID
BEL08,BEL_08_45,4,COMMON_CM,Any visit,2023-08-24,CM,4,2023-08-24 11:52:00,Any visit,CM Trade Name,Gliigestatrilat,CM_CMTRT
BEL08,BEL_08_45,4,COMMON_CM,Any visit,2023-08-24,CM,4,2023-08-24 11:52:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
BEL08,BEL_08_45,4,COMMON_CM,Any visit,2023-08-24,CM,4,2023-08-24 11:52:00,Any visit,CM Indication,Insomnia,CM_CMINDC
BEL08,BEL_08_45,4,COMMON_CM,Any visit,2023-08-24,CM,4,2023-08-24 11:52:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL08,BEL_08_45,4,COMMON_CM,Any visit,2023-08-24,CM,4,2023-08-24 11:52:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL08,BEL_08_45,4,COMMON_CM,Any visit,2023-08-24,CM,4,2023-08-24 11:52:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL08,BEL_08_45,4,COMMON_CM,Any visit,2023-08-24,CM,4,2023-08-24 11:52:00,Any visit,CM Start Date,2003-NK-NK,CM_CMSTDAT
BEL08,BEL_08_45,4,COMMON_CM,Any visit,2023-08-24,CM,4,2023-08-24 11:52:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL08,BEL_08_45,5,COMMON_CM,Any visit,2023-08-24,CM,5,2023-08-24 11:53:00,Any visit,CM Number,5,CM_CMSPID
BEL08,BEL_08_45,5,COMMON_CM,Any visit,2023-08-24,CM,5,2023-08-24 11:53:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
BEL08,BEL_08_45,5,COMMON_CM,Any visit,2023-08-24,CM,5,2023-08-24 11:53:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
BEL08,BEL_08_45,5,COMMON_CM,Any visit,2023-08-24,CM,5,2023-09-01 13:10:00,Any visit,CM Indication,Infection,CM_CMINDC
BEL08,BEL_08_45,5,COMMON_CM,Any visit,2023-08-24,CM,5,2023-08-24 11:53:00,Any visit,CM Dose,10,CM_CMDOSE
BEL08,BEL_08_45,5,COMMON_CM,Any visit,2023-08-24,CM,5,2023-08-24 11:53:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL08,BEL_08_45,5,COMMON_CM,Any visit,2023-08-24,CM,5,2023-08-24 11:53:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL08,BEL_08_45,5,COMMON_CM,Any visit,2023-08-24,CM,5,2023-09-01 13:10:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL08,BEL_08_45,5,COMMON_CM,Any visit,2023-08-24,CM,5,2023-08-24 11:53:00,Any visit,CM Start Date,2003-NK-NK,CM_CMSTDAT
BEL08,BEL_08_45,5,COMMON_CM,Any visit,2023-08-24,CM,5,2023-08-24 11:53:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL08,BEL_08_45,6,COMMON_CM,Any visit,2023-08-24,CM,6,2023-08-24 11:55:00,Any visit,CM Number,6,CM_CMSPID
BEL08,BEL_08_45,6,COMMON_CM,Any visit,2023-08-24,CM,6,2023-08-24 11:55:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
BEL08,BEL_08_45,6,COMMON_CM,Any visit,2023-08-24,CM,6,2023-08-24 11:55:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
BEL08,BEL_08_45,6,COMMON_CM,Any visit,2023-08-24,CM,6,2023-08-24 11:55:00,Any visit,CM Indication,Nausea,CM_CMINDC
BEL08,BEL_08_45,6,COMMON_CM,Any visit,2023-08-24,CM,6,2023-08-24 11:55:00,Any visit,CM Dose,300,CM_CMDOSE
BEL08,BEL_08_45,6,COMMON_CM,Any visit,2023-08-24,CM,6,2023-08-24 11:55:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL08,BEL_08_45,6,COMMON_CM,Any visit,2023-08-24,CM,6,2023-08-24 11:55:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL08,BEL_08_45,6,COMMON_CM,Any visit,2023-08-24,CM,6,2023-08-24 11:55:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL08,BEL_08_45,6,COMMON_CM,Any visit,2023-08-24,CM,6,2023-08-24 11:55:00,Any visit,CM Start Date,2003-NK-NK,CM_CMSTDAT
BEL08,BEL_08_45,6,COMMON_CM,Any visit,2023-08-24,CM,6,2023-08-24 11:55:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL08,BEL_08_45,7,COMMON_CM,Any visit,2023-08-24,CM,7,2023-08-24 11:58:00,Any visit,CM Number,7,CM_CMSPID
BEL08,BEL_08_45,7,COMMON_CM,Any visit,2023-08-24,CM,7,2023-08-24 11:58:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
BEL08,BEL_08_45,7,COMMON_CM,Any visit,2023-08-24,CM,7,2023-08-24 11:58:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
BEL08,BEL_08_45,7,COMMON_CM,Any visit,2023-08-24,CM,7,2023-08-24 11:58:00,Any visit,CM Indication,Insomnia,CM_CMINDC
BEL08,BEL_08_45,7,COMMON_CM,Any visit,2023-08-24,CM,7,2023-08-24 11:58:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL08,BEL_08_45,7,COMMON_CM,Any visit,2023-08-24,CM,7,2023-08-24 11:58:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL08,BEL_08_45,7,COMMON_CM,Any visit,2023-08-24,CM,7,2023-09-01 13:11:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL08,BEL_08_45,7,COMMON_CM,Any visit,2023-08-24,CM,7,2023-08-24 11:58:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL08,BEL_08_45,1,COMMON_CM,Any visit,2023-08-24,CM,1,2023-08-24 11:46:00,Any visit,CM Related Medical History,COPD,CM_MHREL
BEL08,BEL_08_45,2,COMMON_CM,Any visit,2023-08-24,CM,2,2023-08-24 11:48:00,Any visit,CM Related Medical History,Atrial fibrillation,CM_MHREL
BEL08,BEL_08_45,4,COMMON_CM,Any visit,2023-08-24,CM,4,2023-08-24 11:52:00,Any visit,CM Related Medical History,Hypothyroidism,CM_MHREL
BEL08,BEL_08_45,5,COMMON_CM,Any visit,2023-08-24,CM,5,2023-09-01 13:10:00,Any visit,CM Related Medical History,COPD,CM_MHREL
BEL08,BEL_08_45,6,COMMON_CM,Any visit,2023-08-24,CM,6,2023-08-24 11:55:00,Any visit,CM Related Medical History,Arhtritis,CM_MHREL
BEL08,BEL_08_45,7,COMMON_CM,Any visit,2023-08-24,CM,7,2023-08-24 11:58:00,Any visit,CM Related Medical History,Sickle cell anemia,CM_MHREL
BEL04,BEL_04_772,1,COMMON_CM,Any visit,2023-07-11,CM,1,2023-07-11 14:47:00,Any visit,CM Number,1,CM_CMSPID
BEL04,BEL_04_772,1,COMMON_CM,Any visit,2023-07-11,CM,1,2023-07-11 14:47:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
BEL04,BEL_04_772,1,COMMON_CM,Any visit,2023-07-11,CM,1,2023-07-11 14:48:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
BEL04,BEL_04_772,1,COMMON_CM,Any visit,2023-07-11,CM,1,2023-07-11 14:47:00,Any visit,CM Indication,Pain,CM_CMINDC
BEL04,BEL_04_772,1,COMMON_CM,Any visit,2023-07-11,CM,1,2023-07-11 14:47:00,Any visit,CM Dose,80,CM_CMDOSE
BEL04,BEL_04_772,1,COMMON_CM,Any visit,2023-07-11,CM,1,2023-07-11 14:47:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL04,BEL_04_772,1,COMMON_CM,Any visit,2023-07-11,CM,1,2023-07-11 14:47:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL04,BEL_04_772,1,COMMON_CM,Any visit,2023-07-11,CM,1,2023-07-11 14:47:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL04,BEL_04_772,1,COMMON_CM,Any visit,2023-07-11,CM,1,2023-07-11 14:47:00,Any visit,CM Start Date,1995-NK-NK,CM_CMSTDAT
BEL04,BEL_04_772,1,COMMON_CM,Any visit,2023-07-11,CM,1,2023-07-11 14:47:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL04,BEL_04_772,2,COMMON_CM,Any visit,2023-07-11,CM,2,2023-07-11 14:51:00,Any visit,CM Number,2,CM_CMSPID
BEL04,BEL_04_772,2,COMMON_CM,Any visit,2023-07-11,CM,2,2023-07-11 14:51:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
BEL04,BEL_04_772,2,COMMON_CM,Any visit,2023-07-11,CM,2,2023-07-11 14:51:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
BEL04,BEL_04_772,2,COMMON_CM,Any visit,2023-07-11,CM,2,2023-07-11 14:51:00,Any visit,CM Indication,Adverse event,CM_CMINDC
BEL04,BEL_04_772,2,COMMON_CM,Any visit,2023-07-11,CM,2,2023-07-11 14:51:00,Any visit,CM Unit,International Unit (IU),CM_CMDOSU
BEL04,BEL_04_772,2,COMMON_CM,Any visit,2023-07-11,CM,2,2023-07-11 14:51:00,Any visit,CM Frequency,Other,CM_CMDOSFRQ
BEL04,BEL_04_772,2,COMMON_CM,Any visit,2023-07-11,CM,2,2023-07-11 14:51:00,Any visit,CM Frequency Other,1 time every 2 months,CM_CMDOSFRQ_OTH
BEL04,BEL_04_772,2,COMMON_CM,Any visit,2023-07-11,CM,2,2023-07-11 14:51:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL04,BEL_04_772,2,COMMON_CM,Any visit,2023-07-11,CM,2,2023-07-11 14:51:00,Any visit,CM Start Date,2015-NK-NK,CM_CMSTDAT
BEL04,BEL_04_772,2,COMMON_CM,Any visit,2023-07-11,CM,2,2023-07-11 14:51:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL04,BEL_04_772,3,COMMON_CM,Any visit,2023-07-11,CM,3,2023-07-11 15:05:00,Any visit,CM Number,3,CM_CMSPID
BEL04,BEL_04_772,3,COMMON_CM,Any visit,2023-07-11,CM,3,2023-07-11 15:05:00,Any visit,CM Trade Name,Guanatoran,CM_CMTRT
BEL04,BEL_04_772,3,COMMON_CM,Any visit,2023-07-11,CM,3,2023-07-11 15:05:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
BEL04,BEL_04_772,3,COMMON_CM,Any visit,2023-07-11,CM,3,2023-07-11 15:05:00,Any visit,CM Indication,Hypertension,CM_CMINDC
BEL04,BEL_04_772,3,COMMON_CM,Any visit,2023-07-11,CM,3,2023-07-11 15:05:00,Any visit,CM Dose,3,CM_CMDOSE
BEL04,BEL_04_772,3,COMMON_CM,Any visit,2023-07-11,CM,3,2023-07-11 15:05:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL04,BEL_04_772,3,COMMON_CM,Any visit,2023-07-11,CM,3,2023-07-11 15:05:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL04,BEL_04_772,3,COMMON_CM,Any visit,2023-07-11,CM,3,2023-07-11 15:05:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL04,BEL_04_772,3,COMMON_CM,Any visit,2023-07-11,CM,3,2023-07-11 15:05:00,Any visit,CM Start Date,2020-NK-NK,CM_CMSTDAT
BEL04,BEL_04_772,3,COMMON_CM,Any visit,2023-07-11,CM,3,2023-07-11 15:05:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL04,BEL_04_772,4,COMMON_CM,Any visit,2023-07-11,CM,4,2023-07-11 15:06:00,Any visit,CM Number,4,CM_CMSPID
BEL04,BEL_04_772,4,COMMON_CM,Any visit,2023-07-11,CM,4,2023-07-11 15:06:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
BEL04,BEL_04_772,4,COMMON_CM,Any visit,2023-07-11,CM,4,2023-07-11 15:06:00,Any visit,CM Active Ingredient,Loratadine,CM_CMINGRD
BEL04,BEL_04_772,4,COMMON_CM,Any visit,2023-07-11,CM,4,2023-07-11 15:06:00,Any visit,CM Indication,Infection,CM_CMINDC
BEL04,BEL_04_772,4,COMMON_CM,Any visit,2023-07-11,CM,4,2023-07-11 15:06:00,Any visit,CM Dose,300,CM_CMDOSE
BEL04,BEL_04_772,4,COMMON_CM,Any visit,2023-07-11,CM,4,2023-07-11 15:06:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL04,BEL_04_772,4,COMMON_CM,Any visit,2023-07-11,CM,4,2023-07-11 15:06:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL04,BEL_04_772,4,COMMON_CM,Any visit,2023-07-11,CM,4,2023-07-11 15:06:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL04,BEL_04_772,4,COMMON_CM,Any visit,2023-07-11,CM,4,2023-07-11 15:06:00,Any visit,CM Start Date,2020-NK-NK,CM_CMSTDAT
BEL04,BEL_04_772,4,COMMON_CM,Any visit,2023-07-11,CM,4,2023-07-11 15:06:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL04,BEL_04_772,5,COMMON_CM,Any visit,2023-07-11,CM,5,2023-07-11 15:25:00,Any visit,CM Number,5,CM_CMSPID
BEL04,BEL_04_772,5,COMMON_CM,Any visit,2023-07-11,CM,5,2023-07-11 15:25:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
BEL04,BEL_04_772,5,COMMON_CM,Any visit,2023-07-11,CM,5,2023-07-11 15:25:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
BEL04,BEL_04_772,5,COMMON_CM,Any visit,2023-07-11,CM,5,2023-07-11 15:25:00,Any visit,CM Indication,Hypertension,CM_CMINDC
BEL04,BEL_04_772,5,COMMON_CM,Any visit,2023-07-11,CM,5,2023-07-11 15:25:00,Any visit,CM Dose,75,CM_CMDOSE
BEL04,BEL_04_772,5,COMMON_CM,Any visit,2023-07-11,CM,5,2023-07-11 15:25:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL04,BEL_04_772,5,COMMON_CM,Any visit,2023-07-11,CM,5,2023-07-11 15:25:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL04,BEL_04_772,5,COMMON_CM,Any visit,2023-07-11,CM,5,2023-07-11 15:25:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL04,BEL_04_772,5,COMMON_CM,Any visit,2023-07-11,CM,5,2023-07-11 15:25:00,Any visit,CM Start Date,2020-NK-NK,CM_CMSTDAT
BEL04,BEL_04_772,5,COMMON_CM,Any visit,2023-07-11,CM,5,2023-07-11 15:25:00,Any visit,CM Ongoing,No,CM_CMONGO
BEL04,BEL_04_772,5,COMMON_CM,Any visit,2023-07-11,CM,5,2023-07-11 15:25:00,Any visit,CM End Date,2023-06-28,CM_CMENDAT
BEL04,BEL_04_772,6,COMMON_CM,Any visit,2023-07-11,CM,6,2023-07-11 15:26:00,Any visit,CM Number,6,CM_CMSPID
BEL04,BEL_04_772,6,COMMON_CM,Any visit,2023-07-11,CM,6,2023-07-11 15:26:00,Any visit,CM Trade Name,Bolidilanil,CM_CMTRT
BEL04,BEL_04_772,6,COMMON_CM,Any visit,2023-07-11,CM,6,2023-07-11 15:26:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
BEL04,BEL_04_772,6,COMMON_CM,Any visit,2023-07-11,CM,6,2023-07-11 15:26:00,Any visit,CM Indication,Adverse event,CM_CMINDC
BEL04,BEL_04_772,6,COMMON_CM,Any visit,2023-07-11,CM,6,2023-07-11 15:26:00,Any visit,CM Dose,50,CM_CMDOSE
BEL04,BEL_04_772,6,COMMON_CM,Any visit,2023-07-11,CM,6,2023-07-11 15:26:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL04,BEL_04_772,6,COMMON_CM,Any visit,2023-07-11,CM,6,2023-07-11 15:26:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL04,BEL_04_772,6,COMMON_CM,Any visit,2023-07-11,CM,6,2023-07-11 15:26:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL04,BEL_04_772,6,COMMON_CM,Any visit,2023-07-11,CM,6,2023-07-11 15:26:00,Any visit,CM Start Date,2018-NK-NK,CM_CMSTDAT
BEL04,BEL_04_772,6,COMMON_CM,Any visit,2023-07-11,CM,6,2023-07-11 15:26:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL04,BEL_04_772,7,COMMON_CM,Any visit,2023-07-11,CM,7,2023-07-11 15:29:00,Any visit,CM Number,7,CM_CMSPID
BEL04,BEL_04_772,7,COMMON_CM,Any visit,2023-07-11,CM,7,2023-07-11 15:29:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
BEL04,BEL_04_772,7,COMMON_CM,Any visit,2023-07-11,CM,7,2023-07-11 15:29:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
BEL04,BEL_04_772,7,COMMON_CM,Any visit,2023-07-11,CM,7,2023-07-11 15:29:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
BEL04,BEL_04_772,7,COMMON_CM,Any visit,2023-07-11,CM,7,2023-07-11 15:29:00,Any visit,CM Dose,5,CM_CMDOSE
BEL04,BEL_04_772,7,COMMON_CM,Any visit,2023-07-11,CM,7,2023-07-11 15:29:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL04,BEL_04_772,7,COMMON_CM,Any visit,2023-07-11,CM,7,2023-07-11 15:29:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL04,BEL_04_772,7,COMMON_CM,Any visit,2023-07-11,CM,7,2023-07-11 15:29:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL04,BEL_04_772,7,COMMON_CM,Any visit,2023-07-11,CM,7,2023-07-11 15:29:00,Any visit,CM Start Date,2020-NK-NK,CM_CMSTDAT
BEL04,BEL_04_772,7,COMMON_CM,Any visit,2023-07-11,CM,7,2023-07-11 15:29:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL04,BEL_04_772,8,COMMON_CM,Any visit,2023-07-11,CM,8,2023-07-11 15:30:00,Any visit,CM Number,8,CM_CMSPID
BEL04,BEL_04_772,8,COMMON_CM,Any visit,2023-07-11,CM,8,2023-07-11 15:30:00,Any visit,CM Trade Name,Gliigestatrilat,CM_CMTRT
BEL04,BEL_04_772,8,COMMON_CM,Any visit,2023-07-11,CM,8,2023-07-11 15:30:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
BEL04,BEL_04_772,8,COMMON_CM,Any visit,2023-07-11,CM,8,2023-07-11 15:30:00,Any visit,CM Indication,Adverse event,CM_CMINDC
BEL04,BEL_04_772,8,COMMON_CM,Any visit,2023-07-11,CM,8,2023-07-11 15:30:00,Any visit,CM Dose,40,CM_CMDOSE
BEL04,BEL_04_772,8,COMMON_CM,Any visit,2023-07-11,CM,8,2023-07-11 15:30:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL04,BEL_04_772,8,COMMON_CM,Any visit,2023-07-11,CM,8,2023-07-11 15:30:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL04,BEL_04_772,8,COMMON_CM,Any visit,2023-07-11,CM,8,2023-07-11 15:30:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL04,BEL_04_772,8,COMMON_CM,Any visit,2023-07-11,CM,8,2023-07-11 15:30:00,Any visit,CM Start Date,2020-NK-NK,CM_CMSTDAT
BEL04,BEL_04_772,8,COMMON_CM,Any visit,2023-07-11,CM,8,2023-07-11 15:30:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL04,BEL_04_772,9,COMMON_CM,Any visit,2023-07-11,CM,9,2023-07-11 15:31:00,Any visit,CM Number,9,CM_CMSPID
BEL04,BEL_04_772,9,COMMON_CM,Any visit,2023-07-11,CM,9,2023-07-11 15:31:00,Any visit,CM Trade Name,Predacortef,CM_CMTRT
BEL04,BEL_04_772,9,COMMON_CM,Any visit,2023-07-11,CM,9,2023-07-11 15:31:00,Any visit,CM Active Ingredient,Ibuprofen,CM_CMINGRD
BEL04,BEL_04_772,9,COMMON_CM,Any visit,2023-07-11,CM,9,2023-07-11 15:31:00,Any visit,CM Indication,Hypertension,CM_CMINDC
BEL04,BEL_04_772,9,COMMON_CM,Any visit,2023-07-11,CM,9,2023-07-11 15:31:00,Any visit,CM Dose,500,CM_CMDOSE
BEL04,BEL_04_772,9,COMMON_CM,Any visit,2023-07-11,CM,9,2023-07-11 15:31:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL04,BEL_04_772,9,COMMON_CM,Any visit,2023-07-11,CM,9,2023-07-11 15:31:00,Any visit,CM Frequency,Twice per day (BID),CM_CMDOSFRQ
BEL04,BEL_04_772,9,COMMON_CM,Any visit,2023-07-11,CM,9,2023-07-11 15:31:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL04,BEL_04_772,9,COMMON_CM,Any visit,2023-07-11,CM,9,2023-07-11 15:31:00,Any visit,CM Start Date,2020-NK-NK,CM_CMSTDAT
BEL04,BEL_04_772,9,COMMON_CM,Any visit,2023-07-11,CM,9,2023-07-11 15:31:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL04,BEL_04_772,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 11:56:00,Any visit,CM Number,10,CM_CMSPID
BEL04,BEL_04_772,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 11:56:00,Any visit,CM Trade Name,Sulfatoxipladib,CM_CMTRT
BEL04,BEL_04_772,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 11:56:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
BEL04,BEL_04_772,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 11:56:00,Any visit,CM Indication,Nausea,CM_CMINDC
BEL04,BEL_04_772,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 11:56:00,Any visit,CM Dose,5,CM_CMDOSE
BEL04,BEL_04_772,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 11:56:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL04,BEL_04_772,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 11:56:00,Any visit,CM Frequency,Per month (QM),CM_CMDOSFRQ
BEL04,BEL_04_772,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 11:56:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
BEL04,BEL_04_772,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 11:56:00,Any visit,CM Start Date,2023-07-05,CM_CMSTDAT
BEL04,BEL_04_772,10,COMMON_CM,Any visit,2023-08-31,CM,10,2023-08-31 11:56:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL04,BEL_04_772,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 11:57:00,Any visit,CM Number,11,CM_CMSPID
BEL04,BEL_04_772,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 11:57:00,Any visit,CM Trade Name,Bolidilanil,CM_CMTRT
BEL04,BEL_04_772,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 11:57:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
BEL04,BEL_04_772,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 11:57:00,Any visit,CM Indication,Insomnia,CM_CMINDC
BEL04,BEL_04_772,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 11:57:00,Any visit,CM Dose,20,CM_CMDOSE
BEL04,BEL_04_772,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 11:57:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL04,BEL_04_772,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 11:57:00,Any visit,CM Frequency,Per month (QM),CM_CMDOSFRQ
BEL04,BEL_04_772,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 11:57:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
BEL04,BEL_04_772,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 11:57:00,Any visit,CM Start Date,2023-07-05,CM_CMSTDAT
BEL04,BEL_04_772,11,COMMON_CM,Any visit,2023-08-31,CM,11,2023-08-31 11:57:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL04,BEL_04_772,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 12:02:00,Any visit,CM Number,12,CM_CMSPID
BEL04,BEL_04_772,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 12:02:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
BEL04,BEL_04_772,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 12:02:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
BEL04,BEL_04_772,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 12:02:00,Any visit,CM Indication,Adverse event,CM_CMINDC
BEL04,BEL_04_772,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 12:02:00,Any visit,CM Dose,100,CM_CMDOSE
BEL04,BEL_04_772,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 12:02:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL04,BEL_04_772,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 12:02:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
BEL04,BEL_04_772,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 12:02:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL04,BEL_04_772,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 12:02:00,Any visit,CM Start Date,2023-01-NK,CM_CMSTDAT
BEL04,BEL_04_772,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 12:02:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL04,BEL_04_772,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 12:05:00,Any visit,CM Number,13,CM_CMSPID
BEL04,BEL_04_772,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 12:05:00,Any visit,CM Trade Name,Bolidilanil,CM_CMTRT
BEL04,BEL_04_772,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 12:05:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
BEL04,BEL_04_772,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 12:05:00,Any visit,CM Indication,Hypertension,CM_CMINDC
BEL04,BEL_04_772,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 12:05:00,Any visit,CM Dose,2,CM_CMDOSE
BEL04,BEL_04_772,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 12:05:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL04,BEL_04_772,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 12:05:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
BEL04,BEL_04_772,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 12:05:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL04,BEL_04_772,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 12:05:00,Any visit,CM Start Date,2023-01-NK,CM_CMSTDAT
BEL04,BEL_04_772,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 12:05:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL04,BEL_04_772,14,COMMON_CM,Any visit,2023-08-31,CM,14,2023-08-31 13:47:00,Any visit,CM Number,14,CM_CMSPID
BEL04,BEL_04_772,14,COMMON_CM,Any visit,2023-08-31,CM,14,2023-08-31 13:47:00,Any visit,CM Trade Name,Bolidilanil,CM_CMTRT
BEL04,BEL_04_772,14,COMMON_CM,Any visit,2023-08-31,CM,14,2023-08-31 13:47:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
BEL04,BEL_04_772,14,COMMON_CM,Any visit,2023-08-31,CM,14,2023-08-31 13:47:00,Any visit,CM Indication,Adverse event,CM_CMINDC
BEL04,BEL_04_772,14,COMMON_CM,Any visit,2023-08-31,CM,14,2023-08-31 13:47:00,Any visit,CM Dose,500,CM_CMDOSE
BEL04,BEL_04_772,14,COMMON_CM,Any visit,2023-08-31,CM,14,2023-08-31 13:47:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL04,BEL_04_772,14,COMMON_CM,Any visit,2023-08-31,CM,14,2023-08-31 13:47:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL04,BEL_04_772,14,COMMON_CM,Any visit,2023-08-31,CM,14,2023-08-31 13:47:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL04,BEL_04_772,14,COMMON_CM,Any visit,2023-08-31,CM,14,2023-08-31 13:47:00,Any visit,CM Start Date,2023-08-16,CM_CMSTDAT
BEL04,BEL_04_772,14,COMMON_CM,Any visit,2023-08-31,CM,14,2023-08-31 13:47:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL04,BEL_04_772,15,COMMON_CM,Any visit,2023-08-31,CM,15,2023-08-31 13:50:00,Any visit,CM Number,15,CM_CMSPID
BEL04,BEL_04_772,15,COMMON_CM,Any visit,2023-08-31,CM,15,2023-08-31 13:50:00,Any visit,CM Trade Name,Rifatrodast,CM_CMTRT
BEL04,BEL_04_772,15,COMMON_CM,Any visit,2023-08-31,CM,15,2023-08-31 13:50:00,Any visit,CM Active Ingredient,Pantoprazole,CM_CMINGRD
BEL04,BEL_04_772,15,COMMON_CM,Any visit,2023-08-31,CM,15,2023-08-31 13:50:00,Any visit,CM Indication,Pain,CM_CMINDC
BEL04,BEL_04_772,15,COMMON_CM,Any visit,2023-08-31,CM,15,2023-08-31 13:50:00,Any visit,CM Start Date,2023-08-23,CM_CMSTDAT
BEL04,BEL_04_772,15,COMMON_CM,Any visit,2023-08-31,CM,15,2023-08-31 13:50:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL04,BEL_04_772,14,COMMON_CM,Any visit,2023-08-31,CM,14,2023-08-31 13:47:00,Any visit,CM Related AE,Tachycardia,CM_AEREL
BEL04,BEL_04_772,15,COMMON_CM,Any visit,2023-08-31,CM,15,2023-08-31 13:50:00,Any visit,CM Related AE,Urinary tract infection,CM_AEREL
BEL04,BEL_04_772,1,COMMON_CM,Any visit,2023-07-11,CM,1,2023-08-31 10:14:00,Any visit,CM Related Medical History,COPD,CM_MHREL
BEL04,BEL_04_772,2,COMMON_CM,Any visit,2023-07-11,CM,2,2023-07-11 15:07:00,Any visit,CM Related Medical History,Hypertension,CM_MHREL
BEL04,BEL_04_772,3,COMMON_CM,Any visit,2023-07-11,CM,3,2023-07-11 15:05:00,Any visit,CM Related Medical History,Osteoporosis,CM_MHREL
BEL04,BEL_04_772,4,COMMON_CM,Any visit,2023-07-11,CM,4,2023-07-11 15:06:00,Any visit,CM Related Medical History,COPD,CM_MHREL
BEL04,BEL_04_772,5,COMMON_CM,Any visit,2023-07-11,CM,5,2023-07-11 15:25:00,Any visit,CM Related Medical History,Osteoporosis,CM_MHREL
BEL04,BEL_04_772,6,COMMON_CM,Any visit,2023-07-11,CM,6,2023-07-11 15:26:00,Any visit,CM Related Medical History,Osteoporosis,CM_MHREL
BEL04,BEL_04_772,7,COMMON_CM,Any visit,2023-07-11,CM,7,2023-07-11 15:29:00,Any visit,CM Related Medical History,COPD,CM_MHREL
BEL04,BEL_04_772,8,COMMON_CM,Any visit,2023-07-11,CM,8,2023-07-11 15:30:00,Any visit,CM Related Medical History,Epilepsy,CM_MHREL
BEL04,BEL_04_772,9,COMMON_CM,Any visit,2023-07-11,CM,9,2023-07-11 15:31:00,Any visit,CM Related Medical History,Hypertension,CM_MHREL
BEL04,BEL_04_772,12,COMMON_CM,Any visit,2023-08-31,CM,12,2023-08-31 12:04:00,Any visit,CM Related Medical History,Epilepsy,CM_MHREL
BEL04,BEL_04_772,13,COMMON_CM,Any visit,2023-08-31,CM,13,2023-08-31 12:05:00,Any visit,CM Related Medical History,Hypertension,CM_MHREL
BEL08,BEL_08_736,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 14:23:00,Any visit,CM Number,1,CM_CMSPID
BEL08,BEL_08_736,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 14:23:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
BEL08,BEL_08_736,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 14:23:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
BEL08,BEL_08_736,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 14:23:00,Any visit,CM Indication,Infection,CM_CMINDC
BEL08,BEL_08_736,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 14:23:00,Any visit,CM Dose,20,CM_CMDOSE
BEL08,BEL_08_736,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 14:23:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL08,BEL_08_736,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 14:23:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL08,BEL_08_736,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 14:23:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL08,BEL_08_736,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 14:23:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL08,BEL_08_736,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 14:24:00,Any visit,CM Number,2,CM_CMSPID
BEL08,BEL_08_736,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 14:24:00,Any visit,CM Trade Name,Gliigestatrilat,CM_CMTRT
BEL08,BEL_08_736,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 14:24:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
BEL08,BEL_08_736,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 14:24:00,Any visit,CM Indication,Nausea,CM_CMINDC
BEL08,BEL_08_736,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 14:24:00,Any visit,CM Dose,10,CM_CMDOSE
BEL08,BEL_08_736,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 14:24:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL08,BEL_08_736,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 14:24:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL08,BEL_08_736,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 14:24:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL08,BEL_08_736,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 14:24:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL08,BEL_08_736,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 14:27:00,Any visit,CM Number,3,CM_CMSPID
BEL08,BEL_08_736,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 14:27:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
BEL08,BEL_08_736,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 14:27:00,Any visit,CM Active Ingredient,Mefloquine,CM_CMINGRD
BEL08,BEL_08_736,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 14:27:00,Any visit,CM Indication,Hypertension,CM_CMINDC
BEL08,BEL_08_736,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 14:27:00,Any visit,CM Dose,1,CM_CMDOSE
BEL08,BEL_08_736,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 14:27:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL08,BEL_08_736,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 14:27:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL08,BEL_08_736,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 14:27:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL08,BEL_08_736,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 14:27:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL08,BEL_08_736,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 07:47:00,Any visit,CM Number,4,CM_CMSPID
BEL08,BEL_08_736,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 07:47:00,Any visit,CM Trade Name,Sulfatoxipladib,CM_CMTRT
BEL08,BEL_08_736,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 07:47:00,Any visit,CM Active Ingredient,Acetaminophen,CM_CMINGRD
BEL08,BEL_08_736,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 07:47:00,Any visit,CM Indication,Infection,CM_CMINDC
BEL08,BEL_08_736,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 07:47:00,Any visit,CM Dose,5,CM_CMDOSE
BEL08,BEL_08_736,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 07:47:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL08,BEL_08_736,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 07:48:00,Any visit,CM Frequency,Per month (QM),CM_CMDOSFRQ
BEL08,BEL_08_736,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 07:57:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
BEL08,BEL_08_736,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 07:47:00,Any visit,CM Start Date,2023-08-08,CM_CMSTDAT
BEL08,BEL_08_736,4,COMMON_CM,Any visit,2023-08-31,CM,4,2023-08-31 07:48:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL08,BEL_08_736,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 07:54:00,Any visit,CM Number,5,CM_CMSPID
BEL08,BEL_08_736,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 07:54:00,Any visit,CM Trade Name,Gliaetanide,CM_CMTRT
BEL08,BEL_08_736,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 07:54:00,Any visit,CM Active Ingredient,Metoprolol,CM_CMINGRD
BEL08,BEL_08_736,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 07:54:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
BEL08,BEL_08_736,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 07:54:00,Any visit,CM Dose,20,CM_CMDOSE
BEL08,BEL_08_736,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 07:54:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL08,BEL_08_736,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 07:54:00,Any visit,CM Frequency,Per month (QM),CM_CMDOSFRQ
BEL08,BEL_08_736,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 07:54:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
BEL08,BEL_08_736,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 07:54:00,Any visit,CM Start Date,2023-08-08,CM_CMSTDAT
BEL08,BEL_08_736,5,COMMON_CM,Any visit,2023-08-31,CM,5,2023-08-31 07:54:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL08,BEL_08_736,1,COMMON_CM,Any visit,2023-08-30,CM,1,2023-08-30 14:23:00,Any visit,CM Related Medical History,Sickle cell anemia,CM_MHREL
BEL08,BEL_08_736,2,COMMON_CM,Any visit,2023-08-30,CM,2,2023-08-30 14:24:00,Any visit,CM Related Medical History,Epilepsy,CM_MHREL
BEL08,BEL_08_736,3,COMMON_CM,Any visit,2023-08-30,CM,3,2023-08-30 14:27:00,Any visit,CM Related Medical History,Arhtritis,CM_MHREL
BEL07,BEL_07_645,1,COMMON_CM,Any visit,2023-09-14,CM,1,2023-09-14 13:35:00,Any visit,CM Number,1,CM_CMSPID
BEL07,BEL_07_645,1,COMMON_CM,Any visit,2023-09-14,CM,1,2023-09-14 13:35:00,Any visit,CM Trade Name,Bolidermin,CM_CMTRT
BEL07,BEL_07_645,1,COMMON_CM,Any visit,2023-09-14,CM,1,2023-09-14 13:35:00,Any visit,CM Active Ingredient,Oxycodone,CM_CMINGRD
BEL07,BEL_07_645,1,COMMON_CM,Any visit,2023-09-14,CM,1,2023-09-14 13:35:00,Any visit,CM Indication,Hypertension,CM_CMINDC
BEL07,BEL_07_645,1,COMMON_CM,Any visit,2023-09-14,CM,1,2023-09-14 13:35:00,Any visit,CM Dose,75,CM_CMDOSE
BEL07,BEL_07_645,1,COMMON_CM,Any visit,2023-09-14,CM,1,2023-09-14 13:35:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL07,BEL_07_645,1,COMMON_CM,Any visit,2023-09-14,CM,1,2023-09-14 13:35:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL07,BEL_07_645,1,COMMON_CM,Any visit,2023-09-14,CM,1,2023-09-14 13:35:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL07,BEL_07_645,1,COMMON_CM,Any visit,2023-09-14,CM,1,2023-09-14 13:35:00,Any visit,CM Start Date,2019-NK-NK,CM_CMSTDAT
BEL07,BEL_07_645,1,COMMON_CM,Any visit,2023-09-14,CM,1,2023-09-14 13:35:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL07,BEL_07_645,2,COMMON_CM,Any visit,2023-09-14,CM,2,2023-09-14 13:38:00,Any visit,CM Number,2,CM_CMSPID
BEL07,BEL_07_645,2,COMMON_CM,Any visit,2023-09-14,CM,2,2023-09-14 13:38:00,Any visit,CM Trade Name,Sulfaipoetin,CM_CMTRT
BEL07,BEL_07_645,2,COMMON_CM,Any visit,2023-09-14,CM,2,2023-09-14 13:38:00,Any visit,CM Active Ingredient,Metformin,CM_CMINGRD
BEL07,BEL_07_645,2,COMMON_CM,Any visit,2023-09-14,CM,2,2023-09-14 13:38:00,Any visit,CM Indication,Nausea,CM_CMINDC
BEL07,BEL_07_645,2,COMMON_CM,Any visit,2023-09-14,CM,2,2023-09-14 13:38:00,Any visit,CM Dose,1,CM_CMDOSE
BEL07,BEL_07_645,2,COMMON_CM,Any visit,2023-09-14,CM,2,2023-09-14 13:38:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL07,BEL_07_645,2,COMMON_CM,Any visit,2023-09-14,CM,2,2023-09-14 13:38:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL07,BEL_07_645,2,COMMON_CM,Any visit,2023-09-14,CM,2,2023-09-14 13:38:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL07,BEL_07_645,2,COMMON_CM,Any visit,2023-09-14,CM,2,2023-09-14 13:38:00,Any visit,CM Start Date,2019-NK-NK,CM_CMSTDAT
BEL07,BEL_07_645,2,COMMON_CM,Any visit,2023-09-14,CM,2,2023-09-14 13:38:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL07,BEL_07_645,3,COMMON_CM,Any visit,2023-09-14,CM,3,2023-09-14 13:40:00,Any visit,CM Number,3,CM_CMSPID
BEL07,BEL_07_645,3,COMMON_CM,Any visit,2023-09-14,CM,3,2023-09-14 13:40:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
BEL07,BEL_07_645,3,COMMON_CM,Any visit,2023-09-14,CM,3,2023-09-14 13:40:00,Any visit,CM Active Ingredient,Paracetamol,CM_CMINGRD
BEL07,BEL_07_645,3,COMMON_CM,Any visit,2023-09-14,CM,3,2023-09-14 13:40:00,Any visit,CM Indication,Insomnia,CM_CMINDC
BEL07,BEL_07_645,3,COMMON_CM,Any visit,2023-09-14,CM,3,2023-09-14 13:40:00,Any visit,CM Dose,2,CM_CMDOSE
BEL07,BEL_07_645,3,COMMON_CM,Any visit,2023-09-14,CM,3,2023-09-14 13:40:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL07,BEL_07_645,3,COMMON_CM,Any visit,2023-09-14,CM,3,2023-09-14 13:40:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL07,BEL_07_645,3,COMMON_CM,Any visit,2023-09-14,CM,3,2023-09-14 13:40:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL07,BEL_07_645,3,COMMON_CM,Any visit,2023-09-14,CM,3,2023-09-14 13:40:00,Any visit,CM Start Date,2019-NK-NK,CM_CMSTDAT
BEL07,BEL_07_645,3,COMMON_CM,Any visit,2023-09-14,CM,3,2023-09-14 13:40:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL07,BEL_07_645,4,COMMON_CM,Any visit,2023-09-14,CM,4,2023-09-14 13:41:00,Any visit,CM Number,4,CM_CMSPID
BEL07,BEL_07_645,4,COMMON_CM,Any visit,2023-09-14,CM,4,2023-09-14 13:41:00,Any visit,CM Trade Name,Estrizotan,CM_CMTRT
BEL07,BEL_07_645,4,COMMON_CM,Any visit,2023-09-14,CM,4,2023-09-14 13:41:00,Any visit,CM Active Ingredient,Hydroxychloroquine,CM_CMINGRD
BEL07,BEL_07_645,4,COMMON_CM,Any visit,2023-09-14,CM,4,2023-09-14 13:41:00,Any visit,CM Indication,Prophylaxis,CM_CMINDC
BEL07,BEL_07_645,4,COMMON_CM,Any visit,2023-09-14,CM,4,2023-09-14 13:41:00,Any visit,CM Dose,15,CM_CMDOSE
BEL07,BEL_07_645,4,COMMON_CM,Any visit,2023-09-14,CM,4,2023-09-14 13:41:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL07,BEL_07_645,4,COMMON_CM,Any visit,2023-09-14,CM,4,2023-09-14 13:41:00,Any visit,CM Frequency,Per day (QD),CM_CMDOSFRQ
BEL07,BEL_07_645,4,COMMON_CM,Any visit,2023-09-14,CM,4,2023-09-14 13:41:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL07,BEL_07_645,4,COMMON_CM,Any visit,2023-09-14,CM,4,2023-09-14 13:41:00,Any visit,CM Start Date,2019-NK-NK,CM_CMSTDAT
BEL07,BEL_07_645,4,COMMON_CM,Any visit,2023-09-14,CM,4,2023-09-14 13:41:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL07,BEL_07_645,5,COMMON_CM,Any visit,2023-09-14,CM,5,2023-09-14 13:44:00,Any visit,CM Number,5,CM_CMSPID
BEL07,BEL_07_645,5,COMMON_CM,Any visit,2023-09-14,CM,5,2023-09-14 13:44:00,Any visit,CM Trade Name,Ioidiliterol,CM_CMTRT
BEL07,BEL_07_645,5,COMMON_CM,Any visit,2023-09-14,CM,5,2023-09-14 13:44:00,Any visit,CM Active Ingredient,Canakinumab,CM_CMINGRD
BEL07,BEL_07_645,5,COMMON_CM,Any visit,2023-09-14,CM,5,2023-09-14 13:44:00,Any visit,CM Indication,Adverse event,CM_CMINDC
BEL07,BEL_07_645,5,COMMON_CM,Any visit,2023-09-14,CM,5,2023-09-14 13:44:00,Any visit,CM Frequency,As needed (PRN),CM_CMDOSFRQ
BEL07,BEL_07_645,5,COMMON_CM,Any visit,2023-09-14,CM,5,2023-09-14 13:44:00,Any visit,CM Route,Oral (p.o.),CM_CMROUTE
BEL07,BEL_07_645,5,COMMON_CM,Any visit,2023-09-14,CM,5,2023-09-14 13:44:00,Any visit,CM Start Date,2019-NK-NK,CM_CMSTDAT
BEL07,BEL_07_645,5,COMMON_CM,Any visit,2023-09-14,CM,5,2023-09-14 13:44:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL07,BEL_07_645,6,COMMON_CM,Any visit,2023-09-14,CM,6,2023-09-14 15:16:00,Any visit,CM Number,6,CM_CMSPID
BEL07,BEL_07_645,6,COMMON_CM,Any visit,2023-09-14,CM,6,2023-09-14 15:16:00,Any visit,CM Trade Name,Salsteridone,CM_CMTRT
BEL07,BEL_07_645,6,COMMON_CM,Any visit,2023-09-14,CM,6,2023-09-14 15:16:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
BEL07,BEL_07_645,6,COMMON_CM,Any visit,2023-09-14,CM,6,2023-09-14 15:16:00,Any visit,CM Indication,Nausea,CM_CMINDC
BEL07,BEL_07_645,6,COMMON_CM,Any visit,2023-09-14,CM,6,2023-09-14 15:16:00,Any visit,CM Dose,5,CM_CMDOSE
BEL07,BEL_07_645,6,COMMON_CM,Any visit,2023-09-14,CM,6,2023-09-14 15:16:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL07,BEL_07_645,6,COMMON_CM,Any visit,2023-09-14,CM,6,2023-09-14 15:16:00,Any visit,CM Frequency,Per month (QM),CM_CMDOSFRQ
BEL07,BEL_07_645,6,COMMON_CM,Any visit,2023-09-14,CM,6,2023-09-14 15:16:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
BEL07,BEL_07_645,6,COMMON_CM,Any visit,2023-09-14,CM,6,2023-09-14 15:16:00,Any visit,CM Start Date,2023-09-13,CM_CMSTDAT
BEL07,BEL_07_645,6,COMMON_CM,Any visit,2023-09-14,CM,6,2023-09-14 15:16:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL07,BEL_07_645,7,COMMON_CM,Any visit,2023-09-14,CM,7,2023-09-14 15:17:00,Any visit,CM Number,7,CM_CMSPID
BEL07,BEL_07_645,7,COMMON_CM,Any visit,2023-09-14,CM,7,2023-09-14 15:17:00,Any visit,CM Trade Name,Nifurasiban,CM_CMTRT
BEL07,BEL_07_645,7,COMMON_CM,Any visit,2023-09-14,CM,7,2023-09-14 15:17:00,Any visit,CM Active Ingredient,Lisinopril,CM_CMINGRD
BEL07,BEL_07_645,7,COMMON_CM,Any visit,2023-09-14,CM,7,2023-09-14 15:17:00,Any visit,CM Indication,Insomnia,CM_CMINDC
BEL07,BEL_07_645,7,COMMON_CM,Any visit,2023-09-14,CM,7,2023-09-14 15:17:00,Any visit,CM Dose,20,CM_CMDOSE
BEL07,BEL_07_645,7,COMMON_CM,Any visit,2023-09-14,CM,7,2023-09-14 15:17:00,Any visit,CM Unit,Milligram (mg),CM_CMDOSU
BEL07,BEL_07_645,7,COMMON_CM,Any visit,2023-09-14,CM,7,2023-09-14 15:17:00,Any visit,CM Frequency,Per month (QM),CM_CMDOSFRQ
BEL07,BEL_07_645,7,COMMON_CM,Any visit,2023-09-14,CM,7,2023-09-14 15:17:00,Any visit,CM Route,Intravenous (i.v.),CM_CMROUTE
BEL07,BEL_07_645,7,COMMON_CM,Any visit,2023-09-14,CM,7,2023-09-14 15:17:00,Any visit,CM Start Date,2023-09-13,CM_CMSTDAT
BEL07,BEL_07_645,7,COMMON_CM,Any visit,2023-09-14,CM,7,2023-09-14 15:17:00,Any visit,CM Ongoing,Yes,CM_CMONGO
BEL07,BEL_07_645,1,COMMON_CM,Any visit,2023-09-14,CM,1,2023-09-14 13:35:00,Any visit,CM Related Medical History,Sickle cell anemia,CM_MHREL
BEL07,BEL_07_645,2,COMMON_CM,Any visit,2023-09-14,CM,2,2023-09-14 13:38:00,Any visit,CM Related Medical History,Sickle cell anemia,CM_MHREL
BEL07,BEL_07_645,3,COMMON_CM,Any visit,2023-09-14,CM,3,2023-09-14 13:40:00,Any visit,CM Related Medical History,Sickle cell anemia,CM_MHREL
BEL07,BEL_07_645,4,COMMON_CM,Any visit,2023-09-14,CM,4,2023-09-14 13:41:00,Any visit,CM Related Medical History,Sickle cell anemia,CM_MHREL
BEL07,BEL_07_645,5,COMMON_CM,Any visit,2023-09-14,CM,5,2023-09-14 13:44:00,Any visit,CM Related Medical History,Sickle cell anemia,CM_MHREL
